| Package | Version | Identity | Name/Title | Status | Date | Realm | Auth | Source(s) |
|---|
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3114.html  | StudyQuality | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3115.html | StressImagingQualityIssue | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3116.html | NMExtracardiacFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3117.html | AttenuationCorrectionMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3118.html | LevelofRisk | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3119.html | LVFunction | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3120.html | PerfusionFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3121.html | PerfusionMorphology | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3122.html | VentricularEnlargement | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_32.html | NonAcquisitionModality | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3200.html | StressTestProcedure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3201.html | IndicationsforStressTest | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3202.html | ChestPain | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3203.html | ExerciserDevice | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3204.html | StressAgent | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3205.html | IndicationsforPharmacologicalStressTest | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3206.html | NoninvasiveCardiacImagingProcedure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3207.html | StressTestProcedurePhase | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3208.html | ExerciseECGSummaryCode | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3209.html | StressImagingSummaryCode | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3210.html | SpeedofResponse | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3211.html | BPResponse | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3212.html | TreadmillSpeed | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3213.html | StressHemodynamicFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3215.html | PerfusionFindingMethod | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3217.html | ComparisonFinding | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3220.html | StressSymptom | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3221.html | StressTestTerminationReason | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3227.html | QTcMeasurement | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3228.html | ECGTimingMeasurement | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3229.html | ECGAxisMeasurement | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3230.html | ECGFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3231.html | STSegmentFinding | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3232.html | STSegmentLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3233.html | STSegmentMorphology | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3234.html | EctopicBeatMorphology | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3235.html | PerfusionComparisonFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3236.html | ToleranceComparisonFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3237.html | WallMotionComparisonFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3238.html | StressScoringScale | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3239.html | PerceivedExertionScale | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3240.html | ElectrophysiologyMeasurementFunction/Technique | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3241.html | HemodynamicMeasurementTechnique | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3250.html | CatheterizationProcedurePhase | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3254.html | ElectrophysiologyProcedurePhase | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3261.html | StressProtocol | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3262.html | ECGPatientStateValue | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3263.html | ElectrodePlacementValue | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3271.html | HemodynamicPhysiologicalChallenge | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_33.html | Modality | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3335.html | ECGAnnotation | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3337.html | HemodynamicAnnotation | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3339.html | ElectrophysiologyAnnotation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_34.html | WaveformAcquisitionModality | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3400.html | ProcedureLogTitle | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3401.html | LogNoteType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3402.html | PatientStatusandEvent | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3403.html | PercutaneousEntry | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3404.html | StaffAction | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3405.html | ProcedureActionValue | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3406.html | NoncoronaryTranscatheterIntervention | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3407.html | ObjectReferencePurpose | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3408.html | ConsumableAction | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3409.html | Drug/ContrastAdministration | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3410.html | Drug/ContrastNumericParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3411.html | IntracoronaryDevice | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3412.html | InterventionAction/Status | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3413.html | AdverseOutcome | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3414.html | ProcedureUrgency | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3415.html | CardiacRhythm | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3416.html | RespirationRhythm | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3418.html | LesionRisk | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3419.html | FindingTitle | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3421.html | ProcedureAction | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3422.html | DeviceUseAction | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3423.html | NumericDeviceCharacteristic | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3425.html | InterventionParameter | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3426.html | ConsumablesParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3427.html | EquipmentEvent | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3428.html | CardiovascularImagingProcedure | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3429.html | CatheterizationDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3430.html | DateTimeQualifier | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3440.html | PeripheralPulseLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3441.html | PatientAssessment | active | 2025-04 | us | hl7 | sct loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3442.html | PeripheralPulseMethod | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3446.html | SkinCondition | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3448.html | AirwayAssessment | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3451.html | CalibrationObject | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3452.html | CalibrationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3453.html | CardiacVolumeMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3455.html | IndexMethod | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3456.html | SubsegmentMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3458.html | ContourRealignment | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3460.html | CircumferentialExtent | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3461.html | RegionalExtent | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3462.html | ChamberIdentification | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3463.html | VentricleIdentification | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3465.html | QAReferenceMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3466.html | PlaneIdentification | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3467.html | EjectionFraction | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3468.html | EDVolume | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3469.html | ESVolume | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3470.html | VesselLumenCrosssectionalAreaCalculationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3471.html | EstimatedVolume | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3472.html | CardiacContractionPhase | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3480.html | IVUSProcedurePhase | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3481.html | IVUSDistanceMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3482.html | IVUSAreaMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3483.html | IVUSLongitudinalMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3484.html | IVUSIndex/Ratio | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3485.html | IVUSVolumeMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3486.html | VascularMeasurementSite | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3487.html | IntravascularVolumetricRegion | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3488.html | Min/Max/Mean | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3489.html | CalciumDistribution | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3491.html | IVUSLesionMorphology | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3492.html | VascularDissectionClassification | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3493.html | IVUSRelativeStenosisSeverity | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3494.html | IVUSNonMorphologicalFinding | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3495.html | IVUSPlaqueComposition | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3496.html | IVUSFiducialPoint | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3497.html | IVUSArterialMorphology | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3500.html | PressureUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3502.html | HemodynamicResistanceUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3503.html | IndexedHemodynamicResistanceUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3510.html | CatheterSizeUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3515.html | SpecimenCollection | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3520.html | BloodSourceType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3524.html | BloodGasPressure | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3525.html | BloodGasContent | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3526.html | BloodGasSaturation | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3527.html | BloodBaseExcess | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3528.html | BloodpH | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3529.html | Arterial/VenousContent | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3530.html | OxygenAdministrationAction | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3531.html | OxygenAdministration | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3550.html | CirculatorySupportAction | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3551.html | VentilationAction | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3552.html | PacingAction | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3553.html | CirculatorySupport | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3554.html | Ventilation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3555.html | Pacing | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3560.html | BloodPressureMethod | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3600.html | RelativeTime | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3602.html | HemodynamicPatientState | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3604.html | ArterialLesionLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3606.html | ArterialSourceLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3607.html | VenousSourceLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3608.html | AtrialSourceLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3609.html | VentricularSourceLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3610.html | GradientSourceLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3611.html | PressureMeasurement | active | 2025-04 | us | hl7 | sct loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3612.html | BloodVelocityMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3613.html | HemodynamicTimeMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3614.html | NonmitralValveArea | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3615.html | ValveArea | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3616.html | HemodynamicPeriodMeasurement | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3617.html | ValveFlow | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3618.html | HemodynamicFlow | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3619.html | HemodynamicResistanceMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3620.html | HemodynamicRatio | active | 2025-04 | us | hl7 | sct loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3621.html | FractionalFlowReserve | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3627.html | MeasurementType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3628.html | CardiacOutputMethod | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3629.html | ProcedureIntent | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3630.html | CardiovascularAnatomicLocation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3640.html | Hypertension | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3641.html | HemodynamicAssessment | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3642.html | DegreeFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3651.html | HemodynamicMeasurementPhase | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3663.html | BodySurfaceAreaEquation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3664.html | OxygenConsumptionEquation/Table | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3666.html | P50Equation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3667.html | FraminghamScore | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3668.html | FraminghamTable | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3670.html | ECGProcedureType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3671.html | ReasonforECGStudy | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3676.html | LeadMeasurementTechnique | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3677.html | SummaryCodesECG | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3678.html | QTCorrectionAlgorithm | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3680.html | ECGLeadNoiseDescription | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3687.html | ElectrophysiologyWaveformDuration | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3688.html | ElectrophysiologyWaveformVoltage | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3689.html | ECGGlobalWaveformDuration | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3690.html | ECGControlNumericVariable | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3691.html | ECGControlTextVariable | active | 2025-04 | us | hl7 | iso |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3700.html | CathDiagnosis | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3701.html | CardiacValve/Tract | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3703.html | WallMotion | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3704.html | MyocardiumWallMorphologyFinding | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3705.html | ChamberSize | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3706.html | OverallContractility | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3707.html | VSDDescription | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3710.html | CoronaryDominance | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3711.html | ValvularAbnormality | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3712.html | VesselDescriptor | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3713.html | TIMIFlowCharacteristic | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3714.html | Thrombus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3715.html | LesionMargin | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3716.html | Severity | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3717.html | LeftVentricleMyocardialWall17SegmentModel | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3718.html | MyocardialWallSegmentsinProjection | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3719.html | CanadianClinicalClassification | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3721.html | CardiovascularSurgery | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3722.html | DiabeticTherapy | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3723.html | MIType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3724.html | SmokingHistory | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3726.html | CoronaryInterventionIndication | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3727.html | CatheterizationIndication | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3728.html | CathFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3729.html | AdmissionStatus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3730.html | InsurancePayor | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3733.html | PrimaryCauseofDeath | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3735.html | AcuteCoronarySyndromeTimePeriod | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3736.html | NYHAClassification | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3737.html | IschemiaNoninvasiveTest | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3738.html | PreCathAnginaType | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3739.html | CathProcedureType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3740.html | ThrombolyticAdministration | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3741.html | LabVisitMedicationAdministration | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3742.html | PCIMedicationAdministration | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3743.html | Clopidogrel/TiclopidineAdministration | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3744.html | EFTestingMethod | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3745.html | CalculationMethod | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3746.html | PercutaneousEntrySite | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3747.html | PercutaneousClosure | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3748.html | AngiographicEFTestingMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3749.html | PCIProcedureResult | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3750.html | PreviouslyDilatedLesion | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3752.html | GuidewireCrossing | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3754.html | VascularComplication | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3755.html | CathComplication | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3756.html | CardiacPatientRiskFactor | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3757.html | CardiacDiagnosticProcedure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3758.html | CardiovascularFamilyHistory | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3760.html | HypertensionTherapy | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3761.html | AntilipemicAgent | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3762.html | AntiarrhythmicAgent | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3764.html | MyocardialInfarctionTherapy | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3769.html | ConcernType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3770.html | ProblemStatus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3772.html | HealthStatus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3773.html | UseStatus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3774.html | SocialHistory | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3777.html | CardiovascularImplant | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3778.html | Stage | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3779.html | ImplantedDevice | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3781.html | LeftVentricleMyocardialWall18SegmentModel | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3782.html | LeftVentricleBasalWall6Segments | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3783.html | LeftVentricleMidlevelWall6Segments | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3784.html | LeftVentricleApicalWall4Segments | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3785.html | LeftVentricleApicalWall6Segments | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3802.html | PlaqueStructure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3804.html | StenosisMeasurementMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3805.html | StenosisType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3806.html | StenosisShape | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3807.html | VolumeMeasurementMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3808.html | AneurysmType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3809.html | AssociatedCondition | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3810.html | VascularMorphology | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3813.html | StentFinding | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3814.html | StentComposition | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3815.html | SourceofVascularFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3817.html | VascularSclerosisType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3820.html | NoninvasiveVascularProcedure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3821.html | PapillaryMuscleIncluded/Excluded | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3823.html | RespiratoryStatus | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3826.html | HeartRhythm | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3827.html | VesselSegment | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3829.html | PulmonaryArtery | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3831.html | StenosisLength | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3832.html | StenosisGrade | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3833.html | CardiacEjectionFraction | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3835.html | CardiacVolumeMeasurement | active | 2025-04 | us | hl7 | sct loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3836.html | TimebasedPerfusionMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3837.html | FiducialFeature | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3838.html | DiameterDerivation | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3839.html | CoronaryVein | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3840.html | PulmonaryVein | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3843.html | MyocardialSubsegment | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3850.html | ContrastBolusSubstance | active | 2025-04 | us | hl7 | sct rx |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4.html | AnatomicRegion | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_400.html | AuditEventID | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4005.html | PartialViewSectionforMammography | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4009.html | DXAnatomyImaged | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_401.html | AuditEventTypeCode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4010.html | DXView | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4011.html | DXViewModifier | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4012.html | ProjectionEponymousName | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4013.html | AnatomicRegionforMammography | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4014.html | ViewforMammography | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4015.html | ViewModifierforMammography | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4016.html | AnatomicRegionforIntraoralRadiography | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4017.html | AnatomicRegionModifierforIntraoralRadiography | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4018.html | PrimaryAnatomicStructureforIntraoralRadiography(PermanentDentitionDesignationofTeeth) | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4019.html | PrimaryAnatomicStructureforIntraoralRadiography(DeciduousDentitionDesignationofTeeth) | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_402.html | AuditActiveParticipantRoleIDCode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4020.html | PETRadionuclide | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4021.html | PETRadiopharmaceutical | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4025.html | PrimaryAnatomicStructureforIntraoralRadiography(SupernumeraryDentitionDesignationofTeeth) | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4026.html | PrimaryAnatomicStructureforIntraoralandCraniofacialRadiographyTeeth | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4028.html | CraniofacialAnatomicRegion | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4029.html | DermatologyAnatomicSite | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_403.html | SecurityAlertTypeCode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4030.html | CT,MRandPETAnatomyImaged | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4031.html | CommonAnatomicRegion | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4032.html | MRSpectroscopyMetabolite | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4033.html | MRProtonSpectroscopyMetabolite | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_404.html | AuditParticipantObjectIDTypeCode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4040.html | EndoscopyAnatomicRegion | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4042.html | XA/XRFAnatomyImaged | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_405.html | MediaTypeCode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4050.html | DrugorContrastAgentCharacteristic | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4051.html | GeneralDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4052.html | PhantomDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4053.html | CTDIPhantomDevice | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4061.html | HeadandNeckPrimaryAnatomicStructure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4062.html | VLView | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4063.html | VLDentalView | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4064.html | VLViewModifier | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4065.html | VLDentalViewModifier | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4066.html | OrthognathicFunctionalCondition | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4067.html | OrthodonticFindingbyInspection | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4068.html | OrthodonticObservableEntity | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4069.html | DentalOcclusion | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4070.html | OrthodonticTreatmentProgress | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4071.html | GeneralPhotographyDevice | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4072.html | DevicesforthePurposeofDentalPhotography | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4100.html | T1MeasurementMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4101.html | TracerKineticModel | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4102.html | PerfusionMeasurementMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4103.html | ArterialInputFunctionMeasurementMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4104.html | BolusArrivalTimeDerivationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4105.html | PerfusionAnalysisMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4106.html | QuantitativeMethodUsedforPerfusionandTracerKineticModel | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4107.html | TracerKineticModelParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4108.html | PerfusionModelParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4109.html | ModelIndependentDynamicContrastAnalysisParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4110.html | TracerKineticModelingCovariate | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4111.html | ContrastCharacteristic | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_42.html | NumericValueQualifier | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4200.html | OphthalmicImagingAgent | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4201.html | PatientEyeMovementCommand | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4202.html | OphthalmicPhotographyAcquisitionDevice | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4203.html | OphthalmicPhotographyIllumination | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4204.html | OphthalmicFilter | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4205.html | OphthalmicLens | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4206.html | OphthalmicChannelDescription | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4207.html | OphthalmicImagePosition | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4208.html | MydriaticAgent | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4209.html | OphthalmicAnatomicStructureImaged | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4210.html | OphthalmicTomographyAcquisitionDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4211.html | OphthalmicOCTAnatomicStructureImaged | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4214.html | OphthalmicHorizontalDirection | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4215.html | OphthalmicVerticalDirection | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4216.html | OphthalmicVisualAcuityType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4220.html | VisualFixationQualityDuringAcquisition | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4221.html | VisualFixationQualityProblem | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4222.html | OphthalmicMacularGridProblem | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4230.html | OphthalmicUltrasoundAxialMeasurementsType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4231.html | LensStatus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4232.html | VitreousStatus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4233.html | OphthalmicAxialLengthMeasurementsSegmentName | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4234.html | RefractiveSurgeryType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4235.html | KeratometryDescriptor | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4236.html | IOLCalculationFormula | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4237.html | LensConstantType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4238.html | RefractiveErrorType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4239.html | AnteriorChamberDepthDefinition | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4240.html | OphthalmicMeasurementorCalculationDataSource | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4241.html | OphthalmicAxialLengthSelectionMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4242.html | CorneaMeasurementMethodDescriptor | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4243.html | OphthalmicQualityMetricType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4244.html | OphthalmicAgentConcentrationUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4245.html | WideFieldOphthalmicPhotographyTransformationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4250.html | VisualFieldStaticPerimetryTestPattern | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4251.html | VisualFieldStaticPerimetryTestStrategy | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4252.html | VisualFieldStaticPerimetryScreeningTestMode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4253.html | VisualFieldStaticPerimetryFixationStrategy | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4254.html | VisualFieldStaticPerimetryTestAnalysisResult | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4255.html | VisualFieldIlluminationColor | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4256.html | VisualFieldProcedureModifier | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4257.html | VisualFieldGlobalIndexName | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4260.html | OphthalmicMappingUnitforRealWorldValueMapping | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4261.html | OphthalmicMappingAcquisitionMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4262.html | RetinalThicknessDefinition | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4263.html | OphthalmicThicknessMapValueType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4264.html | OphthalmicMapPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4265.html | OphthalmicThicknessDeviationCategory | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4266.html | OphthalmicAnatomicStructureReferencePoint | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4267.html | CornealTopographyMappingUnitforRealWorldValueMapping | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4268.html | CornealTopographyMapValueType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4270.html | OCTAProcessingAlgorithmFamily | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4271.html | EnFaceImageType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4272.html | OPTScanPatternType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4273.html | RetinalSegmentationSurface | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4274.html | EnFaceProcessingAlgorithmFamily | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4275.html | AnteriorEyeSegmentationSurface | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_43.html | NumericValueFailureQualifier | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_44.html | NumericValueUnknownQualifier | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4401.html | FitzpatrickSkinType | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4402.html | HistoryofMalignantMelanoma | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4< | fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6164.html | TimeInterval | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6165.html | BreastLinearMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6166.html | CADGeometrySecondaryGraphicalRepresentation | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_617.html | AirwayManagementMethodCodeTypeforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6170.html | LobeofLung | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6171.html | ZoneofLung | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_618.html | AirwayManagementMethodCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_619.html | AirwayManagementSubMethodCodeTypeforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_62.html | ImagingAgentAdministrationPhaseType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_620.html | AirwayManagementSubMethodCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6200.html | ColonOverallAssessment | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6201.html | ColonFindingorFeature | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6202.html | ColonFindingorFeatureModifier | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6203.html | ColonNonlesionObjectType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6204.html | AnatomicNoncolonFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6205.html | ClockfaceLocationforColon | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6206.html | RecumbentPatientOrientationforColon | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6207.html | ColonQuantitativeTemporalDifferenceType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6208.html | ColonTypesofQualityControlStandard | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6209.html | ColonMorphologyDescriptor | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_621.html | MedicationTypeforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6210.html | LocationinIntestinalTract | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6211.html | ColonCADMaterialDescription | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6212.html | CalculatedValueforColonFinding | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_622.html | MedicationTypeCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_623.html | MedicationforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_624.html | InhalationalAnesthesiaAgentforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_625.html | InjectableAnesthesiaAgentforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_626.html | PremedicationAgentforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_627.html | NeuromuscularBlockingAgentforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_628.html | AncillaryMedicationsforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_629.html | CarrierGasesforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_63.html | ImagingAgentAdministrationMode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_630.html | LocalAnestheticsforSmallAnimalAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6300.html | ProstateAnatomy | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6301.html | ProstateSectorAnatomyfromPIRADSv2 | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6302.html | ProstateSectorAnatomyfromEuropeanConcensus16Sector(Minimal)Model | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6303.html | ProstateSectorAnatomyfromEuropeanConcensus27Sector(Optimal)Model | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6304.html | ProstateSectorAnatomyfromPIRADSv2.1 | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_631.html | ProcedurePhaseRequiringAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6310.html | ProstateReportingSystem | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6311.html | MRSignalIntensity | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6312.html | CrosssectionalScanPlaneOrientation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6313.html | HistoryofProstateDisease | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6314.html | ProstateMRIStudyQualityFinding | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6315.html | ProstateMRISeriesQualityFinding | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6316.html | MRImagingArtifact | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6317.html | ProstateDCEMRIQualityFinding | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6318.html | ProstateDWIMRIQualityFinding | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6319.html | AbdominalInterventionType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_632.html | SurgicalProcedurePhaseRequiringAnesthesia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6320.html | AbdominopelvicIntervention | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6321.html | ProstateCancerDiagnosticProcedure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6322.html | ProstateCancerFamilyHistory | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6323.html | ProstateCancerTherapy | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6324.html | ProstateMRIAssessment | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6325.html | OverallAssessmentfromPIRADS® | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6326.html | ImageQualityControlStandard | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6327.html | ProstateImagingIndication | active | 2025-04 | us | hl7 | sct icd dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6328.html | PIRADS®v2LesionAssessmentCategory | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6329.html | PIRADS®v2T2WIPZLesionAssessmentCategory | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6330.html | PIRADS®v2T2WITZLesionAssessmentCategory | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6331.html | PIRADS®v2DWILesionAssessmentCategory | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6332.html | PIRADS®v2DCELesionAssessmentCategory | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6333.html | mpMRIAssessmentType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6334.html | mpMRIAssessmentTypefromPIRADS® | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6335.html | mpMRIAssessmentValue | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6336.html | MRIAbnormality | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6337.html | mpMRIProstateAbnormalityfromPIRADS® | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6338.html | mpMRIBenignProstateAbnormalityfromPIRADS® | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6339.html | MRIShapeCharacteristic | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_634.html | AnimalHandlingPhase | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6340.html | ProstateMRIShapeCharacteristicfromPIRADS® | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6341.html | MRIMarginCharacteristic | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6342.html | ProstateMRIMarginCharacteristicfromPIRADS® | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6343.html | MRISignalCharacteristic | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6344.html | ProstateMRISignalCharacteristicfromPIRADS® | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6345.html | MRIEnhancementPattern | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6346.html | ProstateMRIEnhancementPatternfromPIRADS® | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6347.html | ProstateMRIExtraprostaticFinding | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6348.html | ProstateMRIAssessmentofExtraprostaticAnatomicSite | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6349.html | MRCoilType | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_635.html | HeatingMethod | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6350.html | EndorectalCoilFillSubstance | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6351.html | ProstateRelationalMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6352.html | ProstateCancerDiagnosticBloodLabMeasurement | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6353.html | ProstateImagingTypesofQualityControlStandard | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_636.html | TemperatureSensorDeviceComponentTypeforSmallAnimalProcedure | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_637.html | ExogenousSubstanceType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_638.html | ExogenousSubstance | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_639.html | TumorGraftHistologicType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_64.html | ImagingAgentAdministrationPatientState | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_640.html | Fibril | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6401.html | NonlesionObjectTypePhysicalObject | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6402.html | NonlesionObjectTypeSubstance | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6403.html | NonlesionObjectTypeTissue | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6404.html | ChestNonlesionObjectTypePhysicalObject | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6405.html | ChestNonlesionObjectTypeTissue | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_641.html | Virus | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_642.html | Cytokine | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_643.html | Toxin | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_644.html | ExogenousSubstanceAdministrationSite | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_645.html | ExogenousSubstanceOriginTissue | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_646.html | PreclinicalSmallAnimalImagingProcedure | active | 2025-04 | us | hl7 | sct loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_647.html | PositionReferenceIndicatorforFrameofReference | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_65.html | ImagingAgentAdministrationPremedication | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_66.html | ImagingAgentAdministrationMedication | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_67.html | ImagingAgentAdministrationCompletionStatus | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_68.html | ImagingAgentAdministrationPharmaceuticalPresentationUnit | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_69.html | ImagingAgentAdministrationConsumable | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7.html | UltrasoundBeamPath | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_70.html | Flush | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7000.html | DiagnosticImagingReportDocumentTitle | active | 2025-04 | us | hl7 | sct loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7001.html | DiagnosticImagingReportHeading | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7002.html | DiagnosticImagingReportElement | active | 2025-04 | us | hl7 | sct loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7003.html | DiagnosticImagingReportPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7004.html | WaveformPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7005.html | ContributingEquipmentPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7006.html | SRDocumentPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7008.html | MediaImport | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7009.html | PurposeofReferencetoPredecessorReport | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_701.html | ContentAssessmentType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7010.html | KeyObjectSelectionDocumentTitle | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7011.html | RejectedforQualityReason | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7012.html | BestinSet | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7013.html | NonImageSourceInstancePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7014.html | ExportAdditionalInformationDocumentTitle | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7015.html | ExportDelayReason | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7016.html | LevelofDifficulty | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7017.html | CategoryofTeachingMaterialImaging | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7018.html | MiscellaneousDocumentTitle | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7019.html | SegmentationNonImageSourcePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_702.html | RTContentAssessmentType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7021.html | MeasurementReportDocumentTitle | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7022.html | RadiotherapyPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7023.html | RTProcessOutput | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7024.html | RTProcessInput | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7025.html | RTProcessInputUsed | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7026.html | RadiotherapeuticDoseMeasurementDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7027.html | SegmentedRadiotherapeuticDoseMeasurementDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_703.html | AssessmentBasis | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7030.html | InstitutionalDepartment/Unit/Service | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7031.html | ReasonforRemovalfromOperationalUse | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7035.html | ActionableFindingClassification | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7036.html | ImageQualityAssessment | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7039.html | PediatricSizeCategory | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7040.html | BroselowLutenPediatricSizeCategory | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7041.html | CalciumScoringPatientSizeCategory | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7042.html | CMDCTECCCalciumScoringPatientSizeCategory | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7050.html | DeidentificationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7060.html | EncapsulatedDocumentSourcePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7061.html | ModelDocumentTitle | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7062.html | PurposeofReferencetoPredecessor3DModel | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7063.html | ModelScaleUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7064.html | ModelUsage | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7070.html | RealTimeVideoRenditionTitle | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_71.html | ImagingAgentAdministrationInjectorEventType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7100.html | RCSRegistrationMethodType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7101.html | BrainAtlasFiducial | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7110.html | FiducialCategory | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7111.html | Fiducial | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7112.html | RadiotherapyFiducial | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7140.html | BrainStructureforVolumetricMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7150.html | SegmentationPropertyCategory | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7151.html | SegmentationPropertyType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7152.html | CardiacStructureSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7153.html | CNSSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7154.html | AbdominalSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7155.html | ThoracicSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7156.html | VascularSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7157.html | DeviceSegmentationType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7158.html | ArtifactSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7159.html | LesionSegmentationType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7160.html | PelvicOrganSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7161.html | PhysiologySegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7162.html | SurfaceProcessingAlgorithmFamily | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7163.html | BreastSegmentationTypes | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7165.html | AbstractSegmentationType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7166.html | CommonTissueSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7167.html | PeripheralNervousSystemSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7168.html | BrainLesionSegmentationTypeWithNecrosis | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7169.html | BrainLesionSegmentationTypeWithoutNecrosis | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7170.html | CouinaudLiverSegment | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7171.html | LiverSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7180.html | AbstractMultidimensionalImageModelComponentSemantic | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7181.html | AbstractMultidimensionalImageModelComponentUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7182.html | AbstractMultidimensionalImageModelDimensionSemantic | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7183.html | AbstractMultidimensionalImageModelDimensionUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7184.html | AbstractMultidimensionalImageModelAxisDirection | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7185.html | AbstractMultidimensionalImageModelAxisOrientation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7186.html | AbstractMultidimensionalImageModelQualitativeDimensionSampleSemantic | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7191.html | TissueSegmentationPropertyType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7192.html | AnatomicalStructureSegmentationPropertyType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7193.html | PhysicalObjectSegmentationPropertyType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7194.html | MorphologicallyAbnormalStructureSegmentationPropertyType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7195.html | FunctionSegmentationPropertyType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7196.html | SpatialandRelationalConceptSegmentationPropertyType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7197.html | BodySubstanceSegmentationPropertyType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7198.html | SubstanceSegmentationPropertyType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7199.html | AnatomicallyLocalizedLesionSegmentationType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_72.html | ImagingAgentAdministrationStepType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7201.html | ReferencedImagePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7202.html | SourceImagePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7203.html | ImageDerivation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7205.html | PurposeofReferencetoAlternateRepresentation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7210.html | RelatedSeriesPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7215.html | SpectroscopyPurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7220.html | RTDoseDerivation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7221.html | RTDosePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7222.html | ParametricMapDerivationImagePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7230.html | AutomationofMeasurement | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7250.html | MultiFrameSubsetType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7260.html | DiffusionAcquisitionValueType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7261.html | DiffusionModelValueType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7262.html | DiffusionTractographyAlgorithmFamily | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7263.html | DiffusionTractographyMeasurementType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7270.html | MRDiffusionComponentSemantic | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7271.html | MRDiffusionAnisotropyIndex | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7272.html | MRDiffusionModelParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7273.html | MRDiffusionModel | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7274.html | MRDiffusionModelFittingMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7275.html | MRDiffusionModelSpecificMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7276.html | MRDiffusionModelInput | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7277.html | DiffusionRateAreaOverTimeUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_73.html | BolusShapingCurve | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7300.html | ImplantMaterial | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7301.html | InterventionType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7302.html | ImplantTemplateViewOrientation | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7303.html | ImplantTemplateModifiedViewOrientation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7304.html | ImplantTargetAnatomy | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7305.html | ImplantPlanningLandmark | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7306.html | HumanHipImplantPlanningLandmark | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7307.html | ImplantComponentType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7308.html | HumanHipImplantComponentType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7309.html | HumanTraumaImplantComponentType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7310.html | ImplantFixationMethod | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7320.html | PlanningMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_74.html | ImagingAgentAdministrationConsumableCatheterType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7445.html | DeviceParticipatingRole | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7448.html | ThirdPersonPronounSet | active | 2025-04 | us | hl7 | loinc |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7449.html | ReaderSpecialty | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7450.html | PersonRole | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7451.html | FamilyMember | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7452.html | OrganizationalRole | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7453.html | PerformingRole | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7454.html | AnimalTaxonomicRankValue | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7455.html | Sex | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7456.html | AgeUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7457.html | SexMaleFemaleorBoth | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7458.html | PersonGenderIdentity | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7459.html | CategoryofSexParametersforClinicalUse | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7460.html | LinearMeasurementUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7461.html | AreaMeasurementUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7462.html | VolumeMeasurementUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7464.html | GeneralRegionofInterestMeasurementModifier | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7465.html | MeasurementDerivedFromMultipleROIMeasurements | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7466.html | PETRegionofInterestMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7467.html | GrayLevelCooccurrenceMatrixMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7468.html | TextureMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7469.html | GenericIntensityandSizeMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7470.html | LinearMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7471.html | AreaMeasurement | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7472.html | VolumeMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7473.html | GeneralAreaCalculationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7474.html | GeneralVolumeCalculationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7475.html | GrayLevelRunLengthBasedFeature | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7476.html | GrayLevelSizeZoneBasedFeature | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7477.html | GlobalShapeDescriptor | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7478.html | IntensityHistogramFeature | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7479.html | GreyLevelDistanceZoneBasedFeature | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7480.html | Breed | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7481.html | BreedRegistry | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7482.html | DXAnatomyImagedforAnimal | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7483.html | CommonAnatomicRegionsforAnimal | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7484.html | DXViewforAnimal | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7486.html | MixedBreed | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7490.html | ResearchAnimalSourceRegistry | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_75.html | LowHighorEqual | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7500.html | NeighbourhoodGreyToneDifferenceBasedFeature | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7501.html | NeighbouringGreyLevelDependenceBasedFeature | active | 2025-04 | us | hl7 | |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7550.html | AngleMeasurement | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7551.html | GenericPurposeofReferencetoImagesandCoordinatesinMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7552.html | GenericPurposeofReferencetoImagesinMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7553.html | GenericPurposeofReferencetoCoordinatesinMeasurement | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_76.html | PremedicationType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7600.html | LymphNodeAnatomicSite | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7601.html | HeadandNeckCancerAnatomicSite | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7602.html | VertebralAnatomicStructure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7603.html | Vertebra | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7604.html | IntervertebralDisc | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7701.html | FiberTractInBrainstem | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7702.html | ProjectionandThalamicFiber | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7703.html | AssociationFiber | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7704.html | LimbicSystemTract | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7705.html | CommissuralFiber | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7706.html | CranialNerve | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7707.html | SpinalCordFiber | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7710.html | TractographyAnatomicSite | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8.html | AngiographicInterventionalDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_800.html | ProtocolAssertion | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8101.html | ContainerType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8102.html | ContainerComponentType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8103.html | AnatomicPathologySpecimenType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8104.html | BreastTissueSpecimenType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8109.html | SpecimenCollectionProcedure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8110.html | SpecimenSamplingProcedure | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8111.html | SpecimenPreparationProcedure | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8112.html | SpecimenStain | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8113.html | SpecimenPreparationStep | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8114.html | SpecimenFixative | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8115.html | SpecimenEmbeddingMedia | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8120.html | WholeSlideMicroscopyImageReferencedImagePurposeofReference | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8121.html | MicroscopyLensType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8122.html | MicroscopyIlluminatorandSensorColor | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8123.html | MicroscopyIlluminationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8124.html | MicroscopyFilter | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8125.html | MicroscopyIlluminatorType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8130.html | StainingProtocol | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8131.html | PathologyImagingProtocol | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8132.html | MagnificationSelection | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8133.html | TissueSelection | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8134.html | AnatomicStructure | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8135.html | MicroscopyAnnotationPropertyType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8136.html | MicroscopyMeasurementType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8201.html | SurfaceScanAcquisitionType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8202.html | SurfaceScanModeType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8203.html | SurfaceScanRegistrationMethodType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_83.html | RealWorldValueMappingUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8300.html | VisualEvaluationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8301.html | TestPatternCode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8302.html | MeasurementPatternCode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8303.html | DisplayDeviceType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_84.html | PETUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_85.html | SUVUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9.html | ImageGuidedTherapeuticProcedure | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9000.html | PhysicalQuantityDescriptor | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_91.html | FunctionalConditionPresentDuringAcquisition | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_92.html | JointPositionDuringAcquisition | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9231.html | WorkitemDefinition | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9233.html | RequestedReportType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9241.html | RadiotherapyGeneralWorkitemDefinition | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9242.html | RadiotherapyAcquisitionWorkitemDefinition | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9243.html | RadiotherapyRegistrationWorkitemDefinition | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9250.html | ScheduledProcessingParameterConceptCodesforRTTreatment | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9260.html | RadiotherapyAcquisitionWorkItemSubtasks | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9261.html | PatientPositionAcquisitionRadiationSourceLocations | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9262.html | EnergyDerivationTypes | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9263.html | KVImagingAcquisitionTechniques | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9264.html | MVImagingAcquisitionTechniques | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9265.html | PatientPositionAcquisitionProjectionTechniques | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9266.html | PatientPositionAcquisition–CTTechniques | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9267.html | PatientPositioningRelatedObjectPurposes | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9268.html | PatientPositionAcquisitionDevices | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9269.html | RTRadiationMetersetUnits | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9270.html | AcquisitionInitiationTypes | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9271.html | RTImagePatientPositionAcquisitionDevices | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9272.html | RTROIImageAcquisitionContext | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9273.html | PatientPositionAcquisition–MRTechniques | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_93.html | JointPositioningMethod | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9300.html | ProcedureDiscontinuationReason | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9301.html | ModalityPPSDiscontinuationReason | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9302.html | MediaImportPPSDiscontinuationReason | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9303.html | InterpretationRequestDiscontinuationReason | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_94.html | PhysicalForceAppliedDuringAcquisition | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9401.html | IEC61217DevicePositionParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9402.html | IEC61217GantryPositionParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9403.html | IEC61217PatientSupportPositionParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9500.html | DosimetricObjectiveType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9501.html | PrescriptionAnatomyCategory | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9502.html | RTSegmentAnnotationCategory | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9503.html | RadiotherapyTherapeuticRoleCategory | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9504.html | RTGeometricInformation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9505.html | FixationorPositioningDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9506.html | BrachytherapyDevice | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9507.html | ExternalBodyModel | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9508.html | NonspecificVolume | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9509.html | PurposeofReferenceforRTPhysicianIntentInput | active | 2025-04 | us | hl7 | loinc dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9510.html | PurposeofReferenceforRTTreatmentPlanningInput | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9511.html | GeneralExternalRadiotherapyProcedureTechnique | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9512.html | TomotherapeuticRadiotherapyProcedureTechnique | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9513.html | FixationDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9514.html | AnatomicalStructureforRadiotherapy | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9515.html | RTPatientSupportDevice | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9516.html | RadiotherapyBolusDeviceType | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9517.html | RadiotherapyBlockDeviceType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9518.html | RadiotherapyAccessoryNoSlotHolderDeviceType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9519.html | RadiotherapyAccessorySlotHolderDeviceType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9520.html | SegmentedRTAccessoryDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9521.html | RadiotherapyTreatmentEnergyUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9522.html | MultiSourceRadiotherapyProcedureTechnique | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9523.html | RoboticRadiotherapyProcedureTechnique | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9524.html | RadiotherapyProcedureTechnique | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9525.html | RadiationTherapyParticle | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9526.html | IonTherapyParticle | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9527.html | TeletherapyIsotope | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9528.html | BrachytherapyIsotope | active | 2025-04 | us | hl7 | sct |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9529.html | SingleDoseDosimetricObjective | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9530.html | PercentageandDoseDosimetricObjective | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9531.html | VolumeandDoseDosimetricObjective | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9532.html | NoParameterDosimetricObjective | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9533.html | DeliveryTimeStructure | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9534.html | RadiotherapyTarget | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9535.html | RadiotherapyDoseCalculationRole | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9536.html | RadiotherapyPrescribingandSegmentingPersonRole | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9537.html | EffectiveDoseCalculationMethodCategory | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9538.html | RadiationTransportBasedEffectiveDoseMethodModifier | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9539.html | FractionationBasedEffectiveDoseMethodModifer | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9540.html | MovableBeamLimitingDeviceType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9541.html | BeamLimitingDeviceType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9542.html | CompensatorDeviceType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9543.html | RadiotherapyTreatmentMachineMode | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9544.html | RadiotherapyDistanceReferenceLocation | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9545.html | FixedBeamLimitingDeviceType | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9546.html | RadiotherapyWedgeType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9547.html | RTBeamLimitingDeviceOrientationLabel | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9548.html | GeneralAccessoryDeviceType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9549.html | RadiationGenerationModeType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9550.html | CArmPhotonElectronDeliveryRateUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9551.html | TreatmentDeliveryDeviceType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9552.html | CArmPhotonElectronDosimeterUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9553.html | TreatmentPoint | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9554.html | EquipmentReferencePoint | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9555.html | RadiotherapyTreatmentPlanningPersonRole | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9556.html | RadiotherapyRoboticNodeSet | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9557.html | TomotherapeuticDosimeterUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9558.html | TomotherapeuticDoseRateUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9559.html | RoboticDeliveryDeviceDosimeterUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9560.html | RoboticDeliveryDeviceDoseRateUnit | active | 2025-04 | us | hl7 | ucum |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9561.html | TreatmentTerminationReason | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9562.html | RadiotherapyTreatmentDeliveryPersonRole | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9563.html | RadiotherapyInterlockResolution | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9564.html | TreatmentSessionConfirmationAssertion | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9565.html | TreatmentToleranceViolationCause | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9566.html | ClinicalToleranceViolationType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9567.html | MachineToleranceViolationType | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9568.html | RadiotherapyTreatmentInterlock | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9569.html | IsocentricPatientSupportPositionParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9570.html | RTOverriddenTreatmentParameter | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9571.html | PatientTreatmentPreparationMethod | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9572.html | PatientShieldingDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9573.html | PatientTreatmentPreparationDevice | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9574.html | PatientPositionDisplacementReferencePoint | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9575.html | PatientAlignmentDevice | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9576.html | ReasonsforRTRadiationTreatmentOmission | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9577.html | PatientTreatmentPreparationProcedure | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9578.html | MotionManagementSetupDevice | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9579.html | RTSegmentMaterial | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9580.html | RTSegmentationPropertyCategory | active | 2025-04 | us | hl7 | sct dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9581.html | RadiotherapyRegistrationMark | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9582.html | RadiotherapyDoseRegion | active | 2025-04 | us | hl7 | dcm |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9583.html | RTPlanRadiotherapyProcedureTechnique | active | 2025-04 | us | hl7 | dcm |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Advance_Directive_Status | Information Persönliche Erklärung | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Allergies | Vorliegen Allergien | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Assessment_Scales | Assessment | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Bathing_Hamburg_Manual | Baden / Duschen - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Bladder_Hamburg_Manual | Harnkontrolle - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Bowel_Hamburg_Manual | Stuhlkontrolle - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Dressing_Hamburg_Manual | An- und Auskleiden - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Feeding_Hamburg_Manual | Essen - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Grooming_Hamburg_Manual | Sich Waschen - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Mobility_Hamburg_Manual | Aufstehen und Gehen - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Stairs_Hamburg_Manual | Treppensteigen - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Toileting_Hamburg_Manual | Toilettenbenutzung - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Barthel_Transfer_Hamburg_Manual | Aufsetzen und Umsetzen - Funktion nach Barthel - Hamburger Manual | active | | | | |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Behavior_Finding | Auffälliges Verhalten | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Bladder_Continence_Status | Harnkontinenz differenzierte Einschätzung | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Bowel_Continence_Status | Stuhlkontinenz differenzierte Einschätzung | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Cognitive_Awareness | Bewusstseinslage | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Constraint_Control_Seclusion | Freiheitsentziehende Maßnahmen | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Diagnosis_ICNP | Pflegeproblem/Pflegediagnose ICNP | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Disability | Einschränkung Funktionen | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Disability_Degree_Presence_Status | Grad Behinderung vorhanden | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Evacuation_Bladder_Content | Art der Harnableitung | active | | | | sct |
| kbv.mio.ueberleitungsbogen | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Evacuation_Intestinal_Contents | Art der | v2-0146 | hl7VS-amountType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0147 | hl7VS-policyType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0148 | hl7VS-penaltyType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0149 | hl7VS-dayType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0150 | hl7VS-precertificationPatientType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0155 | hl7VS-accept-applicationAcknowledgmentConditions | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0156 | hl7VS-whichDate-timeQualifier | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0157 | hl7VS-whichDate-timeStatusQualifier | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0158 | hl7VS-date-timeSelectionQualifier | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0159 | hl7VS-dietType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0160 | hl7VS-trayType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0161 | hl7VS-allowSubstitution | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0162 | hl7VS-routeOfAdministration | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0163 | hl7VS-administriveSite | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0164 | hl7VS-administrationDevice | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0165 | hl7VS-administrationMethod | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0166 | hl7VS-rxComponentType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0167 | hl7VS-substitutionStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0168 | hl7VS-processingPriority | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0169 | hl7VS-reportingPriority | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0170 | hl7VS-derivedSpecimen | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0173 | hl7VS-coordinationOfBenefits | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0174 | hl7VS-natureOfServiceTestObservation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0175 | hl7VS-masterFileIdentifierCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0177 | hl7VS-confidentialityCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0178 | hl7VS-file-levelEventCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0179 | hl7VS-responseLevel | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0180 | hl7VS-masterfileActionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0181 | hl7VS-mfnRecode-levelErrorReturn | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0183 | hl7VS-active-inactive | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0185 | hl7VS-preferredMethodOfContrct | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0187 | hl7VS-providerBilling | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0189 | hl7VS-ethnicGroup | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0190 | hl7VS-addressType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0191 | hl7VS-typeOfData | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0193 | hl7VS-amountClass | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0200 | hl7VS-nameType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0201 | hl7VS-telecommunicationUseCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0202 | hl7VS-telecommunicationEquipmentType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0203 | hl7VS-identifierType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0204 | hl7VS-organizationalNameType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0205 | hl7VS-priceType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0206 | hl7VS-segmentActionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0207 | hl7VS-processingMode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0208 | hl7VS-queryResponseStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0209 | hl7VS-relationalOperator | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0210 | hl7VS-relationalConjunction | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0211 | hl7VS-alternateCharacterSets | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0213 | hl7VS-purgeStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0214 | hl7VS-specialProgramCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0215 | hl7VS-publicityCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0216 | hl7VS-patientStatusCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0217 | hl7VS-visitPriorityCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0220 | hl7VS-livingArrangement | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0223 | hl7VS-livingDependency | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0224 | hl7VS-transportArranged | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0225 | hl7VS-escortRequired | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0227 | PHVS_ManufacturersOfVaccinesMVX_CDC_NIP | active | 2023-06 | uv | hl7 | fhir |
| hl7.terminology.r4b | R4B | v2-0228 | hl7VS-diagnosisClassification | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0230 | hl7VS-procedureFunctionalType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0231 | hl7VS-studentStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0232 | hl7VS-insuranceCompanyContactReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0234 | hl7VS-reportTiming | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0235 | hl7VS-reportSource | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0236 | hl7VS-eventReportedTo | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0237 | hl7VS-eventQualification | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0238 | hl7VS-eventSeriousness | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0239 | hl7VS-eventExpected | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0240 | hl7VS-eventConsequence | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0241 | hl7VS-patientOutcome | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0242 | hl7VS-primaryObserver'sQualification | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0243 | hl7VS-identityMayBeDivulged | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0247 | hl7VS-startOfEvaluation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0248 | hl7VS-productSource | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0250 | hl7VS-relatednessAssessment | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0251 | hl7VS-actionTakenInResponseToTheEvent | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0252 | hl7VS-causalityObservations | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0253 | hl7VS-indirectExposureMechanism | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0254 | hl7VS-kindOfQuantity | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0255 | hl7VS-durationCategories | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0256 | hl7VS-timeDelayPostChallenge | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0257 | hl7VS-natureOfChallenge | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0258 | hl7VS-relationshipModifier | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0260 | hl7VS-patientLocationType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0261 | hl7VS-locationEquipment | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0262 | hl7VS-privacyLevel | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0263 | hl7VS-levelOfCare | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0265 | hl7VS-specialtyType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0267 | hl7VS-daysOfTheWeek | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0268 | hl7VS-override | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0269 | hl7VS-chargeOnIndicator | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0270 | hl7VS-reportTypeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0271 | hl7VS-documentCompletionStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0272 | hl7VS-documentConfidentialityStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0273 | hl7VS-documentAvailabilityStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0275 | hl7VS-documentStorageStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0276 | hl7VS-appointmentReasonCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0277 | hl7VS-appointmentTypeCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0278 | hl7VS-fillerStatusCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0279 | hl7VS-allowSubstitutionCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0280 | hl7VS-referralPriority | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0281 | hl7VS-referralType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0282 | hl7VS-referralDisposition | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0283 | hl7VS-referralStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0284 | hl7VS-referralCategory | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0286 | hl7VS-providerRole | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0287 | hl7VS-actionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0290 | hl7VS-mimeBase64EncodingCharacters | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0292 | PHVS_VaccinesAdministeredCVX_CDC_NIP | active | 2019-12 | uv | hl7 | cvx |
| hl7.terminology.r4b | R4B | v2-0294 | hl7VS-timeSelectionCriteriaParameterClassCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0298 | hl7VS-rangeType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0299 | hl7VS-encoding | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0301 | hl7VS-universalIdType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0305 | hl7VS-personLocationType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0309 | hl7VS-coverageType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0311 | hl7VS-jobStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0315 | hl7VS-livingWill | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0316 | hl7VS-organDonor | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0317 | hl7VS-annotations | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0321 | hl7VS-dispenseMethod | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0322 | hl7VS-completionStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0323 | hl7VS-actionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0324 | hl7VS-locationCharacteristicId | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0325 | hl7VS-locationRelationshipId | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0326 | hl7VS-visitIndicator | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0329 | hl7VS-quantityMethod | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0330 | hl7VS-marketingBasis | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0331 | hl7VS-facilityType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0332 | hl7VS-networkSourceType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0334 | hl7VS-disabledPerson | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0335 | hl7VS-repeatPattern | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0336 | hl7VS-referralReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0337 | hl7VS-certificationStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0338 | hl7VS-practitionerIdNumberType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0339 | hl7VS-advancedBeneficiaryNoticeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0344 | hl7VS-patient’sRelationshipToInsured | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0350 | hl7VS-occurrenceCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0351 | hl7VS-occurrenceSpan | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0353 | hl7VS-cweStatuses | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0354 | hl7VS-messageStructure | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0355 | hl7VS-primaryKeyValueType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0356 | hl7VS-alternateCharacterSetHandlingScheme | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0357 | hl7VS-messageErrorConditionCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0359 | hl7VS-diagnosisPriority | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0360 | hl7VS-degreeLicenseCertificate | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0364 | hl7VS-commentType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0365 | hl7VS-equipmentState | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0366 | hl7VS-local-remoteControlState | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0367 | hl7VS-alertLevel | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0368 | hl7VS-remoteControlCommand | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0369 | hl7VS-specimenRole | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0370 | hl7VS-containerStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0371 | hl7VS-additivePreservative | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0372 | hl7VS-specimenComponent | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0373 | hl7VS-treatment | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0374 | hl7VS-systemInducedContaminants | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0375 | hl7VS-artificialBlood | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0376 | hl7VS-specialHandlingConsiderations | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0377 | hl7VS-otherEnvironmentalFactors | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0383 | hl7VS-substanceStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0384 | hl7VS-substanceType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0387 | hl7VS-commandResponse | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0388 | hl7VS-processingType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0389 | hl7VS-analyteRepeatStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0391 | hl7VS-segmentGroup | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0392 | hl7VS-matchReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0393 | hl7VS-matchAlgorithms | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0394 | hl7VS-responseModality | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0395 | hl7VS-modifyIndicator | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0396 | hl7VS-codingSystem | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0397 | hl7VS-sequencing | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0398 | hl7VS-continuationStyleCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0401 | hl7VS-governmentReimbursementProgram | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0402 | hl7VS-schoolType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0403 | hl7VS-languageAbility | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0404 | hl7VS-languageProficiency | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0406 | hl7VS-organizationUnitType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0409 | hl7VS-applicationChangeType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0415 | hl7VS-drgTransferType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0416 | hl7VS-procedureDrgType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0417 | hl7VS-tissueTypeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0418 | hl7VS-procedurePriority | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0421 | hl7VS-severityOfIllnessCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0422 | hl7VS-triageCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0423 | hl7VS-caseCategoryCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0424 | hl7VS-gestationCategoryCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0425 | hl7VS-newbornCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0426 | hl7VS-bloodProductCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0427 | hl7VS-riskManagementIncidentCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0428 | hl7VS-incidentTypeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0429 | hl7VS-productionClassCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0430 | hl7VS-modeOfArrivalCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0431 | hl7VS-recreationalDrugUseCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0432 | hl7VS-admissionLevelOfCareCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0433 | hl7VS-precautionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0434 | hl7VS-patientConditionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0435 | hl7VS-advanceDirectiveCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0436 | hl7VS-sensitivityToCausativeAgentCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0437 | hl7VS-alertDeviceCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0438 | hl7VS-allergyClinicalStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0440 | hl7VS-dataTypes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0441 | hl7VS-immunizationRegistryStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0442 | hl7VS-locationServiceCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0443 | hl7VS-providerRole | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0444 | hl7VS-nameAssemblyOrder | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0445 | hl7VS-identityReliabilityCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0450 | hl7VS-eventType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0456 | hl7VS-revenueCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0457 | hl7VS-overallClaimDispositionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0465 | hl7VS-name-addressRepresentation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0466 | hl7VS-ambulatoryPaymentClassificationCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0468 | hl7VS-paymentAdjustmentCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0469 | hl7VS-packagingStatusCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0470 | hl7VS-reimbursementTypeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0472 | hl7VS-tqConjunctionId | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0473 | hl7VS-formularyStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0474 | hl7VS-organizationUnitType-Org | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0475 | hl7VS-chargeTypeReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0477 | hl7VS-controlledSubstanceSchedule | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0478 | hl7VS-formularyStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0480 | hl7VS-pharmacyOrderTypes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0482 | hl7VS-orderType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0483 | hl7VS-authorizationMode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0484 | hl7VS-dispenseType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0485 | hl7VS-extendedPriorityCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0487 | hl7VS-specimenType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0488 | hl7VS-specimenCollectionMethod | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0489 | hl7VS-riskCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0490 | hl7VS-specimenRejectReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0491 | hl7VS-specimenQuality | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0492 | hl7VS-specimenAppropriateness | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0493 | hl7VS-specimenCondition | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0494 | hl7VS-specimenChildRole | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0495 | hl7VS-bodySiteModifier | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0496 | hl7VS-consentType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0497 | hl7VS-consentMode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0498 | hl7VS-consentStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0499 | hl7VS-consentBypassReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0500 | hl7VS-consentDisclosureLevel | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0501 | hl7VS-consentNon-disclosureReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0502 | hl7VS-non-subjectConsenterReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0503 | hl7VS-sequenceResultsFlag | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0504 | hl7VS-sequenceConditionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0505 | hl7VS-cyclicEntryExitIndicator | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0506 | hl7VS-serviceRequestRelationship | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0507 | hl7VS-observationResultHandling | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0508 | hl7VS-bloodProductProcessingRequirements | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0510 | hl7VS-bloodProductDispenseStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0511 | hl7VS-bpObservationStatusCodesInterpretation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0513 | hl7VS-bloodProductTransfusion-dispositionStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0514 | hl7VS-transfusionAdverseReaction | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0516 | hl7VS-errorSeverity | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0517 | hl7VS-informPersonCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0518 | hl7VS-overrideType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0520 | hl7VS-messageWaitingPriority | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0523 | hl7VS-computationType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0524 | hl7VS-sequenceCondition | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0527 | hl7VS-calendarAlignment | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0528 | hl7VS-eventRelatedPeriod | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0529 | hl7VS-precision | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0530 | hl7VS-organization-Agency-Department | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0532 | hl7VS-expandedYes-NoIndicator | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0534 | hl7VS-notifyClergyCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0535 | hl7VS-signatureCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0536 | hl7VS-certificateStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0538 | hl7VS-institutionRelationshipType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0540 | hl7VS-inactiveReasonCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0544 | hl7VS-containerCondition | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0547 | hl7VS-jurisdictionalBreadth | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0548 | hl7VS-signatory'sRelationshipToSubject | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0550 | hl7VS-bodyParts | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0553 | hl7VS-invoiceControlCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0554 | hl7VS-invoiceReasonCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0555 | hl7VS-invoiceType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0556 | hl7VS-benefitGroup | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0557 | hl7VS-payeeType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0558 | hl7VS-payeeRelationshipToInvoice | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0559 | hl7VS-product-serviceStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0560 | hl7VS-quantityUnits | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0561 | hl7VS-product-servicesClarification | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0562 | hl7VS-processingConsiderationCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0564 | hl7VS-adjustmentCategoryCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0565 | hl7VS-providerAdjustmentReasonCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0566 | hl7VS-bloodUnitType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0567 | hl7VS-weightUnits | active | 2019-12 | uv | hl7 | ucum |
| hl7.terminology.r4b | R4B | v2-0568 | hl7VS-volumeUnits | active | 2019-12 | uv | hl7 | ucum |
| hl7.terminology.r4b | R4B | v2-0569 | hl7VS-adjustmentAction | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0570 | hl7VS-paymentMethodCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0571 | hl7VS-invoiceProcessingResultsStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0572 | hl7VS-taxStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0615 | hl7VS-userAuthenticationCredentialTypeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0616 | hl7VS-addressExpirationReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0617 | hl7VS-addressUsage | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0618 | hl7VS-protectionCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0625 | hl7VS-itemStatusCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0634 | hl7VS-itemImportanceCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0642 | hl7VS-reorderTheoryCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0651 | hl7VS-laborCalculationType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0653 | hl7VS-dateFormat | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0657 | hl7VS-deviceType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0659 | hl7VS-lotControl | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0667 | hl7VS-deviceDataState | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0669 | hl7VS-loadStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0682 | hl7VS-deviceStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0702 | hl7VS-cycleType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0717 | hl7VS-accessRestrictionValue | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0719 | InformationSensitivityPolicy | retired | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0725 | hl7VS-moodCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0728 | hl7VS-cclValue | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0731 | hl7VS-drgDiagnosisDeterminationStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0734 | hl7VS-grouperStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0739 | hl7VS-statusPatient | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0742 | hl7VS-drgStatusFinancialCalculation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0749 | hl7VS-drgGroupingStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0755 | hl7VS-statusWeightAtBirth | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0757 | hl7VS-statusRespirationMinutes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0759 | hl7VS-statusAdmission | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0761 | hl7VS-drgProcedureDeterminationStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0763 | hl7VS-drgProcedureRelevance | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0776 | hl7VS-itemStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0778 | hl7VS-itemType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0790 | hl7VS-approvingRegulatoryAgency | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0793 | hl7VS-rulingAct | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0806 | hl7VS-sterilizationType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0818 | hl7VS-package | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0868 | hl7VS-telecommunicationExpirationReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0871 | hl7VS-supplyRiskCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0881 | hl7VS-roleExecutingPhysician | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0882 | hl7VS-medicalRoleExecutingPhysician | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0894 | hl7VS-sideOfBody | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0895 | hl7VS-presentOnAdmission(poa)Indicator | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0904 | hl7VS-securityCheckScheme | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0905 | hl7VS-shipmentStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0906 | hl7VS-actpriority | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0907 | hl7VS-confidentiality | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0909 | hl7VS-patientResultsReleaseCategorizationScheme | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0912 | hl7VS-participation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0914 | hl7VS-rootCause | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0916 | hl7VS-relevantClincialInformation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0917 | hl7VS-bolusType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0918 | hl7VS-pcaType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0919 | hl7VS-exclusiveTest | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0920 | hl7VS-preferredSpecimen-AttributeStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0921 | hl7VS-certificationTypeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0922 | hl7VS-certificationCategoryCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0923 | hl7VS-processInterruption | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0924 | hl7VS-cumulativeDosageLimitUom | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0925 | hl7VS-phlebotomyIssue | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0926 | hl7VS-phlebotomyStatus | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0927 | hl7VS-armStick | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0929 | hl7VS-weightUnits | active | 2019-12 | uv | hl7 | ucum |
| hl7.terminology.r4b | R4B | v2-0930 | hl7VS-volumeUnits | active | 2019-12 | uv | hl7 | ucum |
| hl7.terminology.r4b | R4B | v2-0931 | hl7VS-temperatureUnits | active | 2019-12 | uv | hl7 | ucum |
| hl7.terminology.r4b | R4B | v2-0932 | hl7VS-donationDurationUnits | active | 2019-12 | uv | hl7 | ucum |
| hl7.terminology.r4b | R4B | v2-0933 | hl7VS-intendedProcedureType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0935 | hl7VS-processInterruptionReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0936 | hl7VS-VS-observationType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0937 | hl7VS-VS-observationSubtype | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0938 | hl7VS-VS-collectionEvent | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0939 | hl7VS-VS-communicationLocation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0940 | hl7VS-VS-limitationTypeCode | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0942 | V2 Table 0942 Version Master | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0945 | hl7VS-auto-DilutionType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0946 | hl7VS-supplierType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0948 | hl7VS-relationshipType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0949 | hl7VS-orderControlCodeReason | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0950 | hl7VS-orderStatusModifier | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0951 | hl7VS-ReasonForStudy | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0952 | Confidentiality | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0959 | workClassificationODH | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0961 | DeviceType | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0962 | FHIRdeviceStatus | active | 2019-12 | uv | hl7 | fhir |
| hl7.terminology.r4b | R4B | v2-0963 | DeviceSafety | active | 2019-12 | uv | hl7 | |
| hl7.terminology.r4b | R4B | v2-0970 | hl7VS-onlineVerificationResult | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-0971 | hl7VS-onlineVerificationResultErrorCodes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-4000 | hl7VS-name-addressRepresentation | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-notAllCodes-0291 | hl7VS-subtypeOfReferencedData | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v2-notAllCodes-0347 | HL7 Value Set for State/Province | active | 2019-12 | uv | hl7 | iso |
| hl7.terminology.r4b | R4B | v2-notAllCodes-0399 | hl7VS-countryCode-3alpha | active | 2019-12 | uv | hl7 | iso |
| hl7.terminology.r4b | R4B | v2-notAllCodes-0834 | hl7VS-mimeTypes | active | 2019-12 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Abenakian | Abenakian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AccessMedicalDevice | AccessMedicalDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AcknowledgementCondition | AcknowledgementCondition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AcknowledgementDetailCode | AcknowledgementDetailCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AcknowledgementDetailNotSupportedCode | AcknowledgementDetailNotSupportedCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AcknowledgementDetailSyntaxErrorCode | AcknowledgementDetailSyntaxErrorCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AcknowledgementDetailType | AcknowledgementDetailType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AcknowledgementType | AcknowledgementType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAccommodationReason | ActAccommodationReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAccountCode | ActAccountCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAdjudicationCode | ActAdjudicationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAdjudicationGroupCode | ActAdjudicationGroupCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAdjudicationResultActionCode | ActAdjudicationResultActionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAdministrativeAuthorizationDetectedIssueCode | ActAdministrativeAuthorizationDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAdministrativeDetectedIssueCode | ActAdministrativeDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAdministrativeDetectedIssueManagementCode | ActAdministrativeDetectedIssueManagementCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAdministrativeRuleDetectedIssueCode | ActAdministrativeRuleDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAmbulatoryEncounterCode | ActAmbulatoryEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActAntigenInvalidReason | ActAntigenInvalidReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActBillableModifierCode | ActBillableModifierCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActBillingArrangementCode | ActBillingArrangementCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActBoundedROICode | ActBoundedROICode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCareProvisionCode | ActCareProvisionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClaimAttachmentCategoryCode | ActClaimAttachmentCategoryCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClass | ActClass | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassAccession | ActClassAccession | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassAccommodation | ActClassAccommodation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassAccount | ActClassAccount | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassAcquisitionExposure | ActClassAcquisitionExposure | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassAction | ActClassAction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassBattery | ActClassBattery | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassBioSequence | ActClassBioSequence | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassBioSequenceVariation | ActClassBioSequenceVariation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassBoundedRoi | ActClassBoundedRoi | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCareProvision | ActClassCareProvision | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCategory | ActClassCategory | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCdaLevelOneClinicalDocument | ActClassCdaLevelOneClinicalDocument | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassClinicalDocument | ActClassClinicalDocument | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassClinicalTrial | ActClassClinicalTrial | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassClinicalTrialTimepointEvent | ActClassClinicalTrialTimepointEvent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCluster | ActClassCluster | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCompositeOrder | ActClassCompositeOrder | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassComposition | ActClassComposition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassConcern | ActClassConcern | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCondition | ActClassCondition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassConditionNode | ActClassConditionNode | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassConsent | ActClassConsent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassContainer | ActClassContainer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassContainerRegistration | ActClassContainerRegistration | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassContract | ActClassContract | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassControlAct | ActClassControlAct | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCorrelatedObservationSequences | ActClassCorrelatedObservationSequences | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassCoverage | ActClassCoverage | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDetectedIssue | ActClassDetectedIssue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDeterminantPeptide | ActClassDeterminantPeptide | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDiagnosticImage | ActClassDiagnosticImage | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDiet | ActClassDiet | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDisciplinaryAction | ActClassDisciplinaryAction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDocument | ActClassDocument | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDocumentBody | ActClassDocumentBody | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassDocumentSection | ActClassDocumentSection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassElectronicHealthRecord | ActClassElectronicHealthRecord | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassEncounter | ActClassEncounter | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassExposure | ActClassExposure | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassExpressionLevel | ActClassExpressionLevel | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassExtract | ActClassExtract | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassFinancialAdjudication | ActClassFinancialAdjudication | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassFinancialContract | ActClassFinancialContract | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassFinancialTransaction | ActClassFinancialTransaction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassFolder | ActClassFolder | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassGenomicObservation | ActClassGenomicObservation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassGrouper | ActClassGrouper | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassIncident | ActClassIncident | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassInform | ActClassInform | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassInformation | ActClassInformation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassInvestigation | ActClassInvestigation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassInvoiceElement | ActClassInvoiceElement | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassJurisdictionalPolicy | ActClassJurisdictionalPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassLeftLateralDecubitus | ActClassLeftLateralDecubitus | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassLocus | ActClassLocus | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassMonitoringProgram | ActClassMonitoringProgram | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassObservation | ActClassObservation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassObservationSeries | ActClassObservationSeries | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassOrganizationalPolicy | ActClassOrganizationalPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassOutbreak | ActClassOutbreak | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassOutbreak2 | ActClassOutbreak2 | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassOverlayRoi | ActClassOverlayRoi | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPhenotype | ActClassPhenotype | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPolicy | ActClassPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPolypeptide | ActClassPolypeptide | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPosition | ActClassPosition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPositionAccuracy | ActClassPositionAccuracy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPositionCoordinate | ActClassPositionCoordinate | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassProcedure | ActClassProcedure | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassProcessStep | ActClassProcessStep | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassProne | ActClassProne | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPublicHealthCase | ActClassPublicHealthCase | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassPublicHealthCase2 | ActClassPublicHealthCase2 | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassROI | ActClassROI | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassRecordOrganizer | ActClassRecordOrganizer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassRegistration | ActClassRegistration | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassReverseTrendelenburg | ActClassReverseTrendelenburg | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassReview | ActClassReview | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassRightLateralDecubitus | ActClassRightLateralDecubitus | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassRoot | ActClassRoot | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassScopeOfPracticePolicy | ActClassScopeOfPracticePolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSemiFowlers | ActClassSemiFowlers | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSitting | ActClassSitting | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSpecimenCollection | ActClassSpecimenCollection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSpecimenObservation | ActClassSpecimenObservation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSpecimenTreatment | ActClassSpecimenTreatment | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassStandardOfPracticePolicy | ActClassStandardOfPracticePolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassStanding | ActClassStanding | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassStateTransitionControl | ActClassStateTransitionControl | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassStorage | ActClassStorage | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSubjectBodyPosition | ActClassSubjectBodyPosition | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSubjectPhysicalPosition | ActClassSubjectPhysicalPosition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSubstanceAdministration | ActClassSubstanceAdministration | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSubstanceExtraction | ActClassSubstanceExtraction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSubstitution | ActClassSubstitution | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSupine | ActClassSupine | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassSupply | ActClassSupply | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassTopic | ActClassTopic | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassTransfer | ActClassTransfer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassTransmissionExposure | ActClassTransmissionExposure | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassTransportation | ActClassTransportation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassTrendelenburg | ActClassTrendelenburg | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassVerification | ActClassVerification | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActClassWorkingList | ActClassWorkingList | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCode | v3 Code System ActCode | active | 2018-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCodeProcessStep | ActCodeProcessStep | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActConditionList | ActConditionList | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActConsentDirective | ActConsentDirective | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActConsentDirectiveType | ActConsentDirectiveType | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActConsentInformationAccessOverrideReason | ActConsentInformationAccessOverrideReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActConsentType | ActConsentType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActContainerRegistrationCode | ActContainerRegistrationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActControlVariable | ActControlVariable | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageAssessmentObservationValue | ActCoverageAssessmentObservationValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageAuthorizationConfirmationCode | ActCoverageAuthorizationConfirmationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageConfirmationCode | ActCoverageConfirmationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageLimitCode | ActCoverageLimitCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageMaximaCodes | ActCoverageMaximaCodes | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageQuantityLimitCode | ActCoverageQuantityLimitCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageReason | ActCoverageReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCoverageTypeCode | ActCoverageTypeCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCredentialedCareCode | ActCredentialedCareCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCredentialedCareProvisionPersonCode | ActCredentialedCareProvisionPersonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActCredentialedCareProvisionProgramCode | ActCredentialedCareProvisionProgramCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActDetectedIssueCode | ActDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActDetectedIssueManagementCode | ActDetectedIssueManagementCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActDietCode | ActDietCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActEmergencyEncounterCode | ActEmergencyEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActEncounterAccommodationCode | ActEncounterAccommodationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActEncounterCode | ActEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActExposureCode | ActExposureCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActExposureLevelCode | ActExposureLevelCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActFieldEncounterCode | ActFieldEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActFinancialStatusObservationValue | ActFinancialStatusObservationValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActFinancialTransactionCode | ActFinancialTransactionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActHealthInformationManagementReason | ActHealthInformationManagementReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActHealthInsuranceTypeCode | ActHealthInsuranceTypeCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActHomeHealthEncounterCode | ActHomeHealthEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActIncidentCode | ActIncidentCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActIneligibilityReason | ActIneligibilityReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInformationAccess | ActInformationAccess | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInformationAccessCode | ActInformationAccessCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInformationAccessContextCode | ActInformationAccessContextCode | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInformationCategoryCode | ActInformationCategoryCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInformationSensitivityPolicy | ActInformationSensitivityPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInformationTransferCode | ActInformationTransferCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInjuryCodeCSA | ActInjuryCodeCSA | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInpatientEncounterCode | ActInpatientEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInsurancePolicyCode | ActInsurancePolicyCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInsuranceTypeCode | ActInsuranceTypeCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceAdjudicationPaymentCode | ActInvoiceAdjudicationPaymentCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceAdjudicationPaymentGroupCode | ActInvoiceAdjudicationPaymentGroupCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceAdjudicationPaymentSummaryCode | ActInvoiceAdjudicationPaymentSummaryCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailClinicalProductCode | ActInvoiceDetailClinicalProductCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailCode | ActInvoiceDetailCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailDrugProductCode | ActInvoiceDetailDrugProductCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailGenericAdjudicatorCode | ActInvoiceDetailGenericAdjudicatorCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailGenericCode | ActInvoiceDetailGenericCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailGenericModifierCode | ActInvoiceDetailGenericModifierCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailGenericProviderCode | ActInvoiceDetailGenericProviderCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailPreferredAccommodationCode | ActInvoiceDetailPreferredAccommodationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceDetailTaxCode | ActInvoiceDetailTaxCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceElementCode | ActInvoiceElementCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceElementModifier | ActInvoiceElementModifier | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceElementSummaryCode | ActInvoiceElementSummaryCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceGroupCode | ActInvoiceGroupCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceInterGroupCode | ActInvoiceInterGroupCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceOverrideCode | ActInvoiceOverrideCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoicePaymentCode | ActInvoicePaymentCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActInvoiceRootGroupCode | ActInvoiceRootGroupCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActListCode | ActListCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMedicalServiceCode | ActMedicalServiceCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMedicationList | ActMedicationList | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMedicationTherapyDurationWorkingListCode | ActMedicationTherapyDurationWorkingListCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMonitoringProtocolCode | ActMonitoringProtocolCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMood | ActMood | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodActRequest | ActMoodActRequest | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodAppointment | ActMoodAppointment | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodAppointmentRequest | ActMoodAppointmentRequest | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodCompletionTrack | ActMoodCompletionTrack | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodCriterion | ActMoodCriterion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodDefinition | ActMoodDefinition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodDesire | ActMoodDesire | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodEventCriterion | ActMoodEventCriterion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodEventOccurrence | ActMoodEventOccurrence | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodExpectation | ActMoodExpectation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodGoal | ActMoodGoal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodIntent | ActMoodIntent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodOption | ActMoodOption | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodPermission | ActMoodPermission | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodPermissionRequest | ActMoodPermissionRequest | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodPotential | ActMoodPotential | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodPredicate | ActMoodPredicate | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodPromise | ActMoodPromise | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodProposal | ActMoodProposal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodRecommendation | ActMoodRecommendation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodRequest | ActMoodRequest | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodResourceSlot | ActMoodResourceSlot | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActMoodRisk | ActMoodRisk | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActNoImmunizationReason | ActNoImmunizationReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActNonObservationIndicationCode | ActNonObservationIndicationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActObservationList | ActObservationList | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActObservationVerificationType | ActObservationVerificationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPatientAnnotationType | ActPatientAnnotationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPatientTransportationModeCode | ActPatientTransportationModeCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPaymentCode | ActPaymentCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPharmacySupplyType | ActPharmacySupplyType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPolicyType | ActPolicyType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPriority | ActPriority | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPriorityCallback | ActPriorityCallback | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPrivacyLaw | ActPrivacyLaw | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActPrivacyPolicy | ActPrivacyPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActProcedureCodeCCI | Act Procedure Code CCI | retired | 2014-03 | uv | hl7 | |
| hl7.terminology.r4b | R4B | v3-ActProductAcquisitionCode | ActProductAcquisitionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActProgramTypeCode | ActProgramTypeCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActReason | v3 Code System ActReason | active | 2018-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipAccounting | ActRelationshipAccounting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipActProvenance | ActRelationshipActProvenance | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipActiveImmunizationAgainst | ActRelationshipActiveImmunizationAgainst | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipAdjunctCurativeIndication | ActRelationshipAdjunctCurativeIndication | active | 2012-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipAdjunctMitigation | ActRelationshipAdjunctMitigation | active | 2012-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipAdjunctiveTreatment | ActRelationshipAdjunctiveTreatment | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipArrival | ActRelationshipArrival | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipAssignsName | ActRelationshipAssignsName | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipAuthorizedBy | ActRelationshipAuthorizedBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipBlocks | ActRelationshipBlocks | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCheckpoint | ActRelationshipCheckpoint | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCheckpointBeginning | ActRelationshipCheckpointBeginning | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCheckpointEnd | ActRelationshipCheckpointEnd | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCheckpointEntry | ActRelationshipCheckpointEntry | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCheckpointExit | ActRelationshipCheckpointExit | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCheckpointThrough | ActRelationshipCheckpointThrough | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCompliesWith | ActRelationshipCompliesWith | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipConcurrentWith | ActRelationshipConcurrentWith | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipConditional | ActRelationshipConditional | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipContainsEndOf | ActRelationshipContainsEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipContainsStartOf | ActRelationshipContainsStartOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipContainsStartOfEndsBeforeEndOf | ActRelationshipContainsStartOfEndsBeforeEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipContainsTimeOf | ActRelationshipContainsTimeOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCostTracking | ActRelationshipCostTracking | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCoveredBy | ActRelationshipCoveredBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipCurativeIndication | ActRelationshipCurativeIndication | active | 2012-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipDeparture | ActRelationshipDeparture | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipDiagnosis | ActRelationshipDiagnosis | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipDocumentHQMF | ActRelationshipDocumentHQMF | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipDocumentProvenance | ActRelationshipDocumentProvenance | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipDocuments | ActRelationshipDocuments | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipDuring | ActRelationshipDuring | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsAfterEndOf | ActRelationshipEndsAfterEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsAfterOrConcurrentWithEndOf | ActRelationshipEndsAfterOrConcurrentWithEndOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsAfterOrConcurrentWithStartOf | ActRelationshipEndsAfterOrConcurrentWithStartOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsAfterStartOf | ActRelationshipEndsAfterStartOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsBeforeEnd | ActRelationshipEndsBeforeEnd | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsBeforeOrConcurrentWithEndOf | ActRelationshipEndsBeforeOrConcurrentWithEndOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsBeforeOrConcurrentWithStartOf | ActRelationshipEndsBeforeOrConcurrentWithStartOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsBeforeStartOf | ActRelationshipEndsBeforeStartOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsConcurrentWith | ActRelationshipEndsConcurrentWith | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsConcurrentWithStart | ActRelationshipEndsConcurrentWithStart | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsDuring | ActRelationshipEndsDuring | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsNearEnd | ActRelationshipEndsNearEnd | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEndsNearStarts | ActRelationshipEndsNearStarts | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEpisodelink | ActRelationshipEpisodelink | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipEvaluatesGoal | ActRelationshipEvaluatesGoal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipExacerbatredBy | ActRelationshipExacerbatredBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipExcerpt | ActRelationshipExcerpt | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipExcerptVerbatim | ActRelationshipExcerptVerbatim | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipFulfills | ActRelationshipFulfills | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasBaseline | ActRelationshipHasBaseline | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasBoundedSupport | ActRelationshipHasBoundedSupport | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasCharge | ActRelationshipHasCharge | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasComponent | ActRelationshipHasComponent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasContinuingObjective | ActRelationshipHasContinuingObjective | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasContra-indication | ActRelationshipHasContra-indication | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasControlVariable | ActRelationshipHasControlVariable | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasCost | ActRelationshipHasCost | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasCredit | ActRelationshipHasCredit | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasDebit | ActRelationshipHasDebit | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasExplanation | ActRelationshipHasExplanation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasFinalObjective | ActRelationshipHasFinalObjective | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasGeneralization | ActRelationshipHasGeneralization | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasGoal | ActRelationshipHasGoal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasMember | ActRelationshipHasMember | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasMetadata | ActRelationshipHasMetadata | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasOption | ActRelationshipHasOption | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasPart | ActRelationshipHasPart | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasPre-condition | ActRelationshipHasPre-condition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasPreviousInstance | ActRelationshipHasPreviousInstance | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasQualifier | ActRelationshipHasQualifier | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasReferenceValues | ActRelationshipHasReferenceValues | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasRisk | ActRelationshipHasRisk | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasStep | ActRelationshipHasStep | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasSubject | ActRelationshipHasSubject | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasSupport | ActRelationshipHasSupport | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasTrigger | ActRelationshipHasTrigger | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipHasValue | ActRelationshipHasValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipICSRInvestigation | ActRelationshipICSRInvestigation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipImmunizationAgainst | ActRelationshipImmunizationAgainst | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipIndependentOfTimeOf | ActRelationshipIndependentOfTimeOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipInstantiatesMaster | ActRelationshipInstantiatesMaster | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipInterferedBy | ActRelationshipInterferedBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipIsAppendage | ActRelationshipIsAppendage | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipIsDerivedFrom | ActRelationshipIsDerivedFrom | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipIsEtiologyFor | ActRelationshipIsEtiologyFor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipIsManifestationOf | ActRelationshipIsManifestationOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipItemsLocated | ActRelationshipItemsLocated | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipJoin | ActRelationshipJoin | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipJoinDetached | ActRelationshipJoinDetached | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipJoinExclusiveWait | ActRelationshipJoinExclusiveWait | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipJoinKill | ActRelationshipJoinKill | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipJoinWait | ActRelationshipJoinWait | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipLimitedBy | ActRelationshipLimitedBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipMaintenanceTreatment | ActRelationshipMaintenanceTreatment | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipMatchesTrigger | ActRelationshipMatchesTrigger | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipMitigates | ActRelationshipMitigates | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipModifies | ActRelationshipModifies | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipObjective | ActRelationshipObjective | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipOccurrence | ActRelationshipOccurrence | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipOutcome | ActRelationshipOutcome | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipOverlapsWith | ActRelationshipOverlapsWith | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipPalliates | ActRelationshipPalliates | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipPassiveImmunizationAgainst | ActRelationshipPassiveImmunizationAgainst | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipPertains | ActRelationshipPertains | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipPosting | ActRelationshipPosting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipProphylaxisOf | ActRelationshipProphylaxisOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipProvidesEvidenceFor | ActRelationshipProvidesEvidenceFor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipRe-challenge | ActRelationshipRe-challenge | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipReason | ActRelationshipReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipRecovery | ActRelationshipRecovery | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipReferencesOrder | ActRelationshipReferencesOrder | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipRefersTo | ActRelationshipRefersTo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipRelievedBy | ActRelationshipRelievedBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipReplaces | ActRelationshipReplaces | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipReverses | ActRelationshipReverses | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSchedulesRequest | ActRelationshipSchedulesRequest | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSequel | ActRelationshipSequel | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSplit | ActRelationshipSplit | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSplitExclusiveTryOnce | ActRelationshipSplitExclusiveTryOnce | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSplitExclusiveWait | ActRelationshipSplitExclusiveWait | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSplitInclusiveTryOnce | ActRelationshipSplitInclusiveTryOnce | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSplitInclusiveWait | ActRelationshipSplitInclusiveWait | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartAfterStartOfContainsEndOf | ActRelationshipStartAfterStartOfContainsEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsAfterEndOf | ActRelationshipStartsAfterEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsAfterOrConcurrentWithEndOf | ActRelationshipStartsAfterOrConcurrentWithEndOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsAfterOrConcurrentWithStartOf | ActRelationshipStartsAfterOrConcurrentWithStartOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsAfterStartOf | ActRelationshipStartsAfterStartOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsAfterStartOfEndsWith | ActRelationshipStartsAfterStartOfEndsWith | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsAfterStartofEndsAfterEndOf | ActRelationshipStartsAfterStartofEndsAfterEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsBeforeEnd | ActRelationshipStartsBeforeEnd | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsBeforeOrConcurrentWithEndOf | ActRelationshipStartsBeforeOrConcurrentWithEndOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsBeforeOrConcurrentWithStartOf | ActRelationshipStartsBeforeOrConcurrentWithStartOf | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsBeforeStartOf | ActRelationshipStartsBeforeStartOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsBeforeStartOfEndsBeforeEndOf | ActRelationshipStartsBeforeStartOfEndsBeforeEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsBeforeStartOfEndsWith | ActRelationshipStartsBeforeStartOfEndsWith | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsConcurrentWith | ActRelationshipStartsConcurrentWith | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsConcurrentWithEnd | ActRelationshipStartsConcurrentWithEnd | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsDuring | ActRelationshipStartsDuring | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsNearEnd | ActRelationshipStartsNearEnd | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsNearStart | ActRelationshipStartsNearStart | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsWithEndsAfterEndOf | ActRelationshipStartsWithEndsAfterEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipStartsWithEndsBeforeEndOf | ActRelationshipStartsWithEndsBeforeEndOf | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSubset | ActRelationshipSubset | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSucceeds | ActRelationshipSucceeds | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSummarizedBy | ActRelationshipSummarizedBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipSymptomaticRelief | ActRelationshipSymptomaticRelief | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipTemporallyPertains | ActRelationshipTemporallyPertains | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipTemporallyPertainsApproximates | ActRelationshipTemporallyPertainsApproximates | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipTemporallyPertainsEnd | ActRelationshipTemporallyPertainsEnd | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipTemporallyPertainsStart | ActRelationshipTemporallyPertainsStart | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipTransformation | ActRelationshipTransformation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipTreats | ActRelationshipTreats | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipType | ActRelationshipType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipUpdate | ActRelationshipUpdate | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipUpdatesCondition | ActRelationshipUpdatesCondition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActRelationshipUses | ActRelationshipUses | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActResearchInformationAccess | ActResearchInformationAccess | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActShortStayEncounterCode | ActShortStayEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSite | v3 Value Set ActSite | active | 2018-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSpecObsCode | ActSpecObsCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSpecObsDilutionCode | ActSpecObsDilutionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSpecObsInterferenceCode | ActSpecObsInterferenceCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSpecObsVolumeCode | ActSpecObsVolumeCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSpecimenTreatmentCode | ActSpecimenTreatmentCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatus | ActStatus | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusAborted | ActStatusAborted | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusAbortedCancelledCompleted | ActStatusAbortedCancelledCompleted | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusActive | ActStatusActive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusActiveAborted | ActStatusActiveAborted | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusActiveSuspendedObsolete | ActStatusActiveSuspendedObsolete | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusCancelled | ActStatusCancelled | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusCompleted | ActStatusCompleted | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusHeld | ActStatusHeld | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusNew | ActStatusNew | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusNormal | ActStatusNormal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusNullified | ActStatusNullified | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusObsolete | ActStatusObsolete | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActStatusSuspended | ActStatusSuspended | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSubstanceAdministrationCode | ActSubstanceAdministrationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSubstanceAdministrationImmunizationCode | ActSubstanceAdministrationImmunizationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSuppliedItemDetectedIssueCode | ActSuppliedItemDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActSupplyFulfillmentRefusalReason | ActSupplyFulfillmentRefusalReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskClinicalNoteEntryCode | ActTaskClinicalNoteEntryCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskClinicalNoteReviewCode | ActTaskClinicalNoteReviewCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskCode | ActTaskCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskMedicationListReviewCode | ActTaskMedicationListReviewCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskMicrobiologyResultsReviewCode | ActTaskMicrobiologyResultsReviewCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskOrderEntryCode | ActTaskOrderEntryCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskPatientDocumentationCode | ActTaskPatientDocumentationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskPatientInformationReviewCode | ActTaskPatientInformationReviewCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTaskRiskAssessmentInstrumentCode | ActTaskRiskAssessmentInstrumentCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTherapyDurationWorkingListCode | ActTherapyDurationWorkingListCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActTransportationModeCode | ActTransportationModeCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActUSPrivacyLaw | ActUSPrivacyLaw | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActUncertainty | ActUncertainty | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ActVirtualEncounterCode | ActVirtualEncounterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdditionalLocator | AdditionalLocator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AddressLine | AddressLine | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AddressPartType | AddressPartType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AddressRepresentationUse | AddressRepresentationUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AddressUse | AddressUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdjudicatedWithAdjustments | AdjudicatedWithAdjustments | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdministrableDrugForm | AdministrableDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdministrationDetectedIssueCode | AdministrationDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdministrationMedicalDevice | AdministrationMedicalDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdministrativeContactRoleType | AdministrativeContactRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdministrativeGender | AdministrativeGender | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AdoptedChild | AdoptedChild | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AerosolDrugForm | AerosolDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AgeDetectedIssueCode | AgeDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AgeGroupObservationValue | AgeGroupObservationValue | active | 2010-03 | uv | hl7 | |
| hl7.terminology.r4b | R4B | v3-Aleut | Aleut | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Algic | Algic | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Algonquian | Algonquian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AlgorithmicDecisionObservationMethod | AlgorithmicDecisionObservationMethod | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AllergyStatus | Allergy Status | active | 2019-03 | uv | hl7 | sct |
| hl7.terminology.r4b | R4B | v3-AllergyTestValue | AllergyTestValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Ambulance | Ambulance | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AmbulanceHIPAA | AmbulanceHIPAA | retired | 2014-03 | uv | hl7 | nucc |
| hl7.terminology.r4b | R4B | v3-AmericanIndianAlaskaNativeLanguages | AmericanIndianAlaskaNativeLanguages | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AmnioticFluidSacRoute | AmnioticFluidSacRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AnnotationType | AnnotationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Apachean | Apachean | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ApplicationMediaType | ApplicationMediaType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AppropriatenessDetectedIssueCode | AppropriatenessDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ArapahoGrosVentre | ArapahoGrosVentre | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Arapahoan | Arapahoan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ArtificialDentition | ArtificialDentition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AskedButUnknown | AskedButUnknown | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AssignedNonPersonLivingSubjectRoleType | AssignedNonPersonLivingSubjectRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Athapaskan | Athapaskan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AthapaskanEyak | AthapaskanEyak | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AudioMediaType | AudioMediaType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AuthorizationIssueManagementCode | AuthorizationIssueManagementCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AuthorizedParticipationFunction | AuthorizedParticipationFunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AuthorizedReceiverParticipationFunction | AuthorizedReceiverParticipationFunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-AutomobileInsurancePolicy | AutomobileInsurancePolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BarDrugForm | BarDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BarSoapDrugForm | BarSoapDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BiliaryRoute | BiliaryRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BindingRealm | BindingRealm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BiotherapeuticNon-personLivingSubjectRoleType | BiotherapeuticNon-personLivingSubjectRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BlisterPackEntityType | BlisterPackEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BodySurfaceRoute | BodySurfaceRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BottleEntityType | BottleEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BuccalMucosaRoute | BuccalMucosaRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BuccalTablet | BuccalTablet | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-BuildingNumber | BuildingNumber | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CUI | CUI | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CUILabel | CUILabel | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CVDiagTherPracticeSetting | CVDiagTherPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Caddoan | Caddoan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Cahitan | Cahitan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Calendar | Calendar | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CalendarCycle | CalendarCycle | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CalendarCycleOneLetter | CalendarCycleOneLetter | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CalendarCycleTwoLetter | CalendarCycleTwoLetter | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CalendarType | CalendarType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CaliforniaAthapaskan | CaliforniaAthapaskan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CapsuleDrugForm | CapsuleDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CardClinPracticeSetting | CardClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CaseTransmissionMode | CaseTransmissionMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Catawba | Catawba | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CecostomyRoute | CecostomyRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CentralAlaskaYukon | CentralAlaskaYukon | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CentralMuskogean | CentralMuskogean | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CentralNumic | CentralNumic | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CentralSalish | CentralSalish | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CervicalRoute | CervicalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Charset | Charset | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Chew | Chew | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Child | Child | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ChildInLaw | ChildInLaw | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Chimakuan | Chimakuan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Chinookan | Chinookan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ChiwereWinnebago | ChiwereWinnebago | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ChronicCareFacility | ChronicCareFacility | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CitizenRoleType | CitizenRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ClaimantCoveredPartyRoleType | ClaimantCoveredPartyRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ClassNullFlavor | ClassNullFlavor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ClinicalResearchEventReason | ClinicalResearchEventReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ClinicalResearchObservationReason | ClinicalResearchObservationReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ClinicalResearchReason | ClinicalResearchReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CochimiYuman | CochimiYuman | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CodeIsNotValid | CodeIsNotValid | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CodeSystem | CodeSystem | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CodeSystemType | CodeSystemType | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CodingRationale | CodingRationale | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CombinedPharmacyOrderSuspendReasonCode | CombinedPharmacyOrderSuspendReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CommunicationFunctionType | CommunicationFunctionType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Compartment | Compartment | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ComplianceAlert | ComplianceAlert | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ComplianceDetectedIssueCode | ComplianceDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CompliancePackageEntityType | CompliancePackageEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CompositeMeasureScoring | CompositeMeasureScoring | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CompressionAlgorithm | CompressionAlgorithm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ConceptPropertyId | ConceptPropertyId | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ConditionDetectedIssueCode | ConditionDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Conditional | Conditional | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Confidentiality | Confidentiality | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ConfidentialityModifiers | ConfidentialityModifiers | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ConsenterParticipationFunction | ConsenterParticipationFunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ConsultedPrescriberManagementCode | ConsultedPrescriberManagementCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContactRoleType | ContactRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContainerCap | ContainerCap | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContainerEntityType | ContainerEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContainerSeparator | ContainerSeparator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContentProcessingMode | ContentProcessingMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextConductionStyle | ContextConductionStyle | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControl | ContextControl | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlAdditive | ContextControlAdditive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlAdditiveNon-propagating | ContextControlAdditiveNon-propagating | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlAdditivePropagating | ContextControlAdditivePropagating | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlNonPropagating | ContextControlNonPropagating | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlOverriding | ContextControlOverriding | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlOverridingNon-propagating | ContextControlOverridingNon-propagating | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlOverridingPropagating | ContextControlOverridingPropagating | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ContextControlPropagating | ContextControlPropagating | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ControlActNullificationReasonCode | ControlActNullificationReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ControlActNullificationRefusalReasonType | ControlActNullificationRefusalReasonType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ControlActReason | ControlActReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ControlledSubstanceMonitoringProtocol | ControlledSubstanceMonitoringProtocol | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Coosan | Coosan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Country | Country | active | 2014-03 | uv | hl7 | iso |
| hl7.terminology.r4b | R4B | v3-Country2 | Country2 | active | 2014-03 | uv | hl7 | iso |
| hl7.terminology.r4b | R4B | v3-CountryEntityType | CountryEntityType | active | 2014-03 | uv | hl7 | iso |
| hl7.terminology.r4b | R4B | v3-CoverageEligibilityReason | CoverageEligibilityReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CoverageLevelObservationValue | CoverageLevelObservationValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CoverageLimitObservationValue | CoverageLimitObservationValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CoverageParticipationFunction | CoverageParticipationFunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CoverageRoleType | CoverageRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CoverageSponsorRoleType | CoverageSponsorRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CoveredPartyRoleType | CoveredPartyRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CreamDrugForm | CreamDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CreditCard | CreditCard | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Cree | Cree | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CreeMontagnais | CreeMontagnais | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-CriticalityObservationValue | CriticalityObservationValue | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Cupan | Cupan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Currency | Currency | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Dakotan | Dakotan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DecisionObservationMethod | Decision Observation Method | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DedicatedClinicalLocationRoleType | DedicatedClinicalLocationRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DedicatedNonClinicalLocationRoleType | DedicatedNonClinicalLocationRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DedicatedServiceDeliveryLocationRoleType | DedicatedServiceDeliveryLocationRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Delawaran | Delawaran | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DeliveryAddressLine | DeliveryAddressLine | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DeltaCalifornia | DeltaCalifornia | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DentistHIPAA | DentistHIPAA | retired | 2014-03 | uv | hl7 | nucc |
| hl7.terminology.r4b | R4B | v3-Dentition | Dentition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DependentCoveredPartyRoleType | DependentCoveredPartyRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DeviceAlertLevel | DeviceAlertLevel | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Dhegiha | Dhegiha | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DiagTherPracticeSetting | DiagTherPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DiagnosisICD9CM | DiagnosisICD9CM | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Diegueno | Diegueno | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Diffusion | Diffusion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DiseaseProgram | DiseaseProgram | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DispensableDrugForm | DispensableDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Dissolve | Dissolve | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DocumentCompletion | DocumentCompletion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DocumentSectionType | DocumentSectionType | active | 2014-03 | uv | hl7 | tho loinc |
| hl7.terminology.r4b | R4B | v3-DocumentStorage | DocumentStorage | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DocumentStorageActive | DocumentStorageActive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DosageProblem | DosageProblem | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DosageProblemDetectedIssueCode | DosageProblemDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DoseDurationDetectedIssueCode | DoseDurationDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DoseDurationHighDetectedIssueCode | DoseDurationHighDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DoseDurationLowDetectedIssueCode | DoseDurationLowDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DoseHighDetectedIssueCode | DoseHighDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DoseIntervalDetectedIssueCode | DoseIntervalDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DoseLowDetectedIssueCode | DoseLowDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Douche | Douche | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DropsDrugForm | DropsDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DrugEntity | Drug Entity | active | 2022-10 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-DuplicateTherapyAlert | DuplicateTherapyAlert | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ECGObservationSeriesType | ECGObservationSeriesType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EPSG-GeodeticParameterDataset | EPSG-GeodeticParameterDataset | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ERPracticeSetting | ERPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EasternAlgonquin | EasternAlgonquin | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EasternApachean | EasternApachean | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EasternMiwok | EasternMiwok | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EducationLevel | EducationLevel | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ElectroOsmosisRoute | ElectroOsmosisRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EligibilityActReasonCode | EligibilityActReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EmergencyMedicalServiceProviderHIPAA | EmergencyMedicalServiceProviderHIPAA | retired | 2014-03 | uv | hl7 | nucc |
| hl7.terminology.r4b | R4B | v3-EmergencyPharmacySupplyType | EmergencyPharmacySupplyType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EmployeeJobClass | EmployeeJobClass | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EmploymentStatusUB92 | EmploymentStatusUB92 | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EncounterAdmissionSource | EncounterAdmissionSource | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EncounterSpecialCourtesy | EncounterSpecialCourtesy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EndocervicalRoute | EndocervicalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EndocrinologyClinic | EndocrinologyClinic | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Enema | Enema | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EnteralRoute | EnteralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntericCoatedCapsule | EntericCoatedCapsule | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntericCoatedTablet | EntericCoatedTablet | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClass | EntityClass | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassAnimal | EntityClassAnimal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassCertificateRepresentation | EntityClassCertificateRepresentation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassChemicalSubstance | EntityClassChemicalSubstance | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassCityOrTown | EntityClassCityOrTown | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassContainer | EntityClassContainer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassCountry | EntityClassCountry | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassCountyOrParish | EntityClassCountyOrParish | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassDevice | EntityClassDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassFood | EntityClassFood | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassGroup | EntityClassGroup | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassHealthChartEntity | EntityClassHealthChartEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassHolder | EntityClassHolder | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassImagingModality | EntityClassImagingModality | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassLivingSubject | EntityClassLivingSubject | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassManufacturedMaterial | EntityClassManufacturedMaterial | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassMaterial | EntityClassMaterial | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassMicroorganism | EntityClassMicroorganism | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassNation | EntityClassNation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassNonPersonLivingSubject | EntityClassNonPersonLivingSubject | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassOrganization | EntityClassOrganization | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassPerson | EntityClassPerson | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassPlace | EntityClassPlace | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassPlant | EntityClassPlant | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassPublicInstitution | EntityClassPublicInstitution | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassRoot | EntityClassRoot | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassState | EntityClassState | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityClassStateOrProvince | EntityClassStateOrProvince | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityCode | EntityCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityDeterminer | EntityDeterminer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityDeterminerDescribedGroup | EntityDeterminerDescribedGroup | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityDeterminerDescribedQuantified | EntityDeterminerDescribedQuantified | retired | 2012-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityDeterminerDetermined | EntityDeterminerDetermined | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityDeterminerSpecific | EntityDeterminerSpecific | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityDeterminerSpecificGroup | EntityDeterminerSpecificGroup | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityHandling | EntityHandling | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityInformationSensitivityPolicy | EntityInformationSensitivityPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityNamePartQualifier | EntityNamePartQualifier | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityNamePartQualifierR2 | EntityNamePartQualifierR2 | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityNamePartType | EntityNamePartType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityNamePartTypeR2 | EntityNamePartTypeR2 | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityNameUse | EntityNameUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityNameUseR2 | EntityNameUseR2 | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityRisk | EntityRisk | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityStatus | EntityStatus | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityStatusActive | EntityStatusActive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityStatusInactive | EntityStatusInactive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityStatusNormal | EntityStatusNormal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EntityStatusNullified | EntityStatusNullified | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EpiduralRoute | EpiduralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EquipmentAlertLevel | EquipmentAlertLevel | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EskimoAleut | EskimoAleut | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Eskimoan | Eskimoan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Ethnicity | Ethnicity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EthnicityHispanic | EthnicityHispanic | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EthnicityHispanicCentralAmerican | EthnicityHispanicCentralAmerican | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EthnicityHispanicMexican | EthnicityHispanicMexican | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EthnicityHispanicSouthAmerican | EthnicityHispanicSouthAmerican | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-EthnicityHispanicSpaniard | EthnicityHispanicSpaniard | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ExpectedSubset | ExpectedSubset | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ExposureMode | ExposureMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ExtendedReleaseCapsule | ExtendedReleaseCapsule | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ExtendedReleaseSuspension | ExtendedReleaseSuspension | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ExtendedReleaseTablet | ExtendedReleaseTablet | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ExtraAmnioticRoute | ExtraAmnioticRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ExtracorporealCirculationRoute | ExtracorporealCirculationRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-FamilyMember | FamilyMember | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-FirstFillPharmacySupplyType | FirstFillPharmacySupplyType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Flush | Flush | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-FoamDrugForm | FoamDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-FontStyle | FontStyle | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-FosterChild | FosterChild | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GIClinicPracticeSetting | GIClinicPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GIDiagTherPracticeSetting | GIDiagTherPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GTIN | GTIN | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GTSAbbreviation | GTSAbbreviation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GTSAbbreviationBase | GTSAbbreviationBase | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GTSAbbreviationHolidays | GTSAbbreviationHolidays | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GTSAbbreviationHolidaysChristianRoman | GTSAbbreviationHolidaysChristianRoman | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GTSAbbreviationHolidaysUSNational | GTSAbbreviationHolidaysUSNational | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GTSAbbreviationOther | GTSAbbreviationOther | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GasDrugForm | GasDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GasLiquidMixture | GasLiquidMixture | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GasSolidSpray | GasSolidSpray | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GastricRoute | GastricRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GelDrugForm | GelDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GenderStatus | GenderStatus | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GeneralAcuteCareHospital | GeneralAcuteCareHospital | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GeneralAddressUse | GeneralAddressUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GeneralPurposeOfUse | GeneralPurposeOfUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GenericUpdateReasonCode | GenericUpdateReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GeneticObservationInterpretation | GeneticObservationInterpretation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GeneticObservationMethod | GeneticObservationMethod | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GeneticObservationType | GeneticObservationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GeneticObservationValue | GeneticObservationValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GenitourinaryRoute | GenitourinaryRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GingivalRoute | GingivalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GrandChild | GrandChild | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Grandparent | Grandparent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GreatGrandparent | GreatGrandparent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-GregorianCalendarCycle | GregorianCalendarCycle | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HL7AccommodationCode | HL7AccommodationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HL7CalendarCycle | HL7CalendarCycle | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HL7FormatCodes | HL7 ValueSet of Format Codes for use with Document Sharing | active | 2024-02 | uv | hl7 | ihe tho |
| hl7.terminology.r4b | R4B | v3-HL7ITSVersionCode | HL7ITSVersionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HL7SearchUse | HL7SearchUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HL7StandardVersionCode | HL7StandardVersionCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HL7UpdateMode | HL7UpdateMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HairRoute | HairRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HalfSibling | HalfSibling | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HealthCareCommonProcedureCodingSystem | HealthCareCommonProcedureCodingSystem | active | 2023-10 | uv | hl7 | cms |
| hl7.terminology.r4b | R4B | v3-HealthQualityMeasureDocument | HealthQualityMeasureDocument | active | 2014-03 | uv | hl7 | loinc |
| hl7.terminology.r4b | R4B | v3-HealthcareServiceLocation | HealthcareServiceLocation | active | 2014-03 | uv | hl7 | cdc cms |
| hl7.terminology.r4b | R4B | v3-HeightSurfaceAreaAlert | HeightSurfaceAreaAlert | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HemClinPracticeSetting | HemClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Hokan | Hokan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HomeAddress | HomeAddress | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Homeless | Homeless | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HospitalPracticeSetting | HospitalPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HospitalUnitPracticeSetting | HospitalUnitPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HtmlLinkType | HtmlLinkType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HumanActSite | HumanActSite | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HumanLanguage | HumanLanguage | retired | 2024-06 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-HumanSubstanceAdministrationSite | HumanSubstanceAdministrationSite | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ICUPracticeSetting | ICUPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IDClinPracticeSetting | IDClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IdentifierReliability | IdentifierReliability | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IdentifierScope | IdentifierScope | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ImageMediaType | ImageMediaType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ImmunizationObservationType | ImmunizationObservationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Implantation | Implantation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IncidentalServiceDeliveryLocationRoleType | IncidentalServiceDeliveryLocationRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IndividualCaseSafetyReportType | IndividualCaseSafetyReportType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IndividualInsuredCoveredPartyRoleType | IndividualInsuredCoveredPartyRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IndividualPackageEntityType | IndividualPackageEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IndustryClassificationSystem | IndustryClassificationSystem | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InformationSensitivityPolicy | InformationSensitivityPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Infusion | Infusion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InhalantDrugForm | InhalantDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Inhalation | Inhalation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InhalerMedicalDevice | InhalerMedicalDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Injection | Injection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InjectionMedicalDevice | InjectionMedicalDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Insertion | Insertion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Instillation | Instillation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Institution | Institution | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntegrityCheckAlgorithm | IntegrityCheckAlgorithm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InteractionDetectedIssueCode | InteractionDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InterameningealRoute | InterameningealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InteriorSalish | InteriorSalish | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InterstitialRoute | InterstitialRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraabdominalRoute | IntraabdominalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraarterialInjection | IntraarterialInjection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraarterialRoute | IntraarterialRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraarticularRoute | IntraarticularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrabronchialRoute | IntrabronchialRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrabursalRoute | IntrabursalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracardiacInjection | IntracardiacInjection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracardiacRoute | IntracardiacRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracartilaginousRoute | IntracartilaginousRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracaudalRoute | IntracaudalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracavernosalRoute | IntracavernosalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracavitaryRoute | IntracavitaryRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracerebralRoute | IntracerebralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracervicalRoute | IntracervicalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracisternalRoute | IntracisternalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracornealRoute | IntracornealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracoronalRoute | IntracoronalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracoronaryInjection | IntracoronaryInjection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracoronaryRoute | IntracoronaryRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntracorpusCavernosumRoute | IntracorpusCavernosumRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntradermalRoute | IntradermalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntradiscalRoute | IntradiscalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraductalRoute | IntraductalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraduodenalRoute | IntraduodenalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraduralRoute | IntraduralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraepidermalRoute | IntraepidermalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraepithelialRoute | IntraepithelialRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraesophagealRoute | IntraesophagealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntragastricRoute | IntragastricRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrailealRoute | IntrailealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntralesionalRoute | IntralesionalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraluminalRoute | IntraluminalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntralymphaticRoute | IntralymphaticRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntramedullaryRoute | IntramedullaryRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntramuscularInjection | IntramuscularInjection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntramuscularRoute | IntramuscularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraocularRoute | IntraocularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraosseousRoute | IntraosseousRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraovarianRoute | IntraovarianRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrapericardialRoute | IntrapericardialRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraperitonealRoute | IntraperitonealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrapleuralRoute | IntrapleuralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraprostaticRoute | IntraprostaticRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrapulmonaryRoute | IntrapulmonaryRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrasinalRoute | IntrasinalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraspinalRoute | IntraspinalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrasternalRoute | IntrasternalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrasynovialRoute | IntrasynovialRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntratendinousRoute | IntratendinousRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntratesticularRoute | IntratesticularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrathecalRoute | IntrathecalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrathoracicRoute | IntrathoracicRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntratrachealRoute | IntratrachealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntratubularRoute | IntratubularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntratumorRoute | IntratumorRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntratympanicRoute | IntratympanicRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntrauterineRoute | IntrauterineRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntravascularRoute | IntravascularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntravenousInfusion | IntravenousInfusion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntravenousInjection | IntravenousInjection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntravenousRoute | IntravenousRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntraventricularRoute | IntraventricularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntravesicleRoute | IntravesicleRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IntravitrealRoute | IntravitrealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InuitInupiaq | InuitInupiaq | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InvoiceElementAdjudicated | InvoiceElementAdjudicated | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InvoiceElementPaid | InvoiceElementPaid | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-InvoiceElementSubmitted | InvoiceElementSubmitted | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IontophoresisRoute | IontophoresisRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Iroquoian | Iroquoian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Irrigation | Irrigation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IrrigationSolution | IrrigationSolution | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-IssueFilterCode | IssueFilterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-JejunumRoute | JejunumRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Kalapuyan | Kalapuyan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Keresan | Keresan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-KiowaTanoan | KiowaTanoan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-KitEntityType | KitEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-KnowledgeSubjectObservationCode | KnowledgeSubjectObservationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue | active | 2010-03 | uv | hl7 | sct rx tho ndc loinc |
| hl7.terminology.r4b | R4B | v3-KnowledgeSubtopicObservationCode | KnowledgeSubtopicObservationCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue | active | 2010-03 | uv | hl7 | sct |
| hl7.terminology.r4b | R4B | v3-KoyukonIngalik | KoyukonIngalik | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-KutchinHan | KutchinHan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LOINCObservationActContextAgeDefinitionCode | LOINCObservationActContextAgeDefinitionCode | active | 2010-03 | uv | hl7 | loinc |
| hl7.terminology.r4b | R4B | v3-LOINCObservationActContextAgeType | LOINCObservationActContextAgeType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LabResultReportingProcessStepCode | LabResultReportingProcessStepCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LabResultTriggerEvents | LabResultTriggerEvents | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LabSpecimenCollectionProviders | LabSpecimenCollectionProviders | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LaboratoryObservationSubtype | Laboratory Observation Sub-Type | active | 2021-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LacrimalPunctaRoute | LacrimalPunctaRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LanguageAbilityMode | LanguageAbilityMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LanguageAbilityProficiency | LanguageAbilityProficiency | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LaryngealRoute | LaryngealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LavageRoute | LavageRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LengthOutOfRange | LengthOutOfRange | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LifeInsurancePolicy | LifeInsurancePolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LineAccessMedicalDevice | LineAccessMedicalDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LingualRoute | LingualRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Liquid | Liquid | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LiquidCleanser | LiquidCleanser | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LiquidLiquidEmulsion | LiquidLiquidEmulsion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LiquidSolidSuspension | LiquidSolidSuspension | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ListStyle | ListStyle | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LivingArrangement | LivingArrangement | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LivingSubjectProductionClass | LivingSubjectProductionClass | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Loan | Loan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LocalMarkupIgnore | LocalMarkupIgnore | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LocalRemoteControlState | LocalRemoteControlState | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-LogicalObservationIdentifierNamesAndCodes | LogicalObservationIdentifierNamesAndCodes | active | 2014-03 | uv | hl7 | loinc |
| hl7.terminology.r4b | R4B | v3-LoincDocumentOntologyInternational | LoincDocumentOntologyInternational | active | 2014-03 | uv | hl7 | loinc |
| hl7.terminology.r4b | R4B | v3-LotionDrugForm | LotionDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Maiduan | Maiduan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedCarePolicy | ManagedCarePolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedParticipationStatus | ManagedParticipationStatus | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedParticipationStatusActive | ManagedParticipationStatusActive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedParticipationStatusCancelled | ManagedParticipationStatusCancelled | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedParticipationStatusCompleted | ManagedParticipationStatusCompleted | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedParticipationStatusNormal | ManagedParticipationStatusNormal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedParticipationStatusNullified | ManagedParticipationStatusNullified | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManagedParticipationStatusPending | ManagedParticipationStatusPending | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ManufacturerModelNameExample | Manufacturer Model Name Example | active | 2022-10 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MapRelationship | MapRelationship | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MaritalStatus | MaritalStatus | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MaterialDangerInfectious | MaterialDangerInfectious | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MaterialDangerInflammable | MaterialDangerInflammable | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MaterialEntityClassType | MaterialEntityClassType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MedOncClinPracticeSetting | MedOncClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MediaType | MediaType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MedicalDevice | MedicalDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MedicationCap | MedicationCap | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MedicationGeneralizationRoleType | MedicationGeneralizationRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MedicationObservationType | MedicationObservationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MedicationOrderAbortReasonCode | MedicationOrderAbortReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MedicationOrderReleaseReasonCode | MedicationOrderReleaseReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MemberRoleType | MemberRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MessageWaitingPriority | MessageWaitingPriority | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MilitaryHospital | MilitaryHospital | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MilitaryRoleType | MilitaryRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MississippiValley | MississippiValley | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MissouriRiver | MissouriRiver | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Miwokan | Miwokan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MobileUnit | MobileUnit | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MobilityImpaired | MobilityImpaired | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ModelMediaType | ModelMediaType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ModifyIndicator | ModifyIndicator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ModifyPrescriptionReasonType | ModifyPrescriptionReasonType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MucosalAbsorptionRoute | MucosalAbsorptionRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MucousMembraneRoute | MucousMembraneRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MultiUseContainerEntityType | MultiUseContainerEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-MultipartMediaType | MultipartMediaType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Muskogean | Muskogean | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NUCCProviderCodes | NUCCProviderCodes | active | 2014-03 | uv | hl7 | nucc |
| hl7.terminology.r4b | R4B | v3-Nadene | Nadene | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NailRoute | NailRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NameLegalUse | NameLegalUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NasalInhalation | NasalInhalation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NasalRoute | NasalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NationEntityType | NationEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NativeEntityAlaska | NativeEntityAlaska | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NativeEntityContiguous | NativeEntityContiguous | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NaturalChild | NaturalChild | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NaturalParent | NaturalParent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NaturalSibling | NaturalSibling | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Nebulization | Nebulization | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NebulizationInhalation | NebulizationInhalation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NephClinPracticeSetting | NephClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NieceNephew | NieceNephew | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NoInformation | NoInformation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NonDrugAgentEntity | NonDrugAgentEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NonRigidContainerEntityType | NonRigidContainerEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Nootkan | Nootkan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NorthernCaddoan | NorthernCaddoan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NorthernIroquoian | NorthernIroquoian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NullFlavor | NullFlavor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Numic | Numic | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-NursingOrCustodialCarePracticeSetting | NursingOrCustodialCarePracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObligationPolicy | ObligationPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationActContextAgeGroupType | ObservationActContextAgeGroupType | active | 2010-03 | uv | hl7 | loinc |
| hl7.terminology.r4b | R4B | v3-ObservationActContextAgeType | ObservationActContextAgeType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationAlert | ObservationAlert | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationAllergyType | ObservationAllergyType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationAssetValue | ObservationAssetValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationCategory | ObservationCategory | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationCoordinateAxisType | ObservationCoordinateAxisType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationCoordinateSystemType | ObservationCoordinateSystemType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationDetectedIssueCode | ObservationDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationDiagnosisTypes | ObservationDiagnosisTypes | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationDrugIntoleranceType | ObservationDrugIntoleranceType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationEligibilityIndicatorValue | ObservationEligibilityIndicatorValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationEnvironmentalIntoleranceType | ObservationEnvironmentalIntoleranceType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationFoodIntoleranceType | ObservationFoodIntoleranceType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationHealthStatusValue | ObservationHealthStatusValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationIncomeValue | ObservationIncomeValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretation | ObservationInterpretation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationChange | ObservationInterpretationChange | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationDetected | ObservationInterpretationDetected | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationExceptions | ObservationInterpretationExceptions | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationExpectation | ObservationInterpretationExpectation | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationNormality | ObservationInterpretationNormality | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationNormalityAbnormal | ObservationInterpretationNormalityAbnormal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationNormalityCriticallyAbnormal | ObservationInterpretationNormalityCriticallyAbnormal | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationNormalityHigh | ObservationInterpretationNormalityHigh | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationNormalityLow | ObservationInterpretationNormalityLow | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationOustsideThreshold | ObservationInterpretationOustsideThreshold | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationProtocolInclusion | ObservationInterpretationProtocolInclusion | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationInterpretationSusceptibility | ObservationInterpretationSusceptibility | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationIntoleranceType | ObservationIntoleranceType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationIssueTriggerCodedObservationType | ObservationIssueTriggerCodedObservationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationLivingDependencyValue | ObservationLivingDependencyValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationLivingExpenseValue | ObservationLivingExpenseValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationLivingSituationValue | ObservationLivingSituationValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationMeasureCountableItems | ObservationMeasureCountableItems | active | 2010-03 | uv | hl7 | sct |
| hl7.terminology.r4b | R4B | v3-ObservationMeasureScoring | ObservationMeasureScoring | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationMeasureType | ObservationMeasureType | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationMethod | ObservationMethod | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationMethodAggregate | ObservationMethodAggregate | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationNonAllergyIntoleranceType | ObservationNonAllergyIntoleranceType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationPopulationInclusion | ObservationPopulationInclusion | retired | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationQualityMeasureAttribute | ObservationQualityMeasureAttribute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationSequenceType | ObservationSequenceType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationSeriesType | ObservationSeriesType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationSocioEconomicStatusValue | ObservationSocioEconomicStatusValue | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ObservationType | ObservationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OilDrugForm | OilDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OintmentDrugForm | OintmentDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Ojibwayan | Ojibwayan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OphthalmicRoute | OphthalmicRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OralCapsule | OralCapsule | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OralInhalation | OralInhalation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OralRoute | OralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OralSolution | OralSolution | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OralSuspension | OralSuspension | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OralTablet | OralTablet | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OrderableDrugForm | OrderableDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OrderedListStyle | OrderedListStyle | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OregonAthapaskan | OregonAthapaskan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OrganizationEntityType | OrganizationEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OrganizationIndustryClassNAICS | OrganizationIndustryClassNAICS | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OrganizationNamePartQualifier | OrganizationNamePartQualifier | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OrganizationNameUse | OrganizationNameUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OromucosalRoute | OromucosalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OropharyngealRoute | OropharyngealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OrthoClinPracticeSetting | OrthoClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Other | Other | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OtherActionTakenManagementCode | OtherActionTakenManagementCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OticRoute | OticRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OutpatientFacilityPracticeSetting | OutpatientFacilityPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-OverriderParticipationFunction | OverriderParticipationFunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PacificCoastAthapaskan | PacificCoastAthapaskan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PackageEntityType | PackageEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PadDrugForm | PadDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Pai | Pai | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Palaihnihan | Palaihnihan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParanasalSinusesRoute | ParanasalSinusesRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Parent | Parent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParentInLaw | ParentInLaw | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParenteralRoute | ParenteralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PartialCompletionScale | PartialCompletionScale | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationAdmitter | ParticipationAdmitter | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationAnalyte | ParticipationAnalyte | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationAncillary | ParticipationAncillary | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationAttender | ParticipationAttender | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationAuthenticator | ParticipationAuthenticator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationAuthorOriginator | ParticipationAuthorOriginator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationBaby | ParticipationBaby | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationBeneficiary | ParticipationBeneficiary | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationCallbackContact | ParticipationCallbackContact | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationCatalyst | ParticipationCatalyst | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationCausativeAgent | ParticipationCausativeAgent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationConsultant | ParticipationConsultant | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationConsumable | ParticipationConsumable | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationCoverageTarget | ParticipationCoverageTarget | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationCustodian | ParticipationCustodian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationDataEntryPerson | ParticipationDataEntryPerson | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationDestination | ParticipationDestination | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationDischarger | ParticipationDischarger | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationDistributor | ParticipationDistributor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationDonor | ParticipationDonor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationEntryLocation | ParticipationEntryLocation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationEscort | ParticipationEscort | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationExposureagent | ParticipationExposureagent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationExposureparticipation | ParticipationExposureparticipation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationExposuresource | ParticipationExposuresource | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationExposuretarget | ParticipationExposuretarget | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationFunction | ParticipationFunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationGuarantorParty | ParticipationGuarantorParty | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationHolder | ParticipationHolder | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationIndirectTarget | ParticipationIndirectTarget | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationInformant | ParticipationInformant | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationInformationGenerator | ParticipationInformationGenerator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationInformationRecipient | ParticipationInformationRecipient | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationInformationTranscriber | ParticipationInformationTranscriber | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationLegalAuthenticator | ParticipationLegalAuthenticator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationMode | ParticipationMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationModeElectronicData | ParticipationModeElectronicData | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationModeVerbal | ParticipationModeVerbal | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationModeWritten | ParticipationModeWritten | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationNon-reuseableDevice | ParticipationNon-reuseableDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationOrigin | ParticipationOrigin | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationParticipation | ParticipationParticipation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationPhysicalPerformer | ParticipationPhysicalPerformer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationPrimaryInformationRecipient | ParticipationPrimaryInformationRecipient | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationPrimaryPerformer | ParticipationPrimaryPerformer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationProduct | ParticipationProduct | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationReceiver | ParticipationReceiver | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationRecordTarget | ParticipationRecordTarget | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationReferredBy | ParticipationReferredBy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationReferredTo | ParticipationReferredTo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationReferrer | ParticipationReferrer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationRemote | ParticipationRemote | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationResponsibleParty | ParticipationResponsibleParty | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationReusableDevice | ParticipationReusableDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationSecondaryPerformer | ParticipationSecondaryPerformer | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationSignature | ParticipationSignature | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationSpecimen | ParticipationSpecimen | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationSubset | ParticipationSubset | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationTargetDevice | ParticipationTargetDevice | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationTargetDirect | ParticipationTargetDirect | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationTargetLocation | ParticipationTargetLocation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationTargetSubject | ParticipationTargetSubject | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationTracker | ParticipationTracker | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationType | ParticipationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationTypeCDASectionOverride | ParticipationTypeCDASectionOverride | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationUgentNotificationContact | ParticipationUgentNotificationContact | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationVerifier | ParticipationVerifier | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationVia | ParticipationVia | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ParticipationWitness | ParticipationWitness | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PastSubset | PastSubset | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PasteDrugForm | PasteDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PatchDrugForm | PatchDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PatientImmunizationRelatedObservationType | PatientImmunizationRelatedObservationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PatientImportance | PatientImportance | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PatientProfileQueryReasonCode | PatientProfileQueryReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PaymentTerms | PaymentTerms | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PayorParticipationFunction | PayorParticipationFunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PayorRoleType | PayorRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PedsClinPracticeSetting | PedsClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PedsICUPracticeSetting | PedsICUPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PedsPracticeSetting | PedsPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Penutian | Penutian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PerianalRoute | PerianalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PeriarticularRoute | PeriarticularRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PeriduralRoute | PeriduralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PerinealRoute | PerinealRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PerineuralRoute | PerineuralRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PeriodontalRoute | PeriodontalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PermanentDentition | PermanentDentition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PersonDisabilityType | PersonDisabilityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PersonNameUse | PersonNameUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PersonalAndLegalRelationshipRoleType | PersonalAndLegalRelationshipRoleType | active | 2023-06 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PersonalRelationshipRoleType | PersonalRelationshipRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PharmacistHIPAA | PharmacistHIPAA | retired | 2014-03 | uv | hl7 | nucc |
| hl7.terminology.r4b | R4B | v3-PharmacySupplyEventAbortReason | PharmacySupplyEventAbortReason | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PharmacySupplyEventStockReasonCode | PharmacySupplyEventStockReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PharmacySupplyRequestFulfillerRevisionRefusalReasonCode | PharmacySupplyRequestFulfillerRevisionRefusalReasonCode | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PharmacySupplyRequestRenewalRefusalReasonCode | PharmacySupplyRequestRenewalRefusalReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Pidgin | Pidgin | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PillDrugForm | PillDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PlaceEntityType | PlaceEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PlasticBottleEntityType | PlasticBottleEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PlateauPenutian | PlateauPenutian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PolicyOrProgramCoverageRoleType | PolicyOrProgramCoverageRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Pomoan | Pomoan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PopulationInclusionObservationType | PopulationInclusionObservationType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PostalAddressUse | PostalAddressUse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PowderDrugForm | PowderDrugForm | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PowerOfAttorney | PowerOfAttorney | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PrescriptionDispenseFilterCode | PrescriptionDispenseFilterCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PrimaryDentition | PrimaryDentition | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PrivacyMark | PrivacyMark | active | 2019-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PrivateResidence | PrivateResidence | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ProbabilityDistributionType | ProbabilityDistributionType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ProcessingID | ProcessingID | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ProcessingMode | ProcessingMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ProgramEligibleCoveredPartyRoleType | ProgramEligibleCoveredPartyRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ProvenanceEventCurrentState-AS | ProvenanceEventCurrentState-AS | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ProvenanceEventCurrentState-DC | ProvenanceEventCurrentState-DC | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ProvenanceEventCurrentState | ProvenanceEventCurrentState | active | 2014-08 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PublicHealthcareProgram | PublicHealthcareProgram | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PulmonaryRoute | PulmonaryRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-PurposeOfUse | PurposeOfUse | active | 2024-02 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-QualityMeasureSectionType | QualityMeasureSectionType | active | 2014-03 | uv | hl7 | loinc |
| hl7.terminology.r4b | R4B | v3-QualitySpecimenRoleType | QualitySpecimenRoleType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-QueryPriority | QueryPriority | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-QueryRequestLimit | QueryRequestLimit | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-QueryResponse | QueryResponse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-QueryStatusCode | QueryStatusCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ROIOverlayShape | ROIOverlayShape | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Race | Race | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAfricanAmericanAfrican | RaceAfricanAmericanAfrican | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanIndian | RaceAlaskanIndian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanIndianAthabascan | RaceAlaskanIndianAthabascan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNative | RaceAlaskanNative | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeAleut | RaceAlaskanNativeAleut | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeAleutAlutiiq | RaceAlaskanNativeAleutAlutiiq | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeAleutBristolBay | RaceAlaskanNativeAleutBristolBay | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeAleutChugach | RaceAlaskanNativeAleutChugach | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeAleutKoniag | RaceAlaskanNativeAleutKoniag | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeAleutUnangan | RaceAlaskanNativeAleutUnangan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeEskimo | RaceAlaskanNativeEskimo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeInupiatEskimo | RaceAlaskanNativeInupiatEskimo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeSiberianEskimo | RaceAlaskanNativeSiberianEskimo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAlaskanNativeYupikEskimo | RaceAlaskanNativeYupikEskimo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndian | RaceAmericanIndian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianApache | RaceAmericanIndianApache | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianArapaho | RaceAmericanIndianArapaho | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianAssiniboineSioux | RaceAmericanIndianAssiniboineSioux | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCaddo | RaceAmericanIndianCaddo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCahuilla | RaceAmericanIndianCahuilla | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCalifornia | RaceAmericanIndianCalifornia | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianChemakuan | RaceAmericanIndianChemakuan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCherokee | RaceAmericanIndianCherokee | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCheyenne | RaceAmericanIndianCheyenne | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianChickahominy | RaceAmericanIndianChickahominy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianChinook | RaceAmericanIndianChinook | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianChippewa | RaceAmericanIndianChippewa | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianChippewaCree | RaceAmericanIndianChippewaCree | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianChoctaw | RaceAmericanIndianChoctaw | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianChumash | RaceAmericanIndianChumash | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianComanche | RaceAmericanIndianComanche | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCoushatta | RaceAmericanIndianCoushatta | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCreek | RaceAmericanIndianCreek | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianCupeno | RaceAmericanIndianCupeno | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianDelaware | RaceAmericanIndianDelaware | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianDiegueno | RaceAmericanIndianDiegueno | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianEasternTribes | RaceAmericanIndianEasternTribes | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianGrosVentres | RaceAmericanIndianGrosVentres | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianHoopa | RaceAmericanIndianHoopa | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianIowa | RaceAmericanIndianIowa | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianIroquois | RaceAmericanIndianIroquois | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianKickapoo | RaceAmericanIndianKickapoo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianKiowa | RaceAmericanIndianKiowa | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianKlallam | RaceAmericanIndianKlallam | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianLongIsland | RaceAmericanIndianLongIsland | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianLuiseno | RaceAmericanIndianLuiseno | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianMaidu | RaceAmericanIndianMaidu | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianMiami | RaceAmericanIndianMiami | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianMicmac | RaceAmericanIndianMicmac | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianNavajo | RaceAmericanIndianNavajo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianNorthwestTribes | RaceAmericanIndianNorthwestTribes | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianOttawa | RaceAmericanIndianOttawa | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPaiute | RaceAmericanIndianPaiute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPassamaquoddy | RaceAmericanIndianPassamaquoddy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPawnee | RaceAmericanIndianPawnee | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPeoria | RaceAmericanIndianPeoria | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPequot | RaceAmericanIndianPequot | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPima | RaceAmericanIndianPima | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPomo | RaceAmericanIndianPomo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPonca | RaceAmericanIndianPonca | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPotawatomi | RaceAmericanIndianPotawatomi | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPueblo | RaceAmericanIndianPueblo | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianPugetSoundSalish | RaceAmericanIndianPugetSoundSalish | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianSacFox | RaceAmericanIndianSacFox | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianSeminole | RaceAmericanIndianSeminole | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianSerrano | RaceAmericanIndianSerrano | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianShawnee | RaceAmericanIndianShawnee | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianShoshone | RaceAmericanIndianShoshone | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianShoshonePaiute | RaceAmericanIndianShoshonePaiute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianSioux | RaceAmericanIndianSioux | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianTohonoOOdham | RaceAmericanIndianTohonoOOdham | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianUmpqua | RaceAmericanIndianUmpqua | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianUte | RaceAmericanIndianUte | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianWampanoag | RaceAmericanIndianWampanoag | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianWashoe | RaceAmericanIndianWashoe | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianWinnebago | RaceAmericanIndianWinnebago | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianYuman | RaceAmericanIndianYuman | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAmericanIndianYurok | RaceAmericanIndianYurok | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceAsian | RaceAsian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceBlackOrAfricanAmerican | RaceBlackOrAfricanAmerican | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceCanadianLatinIndian | RaceCanadianLatinIndian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceHawaiianOrPacificIsland | RaceHawaiianOrPacificIsland | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceNativeAmerican | RaceNativeAmerican | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RacePacificIslandMelanesian | RacePacificIslandMelanesian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RacePacificIslandMicronesian | RacePacificIslandMicronesian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RacePacificIslandPolynesian | RacePacificIslandPolynesian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceSoutheastAlaskanIndian | RaceSoutheastAlaskanIndian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceSoutheastAlaskanIndianTlingit | RaceSoutheastAlaskanIndianTlingit | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceSoutheastAlaskanIndianTsimshian | RaceSoutheastAlaskanIndianTsimshian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceWhite | RaceWhite | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceWhiteArab | RaceWhiteArab | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceWhiteEuropean | RaceWhiteEuropean | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RaceWhiteMiddleEast | RaceWhiteMiddleEast | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RadDiagTherPracticeSetting | RadDiagTherPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ReactionDetectedIssueCode | ReactionDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ReactionParticipant | ReactionParticipant | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ReactivityObservationInterpretation | ReactivityObservationInterpretation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RectalInstillation | RectalInstillation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RectalRoute | RectalRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RefillPharmacySupplyType | RefillPharmacySupplyType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RefrainPolicy | RefrainPolicy | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RefusalReasonCode | RefusalReasonCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RegulationPolicyActCode | RegulationPolicyActCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RehabilitationHospital | RehabilitationHospital | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RelatedReactionDetectedIssueCode | RelatedReactionDetectedIssueCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RelationalOperator | RelationalOperator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RelationshipConjunction | RelationshipConjunction | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RepetitionsOutOfRange | RepetitionsOutOfRange | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ResearchSubjectRoleBasis | ResearchSubjectRoleBasis | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ResidentialTreatmentPracticeSetting | ResidentialTreatmentPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ResourceGroupEntityType | ResourceGroupEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RespiratoryTractRoute | RespiratoryTractRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ResponseLevel | ResponseLevel | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ResponseModality | ResponseModality | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ResponseMode | ResponseMode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-ResponsibleParty | ResponsibleParty | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RetrobulbarRoute | RetrobulbarRoute | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RheumClinPracticeSetting | RheumClinPracticeSetting | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RigidContainerEntityType | RigidContainerEntityType | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Rinse | Rinse | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-Ritwan | Ritwan | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-River | River | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClass | RoleClass | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAccess | RoleClassAccess | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassActiveIngredient | RoleClassActiveIngredient | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassActiveIngredientBasis | RoleClassActiveIngredientBasis | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassActiveIngredientMoietyBasis | RoleClassActiveIngredientMoietyBasis | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassActiveIngredientReferenceBasis | RoleClassActiveIngredientReferenceBasis | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassActiveMoiety | RoleClassActiveMoiety | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAdditive | RoleClassAdditive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAdjacency | RoleClassAdjacency | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAdjuvant | RoleClassAdjuvant | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAdministerableMaterial | RoleClassAdministerableMaterial | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAffiliate | RoleClassAffiliate | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAgent | RoleClassAgent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAliquot | RoleClassAliquot | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAssignedEntity | RoleClassAssignedEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassAssociative | RoleClassAssociative | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassBase | RoleClassBase | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassBirthplace | RoleClassBirthplace | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassCaregiver | RoleClassCaregiver | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassCaseSubject | RoleClassCaseSubject | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassChild | RoleClassChild | active | 2012-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassCitizen | RoleClassCitizen | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassClaimant | RoleClassClaimant | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassClinicalResearchInvestigator | RoleClassClinicalResearchInvestigator | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassClinicalResearchSponsor | RoleClassClinicalResearchSponsor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassColorAdditive | RoleClassColorAdditive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassCommissioningParty | RoleClassCommissioningParty | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassConnection | RoleClassConnection | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassContact | RoleClassContact | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassContactCode | RoleClassContactCode | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassContaminantIngredient | RoleClassContaminantIngredient | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassContent | RoleClassContent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassContinuity | RoleClassContinuity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassCoverageSponsor | RoleClassCoverageSponsor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassCoveredParty | RoleClassCoveredParty | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassCredentialedEntity | RoleClassCredentialedEntity | active | 2012-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassDedicatedServiceDeliveryLocation | RoleClassDedicatedServiceDeliveryLocation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassDependent | RoleClassDependent | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassDistributedMaterial | RoleClassDistributedMaterial | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassEmergencyContact | RoleClassEmergencyContact | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassEmployee | RoleClassEmployee | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassEquivalentEntity | RoleClassEquivalentEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassEventLocation | RoleClassEventLocation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassExposedEntity | RoleClassExposedEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassExposureAgentCarrier | RoleClassExposureAgentCarrier | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassExposureVector | RoleClassExposureVector | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassFlavorAdditive | RoleClassFlavorAdditive | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassFomite | RoleClassFomite | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassGuarantor | RoleClassGuarantor | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassGuardian | RoleClassGuardian | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassHasGeneric | RoleClassHasGeneric | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassHealthChart | RoleClassHealthChart | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassHealthcareProvider | RoleClassHealthcareProvider | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassHeldEntity | RoleClassHeldEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassICSRInvestigationSubject | RoleClassICSRInvestigationSubject | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassIdentifiedEntity | RoleClassIdentifiedEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassInactiveIngredient | RoleClassInactiveIngredient | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassIncidentalServiceDeliveryLocation | RoleClassIncidentalServiceDeliveryLocation | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassIndividual | RoleClassIndividual | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassIngredientEntity | RoleClassIngredientEntity | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassInstance | RoleClassInstance | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassInvestigationSubject | RoleClassInvestigationSubject | active | 2014-03 | uv | hl7 | tho |
| hl7.terminology.r4b | R4B | v3-RoleClassInvoicePayor http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.107 | Attempted Vacuum Procedure (NCHS) | draft | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.108 | Fetal Presentation at Birth- Breech (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.109 | Fetal Presentation at Birth- Cephalic (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.11 | Newborn Given Surfactant Replacement (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.110 | Fetal Presentation at Birth- Other (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.111 | Route and Method of Delivery - Spontaneous (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.112 | Route and Method of Delivery - Forceps (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.113 | Route and Method of Delivery - Vacuum (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.114 | Route and Method of Delivery - Cesarean (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.115 | Route Method of Delivery - Trial of Labor (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.116 | Route and Method of Delivery - Scheduled C (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.117 | Measured Height (NCHS) | active | 2013-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.118 | Pre-Pregnancy Weight (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.119 | Problem Status Active (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.12 | 5 Min Apgar Score (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.120 | Mothers Delivery Weight (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.121 | Previous Other Pregnancy Outcomes (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.122 | Number of Previous Live Births Now Dead (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.123 | Number of Previous Live Births Now Living (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.124 | Obstetric Estimate of Gestation (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.125 | Cervical Cerclage (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.127 | External Cephalic Version (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.128 | Tocolysis (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.129 | Premature Rupture (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.13 | 10 Min Apgar Score (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.130 | Precipitous Labor (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.131 | Prolonged Labor (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.132 | Birth Plurality of Delivery (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.133 | First Prenatal Care Visit (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.135 | Number Prenatal Care Visits (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.136 | Prepregnancy Diabetes (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.137 | Gestational Diabetes (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.138 | Prepregnancy Hypertension (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.139 | Gestational Hypertension (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.14 | Delivery (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.140 | Eclampsia (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.141 | Preterm Birth (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.142 | Poor Pregnancy Outcome History (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.143 | Infertility Treatment (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.144 | Fertility Enhancing Drugs (NCHS) | active | 2015-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.145 | Artificial or Intrauterine Insemination (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.146 | Assistive Reproductive Technology (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.147 | Listeria (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.148 | Number of Previous Cesareans (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.149 | Neonatal Death (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.15 | Physician (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.150 | Hysterotomy Hysterectomy (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.151 | Fetus Weight (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.153 | Fetal Autopsy (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.154 | Karyotype Determination (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.155 | Education Level 8th (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.156 | Education Level - 9 - 12 No Diploma (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.157 | Education Level - High School (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.158 | Education Level Some College (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.159 | Education Level Associate (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.16 | Doctor of Osteopathic Medicine (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.160 | Education Level Baccalaureate (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.161 | Education Level Graduate Degree (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.164 | Number of Fetal Deaths This Delivery (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.166 | Group B Streptococcus (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.167 | Cytomegalovirus (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.168 | Parvovirus (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.169 | Toxoplasmosis (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.17 | Certified Midwife (NCHS) | active | 2013-01 | us | | nucc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.170 | Married (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.171 | Never Married (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.172 | Previously Married (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176 | Transferred for Maternal Medical or Fetal Indicat | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.177 | Transfer In (NCHS) | active | 2014-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.178 | Antibiotic Administration Procedure (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.179 | Stated Height (NCHS) | active | 2013-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.18 | Midwife (NCHS) | active | 2015-01 | us | | nucc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.180 | Conception Date (NCHS) | active | 2013-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.184 | Birthplace Setting (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.185 | Time of Death (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.187 | Number of Preterm Births (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.188 | ICU Care (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.189 | Cleft Palate Alone (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.19 | U.S. Territories (NCHS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.190 | Transfer to Facility (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.191 | Institution Referred To (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.192 | Birth Place Hospital (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.193 | Birth Place Home Intended (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.194 | Birth Place Home Unintended (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.195 | Birth Place Home Unknown Intention (NCHS) | active | 2014-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.196 | Birth Place Freestanding Birthing Center (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.197 | Birth Place Clinic Office (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.198 | NICU Care (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.2 | Facility Location ICU (NCHS) | active | 2013-01 | us | | cdc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.20 | Birth Weight (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.22 | Augmentation of Labor - Procedure (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.23 | Augmentation of Labor - Medication (NCHS) | active | 2015-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.24 | Chorioamnionitis During Labor (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.25 | Fever Greater Than 100.4 (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.26 | Epidural Anesthesia - Medication (NCHS) | active | 2014-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.27 | Epidural Anesthesia - Procedure (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.28 | Spinal Anesthesia - Medication (NCHS) | active | 2014-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.29 | Spinal Anesthesia - Procedure (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.3 | Antibiotics (NCHS) | active | 2015-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.30 | Fetal Intolerance of Labor (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.31 | In-utero Resuscitation (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.32 | Further Fetal Assessment (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.33 | Operative Delivery (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.34 | Induction of Labor (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.35 | Spontaneous Onset of Labor (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.36 | Meconium Staining (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.37 | Non-vertex presentation in active phase of (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.38 | Glucocortico Steroids (NCHS) | active | 2014-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.39 | Immature Fetus (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.4 | IV Medication Administration Route (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.40 | Inflammation Indication (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.41 | Breastfed Infant (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.42 | Male Gender (NCHS) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.43 | Female Gender (NCHS) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.5 | IM Medication Administration Route (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.53 | Anencephaly of the Newborn (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.54 | Cyanotic Congenital Heart Disease (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.55 | Congenital Diaphragmatic Hernia (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.56 | Karyotype Confirmed (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.57 | Suspected Chromosomal Disorder (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.58 | Cleft Lip with or without Cleft Palate (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.59 | Karyotype Result (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.6 | Neonatal Sepsis (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.60 | Cleft Lip without Cleft Palate (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.61 | Down Syndrome (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.62 | Gastroschisis of the Newborn (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.63 | Hypospadias (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.65 | Meningomyelocele/Spina Bifida - Newborn (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.66 | Omphalocele of the Newborn (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.67 | Date of Last Live Birth (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.68 | Number of Live Births (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.69 | Date of Last Menses (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.70 | Date of Last Other Pregnancy Outcome (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.71 | Number of Prior Pregnancies (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.72 | Hispanic Ethnicity - Mexican (NCHS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.73 | Hispanic Ethnicity - Puerto Rican (NCHS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.74 | Hispanic Ethnicity - Cuban (NCHS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.75 | Other Hispanic Ethnicity (NCHS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.76 | Not Hispanic Ethnicity (NCHS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.77 | Father (NCHS) | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.81 | Race - Asian Indian (NCHS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.9 | Significant Birth Injury (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.93 | Chlamydia (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.95 | Pregnant (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.96 | Hepatitis B (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.97 | Hepatitis C (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.98 | Syphilis (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.99 | Transfusion Whole Blood or Packed Red Bld (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.11 | JCIH-EHDI Hearing Loss Risk Factors | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.12 | JCIH-EHDI Hearing Loss Risk Factors - Procedures | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.13 | JCIH-EHDI NICU Service Delivery Location | active | 2010-01 | us | | cdc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.14 | JCIH-EHDI Newborn Hearing Loss Diagnosis | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.15 | JCIH-EHDI Reason for no Hearing Loss Diagnosis | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.16 | JCIH-EHDI Newborn Hearing Loss Referrals | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.17 | JCIH-EHDI Newborn Hearing Procedure | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.2 | JCIH-EHDI Outpatient Encounter | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.20 | JCIH-EHDI Procedure Declined | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.7 | JCIH-EHDI Reason for no Follow-up - Patient Reason | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.8 | JCIH-EHDI Hearing Screen Left | active | 2010-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.9 | JCIH-EHDI Hearing Screen Right | active | 2010-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.1 | Autopsy Performed (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.13 | Family History (HW) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.14 | Mother Breastfeeding (HW) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.17 | Laboratory Tests (HW) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.19 | Associated Conditions (HW) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.2 | Autopsy Not Performed (NCHS) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.4 | Discharge Death (NCHS) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.6 | Death Certification (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7 | Interventions (HW) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.8 | Dietary Behavior (HW) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.9 | Physical Activity Behavior (HW) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.75 | Joint Commission Medical Reason | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.11222.4.11.5025 | Original Specimen Type Modifier PHLIP | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98 | Route of Administration | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.1 | Administrative Gender (HL7 V3) | active | 2019-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10267 | Participation Function (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10637 | Postal Address Use (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12199 | Language Ability Proficiency (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12212 | Marital Status Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12249 | LanguageAbilityMode Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.14914 | Race Value Set | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.15913 | Entity Name Use (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.159331 | Act Status | active | 2016-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.16866 | Act Priority (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.16926 | Basic Confidentiality Kind (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.18877 | Coverage Role Type Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19185 | Religious Affiliation Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19563 | Personal Relationship Role Type Value Set | active | 2014-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19579 | Family Member Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19601 | x_ServiceEventPerformer (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19717 | No Immunization Reason Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2 | Advance Directive Type Value Set | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.78 | Observation Interpretation (HL7) | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.1 | Amniotic Fluid Conditions (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.10 | Type of Twin (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.11 | Twin Placenta (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.12 | Umbilical Cord Complication (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.13 | Infant Fetal Complications (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) | active | 2017-01 | us | | sct loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.2 | Cord Insertion Type (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.3 | Hospital Care-Setting (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.4 | Maternal Exposures (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.5 | Intended Newborn Feeding Type (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.6 | Placenta Type (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.7 | Placental Conditions (HL7) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.9 | Type of Recreational Drug (HL7) | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.91 | Birth Defects Diagnostic Confirmation (HL7) | active | 2016-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.93 | Birth Defects Laterality at Diagnosis (HL7) | active | 2016-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.10 | eICR Processing Status Reason Detail Type (eCR) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.11 | eICR Initiation | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.3 | Determination of Reportability (eCR) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.4 | External Resource Type (eCR) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.5 | Reportability Priority (eCR) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.6 | Location Relevance (eCR) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.7 | eICR Processing Status Reason (eCR) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.8 | eICR Processing Status (eCR) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.19465 | Healthcare Provider Taxonomy Code (NUCC) | active | 2019-01 | us | | nucc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.12.1 | Personal And Legal Relationship Role Type (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.18 | MoodCodeEvnInt (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.20 | Telecom Use - US Realm Header (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.21 | AgePQ_UCUM | active | 2016-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.22 | Procedure Act Status Code (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.23 | Planned moodCode - Act/Encounter/Procedure (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.24 | Planned moodCode - SubstanceAdministration/Supply | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.25 | Planned moodCode - Observation (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.26 | Entity Person Name Part Qualifier (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.33 | Role Class Codes (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.34 | Patient Education | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.38 | Current Smoking Status (NAACCR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.41 | Tobacco Use | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.60 | Priority Level (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.19 | Healthcare Service Location (NHSN) | active | 2018-01 | us | | cdc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.277 | Birth Defect Diagnosis | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.1 | Immunization Funding Source Excluding Nulls | active | 2012-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.2 | Pt Immunization Registry Status Excluding Nulls | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.3 | Race Category Excluding Nulls | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.4 | Immunization Refusal Reason Excluding Nulls | active | 2012-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.5.20.1 | USDA Subject Descriptor | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.5.20.2 | USDA Subject Function | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.1 | NAACCR Laterality at Diagnosis | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.10 | NAACCR TNM Clinical Stage Descriptor | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.11 | NAACCR Cancer Status | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.12 | NAACCR Quality of Survival | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.13 | NAACCR Screening Result | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.14 | NAACCR Behavior Code | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.15 | NAACCR Grade | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.16 | NAACCR ICD-9-CM Cancer Reportability List | active | 2012-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.21 | TNM Pathologic Stage Descriptor (NAACCR) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.22 | Laterality (NAACCR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.25 | Radiation Rx and Boost Radiation ICD10-PCS (NAACCR | active | 2015-01 | us | | cms |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.26 | Radiation Rx and Boost Radiation SNOMEDCT (NAACCR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.27 | NAACCR TNM Pathologic Staged By (NAACCR) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.29 | NAACCR SNOMEDCT Cancer Reportability List | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.3 | NAACCR Diagnostic Confirmation | active | 2012-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.4 | NAACCR TNM Clinical Staged By | active | 2012-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.5 | NAACCR TNM Edition Number | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.3.2 | Contact Type Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.4.2 | Provider Role Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.2 | Allergy/Adverse Event Type Value Set | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.8 | Problem Severity | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type Value Set | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.4 | Problem Value Set | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.11 | Medication Product Form Value Set | active | 2014-01 | us | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.19 | Medication Type Value Set | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.7 | Medication Route FDA Value Set | active | 2014-01 | us | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.16 | Medication Brand Name Value Set | active | 2022-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.18 | Medication Drug Class Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.21 | Medication Vehicle Value Set | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.39 | Immunization Information Source | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.46 | Document Class Value Set | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.47 | Document Type Value Set | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.60 | Social History Type Value Set | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.62 | Vital Sign Result Value Set | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.64 | Medication Fill Status Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.65 | V3 Result Status Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.66 | Patient Class Value Set | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.68 | Problem Status | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.2.11.7101 | VPD Reason for Study | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1000 | Identity Reliability Code (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1002 | Lab Test Result Name | active | 2020-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1003 | Observation Method | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1004 | Ordered Test | active | 2020-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1006 | Type of Long Term Care Facility | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1007 | Major Site of Disease (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1009 | Microorganism | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1011 | Data Subtype | active | 2008-01 | us | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1012 | Type of Data | active | 2008-01 | us | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1013 | Missing Lab Result Reason | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1014 | Modifier or Qualifier | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1015 | Nationally Notifiable Disease Surveillance System (NNDSS) & Other Conditions of Public Health Importance | active | 2022-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1016 | Nationally Notifiable Infectious Disease reportable to the Nationally Notifiable Disease Surveillance System | active | 2016-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1017 | Nature of Abnormal Test (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1018 | Non Paint Lead Source | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1019 | Non-paint lead source - hobby related | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1021 | Number Of Lesions (VZ) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1023 | Response Flag (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1024 | Extended Priority Codes (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1025 | Order Status (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1026 | Pregnancy Trimester | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1027 | Previous Vaccine History | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1028 | Processing ID (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1029 | Processing Mode (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1031 | Public Health Case Record Type | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1032 | Rash Distribution (VZ) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1036 | Referral Status (CRA) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1037 | Risk Category | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1038 | Sex (MFU) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1039 | Specimen Appropriateness (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1040 | Specimen Child Role (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1041 | Specimen Collection Method (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1042 | Specimen Condition | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1043 | Specimen Quality (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1044 | Specimen Reject Reason (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1045 | Specimen Risk | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1046 | Specimen Role | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1047 | Specimen Treatment | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1048 | Strain Type (VZ) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1049 | Substance Administered (CRA) | active | 2008-01 | us | | cvx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1050 | Batch Deactivation Reason | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) | active | 2015-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1053 | Volume Units | active | 2008-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1054 | Volume Mass Units | active | 2008-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1055 | Universal ID Type (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1057 | Vaccine Contraindications | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1058 | Vaccine Purchased With Funds | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1059 | Value Type (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1061 | PHIN Questions (TB) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1062 | PHIN Questions (Varicella) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1063 | PHIN Questions (Lead Case) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1064 | PHIN Questions (Lead Laboratory Report) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1065 | PHIN Questions (Lead Environmental) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1066 | Healthcare Provider Taxonomy (HIPAA) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1067 | Body Substance | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1068 | Event | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1069 | Material | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1071 | Drug Susceptibility Test Result Name | active | 2008-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name | active | 2008-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1074 | Animal | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1075 | Physical Object | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1076 | Situation with Explicit Context | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1089 | Botulism-like Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1090 | Fever Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1091 | Gastrointestinal Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1092 | Hemorrhagic Illness Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1093 | Localized Cutaneous Lesion Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1094 | Lymphadenitis Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1095 | Neurological Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1096 | Rash Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1097 | Respiratory Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1098 | Severe Illness Or Death Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1099 | Specific Infection Syndrome (BT) | active | 2008-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1100 | Industry (NAICS) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1102 | Drug Active Ingredients | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1103 | Semantic Clinical Drug (Ingredient plus strength and dose form) | active | 2020-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1104 | Semantic Clinical Drug Form (Ingredient plus dose form) | active | 2020-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1105 | Drug Product (NDC) | active | 2008-01 | us | | ndc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1106 | Drug Manufacturers (NDC) | active | 2008-01 | us | | ndc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1107 | Notification Section Header | active | 2015-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1108 | Drug Classes (NDF-RT) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1109 | Procedure by Site (SNOMED) | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3000 | PHLIP Questions (Flu) | active | 2014-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3014 | Source of Comment (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3015 | Ethnicity Group including Unknown | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3016 | Lab Test Order (PHLIP Flu) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) | active | 2019-01 | us | | nucc sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3018 | Patient Location Status at Specimen Collection | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3019 | Resulted Lab Test Name (PHLIP Flu) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3020 | Specimen Source (PHLIP) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3021 | Preferred Method of Contact (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3022 | PHIN Questions (Hepatitis) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3023 | Immunization Body Site | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3025 | Case Confirmation Method | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3026 | Case Detection Method | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3027 | Case Transmission Mode | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3028 | Contact Type (Hepatitis A) | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3029 | Contact Type (Hepatitis B and C) | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3030 | Disease Acquired Jurisdiction | active | 2014-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3031 | Incarceration Type (Hepatitis) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3032 | Notifiable Condition (Hepatitis) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3034 | Outbreak Type (Hepatitis) | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3035 | Reason For Test (Hepatitis) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3036 | Reporting Source Type | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) | active | 2013-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3038 | Vaccine Dose Number (Hepatitis) | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3039 | Isolate Availability EIP Testing | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3040 | Isolate Not Available EIP Test Reason | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3041 | Isolate Not Received Reason | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3042 | Isolate Not Sent To NARMS Reason | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3043 | Lab Test Result Name (Hepatitis) | active | 2008-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3044 | Microbiology strain | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3045 | Microorganism (Hepatitis) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3046 | Specimen Reshipment Reason | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3047 | Specimen Shipped | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3048 | Lab Test Interpretation | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3049 | Lab Test Result Qualitative | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3050 | PHIN Questions (Animal Rabies) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3051 | PHIN Questions (ArboNet) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3052 | PHIN Questions (FDD) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3053 | PHIN Questions (Generic) | active | 2011-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3054 | PHIN Questions (VPD) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3055 | ECOTOX Chemicals (EPA) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3056 | STORET Chemicals (EPA) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3057 | TRI Chemicals (EPA) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3058 | Cancer Type | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3059 | Clinical Syndrome (Arbovirus) | active | 2016-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3060 | Immunosuppressed Condition | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3061 | Public Private Lab | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3062 | Transplant Organ | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3063 | Virus Type (Arboviral Disease) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3064 | Yes No Unknown No Answer | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3065 | Age Category (Animal) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3066 | Bat Species (Animal Rabies) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3067 | Virus Variant Type (Animal Rabies) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3070 | Botulism Food Source Type (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3072 | Animal Type (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3073 | Botulinum Toxin Type (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3074 | Case Traced to Carrier | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3075 | Cholera Risk Factor (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3076 | Cholera Sequelae (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3077 | Cholera Signs Symptoms (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3079 | Day Care Type (FDD) | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3080 | Eosin Units (FDD) | active | 2008-01 | us | | ucum sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3081 | Fetal Neonatal Infection Type (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3083 | Food Cooking Method (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3084 | Food Processing Method (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3088 | Information Source | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3089 | Interview Status | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3090 | Lettuce Type (FDD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3091 | Maternal Infection (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3093 | Non Pork Type (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3094 | Other Related Cases | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3095 | Outbreak Type (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3096 | Pork Type (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3100 | Seafood Type (FDD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3103 | Suspected Food Consumed (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3104 | Swimming Pool Type (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3105 | Tap Water Source (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3106 | Travel Destination Type | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3107 | Travel Mode | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3108 | Travel Purpose | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3109 | Travelers Health Info Source | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3110 | Trichinellosis Signs Symptoms (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3111 | Typhoid Signs Symptoms (FDD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3112 | Underlying Conditions | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3114 | Well Water Treatment (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3115 | Wound History | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3116 | Notifiable Condition (FDD) | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3117 | Body Site (FDD) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3118 | Medication Treatment (FDD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3119 | Acute Convalescent IgG Difference (VPD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3120 | Antibiotic Received (Pertussis) | active | 2015-01 | us | | sct rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3121 | Birth Attendees (VPD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3122 | Birth Location (VPD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3124 | Body Region (Tetanus) | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3125 | Case Classification Exposure Source | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3126 | Genotype (Measles) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3127 | Genotype (Rubella) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3130 | Injury Type (VPD) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3131 | Lab Result (Pertussis) | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3132 | Lab Result (Rubella) | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3133 | Live Birth Outcome (Rubella) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3135 | Non-Live Birth Outcome (VPD) | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3136 | PCR Performed Lab Location (VPD) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3137 | Prenatal Care Provider (Rubella) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3138 | Relationship (VPD) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3139 | Serology Performed Lab Location (Pertussis) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3142 | Test Method EIA IgM | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3143 | Tetanus Type (VPD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3147 | Medication Received (VZ) | active | 2008-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3149 | Lab Test Method (VZ) | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3150 | IgM Test Type (VZ) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3151 | IgG Test Type (VZ) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3152 | Whole Cell ELISA Manufacturer (VZ) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3153 | gp ELISA Manufacturer (VZ) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3154 | Vaccines Administered (VZ) | active | 2008-01 | us | | cvx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3155 | Vaccine Manufacturer (VZ) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3156 | Reporting Area (TB) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3157 | RVCT Link Reason (TB) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3158 | Case Count Status (TB) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3159 | Reporting Lab Type | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3160 | Microscopic Exam Type (TB) | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3162 | Risk Factors (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3163 | Immigration Status | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3166 | Cause of Death Related to TB | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3167 | Therapy Extended Reason (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3168 | Education Level | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3169 | Birth Country (TB) | active | 2016-01 | us | | iso tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3200 | Birth Country | active | 2019-01 | us | | iso tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3201 | Geographical location history | active | 2009-01 | us | | iso tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3203 | Treatment status | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3204 | Non-Laboratory Intervention and Procedure | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3205 | Lab Test Result Name (TB) | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3207 | Lab Test Result Name (Anthrax) | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3208 | Lab Test Result Name (Tularemia) | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3209 | Exposure Location | active | 2009-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3210 | Contact Type (Hepatitis B) | active | 2009-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3211 | Material exposure type | active | 2009-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3212 | Signs and Symptoms (Anthrax) | active | 2009-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3214 | Signs and Symptoms (TB) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3215 | Signs and Symptoms (Tularemia) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3216 | Medication Treatment (Anthrax) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3217 | Medication Treatment (Tularemia) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3218 | Medication Treatment (TB) | active | 2009-01 | us | | rx oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3219 | Vaccine Administered (Hepatitis B) | active | 2009-01 | us | | cvx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3220 | Disease Type (Anthrax) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3222 | Disease Type (TB) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3223 | Disease Type (Tularemia) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3224 | Blood or body fluid exposure event | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3225 | Blood or body fluid exposure frequency | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3226 | Blood or body fluid exposure related procedure | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3227 | Location performing blood or body fluid exposure procedure | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor | active | 2009-01 | us | | sct loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3230 | Disease Type (Hepatitis) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3231 | Disease Type (STD) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3232 | HIV Status (PHCR) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3236 | National Reporting Jurisdiction | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3237 | PHIN Questions (Mumps) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3238 | PHIN Questions (Measles) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3239 | PHIN Questions (Summary) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3240 | Flu Signs and Symptoms | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3241 | Notifiable Event Condition (Flu) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3242 | Risk Factor (Flu) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3243 | Lab Test Finding (Flu) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) | active | 2009-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3245 | Radiology Lab Test (Flu) | active | 2009-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3246 | Specimen (Flu) | active | 2009-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3250 | Vaccines Administered (Flu) | active | 2009-01 | us | | cvx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3251 | Lab Test Procedure (Flu) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3252 | Lab Test Interpretation (Flu) | active | 2009-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3253 | Obesity Severity (Flu) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3254 | Employment Status (Flu) | active | 2009-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3255 | Case Contact Signs and Symptoms (Flu) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3256 | Time Frame (Daily Weekly) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3257 | Surveillance Method (Novel Flu) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3258 | Change Pattern | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3259 | Age Group (Flu) | active | 2009-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3260 | Count Group Type (Flu) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3261 | Death Location (Flu) | active | 2009-01 | us | | cdc sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3262 | Lab Test Procedure (Pediatric Flu) | active | 2009-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3263 | Lab Test Interpretation (Pediatric Flu) | active | 2009-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) | active | 2009-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3265 | Positive Negative Unknown | active | 2009-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) | active | 2009-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) | active | 2009-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) | active | 2009-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) | active | 2009-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3270 | Therapy 7 Days Prior or After Illness Onset (Pediatric Flu) | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3271 | Therapy Prior Illness Onset (Pediatric Flu) | active | 2009-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3272 | Therapy After Illness Onset (Pediatric Flu) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3273 | Vaccines Administered (Pediatric Flu) | active | 2009-01 | us | | cvx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3274 | Timing Prior To Illness Onset | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3275 | Relationship (Flu) | active | 2009-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3276 | PHIN Questions (Flu Summary) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3277 | PHIN Questions (Flu) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3278 | PHIN Questions (Pediatric Flu) | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3279 | H1N1 Vaccine Manufacturer | active | 2009-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3282 | Specimen Collection Method | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3285 | Anatomical Entity (Body Site) | active | 2009-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3286 | Country Subdivision (ISO 3166-2) | active | 2010-01 | us | | iso |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3287 | Immunization Funding Source (IIS) | active | 2016-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3288 | Vaccination Contraindication (IIS) | active | 2010-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3289 | Vaccination Reaction and Adverse Event (IIS) | active | 2012-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3290 | Vaccination Special Indication (IIS) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3291 | Immunization Profile Identifier (IIS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3292 | Immunization Schedule Identifier (IIS) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3293 | Evidence Of Immunity (IIS) | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3294 | PHIN Questions (CRS) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3295 | PHIN Questions (Malaria) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3298 | PHIN Questions (Rubella) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3299 | PHIN Questions (Strep Pneumo) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3300 | Lab Test Procedure (Rubella) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) | active | 2022-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) | active | 2010-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) | active | 2010-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) | active | 2010-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3305 | Type of Deafness (Mumps) | active | 2010-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) | active | 2010-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) | active | 2010-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3308 | Complications (Malaria) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3309 | Lab Test Procedure (Malaria) | active | 2016-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) | active | 2010-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3311 | Medication Prophylaxis (Malaria) | active | 2019-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) | active | 2019-01 | us | | sct rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3313 | Species (Malaria) | active | 2010-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3314 | Specimen Type (Malaria) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3315 | Travel Reason (Malaria) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3316 | Antimicrobial Agent (IPD) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3317 | Antimicrobial Susceptibility Test Method (IPD) | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3318 | Bacterial Infection Syndrome (IPD) | active | 2010-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) | active | 2010-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) | active | 2010-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) | active | 2010-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3322 | Underlying Conditions (IPD) | active | 2010-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3323 | Birth Outcome (Rubella) | active | 2010-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) | draft | | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3337 | Event Type (HL7) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3338 | Coding System HL7 2x Table 0396 | active | 2021-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3339 | Check Digit Scheme (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3340 | Specimen Action Code (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3341 | Message Type (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3342 | Version ID (HL7) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3343 | Abnormal Flag (HL7 27) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3344 | Accept Application Acknowledgment Conditions (HL7) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3345 | Type of Referenced Data (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3346 | Organizational Name Type (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3347 | Alternate Character Sets (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3348 | Visit Indicator (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3349 | Message Structure (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3350 | Alternate Character Set Handling Scheme (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3351 | Name Assembly Order (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3352 | Name Address Representation (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3353 | TQ Conjunction ID (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3354 | Order Type (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3355 | Authorization Mode (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3356 | Risk Codes (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3357 | Observation Result Handling (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3358 | Lab Test Name (NND) | active | 2010-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3359 | Evaluation Finding | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3362 | Event Type (IIS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3363 | Patient Class (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3364 | Message Type (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3365 | Relationship (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3366 | Financial Class (IIS) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3367 | Version ID (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3368 | Order Control Code (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3369 | Route Of Administration (IIS) | active | 2018-01 | us | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3370 | Administrative Site (IIS) | active | 2019-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3371 | Name Type (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3372 | Identifier Type (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3373 | Organizational Name Type (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3374 | Query Response Status (IIS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3375 | Action Code (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3376 | Message Structure (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3377 | Immunization Registry Status (HL7) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3378 | Immunization Registry Status (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3379 | Query Name (IIS) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3380 | Substance Refusal Reason (IIS) | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3381 | Observation Identifier (IIS) | active | 2010-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3382 | Query Priority (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3383 | Quantity Limited Request (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3384 | Publicity Code (IIS) | active | 2010-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3392 | Value Type (IIS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3401 | Facility / Visit Type (Syndromic Surveillance) | active | 2019-01 | us | | cdc nucc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3402 | Age Unit (Syndromic Surveillance) | active | 2011-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3403 | Gender (Syndromic Surveillance) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3404 | Patient Class (Syndromic Surveillance) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3405 | Race Category including Unknown | active | 2011-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3406 | Disease Acquired Jurisdiction (NETSS) | active | 2011-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3407 | Case Class Status (NETSS) | active | 2011-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3408 | Age Unit (NETSS) | active | 2011-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3409 | Transmission Setting (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3410 | Vaccine Not Given Reasons (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3411 | Body Region Tetanus (NETSS) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3412 | Injury Occurred Environment (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3413 | Injury Type (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3414 | Birth Attendees (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3415 | Vaccines Administered (NETSS) | active | 2011-01 | us | | cvx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3416 | Manufacturers Of Vaccines (NETSS) | active | 2011-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3418 | Sexual Preference (NETSS) | active | 2011-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3419 | Lab Test Result Lyme (NETSS) | active | 2011-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3420 | Microorganism (NETSS) | active | 2011-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3421 | Bacterial Infection Syndrome (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3422 | Associated Conditions (NETSS) | active | 2011-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3423 | Antibiotic Treatment (NETSS) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3424 | Hemodialysis Contact Type Hepatitis (NETSS) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) | active | 2011-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3428 | Result Status (NETSS) | active | 2011-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3432 | Serogroup (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3434 | Antimicrobial Agent NETSS | active | 2011-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3435 | Serotype (NETSS) | active | 2011-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3501 | Bacterial Infectious Disease | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3502 | Infectious Disease | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3503 | Pneumonia Disease | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3587 | Flu Activity Code | active | 2010-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3588 | Method of Race and Ethnicity Data Collection | active | 2010-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3589 | Observation Identifier (Syndromic Surveillance) | active | 2017-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3590 | Pulse Oximetry Unit | active | 2010-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 | Source of Payment Typology (PHDSC) | active | 2021-01 | us | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3593 | Cause of Death (ICD-10) | draft | | us | | icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3594 | Campylobacter Organism | active | 2010-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3597 | Identifier Type (Syndromic Surveillance) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3598 | Wound Depth Tetanus (NETSS) | active | 2011-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3599 | Time Period Tetanus (NETSS) | active | 2011-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3600 | Stay Period Hepatitis (NETSS) | active | 2011-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4000 | Lab Result (Amebiasis) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4001 | Lab Result (Anaplasma) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4002 | Lab Result (Anthrax) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4003 | Lab Result (Arbovirus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4004 | Lab Result (Arenavirus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4005 | Lab Result (Babesiosis) | active | 2015-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4006 | Lab Result (Bartonellosis) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4007 | Lab Result (Blastomycosis) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4008 | Lab Result (Botulism) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4009 | Lab Result (Brucellosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4010 | Lab Result (California serogroup virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4011 | Lab Result (Campylobacteriosis) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4012 | Lab Result (Chagas) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4013 | Lab Result (Chancroid) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4014 | Lab Result (Chlamydia trachomatis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4015 | Lab Result (Cholera) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4016 | Lab Result (Clostridium perfringens) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4017 | Lab Result (Clostridium perfringens Epsilon Toxin) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4018 | Lab Result (Coccidioidomycosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4019 | Lab Result (Colorado Tick Fever) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4020 | Lab Result (Creutzfeldt-Jakob disease) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4021 | Lab Result (Cryptococcosis) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4022 | Lab Result (Cryptosporidiosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4023 | Lab Result (Cyclosporiasis) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4024 | Lab Result (Cysticercosis) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4025 | Lab Result (Dengue) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4026 | Lab Result (Diphtheria) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4027 | Lab Result (Eastern equine encephalitis virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4028 | Lab Result (Ebolavirus) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4029 | Lab Result (E. coli STEC) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4030 | Lab Result (Ehrlichia chaffeensis) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4031 | Lab Result (Ehrlichia ewingii) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4032 | Lab Result (Ehrlichiosis Anaplasmosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4033 | Lab Result (Genital Warts) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4034 | Lab Result (Giardiasis) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4035 | Lab Result (Glanders) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4036 | Lab Result (Gonorrhea) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4037 | Lab Result (Granuloma Inguinale) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4038 | Lab Result (Haemophilus influenzae) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4039 | Lab Result (Hansen's Disease) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4040 | Lab Result (Hantavirus Pulmonary Syndrome) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4041 | Lab Result (Hendra virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4042 | Lab Result (Hepatitis A) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4043 | Lab Result (Hepatitis B) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4044 | Lab Result (Hepatitis C) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4045 | Lab Result (Hepatitis D) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4046 | Lab Result (Hepatitis E) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4047 | Lab Result (Herpes Simplex) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4048 | Lab Result (Histoplasmosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4049 | Lab Result (HIV) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4050 | Lab Result (Influenza A virus, H1N1 2009 strain) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4051 | Lab Result (Jamestown Canyon virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4052 | Lab Result (Legionellosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4053 | Lab Result (Leptospirosis) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4054 | Lab Result (Listeriosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4055 | Lab Result (Lyme disease) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4056 | Lab Result (Lymphogranuloma Venereum) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4057 | Lab Result (Malaria) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4058 | Lab Result (Marburgvirus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4059 | Lab Result (Measles) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4060 | Lab Result (Melioidosis) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4061 | Lab Result (Meningococcal Disease) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4062 | Lab Result (Monkeypox Orthopox) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4063 | Lab Result (MRSA) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4064 | Lab Result (Mumps) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4065 | Lab Result (Nipah Virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4066 | Lab Result (Nongonococcal Urethritis) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4067 | Lab Result (Nontuberculous Mycobacteria) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4068 | Lab Result (Norovirus) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4069 | Lab Result RCMT (Pertussis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4070 | Lab Result (Plague) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4071 | Lab Result (Polio) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4072 | Lab Result (Powassan virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4073 | Lab Result (Prion Disease) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4074 | Lab Result (Psittacosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4075 | Lab Result (Q Fever) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4076 | Lab Result (Rabies) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4077 | Lab Result (Relapsing Fever) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4078 | Lab Result (Respiratory Syncytial Virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4079 | Lab Result (Rickettsial infection, other) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4080 | Lab Result (Rift Valley Fever) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4081 | Lab Result (Rotavirus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4082 | Lab Result RCMT (Rubella) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4083 | Lab Result (Salmonellosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4084 | Lab Result (SARS) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4085 | Lab Result (Shigella) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4086 | Lab Result (Smallpox) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4087 | Lab Result (Spotted fever rickettsiosis) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4088 | Lab Result (Staphylococcus aureus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4089 | Lab Result (Staphylococcus aureus enterotoxin B) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4090 | Lab Result (Staphylococcus aureus food poisoning) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4091 | Lab Result (Staphylococcal TSS) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4092 | Lab Result (St. Louis encephalitis virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4093 | Lab Result (Streptococcus pneumoniae) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4094 | Lab Result (Streptococcal TSS) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4095 | Lab Result (Streptococcus, group A) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4096 | Lab Result (Streptococcus, group B) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4097 | Lab Result (Syphilis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4098 | Lab Result (Tetanus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4099 | Lab Result (Toxoplasmosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4100 | Lab Result (Trichinellosis) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4101 | Lab Result (Tuberculosis) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4102 | Lab Result (Tularemia) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4103 | Lab Result (Typhoid Fever) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4104 | Lab Result (Typhus group rickettsiosis) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4105 | Lab Result (Vaccinia) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4106 | Lab Result (Vancomycin resistant Enterococcus) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4107 | Lab Result (Varicella) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4108 | Lab Result (Vesicular Stomatitis) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4109 | Lab Result (Vibriosis, non-cholera) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4110 | Lab Result (Viral Hemorrhagic Fever) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4111 | Lab Result (VISA) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4112 | Lab Result (VRSA) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4113 | Lab Result (Western equine encephalitis virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4114 | Lab Result (West Nile virus) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4115 | Lab Result (Yellow Fever) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4116 | Lab Result (Yersiniosis) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4117 | Lab Test Name (Amebiasis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4118 | Lab Test Name (Anaplasma) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4119 | Lab Test Name (Anthrax) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4120 | Lab Test Name (Arbovirus) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4122 | Lab Test Name (Babesiosis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4123 | Lab Test Name (Bartonellosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4124 | Lab Test Name (Blastomycosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4125 | Lab Test Name (Botulism) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4126 | Lab Test Name (Brucellosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4127 | Lab Test Name (California serogroup virus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4128 | Lab Test Name (Campylobacteriosis) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4129 | Lab Test Name (Chagas) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4130 | Lab Test Name (Chancroid) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4131 | Lab Test Name (Chlamydia trachomatis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4132 | Lab Test Name (Cholera) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4133 | Lab Test Name (Clostridium perfringens) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4134 | Lab Test Name (Coccidioidomycosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4135 | Lab Test Name (Colorado Tick Fever) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4137 | Lab Test Name (Cryptococcosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4138 | Lab Test Name (Cryptosporidiosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4139 | Lab Test Name (Cyclosporiasis) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4140 | Lab Test Name (Cysticercosis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4141 | Lab Test Name (Dengue) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4142 | Lab Test Name (Diphtheria) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4143 | Lab Test Name (Eastern equine encephalitis virus) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4145 | Lab Test Name (E. coli STEC) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4146 | Lab Test Name (Ehrlichia chaffeensis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4147 | Lab Test Name (Ehrlichia ewingii) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4148 | Lab Test Name (Ehrlichiosis Anaplasmosis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4149 | Lab Test Name (Giardiasis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4150 | Lab Test Name (Glanders) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4151 | Lab Test Name (Gonorrhea) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4152 | Lab Test Name (Granuloma Inguinale) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4153 | Lab Test Name (Haemophilus influenzae) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4155 | Lab Test Name (Hantavirus Pulmonary Syndrome) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4157 | Lab Test Name (Hepatitis A) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4158 | Lab Test Name (Hepatitis B) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4159 | Lab Test Name (Hepatitis C) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4160 | Lab Test Name (Hepatitis D) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4161 | Lab Test Name (Hepatitis E) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4162 | Lab Test Name (Herpes Simplex) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4163 | Lab Test Name (Histoplasmosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4164 | Lab Test Name (HIV) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4165 | Lab Test Name (Influenza A virus, H1N1 2009 strain) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4166 | Lab Test Name (Jamestown Canyon virus) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4167 | Lab Test Name (Legionellosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4168 | Lab Test Name (Leptospirosis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4169 | Lab Test Name (Listeriosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4170 | Lab Test Name (Lyme disease) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4171 | Lab Test Name (Lymphogranuloma Venereum) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4172 | Lab Test Name (Malaria) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4174 | Lab Test Name (Measles) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4175 | Lab Test Name (Melioidosis) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4176 | Lab Test Name (Meningococcal Disease) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4177 | Lab Test Name (Monkeypox Orthopox) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4178 | Lab Test Name (MRSA) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4179 | Lab Test Name (Mumps) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4181 | Lab Test Name (Nongonococcal Urethritis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4182 | Lab Test Name (Nontuberculous Mycobacteria) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4183 | Lab Test Name (Norovirus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4184 | Lab Test Name (Pertussis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4185 | Lab Test Name (Plague) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4186 | Lab Test Name (Polio) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4187 | Lab Test Name (Powassan virus) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4188 | Lab Test Name (Prion Disease) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4189 | Lab Test Name (Psittacosis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4190 | Lab Test Name (Q Fever) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4191 | Lab Test Name (Rabies) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4192 | Lab Test Name (Relapsing Fever) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4193 | Lab Test Name (Respiratory Syncytial Virus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4194 | Lab Test Name (Rickettsial infection, other) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4195 | Lab Test Name (Rift Valley Fever) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4196 | Lab Test Name (Rotavirus) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4197 | Lab Test Name (Rubella) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4198 | Lab Test Name (Salmonellosis) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4199 | Lab Test Name (SARS) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4200 | Lab Test Name (Shigella) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4201 | Lab Test Name (Smallpox) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4202 | Lab Test Name (Spotted fever rickettsiosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4203 | Lab Test Name (Staphylococcus aureus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4204 | Lab Test Name (Staphylococcus aureus enterotoxin B) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4205 | Lab Test Name (Staphylococcus aureus food poisoning) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4206 | Lab Test Name (Staphylococcal TSS) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4207 | Lab Test Name (St. Louis encephalitis virus) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4208 | Lab Test Name (Streptococcus pneumoniae) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4210 | Lab Test Name (Streptococcus, group A) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4211 | Lab Test Name (Streptococcus, group B) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4212 | Lab Test Name (Syphilis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4213 | Lab Test Name (Tetanus) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4214 | Lab Test Name (Toxoplasmosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4215 | Lab Test Name (Trichinellosis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4216 | Lab Test Name (Tuberculosis) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4217 | Lab Test Name (Tularemia) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4218 | Lab Test Name (Typhoid Fever) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4219 | Lab Test Name (Typhus group rickettsiosis) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4220 | Lab Test Name (Vaccinia) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4221 | Lab Test Name (Vancomycin resistant Enterococcus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4222 | Lab Test Name (Varicella) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4223 | Lab Test Name (Vesicular Stomatitis) | active | 2016-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4224 | Lab Test Name (Non-Cholera Vibrio) | active | 2016-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4225 | Lab Test Name (Viral Hemorrhagic Fever) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4228 | Lab Test Name (Western equine encephalitis virus) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4229 | Lab Test Name (West Nile virus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4230 | Lab Test Name (Yellow Fever) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4231 | Lab Test Name (Yersiniosis) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4239 | Lab Test Name (Diabetes, hemoglobin A1c) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4240 | Lab Test Name (Asbestosis) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4241 | Lab Test Name (Berylliosis) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4242 | Lab Test Name (Ricin poisoning) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4243 | Lab Test Name (Mushroom poisoning) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4244 | Lab Test Name (Carbon monoxide poisoning) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4245 | Lab Test Name (Pesticide poisoning) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4246 | Lab Test Name (Arsenic poisoning) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4247 | Lab Test Name (Cadmium poisoning) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4248 | Lab Test Name (Lead poisoning) | active | 2016-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4249 | Lab Test Name (Mercury poisoning) | active | 2016-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4250 | Lab Test Name (Acid fast stain) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4251 | Lab Test Name (Bacteria) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4252 | Lab Test Name (Fungus) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4253 | Lab Test Name (Microorganism) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4254 | Lab Test Name (Mycobacteria) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4255 | Lab Test Name (Parasite) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4256 | Lab Test Name (Virus) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4257 | Lab Test Name (Antimicrobial susceptibility tests) | active | 2011-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4258 | Lab Test Name (TB Antimicrobial susceptibility test) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4275 | Lab Result (Cancer Morphology) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4276 | Lab Result (Pesticide) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5000 | Universal Identifier (HL7) (PHLIP) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5001 | Specimen Type PHLIP | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5002 | Order Control Codes (HL7) (PHLIP) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5004 | Specimen Reject Reason (SCT) (PHLIP) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5005 | Lab Test Order (PHLIP Sal) | active | 2011-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5006 | Value Type (HL7) (PHLIP) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5007 | Specimen Related Observations (PHLIP Sal) | active | 2011-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5013 | Suspected Agent (PHLIP Sal) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5014 | Observation Result Status (PHLIP) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5015 | Role (PHLIP) | active | 2011-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5016 | Organization Unit (PHLIP) | active | 2011-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5017 | Resulted Lab Test Name PHLIP Salmonella | active | 2011-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5020 | Acknowledgment Code (HL7) (PHLIP) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5021 | Original Specimen Source Site PHLIP (PLT212) | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5022 | Original Specimen Source Site Modifier PHLIP | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5023 | Original Specimen Collection Method PHLIP | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5024 | Original Specimen Type PHLIP | active | 2011-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5026 | Lab Test Result PHLIP Salmonella | active | 2011-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5027 | Identifier Type (HL7) (PHLIP for PID3.5) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5028 | Method Detail (PHLIP) | active | 2011-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6000 | Problem Goal Action Code (HL7) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6001 | Certifier Types (NCHS) | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6002 | Manner of Death (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6003 | Pregnancy Status (NCHS) | active | 2014-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6004 | Contributory Tobacco Use (NCHS) | active | 2014-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6005 | Transportation Relationships (NCHS) | active | 2014-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6006 | Legacy Reporting Jurisdiction (CDS) | active | 2011-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6013 | Lab Test Type (Hepatitis) | active | 2022-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6014 | Lab Test Type Enzymes (Hepatitis) | active | 2012-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6027 | Smoking Status (PI) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6036 | Occupation (Census) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6037 | Industry (Census) | active | 2012-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6038 | Morphology of Neoplasms ICD-9-CM | active | 2012-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6039 | Funding Eligibility Observation Method (IIS) | active | 2012-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6040 | VIS Vaccines (IIS) | active | 2021-01 | us | | cvx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6041 | VIS Bar Codes (IIS) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6046 | Specimen Type (HL7) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6047 | Message Structure (Syndromic Surveillance) | active | 2019-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6048 | Event Type (Syndromic Surveillance) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6049 | Message Type (Syndromic Surveillance) | active | 2019-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6050 | Universal ID Type (Syndromic Surveillance) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6053 | Lab Test Name (Reportable Conditions) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6054 | Lab Test Result (Reportable Conditions) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6055 | Lab Test Name (HEDIS) | active | 2012-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6056 | Name Type (Syndromic Surveillance) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6057 | Value Type (Syndromic Surveillance) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6062 | Observation Result Status Interpretation Codes | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6063 | Universal ID Type (IIS) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6064 | Value Type (ELR) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6065 | Race (HL7) | active | 2012-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6066 | Ethnic Group (HL7) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6067 | Universal ID Type (ELR) | active | 2012-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6069 | NAACCR ICD-10-CM Cancer Reportability List | active | 2012-01 | us | | icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6071 | Gonorrhea (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6072 | Trachoma (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7055 | Antituberculosis Drugs (TB) | active | 2013-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7102 | VPD Lab Test Identifiers | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7103 | VPD Laboratory Coded Observation | active | 2015-01 | us | | sct rx tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7104 | VPD Specimen Type | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7105 | VPD Specimen Collection Method | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7106 | VPD Specimen Source Body Site | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7107 | VPD Specimen Role | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7108 | VPD Specimen Condition | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7109 | VPD Lab Order Identifier | active | 2015-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7110 | VPD Specimen Reject Reason | active | 2013-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) | active | 2015-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) | active | 2014-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7115 | Karyotype Suspected Chromosomal Disorder (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7116 | Karyotype Down Syndrome (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7117 | Labor and Delivery Characteristics (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7118 | Delivery Routes (NCHS) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7119 | Maternal Morbidities (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7121 | Newborn Abnormal Conditions (NCHS) | active | 2015-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7122 | Newborn Congenital Anomalies (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7123 | Onset Labor (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) | active | 2015-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7126 | Pregnancy Risk Factors (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7129 | Employment Status (ODH) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7130 | Work Schedule (ODH) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7136 | Obstetric Procedures (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7137 | Autopsy Examination (NCHS) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7138 | Histological Placental Examination (NCHS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7140 | Autopsy Planned (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7142 | Non-Vertex Presentation (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7143 | Steroids For Fetal Lung Maturation (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7144 | Assisted Ventilation Minutes After Birth (NCHS) | active | 2014-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7145 | Assisted Ventilation More Than Six Hours (NCHS) | active | 2014-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7153 | Estimated Time of Death No Labor Ongoing (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7154 | Fetal Presentation at Birth- Unknown (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7155 | Height (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7156 | Assisted Ventilation (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7157 | Binational Reporting Criteria | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7158 | State or Province of Exposure | active | 2013-01 | us | | iso oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7159 | Mexican Health Jurisdictions (BIDS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7162 | Country (GEC) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7163 | Birth and Fetal Death Financial Class (NCHS) | active | 2014-01 | us | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7164 | Birth and Fetal Death Report Event Reason (NCHS) | active | 2014-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7165 | Previous Cesarean (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7166 | Binational Reporting Criteria (BIDS) | active | 2013-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) | active | 2013-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7168 | Notifiable Event Disease Condition (BIDS) | active | 2013-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7169 | US Mexico States (BIDS) | active | 2013-01 | us | | iso oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) | active | 2013-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) | active | 2013-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7172 | Shigella Serogroup (BIDS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7173 | Campylobacter Species (BIDS) | active | 2013-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) | active | 2013-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7175 | E. coli Culture Isolate Id Serotype (BIDS) | active | 2013-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7176 | STEC Nonculture Test Type (BIDS) | active | 2013-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) | active | 2013-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) | active | 2013-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) | active | 2013-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) | active | 2013-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) | active | 2013-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) | active | 2013-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7183 | Listeria Culture Species (BIDS) | active | 2013-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7184 | Occupation CDC Census 2002 | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7185 | Industry CDC Census 2002 | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7186 | Occupation CDC Census 2010 | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7187 | Industry CDC Census 2010 | active | 2013-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7188 | Travel Reason (Hepatitis A) | active | 2013-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7189 | Specimen Source (STD) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7190 | Current Sex (NND) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7191 | Syphilis Neurologic Involvement (STD) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7192 | HIV Status (STD) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7193 | YNRD (CDC) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7194 | Drugs Used (STD) | active | 2020-01 | us | | sct rx tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7195 | Clinician Observed Lesions (STD) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7196 | Non Treponemal Serologic Test (STD) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7197 | Treponemal Serologic Test (STD) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7198 | Transmission Category (STD) | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7199 | Detection Method (STD) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7200 | Lab Results (STD) | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7201 | Lab Tests (STD) | active | 2020-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7202 | Country Imported From (NND) | active | 2020-01 | us | | iso oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7204 | Race Category including Refused | active | 2013-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7205 | Race Category including Null Flavor | active | 2013-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7208 | Newborn Vital Signs (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7209 | Maternal Vital Signs (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7210 | Apgar Assessments (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7211 | Influenza Transmission Zones (PHLIP) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7212 | Certifier Titles (NCHS) | active | 2014-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7213 | PHIN Questions (BIDS) | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7216 | Place of Death (NCHS) | active | 2014-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7220 | Pregnancy Treatment Stage (NND) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7221 | Syphilis Treatment Mother (CS) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7222 | Serologic Response (CS) | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7223 | Birth Status (NND) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7226 | X-Ray Result (CS) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7231 | Result Status (NND) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7234 | Qual Lab Result Positive (Reportable Conditions) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7235 | Qual Lab Result Negative (Reportable Conditions) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7236 | Qual Lab Result Inconc (Reportable Conditions) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7243 | Lab Test Name (Ebolavirus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7244 | History of Disease as Evidence Of Immunity (IIS) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7245 | Serological Evidence Of Immunity (IIS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7246 | Vital Signs (Syndromic Surveillance) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7247 | Symptoms (EVD Triage) | active | 2014-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7248 | Countries Widespread Transmission (EVD) | active | 2014-01 | us | | iso |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7249 | Exposure Risk (EVD) | active | 2014-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7250 | Observation Identifiers (EVD Triage) | active | 2014-01 | us | | sct loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7256 | Morphologic Abnormalities of Neoplasms | draft | | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7257 | Abdominal Pain (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7258 | Weakness (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7259 | Fever (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7260 | Headache (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7261 | Hemorrhage (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7262 | Muscle Pain (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7263 | Vomiting (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7264 | Diarrhea (CDS - EHR) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7265 | Duration Unit | active | 2020-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7267 | Death Report Observation Identifier (NCHS) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7268 | Data Elements (NND Gen V2) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7271 | Case Notification Specification Version (NND) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7272 | Case Notification MMG Version (NND) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7273 | Death Pronouncement Finding (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7274 | Death Pronouncement Procedure (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7275 | Nationally Notifiable Event Code (Hepatitis) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7276 | Nationally Notifiable Event Code (STD) | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7277 | Transport Mode to Hospital (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7278 | Lab Test Performed Modifier (CS) | active | 2016-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7279 | Non-Treponemal Test Result (STD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7282 | Complications (Mumps) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) | active | 2015-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7285 | Complications (Pertussis) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7328 | 1 Min Apgar Score (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7329 | Type of Testing at CDC (NND) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7330 | Performing Laboratory Type (VPD) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7331 | Vaccine Administered (MMR) | active | 2015-01 | us | | cvx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7332 | Setting of Further Spread | active | 2015-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) | active | 2015-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) | active | 2016-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7335 | Vaccine Administered (Pertussis) | active | 2020-01 | us | | cvx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7336 | Lab Test Type (Mumps) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7337 | Lab Test Type (Pertussis) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7339 | Lab Test Name (Chikungunya virus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7340 | Lab Test Name (Junin Hemorrhagic fever) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7341 | Lab Test Name (Lassa fever) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7342 | Lab Test Name (Marburgvirus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7343 | Lab Result (Chikungunya virus) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7344 | Lab Result (Crimean-Congo hemorrhagic fever) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7345 | Lab Result (Guanarito hemorrhagic fever) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7346 | Lab Result (Junin hemorrhagic fever) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7347 | Lab Result (Lassa fever) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7348 | Lab Result (Lujo virus) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7349 | Lab Result (Machupo hemorrhagic fever) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7350 | Lab Result (Sabia virus hemorrhagic fever) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7351 | Lab Test Performed Modifier (NND) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7352 | No Prenatal Care Visit (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7354 | Part/line Number | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7356 | Diagnosis (ICD-10 CM) | active | 2021-01 | us | | icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7357 | Hysterectomy (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7358 | Hysterotomy (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) | active | 2015-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7360 | Discharge Disposition IP (NCHS) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) | active | 2015-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) | active | 2015-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7363 | Specialty Unit Type (NCHS) | active | 2015-01 | us | | cdc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7364 | Type of clinic/location (NCHS) | active | 2015-01 | us | | cdc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) | active | 2015-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7366 | Relationship (NND) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7367 | Exposure Time Frame (NND) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) | active | 2015-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7370 | Activity Type (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7371 | Procedure (ICD-10 PCS) | active | 2020-01 | us | | cms |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7372 | Time Units (NCHS) | active | 2015-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7373 | Race (NCHS) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7374 | Place of Injury (NCHS) | active | 2015-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7375 | Ethnicity Group (NCHS) | active | 2016-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7376 | Ethnicity Detail (NCHS) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7377 | Bridged Race (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7378 | Death Reporting Name Type Code (NCHS) | active | 2016-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7379 | Methods of Disposition (NCHS) | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7380 | Marital Status (NCHS) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7382 | Death Reporting Identifier Type (HL70203) (NCHS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7383 | Death Reporting Event Reason (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7385 | Decedent Education Level (NCHS) | active | 2016-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7386 | Death Reporting Profiles (NCHS) | active | 2016-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7387 | Edit Flags (NCHS) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7388 | Education Level Edit Flags (NCHS) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7389 | Intentional Reject Edit Flags (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7390 | Marital Status Edit Flags (NCHS) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7391 | Pregnancy Edit Flags (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7392 | Race Coding Flag (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7393 | Source Flags (NCHS) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7395 | System Reject Codes (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7396 | Transax Conversion Flag (NCHS) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7397 | Void Flags (NCHS) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7398 | Nationally Notifiable Event Code (Syphilis) | active | 2015-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7401 | Triage System (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7402 | Patient Residence (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7403 | Injury or Poisoning (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7404 | Major reason for visit (NCHS) | active | 2014-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7405 | Co-morbid Conditions (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7419 | Provider ED (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7421 | Body Weight (NCHS) | active | 2014-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7423 | Pregnancy Resulting From Fertility Enhancing Drugs | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7426 | Estimated Time Of Fetal Death (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7430 | Histological Placental Exam Performed (NCHS) | active | 2015-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7431 | Surfactant Replacement Therapy (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7432 | Asthma (NCHS) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7433 | Condition Control (NCHS) | active | 2014-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7436 | Disposition (NCHS) | active | 2014-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) | active | 2015-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7438 | Application Error Code (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7439 | Episode of Care (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7440 | Hospital Discharge Status (NCHS) | active | 2015-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7442 | Death Reporting Event Type (NCHS) | active | 2016-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7443 | Death Reporting Message Structure (NCHS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7444 | Death Reporting Message Type (NCHS) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7446 | States Territories Provinces (NCHS) | active | 2021-01 | us | | iso tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7447 | Nationally Notifiable Event Code (Generic) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7448 | Vaccine Type (NND) | active | 2022-01 | us | | cvx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7449 | Qualitative Lab Result (RCMT) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7450 | Vaccine Event Information Source (NND) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7451 | Type of Testing at CDC (VZ) | active | 2016-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7452 | Age Unit (NND) | active | 2016-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7453 | Body Region(s) of Rash | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7454 | Character of Lesions | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7456 | Lab Test Type (Varicella) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7457 | Zika-affected areas | active | 2016-01 | us | | iso |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7458 | Transmission Mode (Zika) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7459 | Signs Symptoms (Zika) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7460 | Signs Symptoms (Arbovirus) | active | 2016-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7462 | Prenatal Diagnostic Procedures | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7463 | Specimen Type (Zika) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7464 | Insect Repellant | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7465 | Vector (Zika) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7466 | Complications (Zika) | active | 2016-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7467 | Drug Disease Interaction (Dengue) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7469 | Microcephaly Causes | active | 2016-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7470 | Head Circumference Findings | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7472 | Lab Test Type (Arbovirus) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) | active | 2016-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7474 | Type of Complication (VZ) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7475 | Epidural/Spinal Anesthesia - Medication (NCHS) | active | 2016-01 | us | | rx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7476 | Positive Negative Equivocal Not Done | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7477 | Positive Negative 4 Fold Rise Not Done | active | 2016-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7478 | Serotype (Dengue) | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7479 | Lab Result (Zika virus) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7480 | Lab Test Name (Zika virus) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7481 | Signs Symptoms (Dengue) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7482 | Signs Symptoms (Chikungunya) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7483 | Signs Symptoms Dengue ICD-10 CM | active | 2016-01 | us | | icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7484 | Signs Symptoms Chikungunya ICD-10 CM | active | 2016-01 | us | | icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7485 | Signs Symptoms Zika ICD-10 CM | active | 2016-01 | us | | icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7486 | Yes No Not Applicable (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7487 | Reason for Hospitalization (VZ) | active | 2016-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7488 | Specimen Type (Arbovirus) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7489 | Transmission Mode (Arbovirus) | active | 2016-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) | active | 2016-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7491 | Pregnancy Complications (Arbovirus) | active | 2016-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7492 | Newborn Complications (Arbovirus) | active | 2016-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7493 | Performing Lab Type (Arbovirus) | active | 2016-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7494 | Pregnancy Outcome | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7495 | Serotype (Arbovirus) | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7496 | Death Reporting Observation Result Status (NCHS) | active | 2016-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7497 | Death Reporting Value Type (NCHS) | active | 2016-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7512 | City Places (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7513 | Message Error Condition Codes (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7515 | Data Elements (NND Hep Core) | active | 2016-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7516 | Data Elements (NND Hep A Acute) | active | 2016-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7517 | Data Elements (NND Hep B Acute) | active | 2016-01 | us | | sct tho oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7518 | Data Elements (NND Hep B Perinatal) | active | 2016-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7519 | Data Elements (NND Hep B Chronic) | active | 2016-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7520 | Data Elements (NND Hep C Acute) | active | 2016-01 | us | | sct tho oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7521 | Data Elements (NND Hep C Chronic) | active | 2016-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7522 | Data Elements (NND Mumps) | active | 2016-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7523 | Data Elements (NND Pertussis) | active | 2016-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7524 | Data Elements (NND STD) | active | 2016-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7525 | Data Elements (NND CS) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7526 | Method of Delivery VaginalSpon Finding (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7527 | Method of Delivery Cesarean Finding (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7528 | Method of Delivery Vaginal Forceps Finding (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7529 | Method of Delivery Vaginal Vacuum Finding (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7530 | Scheduled Cesarean Finding (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7531 | Induction of Labor Finding (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7532 | Augmentation of Labor Finding (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7536 | Height Unit (CDC) | active | 2016-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7537 | Duration Unit (1) | active | 2016-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7539 | Medication Treatment (Babesiosis) | active | 2016-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7540 | Blood Product | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7541 | Clinical Manifestations (Babesiosis) | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7542 | Lab Test Name (Hantavirus Infection) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7543 | Lab Result (Hantavirus Infection) | active | 2016-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7544 | Outdoor Activities | active | 2016-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7545 | Lab Test Type (Babesiosis) | active | 2017-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7546 | NAT Tests (Zika) | active | 2016-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7547 | IgM Ab Tests (Zika) | active | 2016-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7548 | Neutralizing Ab Tests (Zika) | active | 2016-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7549 | Test Type (Syphilis) | active | 2021-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7550 | Lab Test Type (STD) | active | 2021-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7552 | Organism Identified AST (STD) | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7553 | Specimen Type AST (STD) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7555 | Susceptibility Test Type (STD) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7556 | Susceptibility Test Method (STD) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7557 | Susceptibility Test Interpretation (STD) | active | 2017-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7558 | Susceptibility Test Result Units (STD) | active | 2017-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7559 | Susceptibility Test Result Quantitative (STD) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.756 | Gender Identity | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7563 | Sexual Orientation | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7564 | Birth Reporting Address Type (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7565 | Birthdate Edit Flags (NCHS) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7566 | Pregnancy Report Edit Flags (NCHS) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7567 | Estimate Of Gestation Edit Flags (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7568 | Number Of Previous Cesareans Edit Flags (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7569 | Birth Reporting Associated Party Relation (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7570 | Birth Reporting Event Reason (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7571 | Birth Reporting Event Type (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7572 | Birth Reporting Message Structure (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7573 | Birth Reporting Message Type (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7574 | Birth Reporting Value Type (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7575 | Birth Reporting Observation Result Status (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7576 | Birth Weight Edit Flags (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7577 | Plurality Edit Flags (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7578 | Consolidated Ethinicity (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7579 | Weight Of Fetus Edit Flag (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7580 | Informant Relationship to Mother (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7581 | Birth Reporting Associated Party ID Type (NCHS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7582 | Vital Records Education Level (NCHS) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7583 | Birth Reporting Observation Type (NCHS) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7584 | CCOFDI Observation Type (NCHS) | active | 2020-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7585 | Fetal Remains Disposition Method (NCHS) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7586 | JFDI Observation Type (NCHS) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7587 | JLBI Observation Type (NCHS) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7588 | PSFDI Observation Type (NCHS) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7589 | PSFFDI Observation Type (NCHS) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7590 | PSFLBI Observation Type (NCHS) | active | 2020-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7591 | PSLBI Observation Type (NCHS) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7592 | PSMFDI Observation Type (NCHS) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7593 | Consolidated Race (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7594 | PSMLBI Observation Type (NCHS) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7596 | Adverse Event Severity (Malaria) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7597 | Work Classification (ODH) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7598 | Baby Or Fetus Weight Unit Of Measure (NCHS) | active | 2017-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7599 | Birth Reporting Mother's NameType (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7600 | Birth Reporting Related Party Address Type (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7601 | Jurisdiction Certificate ID Type (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7603 | Fetal Death Reporting Associated Party Relation (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7604 | Route Method of Delivery SpontaneousProcedure (NCHS) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7605 | Tobacco Use Unit Of Measure (NCHS) | active | 2017-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7606 | Live Birth Reporting Associated Party Relation (NCHS) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7607 | Type of Testing at CDC | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7610 | Gender Identity (STD) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7611 | Clinical Manifestations (STD) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) | active | 2021-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7613 | Job Supervisory Level or Pay Grade (ODH) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7614 | Case Appraisal (CRS) | active | 2017-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7617 | Organism (FDD) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7618 | Yes No Unknown Refused (NND) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7619 | Antibiotics (FDD) | active | 2018-01 | us | | rx tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7620 | Antacids (FDD) | active | 2017-01 | us | | rx tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7622 | Positive Negative Not Done | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7623 | Test Method (FDD) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7624 | Performing Lab Type (FDD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7625 | Test Type (FDD) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7626 | Test Result (FDD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7628 | Yes No Unknown Maybe (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7629 | Yes No Don't Know Maybe (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7630 | Drinking Water (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7631 | Recreational H2O Treatment (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7632 | Raw Unpasteurized Products (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7634 | Sexual Contact (FDD) | active | 2017-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7635 | Medication Administered (FDD) | active | 2017-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7636 | Medical History (FDD) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7637 | Seafood Preparation (FDD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7638 | Seafood Source (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7639 | Shellfish Distributed (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7640 | Improper Handling Storage (FDD) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7641 | Harvest Region (FDD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7642 | Harvest Classification (FDD) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7643 | Vibrio Species (FDD) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7646 | Vaccine Received (FDD) | active | 2017-01 | us | | cvx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7647 | Typhoid Paratyphoid Serotype (FDD) | active | 2017-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7648 | Yes No Not Tested (NND) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7652 | Mailing Address Indicator (NCHS) | active | 2017-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7655 | PCR Specimen Source (CRS) | active | 2017-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7656 | Specimen Source (Rubella) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7657 | Specimen Type (Rubella) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7658 | CREI Observation Type (NCHS) | active | 2017-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7659 | Type of Testing at CDC(Rubella) | active | 2017-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7660 | Type of Complication (Measles) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7661 | Lab Test Type (Measles) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7663 | Data Elements (NND Malaria) | active | 2018-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7664 | Data Elements (NND Babesiosis) | active | 2018-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7665 | Data Elements (NND Varicella) | active | 2018-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7667 | Eosinophil Units | active | 2018-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7668 | Meat Consumed Type (Trich) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7669 | Food Processing Method (Trich) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7670 | Meat Purchase Info (Trich) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7671 | Food Cooking Method (Trich) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7672 | Performing Lab Type (Trich) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7673 | Lab Test Type (Trich) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7674 | Lab Test Interpretation (Trich) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7675 | Specimen type (Trich) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7676 | Strain Type (Trich) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7677 | Form Status (RIBD) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7678 | Discharge Location (RIBD) | active | 2019-01 | us | | cdc sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7679 | Pregnancy Status (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7680 | Fetal Outcome (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7681 | Underlying Condition (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7682 | Smoking Status (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7683 | Substance Abuse (RIBD) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7684 | Mode of Delivery (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7685 | GBS Time Period (RIBD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7686 | Microorganism (RIBD) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7687 | Performing Lab Type (RIBD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7688 | Vaccine Type (RIBD) | active | 2018-01 | us | | cvx tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7689 | Vaccination Information Source (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7690 | GAS Risk Factor (RIBD) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7691 | GAS Risk Factor Interval (RIBD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7692 | Rehab Type (RIBD) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7693 | Antibiotic Received (RIBD) | active | 2021-01 | us | | sct rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7694 | Administration Route (RIBD) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7695 | Antibiotic Reason (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7696 | Detection Method (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7697 | Birth Location (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7698 | Gestational Age Determination (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7699 | Susceptibility Data NA (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7700 | AR Agent (RIBD) | active | 2018-01 | us | | sct rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7701 | AR Test Method (RIBD) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7703 | MIC Operator (RIBD) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7704 | Susceptibility Interpretation (RIBD) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7705 | ICD Codes (RIBD) | active | 2018-01 | us | | fhir icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7706 | Sequelae (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7707 | Blood Type (RIBD) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7708 | Rupture Type (RIBD) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7709 | Delivery Type (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7710 | Medication Pre-Treatment (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7711 | Contact Type (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7712 | School Year (RIBD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7713 | College Living Situation (RIBD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7716 | Definitely Possibly No (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7717 | Legionella Exposure Setting (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7718 | Healthcare Exposure Type (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7719 | Facility Type (RIBD) | active | 2018-01 | us | | cdc tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7720 | Water Source (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7721 | Cruise Line (RIBD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7722 | Titer Test Type (RIBD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7724 | Personal Protective Equipment (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7725 | Respiratory Protective Equipment (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7726 | Glove Material (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7727 | Titer Test Method (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7728 | Bird Type (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7729 | Establishment Type (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7730 | Residence Location (RIBD) | active | 2018-01 | us | | cdc sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7731 | Insurance Type (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7732 | Infection Type (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7733 | Lab Test Method (RIBD) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7734 | Lab Test Interpretation (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7735 | SPN/IPD Serotype (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7736 | Serotype Method (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7738 | Isolate Not Available (RIBD) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7739 | GAS Lab Test Type (RIBD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7740 | Colony Count Magnitude | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7741 | H Antigens (FDD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7743 | Lab Test Type (TB) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7744 | Lab Test Interpretation (TB) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7745 | Type of Radiology Study | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7746 | Result of Radiology Study (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7747 | Diabetes Status | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7748 | Epidemiological Risk Factors (TB) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7749 | Smoking Status | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7750 | Diagnosis Type (TB) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7751 | Type of Link (TB) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7752 | Strength of Link (TB) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7753 | Directionality of Link (TB) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7754 | Treatment Administration Type (TB) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7755 | LTBI Drug Regimen (TB) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7756 | Reason LTBI Not Started (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7757 | Reason LTBI Treatment Stopped (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7758 | Adverse Event Severity (TB) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7759 | Medication (TB) | active | 2022-01 | us | | rx tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7760 | Susceptibility Test Type (TB) | active | 2022-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7761 | Susceptibility Test Interpretation (TB) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7762 | Susceptibility Test Method (TB) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7763 | Gene Name (TB) | active | 2021-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7764 | Molecular Test Results (TB) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7765 | Molecular Indel (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7766 | Molecular Test Methods (TB) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7767 | Reason Not Treated with RIPE (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7768 | Moved Where During Therapy (TB) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7769 | Final Treatment Outcome (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7771 | Side Effect Time to Onset (TB) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7773 | Serogroup Method (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7774 | Specimen Type (RIBD) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7775 | Lab Test Type (RIBD) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7776 | Emergency Severity Index - Acuity | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7777 | Healthcare Service Location (Syndromic) | active | 2020-01 | us | | cdc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7778 | Specimen Site (FDD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7779 | Condition Status (FDD) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7780 | Lab Test Name (Crimean-Congo hemorrhagic fever) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7781 | Animal Contact Type (Listeria) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7782 | Deli Meats (Listeria) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7783 | Deli Salads (Listeria) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7784 | Diet Type (Listeria) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7785 | Extended Race Group (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7786 | Food (Listeria) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7787 | Food Allergy (Listeria) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7788 | Food Freshness (Listeria) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7789 | Fruit (Listeria) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7790 | Heated Food (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7791 | Hispanic Ethnic Group (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7792 | Illness (Listeria) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7793 | Likely Contact (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7794 | LikelyAte (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7795 | Medical History (Listeria) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7796 | Patient Type (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7797 | Birth Location (Listeria) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7798 | Pregnancy Outcome (Listeria) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7799 | Reason Not Interviewed (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7800 | Respondent (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7801 | Signs and Symptoms (Listeria) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7802 | Specimen Type (Listeria) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7803 | Yes No Unknown Refused (Listeria) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7804 | Patient Outcome (Listeria) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7805 | Yes No None (Listeria) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7806 | Assisted Living Exposure Type (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7807 | Bird Exposure Setting (RIBD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7808 | N. meningitidis Serogroup (RIBD) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7809 | H. influenzae Serotype (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7810 | Provider Information Source (RIBD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7811 | Data Elements (CRS) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7812 | Case Type (CP-CRE) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7813 | Specimen Source (CP-CRE) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7814 | Genotypic Test Result (CP-CRE) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7815 | Death Reporting Provider Identifier Type (HL70203) (NCHS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7816 | Data Elements (Rubella) | active | 2018-01 | us | | sct oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7817 | Type of Dairy Product (Listeria) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7818 | General Condition Status (TB) | active | 2018-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7819 | Unit of Measure (TB) | active | 2018-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7820 | Born in the United States (Listeria) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7821 | Lab Test Type (Psittacosis) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7822 | Lab Test Type (Legionellosis) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7823 | Lab Test Interpretation (Legionellosis) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7824 | Death Reporting Certificate Identifier Type (HL70203) (NCHS) | active | 2019-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7825 | Gene Name (CP-CRE) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7826 | Specimen Source Site (VPD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7827 | Segment Action Code (HL7_2x) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7828 | Immunization Profile ID (IIS) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7829 | Series Status (IIS) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7830 | Observation Identifier V2 (IIS) | active | 2018-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7831 | Evaluation Status Reason (IIS) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7832 | Clinical Manifestation (TBRD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7833 | Complications (TBRD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7834 | Medication Received (TBRD) | active | 2018-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7835 | Lab Test Type (TBRD) | active | 2022-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7836 | Organism (TBRD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7837 | Coinfection Type (TBRD) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7838 | Specimen Type (TBRD) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7839 | Medication Received (Lyme) | active | 2018-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7840 | Clinical Manifestations (Lyme) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7841 | Specimen Type (Lyme) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7843 | Organism (Lyme) | active | 2022-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7844 | Lab Test Type (Lyme) | active | 2018-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7845 | Serotype Master (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7846 | Lab Test Interpretation Master (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7847 | Lab Test Type Master (RIBD) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7848 | Exposure Setting Master (RIBD) | active | 2018-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7849 | Usual Occupation and Industry (TB) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7850 | Organism (CP-CRE) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7851 | Contact Type (FDD) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7852 | Geographic Location | active | 2020-01 | us | | iso tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7853 | MCDI Observation Identifier (NCHS) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7854 | FDDI Observation Identifier (NCHS) | active | 2021-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7855 | DR Observation Identifier (NCHS) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7856 | JDI Death Report Observation Identifier (NCHS) | active | 2020-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7857 | CREI Observation Identifier (NCHS) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7858 | CCOD Observation Identifier (NCHS) | active | 2019-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7859 | Death Reporting Decedent Identifier Type (HL70203) (NCHS) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7860 | Medication Administered Relative to Treatment (Malaria) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7861 | Death Reporting Decedent and Certificate Identifier Type (HL70203) (NCHS) | active | 2018-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7862 | Test Result (CP-CRE) | active | 2018-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7863 | Lab Test Type (C. auris) | active | 2018-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7864 | Specimen Source (C. auris) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7867 | Test Result (C. auris) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7868 | Type of Long Term Care Facility (C. auris) | active | 2019-01 | us | | cdc tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7869 | Specimen Collection Setting Type (C. auris) | active | 2019-01 | us | | cdc sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7870 | Type of Co-infection (C. auris) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7871 | Case Type (RIBD) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7874 | Poison Control Center Record (CO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7875 | Workers Compensation Record (CO) | active | 2022-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7876 | Intent of Exposure (CO) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7877 | Extreme Weather Type (CO) | active | 2022-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7878 | Exposure Source (CO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7879 | Treatment Type (CO) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7880 | Education (CO) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7881 | Generator Location (CO) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7882 | Generator Distance (CO) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7883 | Person/Organization Taking CO Reading (CO) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7884 | Exposure Site Category (CO) | active | 2022-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7885 | Public Site of Exposure (CO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7886 | Treatment Location (CO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7887 | Underlying Conditions (CO) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7888 | Signs and Symptoms (CO) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7889 | ICD Codes List (CO) | active | 2019-01 | us | | tho icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7890 | Treatment Site (CO) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7891 | Data Reporting Source (CO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7892 | Lab Result (Candida auris) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7893 | Lab Test Name Carbapenem Resistant Enterobacteria | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7894 | Lab Test Name (Candida Auris) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7895 | Lab Result Carbapenem Resistant Enterobacteriace | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7896 | Residential Site of Exposure (CO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7897 | Lab Test Measurement (CO) | active | 2019-01 | us | | loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7899 | Household Member Roletype (ODH) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7900 | Industry NAICS Detail (ODH) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7901 | Occupation ONETSOC Detail (ODH) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7902 | GC specimen quality (ARLN) | active | 2019-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7903 | GC beta-lactamase result (ARLN) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7904 | Program study or event (ARLN) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7905 | Age units (ARLN) | active | 2019-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7906 | Test result units (ARLN) | active | 2019-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7907 | Ethnicity (ARLN) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7908 | Gender (ARLN) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7909 | Identifier type (ARLN) | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7910 | Regional Labs (ARLN) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7911 | Clinical sample or isolate (ARLN) | active | 2019-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7912 | Candida auris culture result (ARLN) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7913 | Candida auris PCR result (ARLN) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7914 | Acinetobacter culture result (ARLN) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7915 | Carbapenemase phenotypic result (ARLN) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7916 | CPO phenotypic method (ARLN) | active | 2019-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7917 | CPO PCR method (ARLN) | active | 2019-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7918 | CPO AST method (ARLN) | active | 2019-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7919 | CPO PCR result (ARLN) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7920 | Interpretation codes (ARLN) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7921 | Specimen type (ARLN) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7922 | Microorganism (ARLN) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7923 | Medication Treatment (STD) | active | 2020-01 | us | | sct rx tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7924 | Mother Infant Indicator (NND) | active | 2019-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7925 | Type of Complication (STD) | active | 2019-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) | active | 2019-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7927 | Dose Unit (STD) | active | 2020-01 | us | | ucum sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7928 | Lab Test Result Qualitative (Syphilis) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7929 | Medication Route (STD) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7930 | Route of Administration (STD) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7931 | Medication Frequency Unit (STD) | active | 2020-01 | us | | ucum sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7932 | Duration Units (STD) | active | 2020-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7933 | Cause of Fetal Death ICD-10 | active | 2020-01 | us | | icd |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7934 | Microorganism (STD) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7936 | Contact Type (COVID-19) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7937 | Case Probable Reason (COVID-19) | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7938 | Detection Method (COVID-19) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7939 | Residence Type (COVID-19) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7940 | Healthcare Occupation (COVID-19) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7941 | Job Setting (COVID-19) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7942 | Exposure Setting (COVID-19) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7943 | Data Reporting Source (COVID-19) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7945 | Clinical Finding (COVID-19) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7946 | Animal Type (COVID-19) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7947 | Risk Factor (COVID-19) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7948 | Lab Test Type (COVID-19) | active | 2021-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7949 | Treatment Type (COVID-19) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7950 | Yes No Unknown NA (NND) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7951 | Reason for Test (COVID-19) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7952 | Tribe Name (NND) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) | active | 2020-01 | us | | sct tho oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7954 | Medication Administered (Hansen) | active | 2020-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7955 | Location of Initial Diagnosis (Hansen) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7956 | Type of Leprosy (Hansen) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7957 | Relationship (Hansen) | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7958 | Hospital Procedure (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7959 | Underlying Condition(s) (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7960 | Disease Outcome Type (Leptospirosis) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7961 | Medication (Leptospirosis) | active | 2020-01 | us | | sct rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7962 | Contact Type (Brucellosis) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7963 | Medication Administered (Anthrax) | active | 2020-01 | us | | sct rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7964 | US Vital Records Jurisdictions (NCHS) | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7967 | Animal Type (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7968 | Clinical Manifestations (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7969 | Specimen Type (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7970 | Disease Stage (Brucellosis) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7971 | Animal Type (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7972 | Medication (Brucellosis) | active | 2020-01 | us | | rx tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7973 | Diagnostic Test Finding (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7974 | Specimen Type (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7975 | Specimen Source Site (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7976 | Test Titer Type (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7977 | Brucella Exposure (Brucellosis) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7978 | Exposure Risk (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7979 | Previous Treatment Duration (Hansen) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7980 | Patient Case Status (Hansen) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7981 | Animal Ownership (Brucellosis) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7982 | Vaccine Exposure (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7983 | Time of Day (Anthrax) | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7984 | Hospital Procedure (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7986 | Performing Lab Type (Anthrax) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7987 | Country of Product Acquisition (Brucellosis) | active | 2022-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7988 | Location Type (Leptospirosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7989 | Clinical Outcome (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7990 | Specimen Type (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7991 | Procedure Type (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7992 | Public TransportationType (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7994 | Exposure Type (Leptospirosis) | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7995 | Diet Type (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7996 | Post-exposure or Treatment (NND) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7997 | Treatment Type (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7998 | Severe Weather Type (Leptospirosis) | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7999 | Animal Type (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.800 | Abnormal Flag (HL7) | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8000 | Test Results Anthrax | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8001 | Time of Day (CDC) | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8002 | Reason Medication Not Completed (BSP) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8003 | Smoking Status (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8004 | Test Results (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8005 | Antimicrobials (Anthrax) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8006 | Contact Type (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8007 | Clinical Manifestations (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8008 | Clinical Manifestations (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8009 | Exposure Location (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.801 | Address Type (HL7) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8010 | Organism Name (Brucellosis) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8013 | Exposure Source (Anthrax) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8014 | Activity Type Anthrax | active | 2020-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8015 | Food Product Consumed (Brucellosis) | active | 2022-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8016 | Fresh Water or Mud Type (Leptospirosis) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8017 | Exposure Source (Brucellosis) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8018 | Related Person Relationship Type (NCHS) | active | 2021-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8019 | Alcohol Use Frequency (Anthrax) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.802 | Administration Device (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8020 | Anthrax Vaccine Exposure (Anthrax) | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8021 | Total Doses of Vaccine (Anthrax) | active | 2020-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8022 | Skin Smear Interpretation (Hansen) | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8024 | Medication Completed (Brucellosis) | active | 2021-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8025 | Industry CDC NAICS 2012 | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8026 | Occupation CDC Census 2012 | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8027 | Industry CDC Census 2012 | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8028 | Occupation CDC SOC 2010 | active | 2021-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8029 | Division Vital Statistics (County) | active | 2021-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.803 | Administration Method (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8031 | Decedent Birthplace (Country) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8032 | Decedent Resident (Country) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8033 | Frequency Duration Unit (Hansen) | active | 2021-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8034 | Medication Duration Unit (Hansen) | active | 2021-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8035 | Subject of Medication Received (Hansen) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8036 | Antibiotic Dose Units (Brucellosis) | active | 2021-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8038 | Specimen Source Site (Brucellosis) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8039 | Test Results (Leptospirosis) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8040 | Pregnancy Outcome (Leptospirosis) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8042 | Test Result (Hepatitis A) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8043 | HBeAg Test Result (Hepatitis B Perinatal) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8044 | Infant Nucleic Acid Test Result (Hepatitis C) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8045 | Infant HCV Antigen Test Result (Hepatitis C) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8046 | Mother Nucleic Acid Test Result (Perinatal Hep) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8047 | Common-Source Outbreak (Hepatitis A) | active | 2021-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8048 | Common-Source Outbreak (Hepatitis B) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8049 | Common-Source Outbreak (Hepatitis C) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8050 | Other Case Hepatitides (Hepatitis) | active | 2021-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8051 | Patient Epidemiological Risk Factors (Hepatitis A) | active | 2022-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8052 | Patient Epidemiological Risk Factors (Hepatitis B) | active | 2022-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8053 | Patient Epidemiological Risk Factors (Hepatitis C) | active | 2022-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8054 | Alanine aminotransferase (ALT) Result (Hepatitis) | active | 2021-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8055 | Source of Laboratory Test (Hepatitis) | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8056 | HBsAg Test Result (Hepatitis B Perinatal) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8057 | Infant Anti-HCVTest Result (Hepatitis C Perinatal) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8058 | Nucleic Acid Viral Load Test Result (Hepatitis) | active | 2021-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8059 | Signs and Symptoms (Hepatitis) | active | 2021-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.806 | Allergen Type (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8060 | Test Result (Hepatitis) | active | 2021-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8061 | HBV DNA Test Result (Hepatitis B Perinatal) | active | 2022-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8062 | Gender Identity (USCDI) | active | 2022-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8063 | Sexual Orientation (USCDI) | active | 2022-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8064 | Travel Purpose (CDC) | active | 2022-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8065 | Occupation CDC Census 2018 | active | 2022-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8066 | Industry CDC Census 2018 | active | 2022-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8067 | Industry CDC NAICS 2017 | active | 2022-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8068 | Occupation CDC SOC 2018 | active | 2022-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.807 | Allergy Severity (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.808 | Degree License Certification (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.809 | Marital Status (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.810 | Name Type (HL7) | active | 2011-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.811 | Observation Result Status (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.812 | Production Class (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.813 | Relationship (HL7) | active | 2015-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.814 | Religion (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.815 | Result status (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.816 | Route of Administration (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.817 | Telecommunication Equipment Type (HL7) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.818 | Telecommunication Use Code (HL7) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.819 | Yes No Indicator (HL7) | active | 2019-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.820 | Expanded Yes No (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.821 | Treatment Completion Status (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.822 | Referral Priority (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.823 | Referral Reason (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.825 | Referral Disposition (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.826 | Manufacturers of vaccines (MVX) | active | 2022-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.827 | Diagnosis Type (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.828 | Country | active | 2018-01 | us | | iso tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.829 | County | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.830 | State | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.831 | Language | active | 2020-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.834 | Allergen | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.836 | Race Category | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.837 | Ethnicity group | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.838 | Units of Measure | active | 2015-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.856 | Diagnosis (ICD-9 CM) | active | 2010-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.875 | Null Flavor (HL7 V3) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.876 | Detailed Race | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.877 | Detailed Ethnicity | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.878 | Age unit | active | 2015-01 | us | | ucum tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.879 | Weight Unit | active | 2008-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.883 | PHIN Questions | active | 2013-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.887 | Occupation | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.888 | Yes No Unknown (YNU) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.891 | Height Unit | active | 2008-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.909 | Disease | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.912 | Admission Level of Care (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.913 | Admission Type (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.914 | Diagnosis Priority (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.915 | Discharge Disposition (HL7) | active | 2021-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.916 | Medical Specialty (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.917 | Patient Class (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.918 | Admission Source (HL7) | active | 2019-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.919 | Temperature Unit | active | 2008-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.920 | Blood Pressure Unit | active | 2008-01 | us | | ucum |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.921 | Emergency Department Acuity | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.922 | Diagnostic service section ID (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.923 | Order Control Code (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.925 | Pharmacy Order Type (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.927 | Administrative Sex (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.928 | True False (TF) | active | 2008-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.930 | Chest XRay Result | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason | active | 2021-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.934 | Vaccines administered (CVX) | active | 2022-01 | us | | cvx |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.941 | Susceptibility Result | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.945 | Industry (SIC) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.946 | Specimen | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.950 | Passed Failed Unknown | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.954 | BioSense Observations | active | 2008-01 | us | | oid loinc |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.957 | Abnormal Chest X-Ray Finding (TB) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.958 | Acknowledgment Code (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.960 | Specimen Additive or Preservative (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.961 | Address Type | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.962 | Procedure (ICD-9 CM) | active | 2010-01 | us | | fhir |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.963 | Consequence of Adverse Event | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.964 | Adverse Event Previously Reported | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.965 | Amplification and Extraction Kit | active | 2008-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.967 | Body site | active | 2020-01 | us | | sct |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.968 | Case Classification Status | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.969 | Case investigation closure reason | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.970 | Case Investigation Status | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.972 | Case Verification (TB) | active | 2018-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.973 | City | active | 2020-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.974 | Message Error Condition Codes (HL7) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.975 | Comment Type | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.976 | Confidentiality Code (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.977 | Contact Role | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.979 | Type of Correctional Facility | active | 2019-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.980 | Diagnosed by (VZ) | active | 2017-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.983 | Sites of Directly Observed Therapy (TB) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.984 | Dwelling Type | active | 2008-01 | us | | sct oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.985 | Employment Status | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.986 | Encoding Type (HL7) | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.989 | Countermeasure Encounter Type | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.990 | Specimen Handling Code | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.991 | Environmental Investigation Reason | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.992 | Epilinked Case Type (VZ) | active | 2008-01 | us | | tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.993 | Error Severity (HL7) | active | 2018-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.994 | General Condition Status | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.996 | History Source (CRA) | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.997 | HIV Diagnosis Based On | active | 2008-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.998 | HIV Status | active | 2008-01 | us | | sct tho oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.999 | Identifier Type | active | 2008-01 | us | | tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) | active | 2020-01 | us | | sct tho |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.5.301 | Immunization Service Funding Eligibility Value Set | active | 2009-01 | us | | oid |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/6.1.4.1.19376.1.7.3.1.1.13.8.64 | Limb Reduction Defect (NCHS) | active | 2014-01 | us | | sct |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSauthorRole | IHE XDS authorRole | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSauthorSpeciality | IHE XDS authorSpecialty | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSclassCode | IHE XDS classCode | active | | | | loinc |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDScodeList | IHE XDS codeList | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSconfidentialityCode | IHE XDS confidentialityCode | active | | | | tho |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDScontentTypeCode | IHE XDS contentTypeCode | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSeventCodeList | IHE XDS eventCodeList | active | | | | fhir ihe dcm |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSformatCodeDE | IHE XDS formatCode | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSformatCodeINTL | IHEXDS formatCode (Intl) | active | | | | ihe |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDShealthcareFacilityTypeCode | IHE XDS healthcareFacilityTypeCode | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDShealthcareFacilityTypeCodeOutsidePatientRelatedHealthcare | IHE XDS healthcareFacilityTypeCode Outside Patient-Related Healthcare | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDShealthcareFacilityTypeCodePatientRelatedHealthcare | IHE XDS healthcareFacilityTypeCode Patient Related Healthcare | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSpracticeSettingCode | IHE XDS practiceSettingCode | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSpracticeSettingCodeDoctoral | PracticeSetting doctoral | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDSpracticeSettingCodeNonDoctoral | PracticeSetting non-doctoral | active | | | | |
| de.ihe-d.terminology | R4 | http://ihe-d.de/ValueSets/IHEXDStypeCode | IHE XDS typeCode | active | | | | loinc |
| hl7.fhir.nume.dev | R4 | https://dev.painkillerai.tech/nume/api/fhir/StructureDefinition/ValueSet/EspecialidadeMedico | Especialidade Medica | active | | nume | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/omb-race-category | OMB Race Categories | active | 2022-09 | us | hl7 | vsac |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-observation-category | US Core Screening Assessment Observation Category | active | 2023-03 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/account-status | AccountStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/account-type | Account Types | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/fips-county-co | CO FIPS Counties | draft | 2023-06 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/address-type | AddressType | active | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/address-use | AddressUse | active | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/birthsex | Birth Sex | active | 2022-09 | us | hl7 | vsac |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/chargeitem-status | ChargeItemStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/composition-status | CompositionStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-clinical | Condition Clinical Status Codes | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-severity | Condition/Diagnosis Severity | draft | | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-ver-status | ConditionVerificationStatus | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/contact-attempt-results | Contact Attempt Results | draft | | us | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-class | Coverage Class Codes | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-copay-type | Coverage Copay Type Codes | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-financial-exception | Example Coverage Financial Exception Codes | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/data-absent-reason | DataAbsentReason | active | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/days-of-week | DaysOfWeek | active | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/detailed-ethnicity | Detailed ethnicity | active | 2022-09 | us | hl7 | vsac |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/detailed-race | Detailed Race | active | 2022-09 | us | hl7 | vsac |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/device-action | Procedure Device Action Codes | draft | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/device-kind | FHIR Device Types | draft | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/diagnosis-role | DiagnosisRole | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-classcodes | Document Class Value Set | active | 2019-11 | us | hl7 | loinc |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-reference-status | DocumentReferenceStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-relationship-type | DocumentRelationshipType | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-admit-source | Admit source | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-diet | Diet | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-location-status | EncounterLocationStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-participant-type | Participant type | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-special-arrangements | Special arrangements | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-special-courtesy | Special courtesy | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-status | EncounterStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/episode-of-care-status | EpisodeOfCareStatus | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/episodeofcare-type | Episode of care type | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/event-status | EventStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/c80-facilitycodes | Facility Type Code Value Set | active | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/fm-status | Financial Resource Status Codes | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/formatcodes | DocumentReference Format Code Set | active | 2019-11 | us | hl7 | ihe |
| signal.core.r4 | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32 | Gender Identity | active | 2022-03 | us | hl7 | vsac |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-category | Signal Healthcare Service Category | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/healthcare-service-procedure-code-cpt | HealthCare Service Procedure Code CPT | draft | | us | hl7 | cpt |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-program | Signal Program | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-type | Signal Healthcare Service Type | draft | | us | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/identifier-use | IdentifierUse | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/invoice-priceComponentType | InvoicePriceComponentType | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/invoice-status | InvoiceStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/languages | Common Languages | draft | 2016-08 | us | hl7 | ietf |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-mode | LocationMode | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-physical-type | Location type | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-status | LocationStatus | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/observation-category | Observation Category Codes | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/observation-status | ObservationStatus | active | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/omb-ethnicity-category | OMB Ethnicity Categories | active | 2022-09 | us | hl7 | vsac |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/organization-role | Organization Affiliation Role | draft | 2019-11 | us | hl7 | fhir |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-organization-license | Signal Organization License | draft | 2023-07 | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/ValueSet/signal-organization-type | Signal Organization Type | draft | 2023-07 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/performer-role | Procedure Performer Role Codes | draft | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/place-of-service | Place Of Service | draft | | us | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-category | Procedure Category Codes (SNOMED CT) | draft | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-followup | Procedure Follow up Codes (SNOMED CT) | draft | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-not-performed-reason | Procedure Not Performed Reason (SNOMED-CT) | active | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-outcome | Procedure Outcome Codes (SNOMED CT) | draft | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/progress-made-towards-goals | Progress Made Towards Goals | draft | | us | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/provider-taxonomy | Provider Taxonomy Codes | draft | 2023-03 | us | hl7 | nucc |
| signal.core.r4 | R4 | http://terminology.hl7.org/ValueSet/v2-2.7-0360 | v2 table 0360, Version 2.7 | active | | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/questionnaire-answers-status | QuestionnaireResponseStatus | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-activity-involvement-rating | Questionnaire CCARS Overall Activity Involvement Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-aggression-danger-to-others-rating | Questionnaire CCARS Aggression Danger To Others Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-alcohol-use-rating | Questionnaire CCARS Alcohol Use Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-cognition-rating | Questionnaire CCARS Cognition Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-considerations-for-providers | Questionnaire CCARS Considerations For Providers | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-issues | Questionnaire CCARS Current Issues | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-non-prescription-substance-use | Questionnaire CCARS Current Non-Prescription Substance Use | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-primary-role | Questionnaire CCARS Current Primary Role | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-depressive-issues-rating | Questionnaire CCARS Depressive Issues Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-disabilities | Questionnaire CCARS Disabilities | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-drug-use-rating | Questionnaire CCARS Drug Use Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-empowerment-rating | Questionnaire CCARS Empowerment Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-enrollment-payer | Questionnaire CCARS Enrollment Payer | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-ethnicity | Questionnaire CCARS Ethnicity | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-existence-presenting-problem | Questionnaire CCARS Existence Presenting Problem | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-family-rating | Questionnaire CCARS Family Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-gender | Questionnaire CCARS Gender | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-highest-education-level | Questionnaire CCARS Highest Education Level | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-current-victimization | Questionnaire CCARS History Current Victimization | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-issues | Questionnaire CCARS History Of Issues | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-mental-health-services | Questionnaire CCARS History Of Mental Health Services | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-hope-rating | Questionnaire CCARS Hope Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-interpersonal-rating | Questionnaire CCARS Interpersonal Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-rating | Questionnaire CCARS Legal Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-marital-status | Questionnaire CCARS Marital Status | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-medication-psychiatric-service | Questionnaire CCARS Medication Psychiatric Service | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-mental-health-services-program | Questionnaire CCARS Mental Health Services Program | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-multiple-issues-rating | Questionnaire CCARS Multiple Issues Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-level-of-functioning-rating | Questionnaire CCARS Overall Level Of Functioning Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-recovery-rating | Questionnaire CCARS Overall Recovery Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-symptom-severity-rating | Questionnaire CCARS Overall Symptom Severity Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-physical-health-rating | Questionnaire CCARS Physical Health Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-place-of-residence | Questionnaire CCARS Place Of Residence | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-previous-concurrent-services | Questionnaire CCARS Previous Concurrent Services | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-psychosis-rating | Questionnaire CCARS Psychosis Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-race | Questionnaire CCARS Race | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-rae-aso-identification-codes | Questionnaire CCARS RAE ASO Identification Codes | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-reason-for-discharge | Questionnaire CCARS Reason For Discharge | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-role-performance-rating | Questionnaire CCARS Role Performance Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-development | Questionnaire CCARS School Development | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-problems | Questionnaire CCARS School Problems | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-security-supervision-rating | Questionnaire CCARS Security Supervision Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-self-care-basic-needs-rating | Questionnaire CCARS Self Care Basic Needs Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-sexual-orientation | Questionnaire CCARS Sexual Orientation | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-social-support-rating | Questionnaire CCARS Social Support Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-socialization-rating | Questionnaire CCARS Socialization Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-suicide-danger-to-self-rating | Questionnaire CCARS Suicide Danger To Others Rating | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-tobacco-use | Questionnaire CCARS Tobacco Use | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-discharge | Questionnaire CCARS Type Of Discharge | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-update | Questionnaire CCARS Type Of Update | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-na | Questionnaire CCARS Yes No NA | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-unable-to-assess | Questionnaire CCARS Yes No Unable To Assess | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no | Questionnaire CCARS Yes No | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-admission-route-of-administration | Questionnaire DACODS Admission Route Of Administration | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-client-disability | Questionnaire DACODS Client Disability | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-clinician-diagnostic-impression | Questionnaire DACODS Clinician Diagnostic Impression | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals | Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goals | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-route-of-administration | Questionnaire DACODS Discharge Route Of Administration | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-status | Questionnaire DACODS Discharge Status | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-drug-type-code | Questionnaire DACODS Drug Type Code | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-education-employment-problems | Questionnaire DACODS Education Employment Problems | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-employment-status | Questionnaire DACODS Employment Status | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-family-issues-and-problems | Questionnaire DACODS Family Issues And Problems | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-health-insurance-status | Questionnaire DACODS Health Insurance Status | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-living-situation | Questionnaire DACODS Living Situation | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-marital-status | Questionnaire DACODS Marital Status | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-medical-physical-problems | Questionnaire DACODS Medical Physical Problems | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-reason-for-discharge | Questionnaire Dacods Reason For Discharge | draft | 2023-09 | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-secondary-tertiary-drug-type-code | Questionnaire DACODS Secondary Tertiary Drug Type Code | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-sexual-orientation | Questionnaire DACODS Sexual Orientation | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-socialization-problems | Questionnaire DACODS Socialization Problems | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-illicit-drugs | Questionnaire DACODS Source Of Illicit Drugs | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-income | Questionnaire DACODS Source Of Income | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-payment-for-treatment | Questionnaire DACODS Source Of Payment For Treatment | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-statutory-commitment | Questionnaire DACODS Statutory Commitment | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-tobacco-use | Questionnaire DACODS Tobacco Use | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-transfer-referral-source | Questionnaire DACODS Transfer Referral Source | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-na | Questionnaire DACODS Yes No NA | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unable-to-assess | Questionnaire DACODS Yes No Unable To Assess | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unknown | Questionnaire DACODS Yes No Unknown | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no | Questionnaire DACODS Yes No | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/reason-for-discharge | Reason For Discharge | active | 2023-06 | us | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/referencerange-appliesto | Observation Reference Range Applies To Codes | draft | 2019-11 | us | hl7 | sct tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/referencerange-meaning | Observation Reference Range Meaning Codes | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/service-provision-conditions | ServiceProvisionConditions | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/service-referral-method | ReferralMethod | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/request-intent | RequestIntent | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/servicerequest-orderdetail | Service Request Order Details Codes | draft | 2019-11 | us | hl7 | sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/request-priority | RequestPriority | draft | 2016-07 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/request-status | RequestStatus | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/service-type | Service type | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-classification | Signal FileRepo Classification | draft | 2023-09 | us | hl7 | loinc |
| signal.core.r4 | R4 | http://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-docreviewstatus | Signal FileRepo DocStatus | draft | 2023-09 | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-organization-qualification | Signal Organization Qualification | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-region | Signal Region | draft | | us | hl7 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/ValueSet/signal-state-activity-status | Signal State Activity Status | draft | 2023-09 | us | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/subscriber-relationship | SubscriberPolicyholder Relationship Codes | draft | 2019-11 | us | hl7 | tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/contact-point-system | ContactPointSystem | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/contact-point-use | ContactPointUse | draft | 2019-10 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-discharge-disposition | US Core Discharge Disposition | active | 2022-09 | us | hl7 | |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-encounter-type | US Core Encounter Type | active | 2022-09 | us | hl7 | sct cpt |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-problem-or-health-concern | US Core Problem or Health Concern | active | 2022-09 | us | hl7 | fhir tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-condition-category | US Core Screening Assessment Condition Category | active | 2023-04 | us | hl7 | fhir |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category | US Core ServiceRequest Category Codes | active | 2022-09 | us | hl7 | fhir sct |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-simple-observation-category | US Core Simple Observation Category | active | 2022-09 | us | hl7 | fhir tho |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-usps-state | USPS Two Letter Alphabetic Codes | active | 2022-09 | us | hl7 | |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Base_Excess_Unit | Base Excess Einheit | active | | | | ucum |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Bodysite_Hip | Hüftlateralität | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Examination_Number | Untersuchungsnummer U-Heft | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Foetal_Position | Kindslage aus Sicht d. Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Gender_Birth | Geschlecht | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Graf_Hip_Ultrasound_Classification | Hüfttyp nach Graf | active | | | | |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hearscreening_Method | Hörscreenigmethode | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hearscreening_Result | Hörscreeningbefund Lokalisation | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_History | Hüftanamnese | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_Proceeding | Hüfte - weiteres Vorgehen | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_Screening_Method | Hüftscreening Methode | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Medication_Statement_Status | Vitamin-K-Prophylaxe Status | active | | | | fhir |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Newborn_Blood_Spot_Screening_Type | Typ der Blutabnahme | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Observation_Status | Observation Status | active | | | | fhir |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Percentile_Body_Measure_Loinc | Perzentilkörpermaß LOINC | active | | | | loinc |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Percentile_Body_Measure_Snomed | Perzentilkörpermaß SNOMED | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Practitioner_Speciality | Rolle des Behandelnden | active | | | | sct oid |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pregnancy_History | Schwangerschaftsanamnese | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Procedure_Status | Status einer Procedure | active | | | | fhir |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_Reason | Gründe zur Ablehnung des Pulsoxymetriescreenings | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Measurement_Type | Typ der Pulsoxymetriemessung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Service_Request_Status | Service-Request Status | active | | | | fhir |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_Apgar_Score_Identifier | Apgar Score am Zeitpunkt | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_Apgar_Score_Value | Apgar-Score Wert | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_U3_Birthmode | Geburtsmodus | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_U3_Pulse_Oxymetry_Measurement | Auffälligkeit Sauerstoffsättigung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Consultation | U2 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Current_Child_History | U2 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Family_History | U2 - Familienanamnese | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Head | U2 - Kopf | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Mouth_Nose | U2 - Mundhöhle, Kiefer, Nase | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Musculoskeletal_System | U2 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Skin | U2 - Haut | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Abdomen_Genitals | U2, U3 - Abdomen, Genitale | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Ears | U2, U3 - Ohren | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Eyes | U2, U3 - Augen | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U4_Physical_Exam_Chest_Lung_Respiratory_Tract | U2, U3, U4 - Thorax, Lunge, Atemwege | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U6_Physical_Exam_Heart_Blood_Circulation | U2, U3, U4, U5, U6 - Herz, Kreislauf | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Consultation | U3 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Current_Child_History | U3 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Development_Assessment | U3 - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Family_History | U3 - Familienanamnese | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Physical_Exam_Head | U3 - Kopf | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Physical_Exam_Musculoskeletal_System | U3 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Mouth_Nose | U3, U4 - Mundhöhle, Kiefer, Nase | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Skin | U3, U4 - Haut | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U9_Age_Appropriate_Development | Altersgemäße Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U9_Social_History | U3-U9 - Sozialanamnese | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Consultation | U4 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Current_Child_History | U4 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Development_Assessment | U4 - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Abdomen_Genitals | U4 - Abdomen, Genitale | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Head | U4 - Kopf | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Musculoskeletal_System | U4 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_U5_Physical_Exam_Eyes | U4, U5 - Augen | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Consultation | U5 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Current_Child_History | U5 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Development_Assessment | U5 - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Chest_Lung_Respiratory_Tract | U5 - Thorax, Lunge, Atemwege | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Mouth_Nose | U5 - Mundhöhle, Kiefer, Nase | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Musculoskeletal_System | U5 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Abdomen_Genitals | U5, U6 - Abdomen, Genitale | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Head | U5, U6 - Kopf | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U9_Physical_Exam_Skin | U5, U6, U7, U7a, U8, U9 - Haut | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Consultation | U6 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Current_Child_History | U6 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Development_Assessment | U6 - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Eyes | U6 - Augen | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Mouth_Nose | U6 - Mundhöhle, Kiefer, Nase | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Musculoskeletal_System | U6 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_U7_Physical_Exam_Chest_Lung_Respiratory_Tract | U6, U7 - Thorax, Lunge, Atemwege | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Consultation | U7 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Current_Child_History | U7 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Development_Assessment | U7 - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Eyes | U7 - Augen | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Mouth_Nose | U7 - Mundhöhle, Kiefer, Nase | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Musculoskeletal_System | U7 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_U7a_Physical_Exam_Abdomen_Genitals | U7, U7a - Abdomen, Genitale | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_U9_Physical_Exam_Heart_Blood_Circulation | U7, U7a, U8, U9 - Herz, Kreislauf | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Consultation | U7a - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Current_Child_History | U7a - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Development_Assessment | U7a - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Physical_Exam_Mouth_Nose | U7a - Mundhöhle, Kiefer, Nase | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_U9_Physical_Exam_Eyes | U7a, U8, U9 - Augen | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Chest_Lung_Respiratory_Tract | U7a, U9 - Thorax, Lunge, Atemwege | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Musculoskeletal_System | U7a, U9 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Consultation | U8 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Current_Child_History | U8 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Development_Assessment | U8 - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Abdomen_Genitals | U8 - Abdomen, Genitale | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Chest_Lung_Respiratory_Tract | U8 - Thorax, Lunge, Atemwege | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Ears | U8 - Ohren | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Musculoskeletal_System | U8 - Bewegungsapparat | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_U9_Physical_Exam_Mouth_Nose | U8, U9 - Mundhöhle, Kiefer, Nase | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Consultation | U9 - Beratung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Current_Child_History | U9 - Aktuelle Anamnese des Kindes | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Development_Assessment | U9 - Orient. Beurt. Entwicklung | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Physical_Exam_Abdomen_Genitals | U9 - Abdomen, Genitale | active | | | | sct |
| kbv.mio.u-heft | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_PC_PN_Examination_Number | Untersuchungsnummer Teilnahmekarte | active | | | | sct |
| de.gematik.elektronische-versicherungsbescheinigung | R4 | https://gematik.de/fhir/eeb/ValueSet/EEBAnfrageUrsprungVS | ValueSet of eEB Message Header Events | active | 2025-05 | | | |
| de.gematik.elektronische-versicherungsbescheinigung | R4 | https://gematik.de/fhir/eeb/ValueSet/EEBErrorcodeVS | ValueSet für eEB Fehler | active | 2025-05 | | | |
| kbv.itv.evdga | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_EVDGA_Accident_Type | KBV_VS_EVDGA_Accident_Type | active | 2025-03 | | | |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/document-category | DocumentCategory | active | | | | loinc |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/local-document-type | Local Document Types | active | 2018-12 | | | oid |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/provincial-document-type | Provincial Document Types | active | 2021-09 | | | loinc |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-patient-contact-relationship | acCDR Patient Contact Relationshiip | active | | | | tho |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-v2-document-status | Document Status | active | 2023-05 | | | |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/document-kind-of-document | Document KOD | active | 2023-05 | | | loinc |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/LOINC-ontology-part-types | LOINCOntologyPartTypes | active | | | | loinc |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/documentsubject-matter-domain | Document SMD | active | 2023-05 | | | loinc |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/document-setting | Document Setting | active | 2023-05 | | | loinc |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-province-state-code | ProvinceStateCodeacCDRv2 | active | | | | |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-address-type | Address Type | active | | | | fhir |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-address-use | Address Use | active | | | | fhir |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-v2-observation-status | ObservationStatus | active | 2023-05 | | | tho |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/accdr-mimetype | MimeType | active | | | | ietf |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/accdr-document-code-type | acCDR Document Code Type | active | 2024-04 | | | |
| accdr.fhir.ig.pkg | R4 | http://fhir.infoway-inforoute.ca/io/psca/ValueSet/ICD10CA | International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada All Concepts | active | 2022-01 | ca | national | fhir |
| accdr.fhir.ig.pkg | R4 | https://tgateway.infoway-inforoute.ca/vs/practitionerspecialty | PractitionerSpecialtywithFrench | active | | ca | national | sct |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/document-role | Document Role | active | 2023-05 | ca | national | loinc |
| accdr.fhir.ig.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/document-type-of-service | Document TOS | active | 2023-05 | ca | national | loinc |
| stb.combined | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_SFHIR_TST_TEST | KBV_VS_SFHIR_TST_TEST | draft | 2025-05 | | | |
| vzvz.fhir.nl-vzvz-core | R4B | http://vzvz.nl/fhir/ValueSet/aorta-device | Aorta Device ValueSet | draft | 2025-01 | nl | | oid |
| vzvz.fhir.nl-vzvz-core | R4B | http://vzvz.nl/fhir/ValueSet/audit-event-sub-type | audit-event-sub-type ValueSet | draft | 2022-09 | nl | | fhir tho |
| rambam-fhir.health.gov.il | R4 | http://fhir.rmc.gov.il/ValueSet/rambam-practitioner-exp-occup | Practitioner Expert Occupation | draft | | | | |
| rambam-fhir.health.gov.il | R4 | http://fhir.rmc.gov.il/ValueSet/rambam-practitioner-occup | Practitioner Occupation | draft | | | | |
| rambam-fhir.health.gov.il | R4 | http://fhir.rmc.gov.il/ValueSet/visit-accept-type | Vs RMC Accept Type | draft | | | | |
| ans.fhir.fr.eclaire | R4 | eclaire-category-vs | Value Set type pour spécifier la catégorie l'essai clinique | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-group-characteristic-kind-vs | Type de caractéristique Value Set | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-reglementation-precision-vs | Précision sur la réglementation concernant l'essai Value Set | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-regulation-code-vs | Code de régulation Value Set | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-status-recruitment-vs | Statut de recrutement Value Set | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-study-outcome-type-vs | Type de conséquence Value Set | draft | 2024-02 | fr | national | tho |
| ans.fhir.fr.eclaire | R4 | eclaire-study-party-organization-type-vs | Value Set Eclaire pour les types de parties | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-study-party-role-vs | Value Set Eclaire pour les différents rôles des parties impliquées dans l'essai | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-study-phase-source-vs | Value Set de la phase de l'essai tel que définie dans la base ECLAIRE | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-study-phase-vs | Value Set type de phase de l'essai clinique | draft | 2024-02 | fr | national | internal tho |
| ans.fhir.fr.eclaire | R4 | eclaire-study-population-vs | Caractérisation de la population Value Set | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-study-status-vs | Value Set Statut Eclaire de l'essai | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-study-title-type-vs | Type de titre Value Set | draft | 2024-02 | fr | national | internal |
| ans.fhir.fr.eclaire | R4 | eclaire-type-contact-vs | Type Contact Value Set | draft | 2024-02 | fr | national | internal |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ClasseAsa | ClasseAsa | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ClassificationDeParis | ClassificationDeParis | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Complications | Complications | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ConsentementReponse | ConsentementReponse | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ConsentementType | ConsentementType | active | 2023-09 | | | |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/EchelleBostonScore | EchelleBostonScore | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Etablissements | Etablissements | active | 2023-09 | | | |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/InaptConsentementPar | InaptConsentementPar | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IndicationsEndoscopie | IndicationEndoscopie | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Installations | Installations | active | 2023-09 | | | |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/InstrumentsUtilises | InstrumentsUtilises | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantEndoscopiste | IntervenantEndoscopiste | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantProcedure | IntervenantProcedure | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantResident | IntervenantResident | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/LienUsagerEndo | LienUsagerEndo | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ListeMedicamentsEndo | ListeMedicamentsEndo | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/MethodesAdministration | MethodesAdministration | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Observations | Observations | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/OrganisationsOrdres | OrganisationsOrdres | active | 2023-09 | | | |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/PrecisionProvenanceExterne | PrecisionProvenanceExterne | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/PreparationColiqueLaxatifs | PreparationColiqueLaxatifs | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresEffectuees | ProceduresEffectuees | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresType | ProceduresType | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresTypeSpecimentEnvoye | ProceduresTypeSpecimenEnvoye | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Recommandations | Recommandations | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/RetroflexionEffectuee | RetroflexionEffectuee | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/StatutObservation | StatutObservation | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/StructuresCorporelles | StructuresCorporelles | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/SuiviPriseCharge | SuiviPriseCharge | draft | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TaillesPolype | TaillesPolype | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TypeDossier | TypeDossier | active | 2023-09 | | | |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TypeObservation | TypeObservation | active | 2023-09 | | | sct |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TypesDeRessource | TypesDeRessource | draft | 2023-09 | | | |
| RapportEndoscopieQuebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Villes | Villes | active | 2023-09 | | | |
| OntarioacCDRFHIRImplementationGuide-0.10.00 | R4 | http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-gps-uv-ips | Allergy intolerance substance condition (GPS) - IPS | active | 2020-05 | ca | hl7 | sct |
| OntarioacCDRFHIRImplementationGuide-0.10.00 | R4 | http://hl7.org/fhir/uv/ips/ValueSet/allergy-reaction-gps-uv-ips | Allergy Reaction (GPS) - IPS | active | 2020-05 | ca | hl7 | sct |
| OntarioacCDRFHIRImplementationGuide-0.10.00 | R4 | http://ehealthontario.ca/fhir/ValueSet/acCDR-encounter-priority | EncounterPriority | draft | | ca | hl7 | |
| ans.fhir.fr.telesurveillance | R4 | https://interop.esante.gouv.fr/ig/fhir/tlsv/ValueSet/TLSVCategory | TLSV Categories | draft | 2024-10 | fr | national | tho |
| nictiz.fhir.nl.stu3.eafspraak | R3 | http://nictiz.nl/fhir/ValueSet/ContactTypeCodelijst-en-NHGTable14v7-ContactType | ContactTypeCodelijst_en_NHGTable14v7-ContactType | active | | nl | | |
| ans.fhir.fr.cds | R4 | careteam-roles-vs | Roles des participants dans un cercle de soins | active | 2024-09 | fr | national | |
| kbv.mio.emp | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Creatinine_Unit | Serumkreatinin Einheit | draft | | | | ucum |
| kbv.mio.emp | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Creatinine | Serumkreatinin | draft | | | | loinc |
| kbv.mio.emp | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Dose_Form_SNOMED_CT | Darreichungsform SNOMED CT® | draft | | | | |
| kbv.mio.emp | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Drug_Therapy_Status_SNOMED_CT | Medikation Statusgrund | draft | | | | sct |
| kbv.mio.emp | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Glomerular_Filtration_Rate | Glomeruläre Filtrationsrate (GFR) | draft | | | | loinc |
| kbv.mio.emp | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Provenance_Activity_Type | Art der Aktivität | draft | | | | tho |
| kbv.mio.emp | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Provenance_Participant_Type | Art der Beteiligung | draft | | | | tho |
| de.gematik.epa | R4 | epa-audit-event-agent-type-client-vs | EPA AuditEvent Agent Type Client | active | 2025-05 | de | | dcm |
| de.gematik.epa | R4 | epa-audit-event-agent-type-user-vs | EPA AuditEvent Agent Type User | active | 2025-05 | de | | internal tho |
| de.gematik.epa | R4 | epa-auditevent-purpose-of-event-vs | EPA AuditEvent Purpose of Event | active | 2025-05 | de | | internal |
| de.gematik.epa | R4 | epa-auditevent-service-type-vs | EPA AuditEvent Service Type | active | 2025-05 | de | | internal |
| de.gematik.epa | R4 | epa-auditevent-type-vs | EPA AuditEvent Type | active | 2025-05 | de | | tho dcm |
| ca.on.consent.r4 | R4 | http://ehealthontario.ca/fhir/ValueSet/consent-pcoi-override-reason | OverrideReason | draft | | ca | | tho |
| KBV.ITA.EAU | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_EAU_AU_Error_Kasse | KBV_VS_EAU_AU_Error_Kasse | active | 2021-02 | | | |
| kl.dk.fhir.ffbmessaging | R4 | kl-messaging-ffb-consentPolicyValues | ConsentPolicies | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffbmessaging | R4 | kl-messaging-ffb-guardianshipFormValues | GuardianshipForms | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffbmessaging | R4 | kl-messaging-ffb-participantRoleValues | ParticipantRoles | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffbmessaging | R4 | kl-messaging-ffb-relationshipTypeValues | RelationshipTypes | active | 2023-08 | dk | | internal tho |
| basisprofil.de | R3 | http://fhir.de/ValueSet/deuev/anlage-6-vorsatzworte | deuev-anlage-6-vorsatzworte | draft | 2017-09 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/deuev/anlage-7-namenszusaetze | deuev-anlage-7-namenszusaetze | draft | 2017-09 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/dimdi/icd-10-gm | icd-10-gm | draft | 2017-09 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/dimdi/ops | ops | draft | 2017-09 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/edqm/darreichungsform | EDQMDoseForm | draft | | | hl7 | oid |
| basisprofil.de | R3 | http://fhir.de/ValueSet/einheiten-koerpergewicht | einheiten-koerpergewicht | draft | 2018-09 | | hl7 | ucum |
| basisprofil.de | R3 | http://fhir.de/ValueSet/einheiten-koerpergroesse | einheiten-koerpergroesse | draft | 2018-09 | | hl7 | ucum |
| basisprofil.de | R3 | http://fhir.de/ValueSet/einnahmezeitpunkte | einnahmezeitpunkte | draft | 2017-08 | | hl7 | fhir |
| basisprofil.de | R3 | http://fhir.de/ValueSet/gender-amtlich-de | gender-amtlich-de | draft | 2019-03 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/betriebsstaetten-hierarchie | kbv-betriebsstaetten-hierarchie | draft | 2017-09 | | hl7 | fhir |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-bar-wbo2 | kbv-s-bar-wbo2 | draft | 2018-11 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-bar2-arztnrfachgruppe | kbv-s-bar2-arztnrfachgruppe | draft | 2017-09 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-bmp-darreichungsform | kbv-s-bmp-darreichungsform | draft | 2017-08 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-bmp-dosiereinheit | kbv-s-bmp-dosiereinheit | draft | 2017-08 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-icd-diagnosesicherheit | kbv-s-icd-diagnosesicherheit | draft | 2018-04 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-icd-seitenlokalisation | kbv-s-icd-seitenlokalisation | draft | 2017-09 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-kbv-dmp | kbv-s-kbv-dmp | draft | 2018-07 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-kbv-kv | kbv-s-kbv-kv | draft | 2017-10 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-kbv-personengruppe | kbv-s-kbv-personengruppe | draft | 2018-01 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/kbv/s-kbv-versichertenstatus | kbv-s-kbv-versichertenstatus | draft | 2017-10 | | hl7 | |
| basisprofil.de | R3 | http://fhir.de/ValueSet/raucherstatus | raucherstatus | draft | 2018-09 | | hl7 | |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/ValueSet/provider-role | Argonaut Provider Directory Provider Role (NUCC) | draft | 2016-08 | us | hl7 | nucc |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/ValueSet/provider-specialty | Argonaut Provider Directory Provider Speciality (NUCC) | draft | 2016-08 | us | hl7 | nucc |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/ERGVerkehrsmittel | ERGVerkehrsmittel | draft | | de | | sct |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-abrechnungs-diagnose-use-VS | ERG Abrechnungsdiagnose Use ValueSet | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-audit-event-agent-type-vs | ERG Audit Event Agent Type | active | 2025-04 | de | | tho |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-audit-event-sub-type-vs | ERG Audit Event Sub-Type | active | 2025-04 | de | | fhir |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-audit-event-type-vs | ERG Audit Event Type | active | 2025-04 | de | | dcm |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-chargeitem-type-VS | ERG Typ der Rechnungsposition ValueSet | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-dokument-artderarchivierung-vs | ERG Dokument ArtDerArchivierung VS | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-participant-role-VS | ERG Teilnehmer Rolle | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnung-abrechnungsart-vs | ERG Rechnung Abrechnungsart VS | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnung-behandlungsart-vs | ERG Rechnung Behandlungsart VS | active | 2025-04 | de | | tho |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnung-markierung-vs | ERG Rechnung Markierung VS | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnung-submit-modus-vs | ERG Rechnung Type VS | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnungsart-vs | ERG Rechnungsart VS | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnungsposition-faktor-gruende-auspraegungen-VS | ERG Rechnungsposition Faktor Gründe ValueSet | draft | | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnungsposition-zusatz-VS | ERG Rechnungsposition Zusatz ValueSet | draft | | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-rechnungsstatus-vs | ERG Rechnungsstatus | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-restricted-mime-types-vs | ERG Restricted Mime Types | active | 2025-04 | de | | tho |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-sonstigesdokument-type-vs | ERG Sonstiges Dokument Type VS | active | 2025-04 | de | | |
| de.gematik.erg | R4 | https://gematik.de/fhir/erg/ValueSet/erg-total-price-component-deduction-type-vs | ERG Art des Abzugs von der Summe der gesamten Rechnungspositionen | draft | | de | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/AddressStateVS | AddressStateVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/EndpointConnectionTypeVS | EndpointConnectionTypeVS | active | 2024-10 | | | tho |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/EndpointPayloadTypeVS | EndpointPayloadTypeVS | active | 2024-10 | | | tho |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/EndpointVisibilityVS | EndpointVisibilityVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/HealthcareServiceTypeVS | HealthcareServiceTypeVS | active | 2024-10 | | | oid |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/HealthcareSpecialtyTypeVS | ValueSet of HealthcareService specialities | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/OpeningTimeQualifierVS | OpeningTimeQualifierVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/OrganizationProfessionOIDTypeVS | OrganizationProfessionOIDTypeVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/OrganizationTypeVS | OrganizationTypeVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/OrganizationVisibilityVS | OrganizationVisibilityVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/OriginVS | OriginVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/PhysicalFeaturesHealthCareServiceVS | PhysicalFeaturesHealthCareServiceVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/PractitionerQualificationVS | PractitionerQualificationVS | active | 2024-10 | | | oid |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/healthcare-service-category-codes | HealthcareService Category Codes | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/healthcareservice-technical-characteristic-vs | HealthCareServiceTechnicalCharacteristicVS | active | 2024-10 | | | |
| de.gematik.fhir.directory | R4 | https://gematik.de/fhir/directory/ValueSet/ncpeh-healthcare-service-speciality-cs | NCPeH HealthcareService Speciality ValueSet | active | 2024-10 | | | loinc |
| hitstdio.tw.fhir.dcc | R4 | DCC-QR-Category-Usage-ValueSet | DCC QR Category Usage Codes | active | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | DCC-QR-Format-ValueSet | DCC QR Format Codes | active | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | IdentifierType | Identifier Type | draft | 2021-08 | | | internal tho |
| hitstdio.tw.fhir.dcc | R4 | TWCDC-Vaccine-Code | TWCDC 疫苗 ValueSet | draft | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | atc-vaccines-covid-19 | ATC Vaccine List (COVID-19) | draft | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | covid-19-diseases | COVID-19 Diseases | draft | 2021-08 | | | sct |
| hitstdio.tw.fhir.dcc | R4 | covid-19-lab-methods | COVID-19 Lab Methods | draft | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | covid-19-lab-result | COVID-19 Lab Result | draft | 2021-08 | | | sct |
| hitstdio.tw.fhir.dcc | R4 | covid-19-lab-test-manufacturer-and-name | 廠商代碼表 | draft | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | covid-19-sample-origin | COVID-19 Sample Origin | draft | 2021-08 | | | sct |
| hitstdio.tw.fhir.dcc | R4 | loinc-tests-covid-19 | LOINC Test List (COVID-19) | draft | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | sct-vaccines-covid-19 | SNOMED CT Vaccine List (COVID-19) | draft | 2021-08 | | | sct |
| hitstdio.tw.fhir.dcc | R4 | vaccines-covid-19-names | Vaccine Name List (COVID-19) | draft | 2021-08 | | | internal |
| hitstdio.tw.fhir.dcc | R4 | vaccines-covid-19 | Vaccine List (COVID-19) | draft | 2021-08 | | | internal sct |
| ndhm.in.mirror | R4 | https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnosis-use | Diagnosis Use | draft | 2020-08 | in | national | sct |
| ndhm.in.mirror | R4 | https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnostic-report-type | Diagnostic Report Type | draft | 2020-08 | in | national | sct |
| ndhm.in.mirror | R4 | https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-medicine-codes | Medicine Codes | draft | 2020-09 | in | national | sct |
| ndhm.in.mirror | R4 | https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-practitioner-role | Practitioner Role | draft | 2020-08 | in | national | sct |
| ndhm.in.mirror | R4 | https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-route-of-administration | Route Of Administration | draft | 2020-08 | in | national | sct |
| ndhm.in.mirror | R4 | https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-specimen-types | Specimen Types | draft | 2020-08 | in | national | sct |
| ndhm.in.mirror | R4 | https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-vaccine-codes | Vaccine Codes | draft | 2021-01 | in | national | sct |
| hl7.fhir.be.allergy | R4 | be-allergyintolerancecode | BeAllergyIntoleranceCode | active | 2023-12 | be | hl7 | internal |
| hl7.fhir.be.allergy | R4 | be-causativeagent | BeCausativeAgent | active | 2023-12 | be | hl7 | sct |
| hl7.fhir.be.allergy | R4 | be-exposureroute | BeExposureRoute | active | 2023-12 | be | hl7 | sct |
| hl7.fhir.be.allergy | R4 | be-noallergy | BeNoAllergy | active | 2023-12 | be | hl7 | sct |
| hl7.fhir.be.allergy | R4 | be-riskmanifestation | BeRiskManifestation | active | 2023-12 | be | hl7 | sct |
| hl7.fhir.be.allergy | R4 | be-vs-allergyintolerance-type | BeVSAllergyIntoleranceType | active | 2023-12 | be | hl7 | sct |
| cezih.hr.condition-management | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/health-issue-management-clinical-status-update | Kodovi statusa slučaja (izmjena podataka) | draft | | uv | | tho |
| cezih.hr.condition-management | R4 | http://ent.hr/fhir/ValueSet/health-issue-management-reopen-message-types | Message types used for reopen health issue | draft | | uv | | |
| cezih.hr.condition-management | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/health-issue-management-verification-status-create | Kodovi statusa verifikacije slučaja (kreiranje) | draft | | uv | | tho |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/DiagnosticConfirmationVS | Diagnostic Confirmation VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/GeneNomenclatureVS | Gene Nomenclature VS | draft | | | | gene |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/GeneticVariantVS | Genetic Variant VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/GradingVS | Grading VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/ICDOVersionVS | ICDO Version VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/ICDVersionVS | ICD Version VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/LocalAssessmentResidualTumorVS | Local Assessment Residual Tumor VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/MorphologyICDO3VS | Morphology ICDO3 VS | draft | | | | oid |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/OPIntentionVS | OP Intention VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/OPOPSVersionVS | OPOPS Version VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/OverallAssessmentResidualTumorVS | Overall Assessment Residual Tumor VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/ProgressionLocalTumorStatusVS | Progression Local Tumor Status VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/Projects | Projects | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/PseudonymTypeVS | Pseudonym Type VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/SYSTIntentionVS | SYST Intention VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/SYSTTherapyTypeVS | SYST Therapy Type VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/SampleMaterialType | Sample Material Type | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/SurgicalComplicationsVS | Surgical Complications VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMLCategoryVS | TNML Category VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMMVS | TNMM VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMPnCategoryVS | TNMPn Category VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMSCategoryVS | TNMS Category VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMTVS | TNMT VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMVCategoryVS | TNMV Category VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMVersionVS | TNM Version VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMmSymbolVS | TNMm Symbol VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMrSymbolVS | TNMr Symbol VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TNMySymbolVS | TNMy Symbol VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TopographyICDO3VS | Topography ICDO3 VS | draft | | | | oid |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/TumorSiteLocationVS | Tumor Site Location VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/UICCStageVS | UICC Stage VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/VitalStatusVS | Vital Status VS | draft | | | | |
| cce.fhir.minimal | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/YNUVS | YNU VS | draft | | | | |
| ca.on.mi.pkg | R4 | http://cihi.ca/fhir/ValueSet/AacAdmitSource | AdmitSource | active | 2019-02 | ca | | |
| ca.on.mi.pkg | R4 | http://cihi.ca/fhir/ValueSet/AacDischargeDisposition | DischargeDisposition | active | 2019-02 | ca | | |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/local-document-types | Local Document Types | active | 2018-12 | ca | | oid |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-category-type | Medical Imaging Category Type | active | 2024-04 | ca | | sct |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-code-type | Medical Imaging Code Type | active | 2024-04 | ca | | |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-document-type | Medical Imaging Document Type | active | 2024-04 | ca | | loinc |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-imaging-study-identifier-type | Medical Imaging Study Identifier Type | active | 2024-04 | ca | | tho dcm |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-patient-jhn-system | Patient JHN URI | draft | 2024-04 | ca | | |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-procedure-bodypart-sct | Medical Imaging Procedure Body Part. | active | 2024-04 | ca | | sct |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-procedure-contrast-used | Medical Imaging Procedure Contrast Used | active | 2024-04 | ca | | sct |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-procedure-laterality-sct | Medical Imaging Procedure Laterality - SNOMED CT | active | 2024-04 | ca | | sct |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-procedure-specialty | Medical Imaging Procedure Specialty | active | 2024-04 | ca | | sct |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-procedure-type-provincial | Medical Imaging Provincial Procedure Type | active | 2024-04 | ca | | |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/mi-procedure-type-sct | Medical Imaging SNOMED CT Procedure Type | active | | ca | | sct |
| ca.on.mi.pkg | R4 | http://ontariohealth.ca/fhir/ValueSet/provincial-document-types | Provincial Document Types | active | 2021-09 | ca | | loinc |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/cancer-type-code | Cancer type | active | 2020-11 | nz | hl7 | sct |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/sact-administration-site-code | Administration location | active | 2020-11 | nz | hl7 | sct |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/sact-location-medication-collection-code | Medication collection location | active | 2020-11 | nz | hl7 | sct |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/sact-plan-definition-status-code | PlanDefinition additional status | active | 2020-11 | nz | hl7 | |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/sact-regimen-code | Regimen type code | active | 2020-11 | nz | hl7 | |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/sact-support-factor-code | Support Factors | active | 2020-11 | nz | hl7 | sct |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/sact-support-factor-value-code | Possible values for Support Factors | active | 2020-11 | nz | hl7 | sct |
| hl7.fhir.nz.cca | R4 | https://standards.digital.health.nz/fhir/ValueSet/sact-treatment-intent-code | Treatment intent | active | 2020-11 | nz | hl7 | sct |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.45--20220310164013 | Aanvullende Informatie voor MA | active | 2022-04 | nl | | oid |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.33--20170505131418 | Aanvullende informatie voor VS | active | | nl | | oid |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.32--20230109105413 | Aanvullende wensen voor VV | draft | 2023-01 | nl | | oid |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.9--20160407000000 | Aanvullende gebruiksinstructie | active | | nl | | tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20200901000000 | DagdeelCodelijst | active | | nl | | sct |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.57--20241101000000 | Financiële Indicatiecode | draft | 2024-11 | nl | | tho oid |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054 | MedicatieToedieningRedenVanAfwijkenCodelijst | draft | 2024-01 | nl | | sct tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.13.1--20200901000000 | MedicatieToedieningStatusCodelijst | active | | nl | | tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.13.2--20200901000000 | MedicatieToedieningToedieningswegCodelijst | active | | nl | | oid |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.1--20200901000000 | MedicatieToedieningswegCodelijst | active | | nl | | oid |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.55--20230119145802 | MedicatiegebruikStopTypeCodelijst | draft | 2023-01 | nl | | sct |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.9.1--20200901000000 | MedicatieverstrekkingDistributievormCodelijst | active | | nl | | oid |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942 | PrikPlakLocatieCodeLijst | active | 2022-04 | nl | | sct tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.56--20230213120250 | ProductCodeCodelijsten | draft | 2023-02 | nl | | |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525 | RedenWijzigen-StakenCodelijst | draft | 2022-11 | nl | | sct tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621 | RedenWijzigen-StakenWDSCodelijst | draft | | nl | | sct tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002 | RedenWijzigen-StoppenGebruikCodelijst | draft | 2023-10 | nl | | sct tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.50--20221216102010 | StopTypeCodelijst | draft | 2023-01 | nl | | sct |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643 | Toedieningsafspraak-RedenWijzigen-StakenCodelijst | draft | | nl | | sct tho |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20200901000000 | WeekdagCodelijst | active | | nl | | sct |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.48--20230112155455 | WisselendDoseerschemaStopTypeCodelijst | draft | 2023-01 | nl | | sct |
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.4--20200901000000 | ZonodigCriteriumCodelijst | active | | nl | | tho |
| hl7.fhir.be.vaccination | R4 | be-vs-care-location | BeVSCareLocation | active | 2025-03 | be | hl7 | internal |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccination-administration-route | BeVSVaccineAdministrationRoute | draft | 2025-03 | be | hl7 | internal tho |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccination-bodysite | BeVSVaccinationBodySite | draft | 2025-03 | be | hl7 | sct |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccination-confirmation-status | BeVSVaccinationConfirmationStatus | draft | 2025-03 | be | hl7 | internal |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccination-product | BeVSVaccinationProduct | draft | 2025-03 | be | hl7 | |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccination-reason-code | BeVSVaccinationReasonCode | draft | 2025-03 | be | hl7 | sct |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccination-status-reason | BeVSVaccinationStatusReason | draft | 2025-03 | be | hl7 | internal tho |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccine-code | BeVSVaccineCode | active | 2025-03 | be | hl7 | internal sct |
| hl7.fhir.be.vaccination | R4 | be-vs-vaccine-target-disease | BeVSVaccineTargetDisease | draft | 2025-03 | be | hl7 | internal |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/argo-codesystem | Argonaut Extension Codes | draft | 2016-10 | us | hl7 | |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/condition-category | Argonaut Condition Category Codes | draft | 2016-10 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/detailed-ethnicity | US-Core Detailed ethnicity | draft | 2016-08 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/detailed-race | US-Core Detailed Race | draft | 2016-08 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/device-kind | Argonaut Device Types | draft | 2016-10 | us | hl7 | sct |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/languages | All Languages | draft | 2016-11 | us | hl7 | ietf |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/medication-codes | Medication Clinical Drug (RxNorm) | draft | 2016-05 | us | hl7 | rx |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/narrative-status | Narrative Status | draft | 2016-10 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/ndc-vaccine-codes | Vaccine National Drug Code (NDC) | draft | 2016-10 | us | hl7 | ndc |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/observation-ccdasmokingstatus | Smoking Status | active | 2016-08 | us | hl7 | sct |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/observation-ccdavitalsignresult | Argonaut Vital Sign Codes | active | 2016-08 | us | hl7 | loinc |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/observation-value-codes | Observation Value Codes (SNOMED-CT) | draft | 2016-08 | us | hl7 | sct |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/omb-ethnicity | OMB Ethnicity Categories | draft | 2016-08 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/omb-race | OMB Race Categories | active | 2016-05 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/procedure-icd10pcs | Argonaut Procedure Type ICD-10-PCS Codes | draft | 2016-08 | us | hl7 | |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/procedure-type | Argonaut ProcedureType | draft | 2016-05 | us | hl7 | sct cpt |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/provider-role | Care Team Provider Roles | draft | 2016-10 | us | hl7 | nucc sct |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance-ndfrt | DAF Substance ND-FRT codes | draft | 2016-10 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance-rxnorm | DAF Substance RxNorm Codes | draft | 2016-10 | us | hl7 | rx |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance-sct | DAF SNOMED CT Substances Other Than Clinical Drugs | draft | 2016-10 | us | hl7 | sct |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance | Argonaut Substance-Reactant for Intolerance and Negation Codes | draft | 2016-10 | us | hl7 | sct |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/ucum-vitals-common | Argonaut Vital Signs Units | draft | 2016-05 | us | hl7 | ucum fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/ucum | UCUM units | draft | 2016-08 | us | hl7 | ucum |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/usrealm-birthsex | USRealm Birth Sex Value Set | active | 2016-08 | us | hl7 | fhir |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/vacc-status | Argonaut Immunization Status | draft | 2016-10 | us | hl7 | fhir |
| ehealthplatform.be.r4.federalprofiles | R4 | DispenserTypes | Dispenser Types | draft | | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-allergyintolerancecode | BeAllergyIntoleranceCode | active | | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-causativeagent | BeCausativeAgent | active | | | hl7 | sct |
| ehealthplatform.be.r4.federalprofiles | R4 | be-civilstate | BeCivilstate | active | | | hl7 | internal tho |
| ehealthplatform.be.r4.federalprofiles | R4 | be-contactperson | BeContactPerson | active | | | hl7 | internal tho |
| ehealthplatform.be.r4.federalprofiles | R4 | be-exposureroute | BeExposureRoute | active | | | hl7 | sct |
| ehealthplatform.be.r4.federalprofiles | R4 | be-noallergy | BeNoAllergy | active | | | hl7 | sct |
| ehealthplatform.be.r4.federalprofiles | R4 | be-riskmanifestation | BeRiskManifestation | active | | | hl7 | sct |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-bodysite | Body Site | active | 2021-01 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-care-location | Care Location Value Set | active | 2021-01 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-diarytopic | BeVSDiaryTopic | active | 2021-01 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-laterality | Laterality | active | 2021-01 | | hl7 | fhir |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-patientwill-category | Patient Will Category | active | 2020-10 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-patientwill-code | Patient Will code Value Set | active | 2020-10 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-problem-category | Problem Category | active | 2021-01 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-problem-code | Problem Code | active | 2021-01 | | hl7 | |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-problem-origin-type | Problem Origin Type | active | 2021-01 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-score | Score Value Set | active | 2020-10 | | hl7 | internal sct |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-scorecategory | Score Category Value Set | active | 2021-01 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-vaccination-administration-route | Vaccine Administration Route | active | 2021-01 | | hl7 | internal tho |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-vaccination-confirmation-status | Vaccination status Value Set | active | 2021-01 | | hl7 | internal |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-vaccination-status-reason | Vaccination status reason Value Set | active | 2021-01 | | hl7 | internal tho |
| ca.ab.fhir.aberec1 | R4 | https://www.alberta.ca/fhir/ValueSet/preference-type-code | PreferenceTypeCode | draft | 2025-01 | ca | | |
| ca.ab.fhir.aberec1 | R4 | https://www.alberta.ca/fhir/ValueSet/preference-value-type-code | PreferenceValueTypeCode | draft | 2025-01 | ca | | |
| ca.ab.fhir.aberec1 | R4 | https://www.alberta.ca/fhir/ValueSet/referral-reason-code | ReferralReasonCode | draft | 2025-01 | ca | | sct |
| ca.ab.fhir.aberec1 | R4 | https://www.alberta.ca/fhir/ValueSet/specialty-code | SpecialtyCode | draft | 2025-01 | ca | | |
| ca.ab.fhir.aberec1 | R4 | https://www.alberta.ca/fhir/ValueSet/task-business-status-ab | TaskBusinessStatus_AB | draft | 2024-11 | ca | | |
| ca.ab.fhir.aberec1 | R4 | https://www.alberta.ca/fhir/ValueSet/timestamp-type-code | TimestampType | draft | 2024-12 | ca | | |
| de.diga.caracare | R4 | https://cara.care/fhir/ValueSet/BauchSchmerzenVS | Bauchschmerzen ValueSet | active | | | | |
| de.diga.caracare | R4 | https://cara.care/fhir/ValueSet/BlaehungenVS | Blähungen ValueSet | active | | | | |
| de.diga.caracare | R4 | https://cara.care/fhir/ValueSet/BristolStoolScaleVS | BristolStoolScaleVS | active | | | | |
| de.diga.caracare | R4 | https://cara.care/fhir/ValueSet/StimmungVS | Blähungen ValueSet | active | | | | |
| de.diga.caracare | R4 | https://cara.care/fhir/ValueSet/StressVS | Stress ValueSet | active | | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-additional-infotype | Genomics Additional Information Type | draft | 2024-05 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-business-status | Genomics Business Status | draft | 2024-09 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-message-events | Genomics Message Events | draft | 2024-09 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-patient-choice-category | Genomics Patient Choice Category | draft | 2024-09 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-patientguardian-types | Genomics Patient Guardian | draft | 2024-09 | | | tho |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-reasonfortesting | Genomics Reason for Testing | draft | 2024-07 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-patient-choice-researchparticipation | Genomics Patient Choice Research Participation | draft | 2024-09 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-specimen-collection-specialhandling | Genomics Specimen Collection Special Handling | draft | 2024-08 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-task-code | Genomics Task Code | draft | 2024-09 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-task-statusReason | Genomics Task Status Reason | draft | 2024-09 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-test-types | Genomics Test Types | draft | 2024-09 | | | |
| uk.nhsengland.genomics.r4 | R4 | https://fhir.nhs.uk/ValueSet/genomics-types-of-reanalysistest | Genomics Types of Re-Analysis Test | draft | 2024-07 | | | |
| kbv.basis.with.expansion | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_Base_Medicine_Doseform | medicine-doseform | active | | | | |
| healthhub.fhir.dk.core | R4 | https://plsp.dk/fhir/ValueSet/DiagnosisCategory | Health Hub Dk Core DiagnosisCategory | active | 2024-09 | dk | | |
| healthhub.fhir.dk.core | R4 | https://plsp.dk/fhir/ValueSet/EmployeeIdentifierSystem | Health Hub Employee Identifier System | active | 2024-09 | dk | | oid |
| healthhub.fhir.dk.core | R4 | https://plsp.dk/fhir/ValueSet/Laterality2 | Health Hub Dk Core Laterality | active | 2024-09 | dk | | sct |
| ca.infoway.io.ca-csd | R4 | http://fhir.infoway-inforoute.ca/io/CA-CSD/ValueSet/delivery-method | Delivery Method | draft | | | national | sct |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/AbnormalClinicalFindings | Abnormal Clinical Findings Value Set | active | 2022-03 | | | sct |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/BiologicalSexes | Biological Sexes Value Set | active | 2022-03 | | | sct |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/EncounterClasses | Encounter Class Value Set | active | 2022-03 | | | tho |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/EncounterTypes | Encounter Type Value Set | active | 2022-03 | | | fhir |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/GenomicTestTypes | Genomic Test Types Value Set | active | 2022-03 | | | loinc |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/Lateralities | Lateralities Value Set | active | 2022-03 | | | sct |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/PresenceValues | Presence Value Set | active | 2022-03 | | | sct |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/Severities | Severity Value Set | active | 2022-03 | | | sct |
| agha.fhir.genclipr | R4 | http://aehrc.github.io/genclipr-fhir-ig/ValueSet/TestInterpretationValues | Test Interpretation Value Set | active | 2022-03 | | | sct |
| tw.cathay.fhir.iclaim | R4 | cathay-chargeitemcode-values | 費用項目值集 | active | 2023-06 | tw | | internal |
| tw.cathay.fhir.iclaim | R4 | cathay-healthprofessional-values | 醫事人員類別值集 | active | 2024-07 | tw | | internal sct |
| tw.cathay.fhir.iclaim | R4 | cathay-particulardiagnosis-values | 特殊診斷類別值集 | active | 2023-08 | tw | | internal |
| tw.cathay.fhir.iclaim | R4 | hl7-medicalidentity-values | CoverageSelfPay值集 | active | 2024-07 | tw | | tho |
| tw.cathay.fhir.iclaim | R4 | hl7-pricecomponenttype-values | InvoicePriceComponentType值集 | active | 2024-07 | tw | | fhir |
| tw.cathay.fhir.iclaim | R4 | lia-roc-occupation-values | 臺灣地區傷害保險個人職業分類表值集 | active | 2023-07 | tw | | internal |
| tw.cathay.fhir.iclaim | R4 | loinc-observation-category | LOINC實驗室檢驗檢查報告名稱值集 | active | 2023-02 | tw | | loinc |
| tw.cathay.fhir.iclaim | R4 | loinc-observation-code | LOINC實驗室檢驗檢查值集 | active | 2024-07 | tw | | loinc |
| tw.cathay.fhir.iclaim | R4 | nhi-department-values | 診療科別值集 | active | 2023-11 | tw | | internal |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAnimalSpecies | eHDSI Animal Species | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | eHDSIAnimalSpeciesWithExceptions | eHDSI Animal Species with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup | eHDSI Blood Group | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite | eHDSI Body Site | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIBodySiteLaterality | eHDSI Body Site Laterality | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | eHDSIBodySiteWithExceptions | eHDSI Body Site with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIBodyStructureLocation | eHDSI Body Structure Location Qualifier | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | eHDSIBodyStructureLocationWithExceptions | eHDSI Body Structure Location Qualifier with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSICountry | eHDSI Country | active | 2025-03 | eu | | iso |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIExceptionalValue | eHDSI Exceptional Value | active | 2025-03 | eu | | tho |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIHealthcareProfessionalRole | eHDSI Healthcare Professional Role | active | 2025-03 | eu | | oid |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIIllnessandDisorder | eHDSI Illness and Disorder | active | 2025-03 | eu | | icd |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSILabCode | eHDSI Laboratory Codes | active | 2025-03 | eu | | loinc |
| myhealth.eu.fhir.laboratory | R4 | eHDSILabCodeWithExceptions | eHDSI Laboratory Codes with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSILabSpecimenType | eHDSI Laboratory Specimen Type | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | eHDSILabSpecimenTypeWithExceptions | eHDSI Laboratory Specimen Type with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSILabStudyType | eHDSI Laboratory Study Types | active | 2025-03 | eu | | loinc |
| myhealth.eu.fhir.laboratory | R4 | eHDSILabStudyTypeWithExceptions | eHDSI Laboratory Study Types with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSILabTechnique | eHDSI Laboratory Technique | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | eHDSILabTechniqueWithExceptions | eHDSI Laboratory Technique with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSILaboratoryReportTypes | eHDSI Laboratory Report Types | active | 2025-03 | eu | | loinc |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSILanguage | eHDSI Language | active | 2025-03 | eu | | ietf |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice | eHDSI Medical Device | active | 2025-03 | eu | | sct oid |
| myhealth.eu.fhir.laboratory | R4 | eHDSIMedicalDeviceWithExceptions | eHDSI Medical Device with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIMicroorganism | eHDSI Microorganism | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIMorphologicAbnormality | eHDSI Morphologic Abnormality | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | eHDSIMorphologicAbnormalityWithExceptions | eHDSI Morphologic Abnormality with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIObservationCategory | eHDSI Observation category | active | 2025-03 | eu | | tho |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIObservationInterpretation | eHDSI Observation Interpretation | active | 2025-03 | eu | | tho |
| myhealth.eu.fhir.laboratory | R4 | eHDSIObservationInterpretationWithExceptions | eHDSI Observation Interpretation with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | eHDSIOrderReason | eHDSI Order Reason | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIPerformerFunction | eHDSI Performer Function | active | 2025-03 | eu | | tho |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIPresenceAbsence | eHDSI Presence Absence | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIRareDisease | eHDSI Rare Disease | active | 2025-03 | eu | | oid |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy | eHDSI Reaction Allergy | active | 2025-03 | eu | | sct |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIReferenceRangeAppliesTo | eHDSI Reference Range Applies To | active | 2025-03 | eu | | tho |
| myhealth.eu.fhir.laboratory | R4 | eHDSIReferenceRangeAppliesToWithExceptions | eHDSI Reference Range Applies To with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIReferenceRangeMeaning | eHDSI Reference Range Meaning | active | 2025-03 | eu | | tho |
| myhealth.eu.fhir.laboratory | R4 | eHDSIReferenceRangeMeaningWithExceptions | eHDSI Reference Range Meaning with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | eHDSIResultsCodedValueLaboratory | eHDSI Results Coded Value Laboratory with exceptions | active | 2025-03 | eu | | |
| myhealth.eu.fhir.laboratory | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIUnit | eHDSI Unit | active | 2025-03 | eu | | ucum |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/abnahmeortSNOMED | Abnahmeort | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/anforderungChlamydienSentinelSNOMED | Untersuchungsanlass Chlamydien-Sentinel | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/anforderungMasernSentinelSNOMED | Untersuchungsanlass Masern-Sentinel | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/anforderungSNOMED | Untersuchungsanlass Diagnose oder Screening | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/anforderungSentinelSNOMED | Untersuchungsanlass | draft | 2024-09 | | | |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortGeneSNOMED | Ergebnis der Laboruntersuchung Gene | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortMreSNOMED | Ergebnis der Laboruntersuchung MRE | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortOrdinalSNOMED | Ergebnis der Laboruntersuchung Ordinal | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenBakSNOMED | Ergebnis der Laboruntersuchung BAK | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenMykSNOMED | Ergebnis der Laboruntersuchung MYK | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenParSNOMED | Ergebnis der Laboruntersuchung PAR | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenVirSNOMED | Ergebnis der Laboruntersuchung VIR | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortSNOMED | Ergebnis der Laboruntersuchung | draft | 2024-09 | | | |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/antwortSemiquantitativeErgebnisseSNOMED | Ergebnis der Laboruntersuchung Semiquantitative Ergebnisse | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/diagnosticReportStatus | Status des Laborberichts | draft | 2024-09 | | | fhir |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/fachabteilungsschluesselRki | Fachabteilungsschlüssel (RKI-Ergänzungen) | draft | 2024-09 | | | |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/interpretationSNOMED | Angabe der Interpretation mit SNOMED CT qualifier values | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/materialSNOMED | Probenmaterial | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/methodeSNOMED | Testmethoden | draft | 2024-09 | | | sct |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/norm | Normen | draft | 2024-09 | | | |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/stationstyp | Stationstyp | draft | 2024-09 | | | tho |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testBakLOINC | Gegenstand der Laboruntersuchung BAK | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testLOINC | Gegenstand der Laboruntersuchung | draft | 2024-09 | | | |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testMykLOINC | Gegenstand der Laboruntersuchung MYK | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testParLOINC | Gegenstand der Laboruntersuchung PAR | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testResistenzGenotypischLOINC | Gegenstand der Laboruntersuchung Resistenz Genotypisch | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testResistenzMolekularLOINC | Gegenstand der Laboruntersuchung Resistenz Molekular | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testResistenzPhaenotypischLOINC | Gegenstand der Laboruntersuchung Resistenz Phänotypisch | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testResistenzmechanismusLOINC | Gegenstand der Laboruntersuchung Resistenzmechanismus | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/testVirLOINC | Gegenstand der Laboruntersuchung VIR | draft | 2024-09 | | | loinc |
| rki.demis.ars | R4 | https://demis.rki.de/fhir/ars/ValueSet/versicherungsartErgaenzungen | Versicherungsart (Ergänzungen) | draft | 2024-09 | | | |
| egde.health.gateway | R4 | care-team-role-vs | Care Team role | active | 2023-03 | | | sct |
| egde.health.gateway | R4 | consent-vs | Consent codes from Loinc and Snomed-ct | active | 2023-03 | | | sct tho loinc |
| egde.health.gateway | R4 | documentype-9602-vs | Volven 9602 Dokumenttyper | active | 2023-03 | | | oid |
| egde.health.gateway | R4 | organisatorisk-betingelse-8624vs | Organisatorisk betegnelse | active | 2023-03 | | | oid |
| egde.health.gateway | R4 | organization-type-vs | Organization type | active | 2023-03 | | | sct |
| egde.health.gateway | R4 | specimen-type-vs | Specimen types | active | 2023-03 | | | |
| globalalliant.us.eom-updates | R4 | eom-tumor-marker-result-valueset | TumorMarkerTestResultValueSet | draft | 2025-01 | | | loinc |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/body-parts | Body parts | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/ctcae-symptom-grades | CTCAE symptom grades | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/message-recipients | CAPABLE message recipients | draft | | | | |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/capsules | Capsule list | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/hobbies | Hobbies | draft | | | | sct loinc |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/list-codes | List codes | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/medical-prescriptions | Medical prescriptions | draft | | | | rx |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/medication-performer-type | Medication performer types | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/melanoma-types | Types of melanoma | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/patient-goals | Patient goals | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/prescription-type | Prescription types | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/symptom-codes | Symptom codes | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/units-of-measure | Units of measure | draft | | | | ucum |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/visit-types | Visit types | draft | | | | sct |
| Capable.repository | R4 | http://capable-project.eu/data/fhir/ValueSet/who-score | WHO score | draft | | | | sct |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/admission-priority | Prioridade de admissão | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/allergy-category | Categoria da Alergia | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/assessment-position | Posição do Corpo e Postura | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/assessment-spot | Local de Aferição | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/care-modality | Modalidade Assistencial | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/condition-category | Categoria da condição | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/condition-status | Status da Condição | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/criticality-level | Nível de Criticidade | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/discharge-nature | Motivo da Alta | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/episode-admission | Tipo de Admissão do episódio | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/examination-finding | Achados do Exame Físico | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/frequency | Frequência | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/general-finding | Achado Geral de Observação do Paciente | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/human-gender | Gênero | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/human-race | Raça/Cor | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/human-sex | Sexo | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/human-sex-orientation | Orientação sexual | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/hydration-degree | Grau de Hidratação | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/laterality | Lateralidade | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/measurement-type-physical-exam | Mensurações - Exame Físico | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/measurement-type-rating-scales | Mensurações - Escalas de Avaliação Médica | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/motor-response | Resposta Motora | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/ocular-response | Resposta Ocular | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/palor-degree | Grau de Palidez | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/place-of-service | Local de Atendimento | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/previous-awareness | Conscientização Anterior | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/previous-place | Procedência | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/procedure-status | Status do Procedimento | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/psychoactive-substance | Substância Psicoativa | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/resolution-state | Estado de Resolução | active | 2022-02 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/skin-perfusion | Perfusão capilar | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/unit-of-measurement-ucum | Unidades de Medida | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/verbal-response | Resposta Verbal | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/cardiac-pace | Ritmo Cardíaco | active | 2021-12 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/ciap2 | Problema/Queixa principal | active | 2022-03 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/cyanosis-presence | Presença de Cianose | active | 2021-12 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/icterus-presence | Presença de Icterícia | active | 2021-12 | sami | hl7 | |
| hl7.fhir.sami.core | R4 | https://www.samisaude.com.br/fhir/r4/ValueSet/procedure-category | Categoria do Procedimento | active | 2022-02 | sami | hl7 | |
| cens.fhir.poclis-ssmso | R4 | http://cens.cl/fhir/ValueSet-MotivoMuestraSSMSO | MotivoMuestraSSMSO | active | 2020-05 | | | |
| cens.fhir.poclis-ssmso | R4 | http://cens.cl/fhir/ValueSet/PocSeguimientoResultadoCovid | PocSeguimientoResultadoCovid | active | 2020-05 | | | |
| cens.fhir.poclis-ssmso | R4 | http://cens.cl/fhir/ValueSet-PrevisionMinsalDecreto643 | PrevisionMinsalDecreto643 | active | 2020-05 | | | |
| kl.dk.fhir.core | R4 | KLCarePlanCategoryCodes | KLIndsatsforløbTypekoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLChangeValueCodes | KLMåltypeKoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLChangeValueCodesFFB | KLMåltypekoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLChangeValueCodesFSIII | KLMåltypeKoderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLCitizenObservationCodesFSIII | KLBorgervurderingsObservationskoderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLCitizenObservationResultCodesFSIII | KLBorgervurderingsResultatkoderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLComplicationCodesSCT | KLKomplikationskoderSCT | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionADCodesFFB | KLTilstandADKoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionCodes | KLTilstandKoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionCodesFFB | KLTilstandKoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionCodesFSIII | KLTilstandKoderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionCodesHomeCare | KLTilstandeKoderHjemmepleje | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionCodesNursing | KLTilstandeKoderSygepleje | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionCodesPrevention | KLTilstandKoderForebyggelse | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionCodesTheraphy | KLTilstandKoderTræning | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionFFCodesFFB | KLTilstandFFKoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionOCodesFFB | KLTilstandOKoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConditionsAndTargetGroupsFFB | KLTilstandeOgMålgrupperFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLConsentToLiasing | KLBorgerIndforståetMedHenvendelseKoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLEncounterTypes | KLKontaktTyper | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLEvaluationTypeCodes | KLVurderingTypekoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLEvaluationTypeCodesSCT | KLVurderingTypekoderSCT | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLFollowUpCodes | KLOpfølgningKodes | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLFollowUpCodesFFB | KLOpfølgningKoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLFollowUpCodesFSIII | KLOpfølgningKoderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLGeneralInformationFSIII | KLGenerelInformationFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLGoalTypeCodes | KLMålKategoriKoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLHomeCareAreasFSIII | KLHjemmeplejeOmråderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLHomeCareInterventionsFSIII | KLHjemmeplejeIndsatserFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLImportanceLevelCodesFSIII | KLBetydningKoderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLInformationCodes | KLOplysningKoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLInformationGatheringInvestigationCodes | KLOplysningsaktivitetsOgVurderingskoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLInformationGatheringTypeCodes | KLOplysningsaktivitetsTypeKoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLInterventions | KLIndsatser | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLInterventionsFFB | KLYdelserFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLInterventionsFSIII | KLIndsatserFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLMatterOfInterestInformerFFB | KLKildeTilOplysningFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLMatterOfInterestValues | KLOplysningKoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLNeedsAssessmentCodesFFB | KLStøttebehovsvurderingskoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLNursingAreasFSIII | KLSygeplejeOmråderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLNursingInterventionsFSIII | KLSygeplejeIndsatserFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLObservationCodes | KLObservationskoder | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLPerformanceLevelCodesFSIII | KLUdførelsesKoderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLPreventionAreasFSIII | KLForebyggelseOmråderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLPreventionInterventionsFSIII | KLForebyggelseIndsatserFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLRequestFromFSIII | KLHenvendelseHenvisningFraFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLServiceCodesFFB | KLTilbudsKoderFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLServicesTypes | KLServiceTyper | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLSeverities | KLSværhedgrader | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLSeveritiesFFB | KLFunktionsevneniveauFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLSeveritiesFSIII | KLFunktionsevneniveauFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLTargetGroupsFFB | KLMålgrupperFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLTargetMeasureCodes | KLTypeAfObservationPåMål | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLThemesFFB | KLTemaerFFB | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLTheraphyAreasFSIII | KLTræningOmråderFSIII | active | 2023-06 | dk | | |
| kl.dk.fhir.core | R4 | KLTrainingInterventionsFSIII | KLTræningIndsatserFSIII | active | 2023-06 | dk | | |
| ca.infoway.io.psca | R4 | CVC-AnatomicalSite | Canadian Vaccine Catalogue Anatomical Site | active | 2022-03 | ca | national | |
| ca.infoway.io.psca | R4 | CVC-Disease | Canadian Vaccine Catalogue Vaccine Preventable Disease | active | 2022-03 | ca | national | |
| ca.infoway.io.psca | R4 | CVC-Generic | Canadian Vaccine Catalogue Vaccine Generic Names | active | 2022-01 | ca | national | |
| ca.infoway.io.psca | R4 | CVC-RouteOfAdmin | Canadian Vaccine Catalogue Route of Administration | active | 2022-03 | ca | national | |
| ca.infoway.io.psca | R4 | CVC-Tradename | Canadian Vaccine Catalogue Vaccine Tradenames | active | 2022-03 | ca | national | |
| ca.infoway.io.psca | R4 | https://fhir.infoway-inforoute.ca/ValueSet/allergicconditioncode | Allergic Condition Code | draft | | ca | national | sct |
| ca.infoway.io.psca | R4 | https://fhir.infoway-inforoute.ca/ValueSet/allergyintolerancestatuscode | Allergy/Intolerance Status Code | draft | 1900-01 | ca | national | sct |
| ca.infoway.io.psca | R4 | hc-CCDD | Canadian Clinical Drug Data Set | draft | 1900-01 | ca | national | tho |
| ca.infoway.io.psca | R4 | CCI | Canadian Classification of Health Interventions All Concepts | active | 2022-01 | ca | national | |
| ca.infoway.io.psca | R4 | DIN | DIN All Concepts | draft | 2025-03 | ca | national | fhir |
| ca.infoway.io.psca | R4 | https://fhir.infoway-inforoute.ca/ValueSet/drugormedicamentsubstancecode | Drug Or Medicament Substance Code | draft | 1900-01 | ca | national | sct |
| ca.infoway.io.psca | R4 | HealthCanadaNaturalProductNumber | Health Canada Natural Product Number (hcNPN) | active | 2022-01 | ca | national | tho |
| ca.infoway.io.psca | R4 | ICD9CM | ICD-9 CM All Concepts | active | 2022-01 | ca | national | tho |
| ca.infoway.io.psca | R4 | https://fhir.infoway-inforoute.ca/ValueSet/immunizationrouteofadministrationcode | Immunization Route Of Administration Code | draft | 1900-01 | ca | national | |
| ca.infoway.io.psca | R4 | pCLOCD | pCLOCD Codes | draft | 2023-12 | ca | national | |
| ca.infoway.io.psca | R4 | substanceandpharmaceuticalbiologicproductcode | Substance And Pharmaceutical/Biologic Product Code | draft | 1900-01 | ca | national | |
| nxh.fhir.r4 | R4 | https://fhir.nxh.com/standards/fhir/ValueSet/nxh-vs-parameter-attribute-definition | NxhVSParameterAttributeDefinition | active | | | | |
| nxh.fhir.r4 | R4 | https://fhir.nxh.com/standards/fhir/ValueSet/nxh-vs-parameter-code | NxhVSParameterCode | active | | | | |
| nxh.fhir.r4 | R4 | https://fhir.nxh.com/standards/fhir/ValueSet/nxh-vs-user-role | NxhVSUserRole | active | | | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-allgemeiner-leistungszustand-ecog | MII VS Onkologie Allgemeiner Leistungszustand nach ECOG | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-allgemeiner-leistungszustand-karnofsky | MII VS Onkologie Allgemeiner Leistungszustand nach Karnofsky | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-beurteilung-lokaler-residualstatus | MII VS Onkologie Beurteilung des lokalen Residualstatus | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-fernmetastasen | MII VS Onkologie Fernmetastasen | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-genetische-variante-auspraegung | MII_VS Onkologie Genetische Variante Ausprägung | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-gesamtbeurteilung-residualstatus | MII VS Onkologie Gesamtbeurteilung des Residualstatus | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-grading | MII VS Onkologie Grading | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-icdo3-morphologie | MII VS Onkologie ICD-O-3 Morphologie | active | | de | | tho |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-icdo3-topographie | MII VS Onkologie ICD-O-3 Topographie | active | | de | | tho |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-nebenwirkung-art | MII VS Onkologie Nebenwirkung nach CTCAE Art | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-nebenwirkung-ctcae-grad | MII VS Onkologie Nebenwirkung nach CTCAE Grad | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-operation-intention | MII VS Onkologie Operation Intention | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-operation-komplikation | MII VS Onkologie Operation Komplikationen | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-ops-nuklearmedizin | MII VS Onkologie OPS Nuklearmedizin | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-ops-strahlentherapie | MII VS Onkologie OPS Strahlentherapie | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-primaertumor-diagnosesicherung | MII VS Onkologie Primärtumor Diagnosesicherung | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-seitenlokalisation | MII VS Onkologie Primärtumor Seitenlokalisation | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-sstrahlentherapie-applikationsart | MII VS Onkologie Strahlentherapie Applikationsart | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-strahlentherapie-boost | MII VS Onkologie Strahlentherapie Boost | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-strahlentherapie-ende-grund | MII VS Onkologie Strahlentherapie Ende Grund | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-strahlentherapie-intention | MII VS Onkologie Strahlentherapie Intention | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-strahlentherapie-stellungzurop | MII VS Onkologie Strahlentherapie Stellung zur OP | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-strahlentherapie-strahlenart | MII VS Onkologie Strahlentherapie Strahlenart | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-strahlentherapie-strahlungseinheit | MII VS Onkologie Strahlentherapie Strahlungseinheit | active | | de | | ucum |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-strahlentherapie-zielgebiet | MII VS Onkologie Strahlentherapie Zielgebiet | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-studienteilnahme | MII VS Onkologie Studienteilnahme | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-art | MII VS Onkologie Systemische Therapie Art | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-systemische-therapie-ende-grund | MII VS Onkologie Systemische Therapie Ende Grund | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-intention | MII VS Onkologie Systemische Therapie Intention | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-systemische-therapie-stellungzurop | MII VS Onkologie Systemische Therapie Stellung | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-therapieabweichung | MII VS Onkologie Therapieabweichung | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-therapieempfehlung-typ | MII VS Onkologie Therapieempfehlung Typ | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-therapieplanung-typ | MII VS Onkologie Therapieplanung Typ | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-cp-praefix | MII VS Onkologie TNM cpu Praefix | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-itc-suffix | MII VS Onkologie TNM ITC Suffix | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-klassifikation-typ | MII VS Onkologie TNM Klassifikation Typ | active | | de | | sct |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-l-kategorie-werte | MII VS Onkologie TNM L Kategorie Werte | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-m-kategorie-werte | MII VS Onkologie TNM M Kategorie Werte | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-m-kategorie | MII VS Onkologie TNM M Kategorie | active | | de | | sct |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-m-symbol | MII VS Onkologie TNM m-Symbol | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-n-kategorie-werte | MII VS Onkologie TNM N Kategorie Werte | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-n-kategorie | MII VS Onkologie TNM N Kategorie | active | | de | | sct |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-pn-kategorie-werte | MII VS Onkologie TNM Pn Kategorie Werte | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-s-kategorie-werte | MII VS Onkologie TNM S Kategorie Werte | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-sn-suffix | MII VS Onkologie TNM SN Suffix | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-t-kategorie-werte | MII VS Onkologie TNM T Kategorie Werte | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-t-kategorie | MII VS Onkologie TNM T Kategorie | active | | de | | sct |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-uicc-stadium | MII VS Onkologie TNM UICC Stadium | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-v-kategorie-werte | MII VS Onkologie TNM V Kategorie Werte | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-version | MII VS Onkologie TNM Version | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tod | MII VS Onkologie Tod | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-verlauf-fernmetastasen | MII VS Onkologie Verlauf Fernmetastasen | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-verlauf-gesamtbeurteilung | MII VS Onkologie Verlauf Gesamtbeurteilung | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-verlauf-lymphknoten | MII VS Onkologie Verlauf Lymphknoten | active | | de | | |
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-verlauf-primaertumor | MII VS Onkologie Verlauf Primärtumor | active | | de | | |
| ch.fhir.ig.swissnoso | R4 | swissnoso-bacterial-count-in-urine | Swissnoso Bacterial Count in Urine | active | 2022-06 | ch | hl7 | internal |
| ch.fhir.ig.swissnoso | R4 | swissnoso-clinical-symptom | Swissnoso Clinical Symptom | active | 2022-06 | ch | hl7 | internal |
| ch.fhir.ig.swissnoso | R4 | swissnoso-germ | Swissnoso Germ | active | 2022-06 | ch | hl7 | sct |
| ch.fhir.ig.swissnoso | R4 | swissnoso-indication | Swissnoso Indication | active | 2022-06 | ch | hl7 | internal |
| ch.fhir.ig.swissnoso | R4 | swissnoso-number-of-different-germs | Swissnoso Number of Different Germs | active | 2022-06 | ch | hl7 | internal |
| ch.fhir.ig.swissnoso | R4 | swissnoso-organizational-unit | Swissnoso Organizational Unit | active | 2022-06 | ch | hl7 | internal |
| ch.fhir.ig.swissnoso | R4 | swissnoso-procedure-location | Swissnoso Procedure Location | active | 2022-06 | ch | hl7 | internal |
| ch.fhir.ig.swissnoso | R4 | swissnoso-specialty | Swissnoso Specialty | active | 2022-06 | ch | hl7 | internal |
| cce.fhir | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/DiagnosesicherungVS | DiagnosticbackupVS | draft | | | | |
| cce.fhir | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/LocalAssessmentResidualStatusVS | LocalAssessmentResidualStatusVS | draft | | | | |
| cce.fhir | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/OverallAssessmentResidualstatusVS | OverallAssessmentResidualstatusVS | draft | | | | |
| cce.fhir | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/ProgressionLocalTumorstatusVS | ProgressionLocalTumorstatusVS | draft | | | | |
| cce.fhir | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/SitelocationVS | SitelocationVS | draft | | | | |
| cce.fhir | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/UiccstageVS | UiccstageVS | draft | | | | |
| cce.fhir | R4 | https://www.cancercoreeurope.eu/fhir/core/ValueSet/VitalstatusVS | VitalstatusVS | draft | | | | |
| silth.fhir.terminology.core | R5 | th-24drug | TH: รหัสยามาตรฐาน 24 หลัก โดย THCC | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | th-tmlt | TH: รหัส TMLT | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | th-tmt | TH: รหัส TMT | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43file-pid-remove-reason | 43File: รหัสสถานะ/สาเหตุการจำหน่าย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43file-refer-care-procedure | 43File: รหัสแสดงการให้การดูแลหรือปฐมพยาบาลผู้ป่วยขณะส่งต่อผู้ป่วย | active | 2023-10 | | | internal sct |
| silth.fhir.terminology.core | R5 | vs-43file-refer-encounter-class | 43File: รหัสประเภทผู้ป่วยสำหรับการส่งต่อ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43file-refer-result | 43File: รหัสผลการส่งต่อ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43file-refer-special-disease | 43File: รหัสกลุ่มโรคเฉพาะเพื่อการส่งต่อ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-cancer-dx-source | 43Plus: รหัสวิธีวินิจฉัยโรคมะเร็ง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-cancer-grade | 43Plus: รหัสระดับความรุนแรงของชิ้นเนื้อ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-cancer-staging | 43Plus: รหัสระยะของโรคมะเร็ง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-coverage-use | 43Plus: รหัสการใช้สิทธิ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-encounter-diagnosis-role | 43Plus: รหัสประเภทการวินิจฉัย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-medication-delivery | 43Plus: รหัสการส่งมอบยา (กรณีจ่ายไปใช้ที่บ้าน) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-ncd-status | 43Plus: รหัสสถานะการเป็นผู้ป่วยโรคเรื้อรัง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-refer-reason | 43Plus: รหัสสาเหตุการส่งต่อผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-43plus-service-priority | 43Plus: รหัสสถานะความฉุกเฉิน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-admit-source | CHI: รหัสที่มาการ admit (ที่มา: สกส. CIPN IPADT) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-admit-type | CHI: รหัสประเภทการรับ admit (ที่มา: สกส. CIPN IPADT) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-claim-coinsurance-cat | CHI: รหัสประเภทค่ารักษา Coinsurance (ที่มา: สกส. CIPN Coinsurance) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-claim-condition | CHI: เงื่อนไขกำกับการเบิก (ที่มา: สกส. CSOP BillDisp) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-clinic | CHI: รหัสแผนกหรือสถานที่ในการให้บริการ (ที่มา: สกส. CSOP OPServices) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-encounter-accident-emer | CHI: รหัสระบุเป็นการรักษากรณีอุบัติเหตุและ/หรือฉุกเฉิน (ที่มา: สกส. SSI IPAEREF) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-encounter-diagnosis-role | CHI: รหัสประเภทการวินิจฉัย (ที่มา: สกส. CIPN IPDx) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-fee-category | CHI: หมวดค่าใช้จ่ายบริการสาธารณสุข (ที่มา: สกส. CSOP, CIPN, SSI) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-ip-service-type | CHI: รหัสแยกประเภทการรักษากรณีผู้ป่วยใน (ที่มา: สกส. CIPN ClaimAuth) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-item-claim-cat | CHI: รหัสประเภทการเบิก (ที่มา: สกส. CIPN IPADT) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-patient-marital | CHI: รหัสสถานะการสมรส (ที่มา: สกส. CIPN IPADT) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-product-cat | CHI: ประเภทยาและเวชภัณฑ์ (ที่มา: สกส. CSOP BillDisp) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-provider-type | CHI: รหัสประเภทสถานพยาบาลที่รักษา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-refer-purpose | CHI: รหัสสาเหตุการส่งต่อผู้ป่วย (ที่มา: สกส. SSI IPAEREF) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-reimburser-type | CHI: ประเภทผู้เบิก (ที่มา: สกส. CSOP BillDisp) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-service-class | CHI: รหัสประเภทของบริการ (ที่มา: สกส. CSOP OPServices) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-substitution-code | CHI: รหัสการจ่ายยา generic แทนตามที่ผู้สั่งยากำหนดไว้ (ที่มา: สกส. CSOP BillDisp) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-typein | CHI: รหัสประเภทการให้บริการครั้งนี้ (ที่มา: สกส. CSOP OPServices) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-typeout | CHI: รหัสประเภทการสิ้นสุดการรับบริการครั้งนี้ (ที่มา: สกส. CSOP OPServices) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-chi-typeserv | CHI: รหัสประเภทการให้บริการครั้งนี้ (ที่มา: สกส. CSOP OPServices) | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-dopa-location-city | DOPA: รหัสจังหวัด ตามมาตรฐาน มอก.1099-2535 | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-dopa-location-district | DOPA: รหัสอำเภอ ตามมาตรฐาน มอก.1099-2535 | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-dopa-location-subdistrict | DOPA: รหัสตำบล ตามมาตรฐาน มอก.1099-2535 | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-dopa-location | DOPA: รหัสสถานที่ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-dopa-nameprefix | DOPA: รหัสคำนำหน้าชื่อ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-accident-coverage | eClaim: รหัสสิทธิการรักษาอื่นกรณีอุบัติเหตุ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-adp-type | eClaim: รหัสบริการที่ยังไม่ได้จัดหมวด (ADP) โดย e-Claim 16 แฟ้ม | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-cancer-type | eClaim: รหัสรายละเอียดเพิ่มเติมกรณีมะเร็ง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-charge-item | eClaim: รายการค่าบริการทางการแพทย์ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-clinic | eClaim: รหัสคลินิก/แผนกที่รับไว้รักษา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-coverage-use | eClaim: รหัสประเภทสิทธิการรักษา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-medication-category | eClaim: รหัสหมวดรายการยา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-medication-ned-criteria | eClaim: รหัสเหตุผลการใช้ยานอกบัญชียาหลัก | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-procedure-type | eClaim: รหัสชนิดของหัตถการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-provider-type | eClaim: รหัสประเภทสถานพยาบาลที่รักษา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-refer-priority-code | eClaim: รหัสข้อบ่งชี้ของกรณีฉุกเฉินตามเงื่อนไข | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-refer-reason | eClaim: รหัสสาเหตุการส่งต่อผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-refer-thai-priority | eClaim: รหัสลำดับความสำคัญของอ้างอิงการส่งต่อผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-refer-type-eclaim | eClaim: รหัสบ่งบอกการรักษากรณีอุบัติเหตุ/ฉุกเฉิน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-eclaim-service-type-th | eClaim: รหัสประเภทการให้บริการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-int-icd9cm-procedure | ICD-9-CM Procedure Codes | active | 2023-10 | | | tho |
| silth.fhir.terminology.core | R5 | vs-int-icdo3 | ICD-O 3 | active | 2023-10 | | | tho |
| silth.fhir.terminology.core | R5 | vs-int-icf | Inter: รหัสสภาวะสุขภาพตาม ICF | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-int-isced-97 | Inter: ชุดรหัสการศึกษา ISCED 1997 | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-int-isco-08 | Inter: รหัสอาชีพ ISCO-08 | active | 2023-10 | | | oid |
| silth.fhir.terminology.core | R5 | vs-meta-accident-obs | Metadata: รหัสชนิดประวัติการเกิดอุบัติเหตุ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-accident-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับอุบัติเหตุ | active | 2023-10 | | | internal loinc |
| silth.fhir.terminology.core | R5 | vs-meta-cancer-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับมะเร็ง | active | 2023-10 | | | loinc |
| silth.fhir.terminology.core | R5 | vs-meta-child-development-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับพัฒนาการเด็ก | active | 2023-10 | | | internal sct loinc |
| silth.fhir.terminology.core | R5 | vs-meta-extended-hl7-diagnosis-role | Metadata: รหัสบทบาทการวินิจฉัยเพิ่มเติมจากที่มีใน HL7 | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-functional-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับสมรรถภาพของร่างกาย | active | 2023-10 | | | internal loinc |
| silth.fhir.terminology.core | R5 | vs-meta-ipd-journey | Metadata: รหัสชนิดของแผนกที่ผู้ป่วยในรับบริการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-lab-observations | Metadata: รหัสการตรวจทางห้องปฏิบัติการบางส่วน | active | 2023-10 | | | sct loinc |
| silth.fhir.terminology.core | R5 | vs-meta-misc-obs-type | Metadata: รหัสการตรวจที่ยังไม่สามารถหารหัสมาตรฐาน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-misc-pregnancy-obs | Metadata: รหัสการตรวจอื่น ๆ เกี่ยวกับอนามัยแม่และเด็ก | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-ncd-observations | Metadata: รหัสการตรวจหรือบริการคัดกรองโรค NCD | active | 2023-10 | | | internal sct loinc |
| silth.fhir.terminology.core | R5 | vs-meta-neonate-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับทารกแรกคลอด | active | 2023-10 | | | sct loinc |
| silth.fhir.terminology.core | R5 | vs-meta-participant-type | Metadata: ประเภทแพทย์เพิ่มเติม | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-physical-observations | Metadata: รหัสการตรวจร่างกาย | active | 2023-10 | | | sct loinc |
| silth.fhir.terminology.core | R5 | vs-meta-pregnancy-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับการตั้งครรภ์ | active | 2023-10 | | | internal sct loinc |
| silth.fhir.terminology.core | R5 | vs-meta-provider-type-coverage | Metadata: รหัสประเภทสถานพยาบาล ตามสิทธิการรักษา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-screening-result | Metadata: รหัสผลการตรวจคัดกรอง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-social-obs-type | Metadata: รหัสชนิดประวัติทางสังคม | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-meta-social-observations | Metadata: รหัสการตรวจประวัติทางสังคม | active | 2023-10 | | | internal loinc |
| silth.fhir.terminology.core | R5 | vs-meta-vital-observations | Metadata: รหัสการตรวจสัญญาณชีพ | active | 2023-10 | | | loinc |
| silth.fhir.terminology.core | R5 | vs-pcu-clnical-status | PCU: รหัสสภาพผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-fp-case-type | PCU: รหัสประเภทการวางแผนครอบครัว | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-labor-presentation | PCU: รหัสท่าเด็กตอนคลอด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-postnatal-breastfeeding | PCU: รหัสการไหลของน้ำนมหลังคลอด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-postnatal-mens | PCU: รหัสประจำเดือนหลังคลอด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-postnatal-perineum | PCU: รหัสการตรวจฝีเย็บหลังคลอด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-refer-outcome | PCU: รหัสผลการส่งต่อไปรับบริการในสถานพยาบาลอื่น | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-service-location-type | PCU: รหัสสถานที่ที่ให้บริการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-pcu-village-area | PCU: เขตที่ตั้งของหมู่บ้าน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-snomed-blood-abo | SNOMED CT Blood Group - ABO | active | 2023-10 | | | sct |
| silth.fhir.terminology.core | R5 | vs-snomed-blood-rh | SNOMED CT Blood Group - Rh | active | 2023-10 | | | sct |
| silth.fhir.terminology.core | R5 | vs-snomed-bloodgroup | SNOMED CT Blood Group | active | 2023-10 | | | sct |
| silth.fhir.terminology.core | R5 | vs-snomed-int | SNOMED-CT International Release | active | 2023-10 | | | sct |
| silth.fhir.terminology.core | R5 | vs-std15-allergy-verify | Std15: รหัสสถานะการแพ้ยา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-std15-appoint-service-category | Std15: รหัสประเภทการนัด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-std15-medication-source | Std15: รหัสประเภทยาที่ใช้ปัจจุบัน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-std15-refer-answer-type | Std15: รหัสประเภทการตอบรับหรือปฎิเสธ อัตโนมัติ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-std15-refer-reason | Std15: รหัสสาเหตุการส่งต่อผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-std15-refer-status | Std15: รหัสสถานะของการอ้างอิงการส่งต่อผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-th-coverage-type | TH: รหัสประเภทสิทธิการรักษาในประเทศไทย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-th-fee-category | TH: หมวดค่าใช้จ่ายบริการสาธารณสุข | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-th-file-list | TH: รายการโครงสร้างข้อมูล 43 แฟ้ม plus | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-th-icd10tm-lab | THCC: รหัสการตรวจทางห้องปฎิบัติการ ICD-10-TM | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-th-icd10tm | TH: รหัส ICD-10-TM | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-th-identifier-type | TH: ชนิดการระบุตัวตนในประเทศไทย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-2digit-lab | THCC: รหัสการตรวจทางห้องปฎิบัติการเดิม 2 หลัก | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-admit-source | THCC: รหัสประเภทการมารับบริการกรณีอุบัติเหตุฉุกเฉิน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-bleeding | THCC: รหัสชนิดการห้ามเลือด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-breathing | THCC: รหัสชนิดการดูแลการหายใจ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-cause-group | THCC: รหัสประเภทผู้ป่วยอุบัติเหตุ 19 สาเหตุ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-iv-fluid | THCC: รหัสชนิดการให้น้ำเกลือ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-location | THCC: รหัสสถานที่เกิดอุบัติเหตุฉุกเฉิน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-patient-type | THCC: รหัสประเภทผู้บาดเจ็บ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-priority | THCC: รหัสระดับความเร่งด่วน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-splint | THCC: รหัสชนิดการใส่ splint/ slab | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-accident-vehicle | THCC: รหัสประเภทยานพาหนะที่เกิดเหตุ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-admit-source | THCC: รหัสประเภทการมารับบริการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-allergy-assert-type | THCC: รหัสผู้ให้ประวัติการแพ้ยา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-allergy-certainty | THCC: รหัสระดับความแน่ใจการแพ้ยา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-allergy-manifest | THCC: รหัสลักษณะอาการแพ้ยาที่พบ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-allergy-severity | THCC: รหัสระดับความรุนแรงของการแพ้ยา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-appoint-service-type | THCC: รหัสชื่อบริการที่นัดรับ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-causative-agent | THCC: รหัสชนิดของเชื้อโรค | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-child-dev-level | THCC: รหัสระดับพัฒนาการเด็ก | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-child-food | THCC: รหัสอาหารที่รับประทานปัจจุบัน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-chronic-discharge-reason | THCC: รหัสประเภทการจำหน่าย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-community-activity | THCC: รหัสกิจกรรมในชุมชน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-community-service | THCC: รหัสการให้บริการสุขภาพระดับบุคคลในชุมชน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-contraceptive-method | THCC: รหัสวิธีการคุมกำเนิด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-coverage-type | THCC: รหัสสิทธิการรักษาพยาบาล | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-death-location-type | THCC: รหัสสถานที่ตาย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-death-pregnancy | THCC: รหัสการเสียชีวิตที่เกี่ยวข้องกับตั้งครรภ์และการคลอด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-disability-reason | THCC: รหัสสาเหตุความพิการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-disability-type | THCC: รหัสประเภทความพิการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-discharge-status | THCC: รหัสสถานะผู้มารับบริการเมื่อเสร็จสิ้นบริการ OPD | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-disease-cause | THCC: รหัสสาเหตุการป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-education-level | THCC: รหัสการศึกษา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-foreigner-type | THCC: รหัสความเป็นคนต่างด้าว | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-functional-conclusion | THCC: รหัสภาวะพึ่งพิงของผู้สูงอายุ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-functional-test | THCC: รหัสวิธีประเมินความบกพร่อง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-house-type | THCC: รหัสลักษณะที่อยู่ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-in-municipality | THCC: รหัสที่ตั้ง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-individual-provider-type | THCC: รหัสประเภทบุคลากรทางการแพทย์และสาธารณสุข | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-ipd-discharge-status | THCC: รหัสสถานภาพการจำหน่ายผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-ipd-discharge-type | THCC: รหัสวิธีการจำหน่ายผู้ป่วย | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-labor-location | THCC: รหัสสถานที่คลอด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-labor-performer-role | THCC: รหัสประเภทของผู้ทำคลอด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-labor-procedure | THCC: รหัสวิธีการคลอด/สิ้นสุดการตั้งครรภ์ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-marital | THCC: รหัสสถานะการสมรส | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-nationality | THCC: รหัสเชื้อชาติ-สัญชาติ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-ncd-alchohol | THCC: รหัสประวัติดื่มเครื่องดื่มแอลกอฮอลล์ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-ncd-fbs-method | THCC: รหัสวิธีการตรวจน้ำตาลในเลือด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-ncd-foot-exam | THCC: รหัสตรวจเท้า | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-ncd-retina-exam | THCC: รหัสตรวจจอประสาทตา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-ncd-smoking | THCC: รหัสประวัติสูบบุหรี่ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-newborn-food | THCC: รหัสอาหารที่รับประทาน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-no-contraceptive | THCC: รหัสสาเหตุที่ไม่คุมกำเนิด | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-occupation | THCC: รหัสอาชีพ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-patient-location-type | THCC: รหัสที่ตั้งของที่อยู่ผู้รับบริการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-person-status | THCC: รหัสสถานะบุคคล | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-pregnancy-outcome | THCC: รหัสผลการสิ้นสุดการตั้งครรภ์ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-qualification-issuer | THCC: รหัสสภาวิชาชีพ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-refer-in-reason | THCC: รหัสสาเหตุการส่งผู้ป่วยมารับบริการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-refer-thai-priority | THCC: รหัสระดับความเร่งด่วน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-rehab-device | THCC: รหัสกายอุปกรณ์ที่ได้รับ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-rehab-service-type | THCC: รหัสบริการฟื้นฟูสภาพ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-religion | THCC: รหัสศาสนา | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-service-hour | THCC: รหัสเวลามารับบริการ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-special-pp-service | THCC: รหัสบริการส่งเสริมป้องกันเฉพาะ | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-status-in-family | THCC: รหัสสถานะในครอบครัว | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-status-in-village | THCC: รหัสสถานะในชุมชน | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-surveillance-group | THCC: รหัสกลุ่มอาการที่เฝ้าระวัง | active | 2023-10 | | | internal |
| silth.fhir.terminology.core | R5 | vs-thcc-vaccine-code | THCC: รหัสวัคซีน | active | 2023-10 | | | internal |
| uk.gm | R4 | https://fhir.lhcre.nhs.uk/ValueSet/GM-questionnaire-supported-types | GM-questionnaire-supported-types | draft | | | | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nhi-identifier-use-code | NHI Identifier | active | 2024-10 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nhi-address-not-validated-reason-code | Address Not Validated Reason | active | 2020-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/country-code | ISO 3166-1:2013 (2-alpha country code) | active | 2020-02 | | national | iso |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/coverage-type-code | Coverage Type | active | 2024-10 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/gender-code | Gender | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-contact-point-system-code | Use values for a ContactSystem | active | 2021-04 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-contact-point-use-code | Use values for a ContactPoint | active | 2021-04 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-contact-type | Contact Type | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-contact-usage | Contact Usage | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-disestablishment-reason | HPI Disestablishment Reason | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/ethnic-group-level-2-code | HPI 2 digit ethnicity codes | active | 2020-10 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/ethnic-group-level-3-code | HPI 3 digit ethnicity codes | active | 2020-10 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/ethnic-group-level-4-code | HPI 4 digit ethnicity codes | active | 2020-10 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-facility-address-purpose | Address Purpose (Qualifier) for Facility | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-facility-address-type | Address Type for Facility | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-facility-name-qualifier | Name qualifier for Facility | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-facility-type | Facility Type | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-human-name-use-code | Use values for a HumanName | active | 2021-04 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-identifier-use-code | IdentifierUse | active | 2020-12 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/language-code | ISO 639-3:2007 (3-alpha language code) | active | 2020-02 | | national | iso |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-legacy-language-code | Old HPI two alpha language codes | active | 2020-10 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-legal-entity-type | Legal Entity Type | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-location-address-use-code | Address Use for Location | active | 2020-02 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/location-alias-type-code | HPI Alias Type (Location) | active | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-location-status-code | HPI Location Status | active | 2022-04 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/location-type-code | HPI Location Type | active | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-name-type | HPI Legacy Name Type | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-nzscc4n | NZSCC4N99 four digit country code | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-organisation-address-purpose | Address Purpose (Qualifier) for Organisation | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-organisation-address-type | Address Type for Organisation | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-organisation-address-use-code | Address Use for Organisation | active | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-organisation-name-qualifier | Name qualifier for Organisation | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/organisation-type-code | Organisation Type | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/organization-alias-type-code | HPI Alias Type (Organization) | active | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-role-code | PractitionerRole code | active | 2020-11 | | national | sct |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-ra-identifier-code | RaIdentifier | active | 2020-12 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-registration-status | HPI Registration Status | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-registration-type | HPI Registration Type | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-registration-authority-code | HPI Registration Type | active | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/mws-clinical-status | MWS Clinical status | active | 2024-03 | | national | tho |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/mws-substance-combined | NZULM codes | active | 2020-11 | | national | sct |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/mws-verification-status | MWS verification status | active | 2024-03 | | national | tho |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/name-prefix-code | Name Prefix Codes | retired | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/name-suffix-code | Name Suffix Codes | active | 2024-10 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nes-enrolment-termination-reason | NES Enrolment Termination Reason | active | 2023-08 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nes-enrolment-type | NES Enrolment Type | active | 2023-08 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nes-entitlement-identifier-code | NES Entitlement System Identifiers | active | 2020-12 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nes-episode-of-care-status | NES Enrolment Status | active | 2023-10 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nhi-address-type | Address Type for Patient | active | 2020-02 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/addressType | NHI Address Type Codes | active | 2024-10 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nhiaddressUse | NHI Address Use Codes | active | 2024-10 | | national | fhir |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nz-citizenship-source-code | NZ Citizenship Information Source | active | 2020-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/country-of-birth-source-code | Country of Birth Information Source | active | 2020-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/date-of-birth-source-code | Date of Birth Information Source | active | 2020-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/dod-information-source-code | Date of Death Information Source | active | 2020-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/name-source-code | Name Information Source | active | 2020-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nhi-name-use-extra-code | NHI Name Use Extra | active | 2022-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nz-residency-source-code | NZ Residency Information Source | active | 2020-04 | | national | |
| tewhatuora.hip-core | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-scope-of-practice-code | Scope of practice | active | 2024-10 | | national | |
| rdc.interoperability.guide | R5 | http://roche.com/fhir/iop/ValueSet/device-kind | device-kind | active | 2023-10 | | | sct |
| rdc.interoperability.guide | R5 | http://roche.com/fhir/iop/ValueSet/device-settings-codes | device-settings-codes | active | | | | sct |
| rdc.interoperability.guide | R5 | http://roche.com/fhir/iop/ValueSet/insulin-codes | insulin-codes | active | | | | |
| rdc.interoperability.guide | R5 | http://roche.com/fhir/iop/ValueSet/observation-codes | observation-codes | active | | | | sct loinc |
| rdc.interoperability.guide | R5 | http://roche.com/fhir/iop/ValueSet/report-codes | report-codes | active | | | | |
| kbv.mio.zaeb | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type | KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type | active | | | | sct |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/annotation-type | Tip zabilješke | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/audit-event-sub-type | Vrste događaja revizijskog zapisa | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/condition-annotation-type | Vrsta zabilješke uz slučaj | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/djelatnosti-zz | Djelatnosti zdravstvene zaštite | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/document-section | Kodovi sekcija (dijelova) kliničkog dokumenta | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/document-type | Vrsta dokumenta | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/g1sspol | Spol (g1) | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/hr-encounter-status | Status posjete | draft | 2024-01 | | | fhir |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/hr-process-types | Vrste procesa | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/hr-tip-posjete | Tip posjete | active | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/icd10-hr | Skup koncepata MKB-10 dijagnoza | active | 2024-01 | | | |
| cezih.osnova | R4 | http://ent.hr/fhir/ValueSet/identifier-type | ENT Identifier Types | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/lista-lijekova | Jedinstvena lista lijekova | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://ent.hr/fhir/ValueSet/message-error-type | Error types | active | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/message-types | Kodovi vrste poruka | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/mkb10-chronic | Kronične dijagnoze | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/nacin-prijema | Način prijema | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/observations | Kodovi Opservacija | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/procedures | Vrsta medicinskih procedura | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/sifra-oslobodjenja-od-sudjelovanja-u-troskovima | Šifra oslobođenja pacijenta od sudjelovanja u troškovima liječenja | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/sudjelovanje-u-troskovima | Sudjelovanje pacijenta u troškovima liječenja | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/tip-identifikatora-pacijenta | Tip identifikatora pacijenta | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://hl7.org/fhir/ValueSet/ucum-units | UCUM Codes | draft | 2024-01 | | | ucum |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/vrsta-komunikacije | Vrsta komunikacije | draft | 2024-01 | | | |
| cezih.osnova | R4 | http://fhir.cezih.hr/specifikacije/ValueSet/vrsta-posjete | Vrsta posjete | active | 2024-01 | | | |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AdditionalWishes | AdditionalWishes | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AdministrationAgreementAdditionalInformation | AdministrationAgreementAdditionalInformation | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AdministrationAgreementStopType | AdministrationAgreementStopType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AdministrationDevice | AdministrationDevice | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AlcoholUseStatus | AlcoholUseStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AlertName | AlertName | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AlertType | AlertType | draft | | | | loinc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AllergyCategory | AllergyCategory | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AllergyStatus | AllergyStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AnatomicalStage | AnatomicalStage | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AppearanceScore | AppearanceScore | draft | | | | loinc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AppetiteScore | AppetiteScore | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/AsNeededCriterium | AsNeededCriterium | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Assent | Assent | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Bathing | Bathing | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/BathingOneself | BathingOneself | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/BiologicalRelationship | BiologicalRelationship | draft | | | | tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Bladder | Bladder | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/BodyPartToBeBathed | BodyPartToBeBathed | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/BodyPartToBeDressed | BodyPartToBeDressed | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/BodyWeightUnits | HdBe-BodyWeight units | draft | | | | ucum |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Bowels | Bowels | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/BurnwoundDepth | BurnwoundDepth | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/BurnwoundLaterality | BurnwoundLaterality | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/CausativeAgent | CausativeAgent | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ChangingPosition | ChangingPosition | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ClimbingStairs | ClimbingStairs | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Clothing | Clothing | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/CollectionMethod | CollectionMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/CommunicationDetails | CommunicationDetails | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/CommunicationLanguage | CommunicationLanguage | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ConditionsDuringMeasurement | ConditionsDuringMeasurement | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ContactType | ContactType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ContainerType | ContainerType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/CountryISO | CountryISO | draft | | | | iso |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/CriticalExtent | CriticalExtent | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/CuffType | CuffType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DASMethod | DASMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DeathIndicator | DeathIndicator | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DecubitusCategory | DecubitusCategory | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DefecationColor | DefecationColor | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DefecationConsistency | DefecationConsistency | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DentalHygiene | DentalHygiene | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DepartmentIdentificationNumber | DepartmentIdentificationNumber | draft | | | | |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DepartmentSpecialty | DepartmentSpecialty | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Depth | Depth | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Destination | Destination | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DevelopmentCognition | DevelopmentCognition | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DevelopmentLinguistics | DevelopmentLinguistics | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DevelopmentLocomotion | DevelopmentLocomotion | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DevelopmentSocialChild | DevelopmentSocialChild | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DeviatingBreathingPattern | DeviatingBreathingPattern | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DeviceAnatomicalLocation | DeviceAnatomicalLocation | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DiastolicEndpoint | DiastolicEndpoint | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DistributionForm | DistributionForm | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Dressing | Dressing | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DressingOneself | DressingOneself | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Drinking | Drinking | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DrinkingLimitations | DrinkingLimitations | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/DrugUseStatus | DrugUseStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Eating | Eating | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/EatingLimitations | EatingLimitations | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/EstimatingMethod | EstimatingMethod | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/FamilyComposition | FamilyComposition | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/FamilyCompositionChild | FamilyCompositionChild | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/FecalContinence | FecalContinence | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/FeedingMethod | FeedingMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/FeedingTubeType | FeedingTubeType | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/FeedingType | FeedingType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/FrequencyQualifier | FrequencyQualifier | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Gender | Gender | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/GrimaceScore | GrimaceScore | draft | | | | loinc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Grooming | Grooming | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HeadCircumferenceMeasuringMethod | HeadCircumferenceMeasuringMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HealthProfessionalRole | HealthProfessionalRole | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HearingAidType | HearingAidType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HearingFunction | HearingFunction | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HeartRateMeasurementMethod | HeartRateMeasurementMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HeartbeatRegularity | HeartbeatRegularity | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HomeAccessibility | HomeAccessibility | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HomeAdaption | HomeAdaption | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/HouseNumberIndication | HouseNumberIndication | draft | | | | |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/IndependentMedicationUse | IndependentMedicationUse | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/InfusionCatheterType | InfusionCatheterType | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/InsuranceType | InsuranceType | draft | | | | |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/InterpretationHeartRate | InterpretationHeartRate | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/InterpretationMethod | InterpretationMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Intervention | Intervention | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LanguageControlListening | LanguageControlListening | draft | | | | tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LanguageControlReading | LanguageControlReading | draft | | | | tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LanguageControlSpeaking | LanguageControlSpeaking | draft | | | | tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Laterality | Laterality | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LegalStatus | LegalStatus | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LifeStance | LifeStance | draft | | | | sct tho oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LineStatus | LineStatus | draft | | | | tho oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Location | Location | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LocationIdentificationNumber | LocationIdentificationNumber | draft | | | | |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/LumenLocation | LumenLocation | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MaintainingPosition | MaintainingPosition | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ManagingStairs | ManagingStairs | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MaritalStatus | MaritalStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MeasuringLocation | MeasuringLocation | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MeasuringMethod | MeasuringMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MeasuringPosition | MeasuringPosition | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MedicationAdministrationReasonForDeviation | MedicationAdministrationReasonForDeviation | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MedicationAdministrationStatus | MedicationAdministrationStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MedicationAgreementAdditionalInformation | MedicationAgreementAdditionalInformation | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MedicationContraIndicationName | MedicationContraIndicationName | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MedicationDispenseAdditionalInformation | MedicationDispenseAdditionalInformation | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MedicationReason | MedicationReason | draft | 2022-07 | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MedicationStopType | MedicationStopType | draft | 2022-07 | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MenstrualCare | MenstrualCare | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Microorganism | Microorganism | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Mobility | Mobility | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Morphology | Morphology | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MultipleBirthIndicator | MultipleBirthIndicator | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Municipality | Municipality | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/MusleToneScore | MusleToneScore | draft | | | | loinc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/NameUsage | NameUsage | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/NutritionScore | NutritionScore | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/OrganizationType | OrganizationType | draft | | | | |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Origin | Origin | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PainCourse | PainCourse | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PainMeasuringMethod | PainMeasuringMethod | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PainPattern | PainPattern | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PainType | PainType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PanelOrBattery | PanelOrBattery | draft | | | | loinc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PerformNursingActivity | PerformNursingActivity | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PharmaceuticalForm | PharmaceuticalForm | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PlaceOfResidence | PlaceOfResidence | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Position | Position | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Postcode | Postcode | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProblemName | ProblemName | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProblemStatus | ProblemStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProblemType | ProblemType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProcedureMethod | ProcedureMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProcedureType | ProcedureType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProductCode | ProductCode | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProductType | ProductType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PrognosticStage | PrognosticStage | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ProthesisType | ProthesisType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PulseRegularity | PulseRegularity | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/PulseScore | PulseScore | draft | | | | loinc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ReasonForUse | ReasonForUse | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/RefractionMeasurementMethod | RefractionMeasurementMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Relationship | Relationship | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Representation | Representation | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/RespiratoryScore | RespiratoryScore | draft | | | | loinc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ResultFlags | ResultFlags | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ResultType | ResultType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Rhythm | Rhythm | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Role | Role | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/RouteOfAdministration | RouteOfAdministration | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/RouteOfExposure | RouteOfExposure | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/RouteOfMedicationAdministration | RouteOfMedicationAdministration | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/SOAPLineCode | SOAPLineCode | draft | | | | icpc |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/SOAPLineHeader | SOAPLineHeader | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/SmokingStatus | SmokingStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/SpecimenMaterial-and-Microorganism | SpecimenMaterial-and-Microorganism | draft | | | | |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/SpecimenMaterial | SpecimenMaterial | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/SpecimenSource | SpecimenSource | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/StatusName | StatusName | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/StatusValue | StatusValue | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/StomaType | StomaType | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/SubstanceCode | SubstanceCode | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Symptom | Symptom | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TL-LymphaticInvasion | TL-LymphaticInvasion | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TNMVersion | TNMVersion | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TemperatureType | TemperatureType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TestMethod | TestMethod | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TestResultStatus | TestResultStatus | draft | | | | fhir |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TextResultStatus | TextResultStatus | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TextResultType | TextResultType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TimeOfDay | TimeOfDay | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ToiletTrainednessFeces | ToiletTrainednessFeces | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ToiletTrainednessUrine | ToiletTrainednessUrine | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/ToiletUse | ToiletUse | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Transfer | Transfer | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Transfers | Transfers | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Treatment | Treatment | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TreatmentDecision | TreatmentDecision | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TypeOfDisorder | TypeOfDisorder | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TypeOfDrugOrMedication | TypeOfDrugOrMedication | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TypeOfHelp | TypeOfHelp | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TypeOfHome | TypeOfHome | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TypeOfIntervention | TypeOfIntervention | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TypeOfLivingWill | TypeOfLivingWill | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/TypeOfSmokingOrTobacco | TypeOfSmokingOrTobacco | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/UrineCatheterType | UrineCatheterType | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/UrineContinence | UrineContinence | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/V-VenousInvasion | V-VenousInvasion | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/VaccineProduct | VaccineProduct | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/VerificationStatus | VerificationStatus | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/VisualAcuityMeasurementChart | VisualAcuityMeasurementChart | draft | | | | tho oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/VisualAcuityMeasurementDevice | VisualAcuityMeasurementDevice | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/VisualAcuityType | VisualAcuityType | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/VisualAidType | VisualAidType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/VisualFunction | VisualFunction | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/Walking | Walking | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/WeekDay | WeekDay | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/WeightLossScore | WeightLossScore | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/WoundDrainType | WoundDrainType | draft | | | | sct |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/WoundEdge | WoundEdge | draft | | | | sct tho |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/WoundMoisture | WoundMoisture | draft | | | | oid |
| healthdata.be.r4.cbb | R4 | https://fhir.healthdata.be/ValueSet/WoundType | WoundType | draft | | | | sct tho |
| ihe.iti.basicaudit | R4 | AuthZsubTypeVS | Authorization subType events valueset | active | 2022-03 | uv | ihe | ihe |
| ihe.iti.basicaudit | R4 | BasicAuditEntityTypesVS | Entity Types used by IHE BasicAudit | active | 2022-03 | uv | ihe | ihe |
| ihe.iti.basicaudit | R4 | DataSources | participant source types for RESTful create | active | 2022-03 | uv | ihe | tho |
| ihe.iti.basicaudit | R4 | OtherIdentifierTypesVS | Other Id Types ValueSet | active | 2022-03 | uv | ihe | ihe tho |
| ihe.iti.basicaudit | R4 | RestObjectRoles | RESTful objects role in the event | active | 2022-03 | uv | ihe | tho |
| ihe.iti.basicaudit | R4 | UserAgentTypesVS | Agent types holding User-Agent | active | 2022-03 | uv | ihe | ihe |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/bcp13 | Bcp13 | active | | | | ietf |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/device-kind | DeviceKind | active | | | | sct |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/device-settings-codes | DeviceSettingsCodes | active | | | | sct |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/insulin-codes | InsulinCodes | active | | | | |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/observation-codes | ObservationCodes | active | | | | sct loinc |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/report-codes | ReportCodes | active | | | | |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/SNOMED-CT | SNOMEDCT | active | | | | sct |
| navify.fhir.r5.rdc | R5 | https://roche.com/fhir/iop/ValueSet/user-identifier-type-codes | UserIdentifierTypeCodes | active | | | | tho |
| ndhm.in | R4 | ndhm-adjudication-reason | Adjudication Reason | draft | 2023-11 | in | national | internal |
| ndhm.in | R4 | ndhm-alcohol-drinking-status | Alcohol Drinking Status | draft | 2021-03 | in | national | sct |
| ndhm.in | R4 | ndhm-benefit-type | Benefit Type | draft | 2023-07 | in | national | sct |
| ndhm.in | R4 | ndhm-benefitcategory | Benefit Category | draft | 2022-07 | in | national | sct |
| ndhm.in | R4 | ndhm-body-measurement | Body Measurement | draft | 2021-03 | in | national | loinc |
| ndhm.in | R4 | ndhm-care-team-qualification | Care Team Qualification | draft | 2023-07 | in | national | sct |
| ndhm.in | R4 | ndhm-care-team-role | Care Team Role | draft | 2023-07 | in | national | sct |
| ndhm.in | R4 | ndhm-chargeitem-types | ChargeItem Type | draft | 2023-08 | in | national | internal |
| ndhm.in | R4 | ndhm-claim-exclusion | Claim Exclusion | draft | 2023-07 | in | national | internal |
| ndhm.in | R4 | ndhm-claim-type | Claim Type | draft | 2023-07 | in | national | sct |
| ndhm.in | R4 | ndhm-coverage-type | Coverage Type | draft | 2023-07 | in | national | sct |
| ndhm.in | R4 | ndhm-diagnostic-code | ICD10 Diagnostic codes | draft | 2023-07 | in | national | icd |
| ndhm.in | R4 | ndhm-diagnostic-type | Diagnostic Type | draft | 2023-07 | in | national | sct |
| ndhm.in | R4 | ndhm-diet-type | Diet Type | draft | 2021-03 | in | national | sct |
| ndhm.in | R4 | ndhm-encounter-type | EncounterTypes | draft | 2022-06 | in | national | sct |
| ndhm.in | R4 | ndhm-form-code | Form Code | draft | 2023-11 | in | national | internal |
| ndhm.in | R4 | ndhm-general-assessment | General Assessment | draft | 2021-03 | in | national | sct loinc |
| ndhm.in | R4 | ndhm-general-well-being | General Wellbeing | draft | 2021-03 | in | national | sct |
| ndhm.in | R4 | ndhm-identifier-type-code | Identifier Type | draft | 2022-07 | in | national | internal tho |
| ndhm.in | R4 | ndhm-insuranceplan-type | InsurancePlan Type | draft | 2023-07 | in | national | internal |
| ndhm.in | R4 | ndhm-invoice-types | Invoice Type | draft | 2021-08 | in | national | internal |
| ndhm.in | R4 | ndhm-lifestyle | Lifestyle | draft | 2021-03 | in | national | sct |
| ndhm.in | R4 | ndhm-mental-status | Mental Status | draft | 2021-03 | in | national | sct |
| ndhm.in | R4 | ndhm-payment-type | Payment Type | draft | 2023-11 | in | national | internal tho |
| ndhm.in | R4 | ndhm-physical-activity | Physical Activity | draft | 2021-03 | in | national | loinc |
| ndhm.in | R4 | ndhm-plan-type | Plan Type | draft | 2023-07 | in | national | internal |
| ndhm.in | R4 | ndhm-price-components | Price Component | draft | 2021-08 | in | national | internal |
| ndhm.in | R4 | ndhm-productorservice | ProductorService | draft | 2022-07 | in | national | sct |
| ndhm.in | R4 | ndhm-program-code | Program Code | draft | 2022-09 | in | national | internal |
| ndhm.in | R4 | ndhm-reason-code | Reason Code | draft | 2023-11 | in | national | internal |
| ndhm.in | R4 | ndhm-related-claim-relationship-code | Related Claim Relationship | draft | 2023-07 | in | national | internal tho |
| ndhm.in | R4 | ndhm-supportinginfo-category | SupportingInfo Category | draft | 2022-07 | in | national | internal |
| ndhm.in | R4 | ndhm-supportinginfo-code | SupportingInfo Code | draft | 2022-07 | in | national | internal tho |
| ndhm.in | R4 | ndhm-task-codes | Task Code | draft | 2023-11 | in | national | internal fhir tho |
| ndhm.in | R4 | ndhm-task-input-type-code | Task Input Type | draft | 2023-11 | in | national | internal tho |
| ndhm.in | R4 | ndhm-task-output-type | Task Output Type | draft | 2023-11 | in | national | internal |
| ndhm.in | R4 | ndhm-task-output-value | Task Output Value | draft | 2023-11 | in | national | internal |
| ndhm.in | R4 | ndhm-tobacco-chewing-status | Tobacco Chewing Status | draft | 2021-03 | in | national | sct |
| ndhm.in | R4 | ndhm-tobacco-smoking-status | Tobacco Smoking Status | draft | 2021-03 | in | national | sct |
| ndhm.in | R4 | ndhm-vital-signs | Vital Signs | draft | 2021-03 | in | national | loinc |
| ndhm.in | R4 | ndhm-women-health | Women Health | draft | 2021-03 | in | national | loinc |
| de.gematik.erp-servicerequest | R4 | https://gematik.de/fhir/erp-servicerequest/ValueSet/delivery-type-vs | Art der Belieferung (VS) | draft | 2025-01 | | | |
| de.gematik.erp-servicerequest | R4 | https://gematik.de/fhir/erp-servicerequest/ValueSet/medication-request-reason-vs | Reason for medication request (VS) | draft | 2025-01 | | | |
| de.gematik.erp-servicerequest | R4 | https://gematik.de/fhir/erp-servicerequest/ValueSet/service-identifier-vs | Identifier of the use case | draft | 2025-01 | | | |
| de.gematik.erp-servicerequest | R4 | https://gematik.de/fhir/erp-servicerequest/ValueSet/service-request-organization-type-vs | ServiceRequest Organization Type (VS) | draft | 2025-01 | | | |
| de.gematik.erp-servicerequest | R4 | https://gematik.de/fhir/erp-servicerequest/ValueSet/service-request-priority-vs | Service Request Priority VS | draft | 2025-01 | | | fhir |
| de.gematik.erp-servicerequest | R4 | https://gematik.de/fhir/erp-servicerequest/ValueSet/service-request-status-vs | Status des ServiceRequests | draft | 2025-01 | | | fhir |
| de.gematik.erp-servicerequest | R4 | https://gematik.de/fhir/erp-servicerequest/ValueSet/service-request-type-vs | Art des ServiceRequests (VS) | draft | 2025-01 | | | |
| hl7.fhir.be.lab | R4 | be-vs-coded-annotation-types | Coded Annotation Types | active | 2022-09 | be | hl7 | internal |
| logex.internal.fhir.profiles | R3 | http://mrdm.nl/fhir/ValueSet/administrative-gender | administrative-gender | draft | 2023-04 | | | |
| logex.internal.fhir.profiles | R3 | http://mrdm.nl/fhir/ValueSet/questionnaire-item-value-types | questionnaire-item-value-types | draft | 2023-04 | | | |
| logex.internal.fhir.profiles | R3 | https://mrdm/fhir/ValueSet/mrdm-dbir-device-action-codes | mrdm-valueset-dbir-device-action-codes | draft | 2023-06 | | | |
| de.gkvsv.erezeptabrechnungsdaten | R4 | https://fhir.gkvsv.de/ValueSet/GKVSV_VS_ERP_Import | GKVSV_VS_ERP_Import | active | 2025-03 | | | |
| de.gkvsv.erezeptabrechnungsdaten | R4 | https://fhir.gkvsv.de/ValueSet/GKVSV_VS_ERP_Leistungserbringer_Sitz | GKVSV_VS_ERP_Leistungserbringer_Sitz | active | 2025-03 | | | |
| de.gkvsv.erezeptabrechnungsdaten | R4 | https://fhir.gkvsv.de/ValueSet/GKVSV_VS_ERP_Leistungserbringertyp | GKVSV_VS_ERP_Leistungserbringertyp | active | 2025-03 | | | |
| de.gkvsv.erezeptabrechnungsdaten | R4 | https://fhir.gkvsv.de/ValueSet/GKVSV_VS_ERP_Positionstyp | GKVSV_VS_ERP_Positionstyp | active | 2025-03 | | | |
| de.gkvsv.erezeptabrechnungsdaten | R4 | https://fhir.gkvsv.de/ValueSet/GKVSV_VS_ERP_Rechnungsart | GKVSV_VS_ERP_Rechnungsart | active | 2025-03 | | | |
| de.gkvsv.erezeptabrechnungsdaten | R4 | https://fhir.gkvsv.de/ValueSet/GKVSV_VS_ERP_Verwurf | GKVSV_VS_ERP_Verwurf | active | 2025-03 | | | |
| de.gkvsv.erezeptabrechnungsdaten | R4 | https://fhir.gkvsv.de/ValueSet/GKVSV_VS_ERP_ZuAbschlagKey | GKVSV_VS_ERP_ZuAbschlagKey | active | 2025-03 | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/blood-gas-analysis-combined | Blood Gas Analysis Combined | draft | 2021-10 | | | sct loinc |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/diseases-combined | Diseases Combined | draft | 2021-10 | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/procedures-combined | Procedures Combined | draft | 2021-10 | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/sars-cov-2-detection-combined | SARS-CoV-2 Detection Combined | draft | 2021-10 | | | loinc |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/vaccination-substances-combined | Vaccination Substances Combined | draft | 2021-10 | | | fhir sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/ace-inhibitors-atc | ACE inhibitors ATC | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/anticoagulants-atc | Anticoagulants ATC | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/apheresis-procedures-ops | Apheresis Procedures OPS | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/apheresis-procedures | Apheresis-Procedures | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/birth-sex | Birth-Sex | active | | | | fhir |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/cardiovascular-diseases-icd | Cardiovascular Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/cardiovascular-diseases | Cardiovascular-Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-kidney-diseases-icd | Chronic Kidney Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-kidney-diseases | Chronic Kidney Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-liver-diseases-icd | Chronic Liver Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-liver-diseases | Chronic-Liver-Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-lung-diseases-icd | Chronic Lung Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-lung-diseases | Chronic Lung Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-neurological-mental-diseases-icd | Chronic Neurological Mental Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-neurological-mental-diseases | Chronic Neurological Mental Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/complications-covid-19-icd | Complications Covid-19 ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/complications-covid-19 | Complications of Covid-19 | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/condition-severity | Condition Severity | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/detected-not-detected-inconclusive | Detected Not-detected Inconclusive | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/diabetes-mellitus-diseases-icd | Diabetes Mellitus Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/diabetes-mellitus-diseases | Diabetes Mellitus Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/dialysis-procedures-ops | Dialysis Procedures OPS | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/dialysis-procedures | Dialysis Procedures | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/discharge-disposition | Discharge Disposition | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/ecrf-parameter-codes | Parameter Codes eCRF | active | 2020-08 | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/ethnic-groups | Ethnic Groups | active | | | | sct oid |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/extracorporeal-membrane-oxygenation | ECMO Therapies OPS | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/frailty-score | Frailty Score | active | 2020-05 | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/gastrointestinal-ulcers-icd | Gastrointestinal Ulcers ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/gastrointestinal-ulcers | Gastrointestinal Ulcers | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/history-of-organ-transplantation-icd | History of transplantation ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/human-immunodeficiency-virus-infections-icd | Human Immunodeficiency Virus Infections ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/human-immunodeficiency-virus-infections | Human Immunodeficiency Virus Infections | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/immunoglobulins-atc | Immunoglobulins ATC | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/known-exposure | Known Exposure to SARS-CoV-2 | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/lab-tests-gecco | Laboratory Tests GECCO | active | | | | loinc |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/malignant-neoplastic-diseases-icd | Malignant Neoplastic Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/malignant-neoplastic-diseases | Malignant Neoplastic Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/organs-for-transplant | Organs for Transplantation | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-atc | Pharmacological Therapy ATC | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-ops | Pharmacological Therapy OPS | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-snomed | Drug Therapy SNOMED | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pregnancy-status | Pregnancy Status | active | | | | sct loinc |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/radiology-findings | Radiology Findings | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/radiology-procedures-dicom | Radiology Procedures DICOM | active | | | | dcm |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/radiology-procedures | Radiology Procedures | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/respiratory-therapies-devices | Respiratory Therapy Devices | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/respiratory-therapies | Respiratory Therapies | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/resuscitation-status | Do-Not-Resuscitate-Order | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/rheumatological-immunological-diseases-icd | Rheumatological Immunological Diseases ICD-10-GM | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/rheumatological-immunological-diseases | Rheumatological Immunological Diseases | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/sars-cov-2-symptoms | SARS-CoV-2-Symptoms | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/smoking-status | Smoking Status | active | | | | loinc |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/sofa-score | SOFA-Score | active | 2020-08 | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/stage-at-diagnosis | Stage at Diagnosis | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/therapeutic-intent | Therapeutic Intent | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/vaccines-snomed | Vaccines SNOMED | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/vaccines-atc | Vaccines ATC | active | | | | |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/verification-status | ConditionVerificationStatus SNOMED | active | | | | sct |
| de.gecco | R4 | https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/yes-no-unknown-other-na | Yes-No-Unknown-Other-Na | active | | | | sct |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-data-models | DAF Research Data Models | active | 2016-07 | us | hl7 | fhir |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-query-formats | DAF Research Query Formats | active | 2016-07 | us | hl7 | fhir |
| rki.emiga.outbreak | R4 | https://emiga.rki.de/fhir/ValueSet/OutbreakCategoryVS | Ausbruchskategorie-Werteliste | active | 2025-03 | | | tho |
| rki.emiga.outbreak | R4 | https://emiga.rki.de/fhir/outbreak/ValueSet/OutbreakEnvironmentSettingVS | Infektionsumfeld | active | 2025-02 | | | tho |
| rki.emiga.outbreak | R4 | https://emiga.rki.de/fhir/ValueSet/OutbreakInfectionRouteVS | Infektionsweg | active | 2025-02 | | | tho |
| rki.emiga.outbreak | R4 | https://emiga.rki.de/fhir/outbreak/ValueSet/OutbreakTypeVS | Typ des Ausbruchs | active | 2025-03 | | | |
| rki.emiga.outbreak | R4 | https://emiga.rki.de/fhir/common/ValueSet/ProcessingStatusVS | Bearbeitungsstatus | active | 2025-02 | | | |
| rki.emiga.outbreak | R4 | https://emiga.rki.de/fhir/ValueSet/YesNoNullFlavor | Ja, Nein, Nicht ermittelbar, Nicht erhoben Antworten | active | 2025-02 | | | sct tho |
| de.medizininformatikinitiative.kerndatensatz.person | R4 | http://hl7.org/fhir/sid/icd-10/vs | MII VS Person ICD-10-WHO | active | 2024-12 | de | | icd |
| de.medizininformatikinitiative.kerndatensatz.person | R4 | https://www.medizininformatik-initiative.de/fhir/core/modul-person/ValueSet/Vitalstatus | MII VS Person Vitalstatus | active | 2024-12 | de | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/identifier/allergyInt-code-comment | Allergy Intolerance Code Comment | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/allergy-int-ext-code-other-uri | Allergy Intolerance Code External | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/allergy-int-code-med-uri | Allergy Intolerance Code Medication | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/allergy-int-code-other-uri | Allergy Intolerance Code Other | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/allergy-int-identifier-comment-uri | Allergy Intolerance Identifier Comment | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/allergy-int-identifier-med-uri | Allergy Intolerance Identifier Medication | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/allergy-int-identifier-other-uri | Allergy Intolerance Identifier Other | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/allergy-int-manifestation-uri | Allergy Intolerance Manifestation | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-counseling-answer-uri | Hospitals Uris Chameleon Answer | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-bed-id-uri | Chameleon Bed Id | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-consultation-type | Chameleon Consultation Type | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/diagnosis-code-uri | Hospitals Uris Chameleon Diagnosis Code | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-diagnosis-rowid-uri | Chameleon Diagnosis Table ID | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-hosp-code-uri | Chameleon Hospital Codes | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-medical-record-uri | Hospitals Uris Chameleon Medical Record | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-ou-code-uri | Hospitals Uris Chameleon OU Code | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-pat-internal-uri | Hospitals Uris Chameleon Patient Internal | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-counseling-request-uri | Hospitals Uris Chameleon Request | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-room-id-uri | Chameleon Room Id | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/coview-imaging-unit-category-uri | Coview Imaging Unit Category Uri | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/encounter-diet-pref-uri | Hospitals Uris Encounter Diet Preference | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/ad-username-uri | Hospitals Uris Active Directory User-name | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-user-code-uri | Hospitals Uris Chameleon User code | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/sap-user-vma-uri | Hospitals Uris SAP User VMA | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/img-doc-abnormal-flag-uri | Img Doc Abnormal Flag Uri | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-case-number-uri | Hospitals Uris Namer Case Number | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-hmo-code | Namer Hmo Code | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-img-doc-identifier-uri | Nmr Img Doc Identifier URI | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-img-doc-ver-identifier-uri | Nmr Img Doc Version Identifier URI | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-img-order-number-uri | Nmr Image Order Number Uris | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-img-order-service-uri | Nmr Image Order Service Uris | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-img-service-group-uri | Nmr Img Service Group Uri | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-move-num-uri | Hospitals Uris for Namer Movement Number | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-ou-code-uri | Hospitals Uris Namer OU Code | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-ou-text-uri | Hospitals Uris Namer OU Text | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-ou-type | Nmr OU Type | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-pat-internal-uri | Hospitals Uris Namer Patient Internal | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr-pat-temp-uri | Hospitals Uris Namer Patient Temp | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/nmr2cml-identifier-uri | Hospitals Uris Maner to Chameleon Identifier | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/ou-classification-flag | OU Classification Flag | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/patient-visitor-type | Patient Visitor Type | draft | 2025-03 | | | |
| il.fhir.r4.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/body-site-laterlity | Body Site Laterality | draft | 2025-03 | | | sct |
| kl.dk.fhir.ffinst | R4 | BodyTemperatureSCTObservables | TemperatureSCTObservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | BodyheightSCTobservables | BodyheightSCTobservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | BodyweightSCTobservables | BodyweightSCTobservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | ConsciousnessCodes | ConsciousnessCodes | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | ConsciousnessSCTFindings | ConsciousnessSCTFindings | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | DiastolicBloodPressureSCTObservables | DiastolicBloodPressureSCTObservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | EQ5DSCTfindingsActivity | EQ5DSCTfindingsActivity | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | EQ5DSCTfindingsAnxiety | EQ5DSCTfindingsAnxiety | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | EQ5DSCTfindingsHygiene | EQ5DSCTfindingsHygiene | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | EQ5DSCTfindingsMobility | EQ5DSCTfindingsMobility | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | EQ5DSCTfindingsPain | EQ5DSCTfindingsPain | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | EQ5Dactivity | EQ5Dactivity | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | EQ5Danxiety | EQ5Danxiety | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | EQ5Dhygiene | EQ5Dhygiene | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | EQ5Dmobility | EQ5Dmobility | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | EQ5Dpain | EQ5Dpain | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | FindingInformerCodes | FindingInformerCodes | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | HeartRateSCTobservables | HeartRateSCTobservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | KLtechniquesCodes | KLtechniquesCodes | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | NPUUrinStix | NPUUrinStix | active | 2023-08 | dk | | oid |
| kl.dk.fhir.ffinst | R4 | OxygenSaturationSCTobservables | OxygenSaturationSCTobservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | RespirationRateSCTObservables | RespirationRateSCTObservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | SCTUrinStix | SCTUrinStix | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | SystolicBloodPressureSCTObservables | SystolicBloodPressureSCTObservables | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | TechniqesSCTCodes | TechniqesSCTCodes | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | VRSSCTfindingsPain | VRSSCTfindingsPain | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | VRSpain | VRSpain | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | WHO5AnswerCodesActive | WHO5AnswerCodesActive | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | WHO5AnswerCodesCalm | WHO5AnswerCodesCalm | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | WHO5AnswerCodesHappy | WHO5AnswerCodesHappy | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | WHO5AnswerCodesInterest | WHO5AnswerCodesInterest | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | WHO5AnswerCodesRested | WHO5AnswerCodesRested | active | 2023-08 | dk | | internal |
| kl.dk.fhir.ffinst | R4 | WHO5SCTfindingsActive3 | WHO5SCTfindingsActive3 | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | WHO5SCTfindingsCalm2 | WHO5SCTfindingsCalm2 | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | WHO5SCTfindingsHappy1 | WHO5SCTfindingsHappy1 | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | WHO5SCTfindingsInterest5 | WHO5SCTfindingsInterest5 | active | 2023-08 | dk | | sct |
| kl.dk.fhir.ffinst | R4 | WHO5SCTfindingsRested4 | WHO5SCTfindingsRested4 | active | 2023-08 | dk | | sct |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Altersteilzeit | Frage zur Altersteilzeit | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_AnfrageRehabilitationseinrichtung | Kommunikation auf Deutsch | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Aufzug_vorhanden | Aufzug vorhanden | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_AnAuskleiden | Aufzug vorhanden | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_Aufsetzen_Umsetzen | Aufsetzen und Umsetzen | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_AufstehenGehen | Aufstehen und Gehen | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_BadenDuschen | Baden/Duschen | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_Essen | Essen | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_Harninkontinenz | Harninkontinenz | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_Sich_waschen | Sich waschen | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_Stuhlkontinenz | Stuhlkontinenz | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_Toilettenbenutzung | Toilettenbenutzung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BI_Treppensteigen | Treppensteigen | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_AA | Alltagsrelevante Beeinträchtigungen - Allgemeine Aufgaben | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_BLB | Alltagsrelevante Beeinträchtigungen - Bedeutende Lebensbereiche | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_GL | Alltagsrelevante Beeinträchtigungen - Gemeinschaftsleben | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_HL | Alltagsrelevante Beeinträchtigungen - Häusliches Leben | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_IIB | Alltagsrelevante Beeinträchtigungen - Interpersonelle Interaktionen und Beziehungen | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_KO | Alltagsrelevante Beeinträchtigungen - Kommunikation | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_LW | Alltagsrelevante Beeinträchtigungen - Lernen und Wissensanwendung | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_MO | Alltagsrelevante Beeinträchtigungen - Mobilität | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Beeintraechtigungen_SV | Alltagsrelevante Beeinträchtigungen - Selbstversorgung | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Belastbarkeit | Voraussichtliche Belastbarkeit | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Belastbarkeit_Status | Status der körperlichen und psychisch/kognitiven Belastbarkeit | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Direktverlegung_Status | Direktverlegung nötig - Status | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_DurchgefuehrteBehandlungen | Direktverlegung nötig - Status | active | 2021-05 | | | loinc |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Interimsprothese | Anpassung einer Interimsprothese | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Komplikationen | Komplikationen im aktuellen Behandlungsverlauf | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Komplikationen_Status | Komplikationen im aktuellen Behandlungsverlauf - Status | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Komplikationen_mulires_Keime | Komplikationen im aktuellen Behandlungsverlauf - multiresistente Keime | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Komplikationen_multires_Keime | Komplikationen im aktuellen Behandlungsverlauf - multiresistente Keime | active | 2021-09 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_Rehabilitationsart | Rehabilitationsart | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_UnterstuetzungsbedarfSelbstversorgung | Unterstützungsbedarf im Bereich der Selbstversorgung | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_besondereAnforderungen | Besondere Anforderungen an die Rehabilitationseinrichtung | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Befund_besondereAnforderungen_Status | Besondere Anforderungen an die Rehabilitationseinrichtung - Status | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Begleitperson_erforderlich_Status | Begleitperson bei Anreise | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Beitraege_Rentenversicherung | Frage zu Beiträgen Rentenversicherung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Beitraege_Rentenversicherung_Grund | Grund für Beiträge zur Rentenversicherung oder zur Alterssicherung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_BestehtPflegebeduerftigkeit | Besteht Pflegebedürftigkeit | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Durchfuehrung_Fruehreha_Massnahmen | Durchführung Frührehabilitationsmaßnahmen | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_FR_IntensivmedZustand | Intensivmedizinisch überwachungspflichtiger Zustand | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_FR_IntermittierendeBeatmung | Intermittierende Beatmung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_FR_Orientierungsstoerung | Beaufsichtigungspflichtige Orientierungsstörung (Verwirrtheit) | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_FR_Schluckstoerung | Beaufsichtigungspflichtige Schluckstörung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_FR_Tracheostoma | Absaugpflichtiges Tracheostoma | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_FR_Verhaltensstoerung | Beaufsichtigungspflichtige Verhaltensstörung (mit Eigen- und/oder Fremdgefährdung) | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_FR_Verstaendigungsstoerung | Schwere Verständigungsstörung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Indikation | Indikation | active | 2021-04 | | | loinc |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_KommunikationAufDeutsch | Kommunikation auf Deutsch | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Pflegegrad | Pflegegrad ohne Antrag auf Einstufung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Rentenantrag_Altersrente | Fragen zum Antrag von Altersrente | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Rentenantrag_Erwerbsminderung | Fragen zum Antrag von Rente wegen Erwerbsminderung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Rentenbezug_Altersrente | Fragen zum Bezug von Altersrente | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Rentenbezug_Erwerbsminderung | Fragen zum Bezug von Rente wegen Erwerbsminderung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Ursache_Erkrankung | Ursache der Erkrankung | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Verkehrsmittel | Verkehrsmittel für die Anreise | active | 2021-05 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_Zustand_Wunde | Wunde geschlossen und reizlos | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_haeusliche_Versorgung_sichergestellt | Häusliche Versorgung sichergestellt | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_haeusliche_Versorgungssituation | Häusliche Versorgungssituation | active | 2021-04 | | | |
| de.gevko.eahb | R4 | https://fhir.gevko.de/ValueSet/EAHB_VS_sozielae_Versorgungssituation | Soziale Versorgungssituation | active | 2021-04 | | | |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/absent-or-unknown-allergies-uv-ips | Absent or Unknown Allergies - IPS | active | 2022-01 | uv | hl7 | fhir |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/absent-or-unknown-devices-uv-ips | Absent or Unknown Devices - IPS | active | 2022-01 | uv | hl7 | fhir |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/absent-or-unknown-immunizations-uv-ips | Absent or Unknown Immunization - IPS | active | 2022-01 | uv | hl7 | fhir |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/absent-or-unknown-medications-uv-ips | Absent or Unknown Medication - IPS | active | 2022-01 | uv | hl7 | fhir |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/absent-or-unknown-problems-uv-ips | Absent or Unknown Problems - IPS | active | 2022-01 | uv | hl7 | fhir |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/absent-or-unknown-procedures-uv-ips | Absent or Unknown Procedures - IPS | active | 2022-01 | uv | hl7 | fhir |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-uv-ips | Allergy intolerance substance condition - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/condition-severity-uv-ips | Problem Severity - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/core-problem-finding-situation-event-gps-uv-ips | CORE Problem List Finding/Situation/Event (GPS) - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/current-smoking-status-uv-ips | Current Smoking Status - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/edd-method-uv-ips | Pregnancy Expected Delivery Date Method - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/healthcare-professional-roles-uv-ips | Healthcare Professional Roles - IPS | active | 2022-01 | uv | hl7 | oid |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/medical-devices-uv-ips | Medical Devices - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips | Medications (example) - IPS | active | 2022-01 | uv | hl7 | sct rx ndc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/medication-snomed-uv-ips | Medications (SNOMED CT) - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/medicine-active-substances-uv-ips | Medicine Active Substances - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/medicine-doseform | Medicine Doseform - IPS | active | 2022-01 | uv | hl7 | |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/medicine-route-of-administration | Medicine Route of Administration - IPS | active | 2022-01 | uv | hl7 | |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/personal-relationship-uv-ips | Personal Relationship - IPS | active | 2022-01 | uv | hl7 | tho |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/pregnancies-summary-uv-ips | Pregnancies Summary - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/pregnancy-status-uv-ips | Pregnancy Status - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/problem-type-uv-ips | Problem Type - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/procedures-uv-ips | Procedures - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/result-coded-value-laboratory-gps-uv-ips | Results Coded Values Laboratory (GPS) - IPS | active | 2022-01 | uv | hl7 | fhir |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/result-coded-value-pathology-gps-uv-ips | Results Coded Values Pathology (GPS) - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-laboratory-blood-abo-rh-grp-gps-uv-ips | Results Laboratory ABO+RH Group (GPS) - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-laboratory-observations-uv-ips | Results Laboratory Observation - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-laboratory-presence-absence-gps-uv-ips | Results Laboratory Presence/Absence (GPS) - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-organism-gps-uv-ips | Results Organism (GPS) - IPS | active | 2022-01 | uv | hl7 | sct |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-pathology-observations-uv-ips | Results Pathology Observation - IPS | active | 2022-01 | uv | hl7 | loinc |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-numobs-gps-dicom-uv-ips | Results Radiology Measurement Observation (GPS-DICOM) - IPS | active | 2022-01 | uv | hl7 | sct dcm |
| HIE2.packages | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-observations-uv-ips SleepCodes | SøvnKoder | active | 2024-10 | dk | | |
| kl.dk.fhir.children | R4 | SocialInteractionCodes | SocialKontaktKoder | active | 2024-10 | dk | | |
| kl.dk.fhir.children | R4 | SocialSupportNetworkCodes | NetværkKoder | active | 2024-10 | dk | | |
| hl7.fhir.us.sdcde | R3 | dataelement-sdccode | DataElement SDC Concept | draft | 2017-04 | us | hl7 | sct rx loinc |
| de.gematik.dev.ti | R4 | https://gematik.de/fhir/ti/ValueSet/ti-operation-outcome-details | TI Operation Outcome Details Value Set | active | 2025-02 | | | tho |
| furore.test.fsh.demo | R4 | https://furore.com/data/fhir/ValueSet/EducationLevelVS | Education level of patient ValueSet | active | | | | sct |
| furore.test.fsh.demo | R4 | https://furore.com/data/fhir/ValueSet/PatientComorbidityHistory | Patient's comorbidity history ValueSet | active | | | | fhir tho |
| furore.test.fsh.demo | R4 | https://furore.com/data/fhir/ValueSet/ProcedureIntentVS | Procedure Intent Value Set | active | | | | sct |
| hl7.fhir.it.lab-report | R4 | URI-idStp | Identificativi per codici STP regionali | active | 2024-03 | it | hl7 | ietf |
| hl7.fhir.it.lab-report | R4 | VstipoIdentificatore | Tipo identificatore | active | 2019-11 | it | hl7 | internal tho |
| hl7.fhir.it.lab-report | R4 | additivo-campione-it | Additivo Campione | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | aifa-aic | AIFA AIC | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | campione-container-lab-it | Container Campione | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | iso-ehicCountryCode | ISO 3166 - EHIC Country Codes | active | 2024-03 | it | hl7 | iso |
| hl7.fhir.it.lab-report | R4 | istat-cittadinanza | ISTAT - Cittadinanza | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | istat-comune | ISTAT - Comuni | active | 2024-03 | it | hl7 | internal tho |
| hl7.fhir.it.lab-report | R4 | istat-dug | ISTAT - DUG | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | istat-luogoNascita | ISTAT - Comune/Stato di Nascita | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | istat-professione | ISTAT - Professioni | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | istat-provincia | ISTAT - Province | active | 2024-03 | it | hl7 | internal tho |
| hl7.fhir.it.lab-report | R4 | istat-stato | ISTAT - Stati | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | istat-statoCivile-vs | ISTAT - Stato Civile | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | istat-titoloStudio | ISTAT - Titolo Studio | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | lab-orderCodes-it-lab | Codice Richiesta esame di Laboratorio [LOINC] | active | 2024-03 | it | hl7 | fhir loinc |
| hl7.fhir.it.lab-report | R4 | minsan-asl | MDS - ASL | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | minsan-esenzioni | MDS - Esenzioni | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | minsan-idAziendeOspedaliere | MDS - ID Aziende Ospedaliere | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | minsan-idStrutture | MDS - ID Strutture Ricovero | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | minsan-idStruttureInterne | MDS - ID Strutture Interne di Ricovero | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | minsan-regione | MDS - Codici Regionali | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | mmgOrPls | Tipo medico di famiglia | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | oid-ehicPersonalId | EHIC Personal ID (system IDs - oid) | active | 2024-03 | it | hl7 | ietf |
| hl7.fhir.it.lab-report | R4 | results-microorganism-snomed-ct-ips-free-set | Risultato osservazione codificato - microorganismo IPS di SNOMED CT | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | results-observation-bloodgroup | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | results-presence-absence-snomed-ct-ips-free-set | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | risultato-osservazione | Tipo Osservazione | active | 2024-03 | it | hl7 | loinc |
| hl7.fhir.it.lab-report | R4 | sezione-referto-laboratorio | Sezioni Composition Lab Report | active | 2024-03 | it | hl7 | loinc |
| hl7.fhir.it.lab-report | R4 | statoCivile | Stato Civile | active | 2024-03 | it | hl7 | internal tho |
| hl7.fhir.it.lab-report | R4 | tipo-campione-lab-it | Tipo campione | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | tipo-campione | Tipo Campione | active | 2024-03 | it | hl7 | tho |
| hl7.fhir.it.lab-report | R4 | tipoCertificatore | Tipo certificatore | active | 2024-03 | it | hl7 | internal tho |
| hl7.fhir.it.lab-report | R4 | tipoOrgSocioSanitaria | Tipo organizzazione socio-sanitaria | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | tipoOrganizzazione | Tipo organizzazione (esempio) | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | uri-idAslRegione | Identificativi regionali per ASL (3 char) | active | 2024-03 | it | hl7 | ietf |
| hl7.fhir.it.lab-report | R4 | uri-idEni | Identificativi per codici ENI regionali | active | 2024-03 | it | hl7 | ietf |
| hl7.fhir.it.lab-report | R4 | valueset-observation-value-bloodgroup | Risultato osservazione codificato gruppo sanguigno | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | valueset-observation-value-microorganism | Risultato osservazione codificato microorganismi | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | valueset-observation-value-presence-absence | Risultato osservazione codificato presenza/assenza | active | 2024-03 | it | hl7 | sct |
| hl7.fhir.it.lab-report | R4 | valueset-status-obs-it | Observation status code | active | 2024-03 | it | hl7 | fhir |
| hl7.fhir.it.lab-report | R4 | valueset-valuecodeableconcept-obs-it | Risultato osservazione codificato | active | 2024-03 | it | hl7 | internal |
| hl7.fhir.it.lab-report | R4 | vs-anagrafi-regionali | Anagrafi Regionali | active | 2024-03 | it | hl7 | ietf |
| hl7.fhir.it.lab-report | R4 | who-icd9cm | WHO ICD-9-CM | active | 2024-03 | it | hl7 | icd |
| tsti.adultcheck | R4 | https://tstifhir.azurehealthcareapis.com/ValueSet/adultcheck-code | 成人預防保健疾病史代碼集值 | draft | | | | sct |
| tsti.adultcheck | R4 | https://tstifhir.azurehealthcareapis.com/ValueSet/adultcheck-lifecode | 成人預防保健生活史代碼集值 | active | | | | sct |
| hie2.packages | R4 | http://fhir.hie.moh.gov.my/ValueSet/program-my-core | ValueSetProgram (MY Core) | active | 2022-03 | | | |
| hie2.packages | R4 | http://fhir.hie.moh.gov.my/ValueSet/service-category-my-core | ValueSetServiceCategory (MY Core) | active | 2022-03 | | | |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Appointment_Status | AppointmentStatus | draft | | | | fhir |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Clinical_Course | Verlauf | draft | | | | sct loinc |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Department_With_Specializations | Fachabteilungsschlüssel mit Spezialisierungen | draft | | | | |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Encounter_Class | Begegnungen Setting | draft | | | | tho |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Encounter_Status | Begegnungen Status | draft | | | | fhir |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Event_Timing | Dosierung mittels 4-teiligem Schema | draft | | | | fhir |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_GoalLifecycleStatus | GoalLifecycleStatus | draft | | | | fhir |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_MIME_Types | MIME-Types ePA | draft | | | | ietf |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Observation_Interpretation | ObservationInterpretationCodes | draft | | | | tho |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Participation_Status | Teilnahmestatus | draft | | | | fhir |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Procedure_And_Recommendations | Weiteres Procedere und Empfehlung | draft | | | | sct loinc |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Request_Intent | Intention der geplanten Prozedur | draft | | | | fhir |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Results_Type | Befundtyp | draft | | | | sct |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Role_Care | Rolle in Bezug auf die Einrichtung | draft | | | | |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Role_CareTeam | Rolle in Bezug auf den bzw die Patientin | draft | | | | |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes | Medikation Therapie Statuscodes SNOMED CT® | draft | | | | sct |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_S_BMP_DOSING_UNIT | Dosiereinheit | draft | | | | |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Type_Of_Facility | Typ der Einrichtung | draft | | | | oid |
| kbv.mio.tele | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Type_Of_Medical_History | Art der Anamnese | draft | | | | sct |
| de.gematik.epa.audit | R4 | https://gematik.de/fhir/epa/ValueSet/epa-auditevent-sourcetype-vs | EPA AuditEvent Source Type | draft | 2025-02 | | | |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/age-group | Agegroup | active | | | | |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/chronic-condition-set | ChronicConditions | active | | | | sct loinc |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/covapp-symptoms-group-1 | Symptoms | active | | | | |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/covapp-symptoms-group-2 | Symptoms | active | | | | |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/fever-class | Feverclass | active | | | | loinc |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/housing-situation | Housingsituation | active | | | | loinc |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/occupation-class | Occupationclass | active | | | | loinc |
| d4l-data4life.covid-19.r4 | R4 | http://loinc.org/vs/LL4129-4 | Pregnant|Not pregnant|Unknown | active | | | | loinc |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/shared-location-class | Sharedlocationclass | active | | | | loinc |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/yesno | Yesno | active | | | | loinc |
| d4l-data4life.covid-19.r4 | R4 | http://fhir.data4life.care/covid-19/r4/ValueSet/yesnodontknow | Yesnodontknow | active | | | | loinc |
| de.gevko.evo.hlm | R4 | https://fhir.gevko.de/ValueSet/EVO_VS_HLM_Katalog | Heilmittelkatalog | active | 2022-04 | | | |
| de.gevko.evo.hlm | R4 | https://fhir.gevko.de/ValueSet/EVO_VS_HLM_Leitsymptomatik | Patientenindividuellen Leitsymptomatik | active | 2023-10 | | | |
| test.module3.v2 | R4 | https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-identity-reliability | FR Core ValueSet Identity reliability | active | 2024-09 | | | |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | ceosys-vs-recommendation-strength | Recommendation Strength | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | cochrane-pico-intervention | Cochrane PICO Intervention | draft | 2022-09 | uv | hl7 | |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | cochrane-pico-outcome | Cochrane PICO Outcome | draft | 2022-09 | uv | hl7 | |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | cochrane-pico-population | Cochrane PICO Population | draft | 2022-09 | uv | hl7 | |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | cochrane-pico | Cochrane PICO | draft | 2022-09 | uv | hl7 | |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-action-selection-behavior-required | Action Selection Behavior Required | draft | 2022-11 | uv | hl7 | fhir |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-allergic-disposition-sct | Allergic Disposition SCT | draft | 2022-09 | uv | hl7 | sct |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-body-positioning-snomed | Body Positioning SNOMED CT | draft | 2022-09 | uv | hl7 | sct |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-episode-of-care-type | Episode Of Care Type | draft | 2022-09 | uv | hl7 | |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-guideline-recommendation-status | Guideline Recommendation Status | draft | 2022-09 | uv | hl7 | fhir |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-guideline-stage-classification | Guideline Stage Classification | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-laboratory-observations | Laboratory Observations | draft | 2022-11 | uv | hl7 | loinc |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-mean-difference-type | Mean Difference Type | draft | 2022-09 | uv | hl7 | tho |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-radiologic-finding-sct | Radiologic Finding SCT | draft | 2022-09 | uv | hl7 | sct |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-acceptability | Rating Acceptability | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-benefit-and-harms | Rating Benefit And Harms | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-certainty-of-evidence | Rating Certainty Of Evidence | draft | 2022-09 | uv | hl7 | fhir |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-clinical-importance | Clinical Importance of Outcome | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-concern-degree | Rating Concern Degree | draft | 2022-09 | uv | hl7 | fhir |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-consensus | Rating Consensus | draft | 2022-09 | uv | hl7 | tho |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-equity | Rating Equity | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-feasibility | Rating Feasibility | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-preference-and-values | Rating Preference And Values | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-resources | Rating Resources | draft | 2022-09 | uv | hl7 | internal |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-uprating-one-level | Rating Up Rating One Level | draft | 2022-09 | uv | hl7 | fhir |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-rating-uprating-two-levels | Rating Up Rating Two Levels | draft | 2022-09 | uv | hl7 | fhir |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-relative-effect-type | Relative Effect Type | draft | 2022-09 | uv | hl7 | tho |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-substances-snomed | Substances SNOMED CT | draft | 2022-09 | uv | hl7 | sct |
| ebm-cpg.netzwerk-universitaetsmedizin.de | R5 | vs-ventilation-observable-sct | Ventilation Observable SCT | draft | 2022-09 | uv | hl7 | sct |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | http://gen.kanta.fi/ValueSet/figen-vs-provenancerolecategory | Value Set Kanta Provenance Role Category | active | 2023-12 | | | |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-appointmentstatus | fipta-vs-appointmentstatus | draft | 2023-12 | | | fhir |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-appointmenttype | fipta-vs-appointmenttype | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-appointmenttypecategory | fipta-vs-appointmenttypecategory | draft | 2023-12 | | | |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-cancelationreason | fipta-vs-cancelationreason | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-contactreason | fipta-vs-contactreason | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-contactrelationship | fipta-vs-contactrelationship | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-deletereason | fipta-vs-deletereason | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-detailedcontent | fipta-vs-detailedcontent | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-gender | fipta-vs-gender | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-notificationmedium | fipta-vs-notificationmedium | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-organization | fipta-vs-organization | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-recordstatus | fipta-vs-recordstatus | draft | 2023-09 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-recordstatusremoved | fipta-vs-recordstatusremoved | draft | 2023-09 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-registertype | fipta-vs-registertype | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-resourceprofession | fipta-vs-resourceprofession | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-restrictionparent | fipta-vs-restrictionparent | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-servicecategory | fipta-vs-servicecategory | draft | 2024-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-specialty | fipta-vs-specialty | draft | 2024-03 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-tableofcontentsprotected | fipta-vs-tableofcontentsprotected | draft | 2025-02 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-updatereason | fipta-vs-updatereason | draft | 2023-12 | | | oid |
| fi.kela.kanta.pta.ajanvaraus.r4 | R4 | https://pta.kanta.fi/fhir/ValueSet/fipta-vs-visible | fipta-vs-visible | draft | 2023-12 | | | oid |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Abrechnung_Art_Privat | KBV_VS_AW_Abrechnung_Art_Privat | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Abrechnung_Auslagenart | KBV_VS_AW_Abrechnung_Auslagenart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Abrechnung_Mahnung | KBV_VS_AW_Abrechnung_Mahnung | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Anlage_Identifiertyp | KBV_VS_AW_Anlage_Identifiertyp | active | 2020-02 | | | fhir |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Anlagetyp | KBV_VS_AW_Anlagetyp | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Arzneimittelart | KBV_VS_AW_Arzneimittelart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Befundart | KBV_VS_AW_Befundart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Behandlungsbaustein_Verordnung_Typ | KBV_VS_AW_Behandlungsbaustein_Verordnung_Typ | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Betriebsstaetten_Hierarchie | KBV_VS_AW_Betriebsstaetten_Hierarchie | active | 2020-08 | | | tho |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Datenbereich | KBV_VS_AW_Datenbereich | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Datenbereichparameter | KBV_VS_AW_Datenbereichparameter | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Diagnoseart | KBV_VS_AW_Diagnoseart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Diagnosekategorie | KBV_VS_AW_Diagnosekategorie | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Entschaedigungsart | KBV_VS_AW_Entschaedigungsart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Gebuehrenordnung | KBV_VS_AW_Gebuehrenordnung | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Gesundheitspass_Typ | KBV_VS_AW_Gesundheitspass_Typ | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Hausbesuch_Besuchszonen | KBV_VS_AW_Hausbesuch_Besuchszonen | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Hilfsmittel_Hilfsmittelart | KBV_VS_AW_Hilfsmittel_Hilfsmittelart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Kostentraeger-Abrechnungsbereich | KBV_VS_AW_Kostentraeger-Abrechnungsbereich | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krankenbefoerderung_Befoerderungsmittel_Von_Nach | KBV_VS_AW_Krankenbefoerderung_Befoerderungsmittel_Von_Nach | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krankenbefoerderung_Befoerderungsmitteltyp | KBV_VS_AW_Krankenbefoerderung_Befoerderungsmitteltyp | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Befund_Rektum_Kolon | KBV_VS_AW_Krebsfrueherkennung_Befund_Rektum_Kolon | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Anamnese_Diverse | KBV_VS_AW_Krebsfrueherkennung_Frauen_Anamnese_Diverse | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Auftrag_Alterskategorie | KBV_VS_AW_Krebsfrueherkennung_Frauen_Auftrag_Alterskategorie | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Befund_Diverse | KBV_VS_AW_Krebsfrueherkennung_Frauen_Befund_Diverse | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Befund_Diverse_Ab30 | KBV_VS_AW_Krebsfrueherkennung_Frauen_Befund_Diverse_Ab30 | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_HPV_HR | KBV_VS_AW_Krebsfrueherkennung_Frauen_HPV_HR | active | 2018-10 | | | tho |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_HPV_HR_Impfung | KBV_VS_AW_Krebsfrueherkennung_Frauen_HPV_HR_Impfung | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund | KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund_Diverse | KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund_Diverse | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund_Diverse_2020 | KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund_Diverse_2020 | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund_Empfehlung_2020 | KBV_VS_AW_Krebsfrueherkennung_Frauen_Zytologischer_Befund_Empfehlung_2020 | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Maenner_Anamnese_Diverse | KBV_VS_AW_Krebsfrueherkennung_Maenner_Anamnese_Diverse | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Krebsfrueherkennung_Maenner_Befund_Diverse | KBV_VS_AW_Krebsfrueherkennung_Maenner_Befund_Diverse | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Leistungsart | KBV_VS_AW_Leistungsart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Patient_VSDM_Gender | KBV_VS_AW_Patient_VSDM_Gender | active | 2018-10 | | | fhir |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Psychotherapie_Behandlungsart | KBV_VS_AW_Psychotherapie_Behandlungsart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Psychotherapie_Personenbezug | KBV_VS_AW_Psychotherapie_Personenbezug | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Report_Export_Purpose | KBV_VS_AW_Report_Export_Purpose | active | 2018-10 | | | tho |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Ringversuchszertifikat_pnSD_UU | KBV_VS_AW_Ringversuchszertifikat_pnSD_UU | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Ringversuchzertifikat_RV-Zertifikat | KBV_VS_AW_Ringversuchzertifikat_RV-Zertifikat | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_TSVG_Vermittlungsart | KBV_VS_AW_TSVG_Vermittlungsart | active | 2020-02 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Ueberweisung_Auftragsart | KBV_VS_AW_Ueberweisung_Auftragsart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Ueberweisung_KH-Einweisung_Typ | KBV_VS_AW_Ueberweisung_KH-Einweisung_Typ | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Vermittlungsart | KBV_VS_AW_Vermittlungsart | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Verordnung_Arbeitsunfaehigkeit_AU-Art | KBV_VS_AW_Verordnung_Arbeitsunfaehigkeit_AU-Art | active | 2018-10 | | | |
| kbv.ita.aws | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_AW_Verordnung_Kur_Kurart | KBV_VS_AW_Verordnung_Kur_Kurart | active | 2018-10 | | | |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ACVPU-1 | Care Connect ACVPU | draft | 2018-11 | | hl7 | sct |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-AllergyCertainty-1 | Care Connect Allergy Certainty | draft | 2018-03 | | hl7 | sct |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ClinicalDisciplines-1 | Care Connect Clinical Disciplinesy | draft | 2019-03 | | hl7 | |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-InspiredOxygen-1 | Care Connect Inspired Oxygen | draft | 2018-10 | | hl7 | sct |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-InterpretationCode-1 | Care Connect Extended Interpretation Code | draft | 2019-03 | | hl7 | |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-MedicationSupplyType-1 | Care Connect Medication Supply Type | draft | 2018-07 | | hl7 | |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ObservationInterpretation-1 | CareConnect Observation Interpretation | draft | 2021-04 | | hl7 | tho |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-SaturatedOxygenSp02Scale-1 | Care Connect Saturated Oxygen Sp02 Scale | draft | 2018-10 | | hl7 | sct |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ObservationMethod-1 | Care Connect Observation Method | draft | 2018-10 | | hl7 | sct |
| careconnect.stu3.03.00.00 | R3 | https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ObservationType-1 | Care Connect Observation Type | draft | 2018-10 | | hl7 | sct |
| hl7.terminology.r3 | R3 | CMSPlaceOfServiceCodes | CMS Place of Service Codes (POS) | active | 2024-07 | uv | hl7 | cms |
| hl7.terminology.r3 | R3 | ILRSpeakingSkillScale | Interagency Language Roundtable Speaking Skill Scale | active | 2024-07 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | Languages | Languages | active | 2024-07 | uv | hl7 | ietf |
| hl7.terminology.r3 | R3 | USPS-State | USPS Two Letter Alphabetic Codes | active | 2025-05 | uv | hl7 | |
| hl7.terminology.r3 | R3 | accepting-patients | Accepting Patients | active | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | artifact-contribution-instance-type | Artifact Contribution Instance Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | artifact-relationship-type | Artifact Relationship Type | active | 2025-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | artifact-url-classifier | Artifact Url Classifier | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | care-service-accessibility | Care Service Accessibility | active | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | certainty-type | Evidence Certainty Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | citation-artifact-classifier | Citation Artifact Classifier | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | citation-classification-type | Citation Classification Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | citation-summary-style | Citation Summary Style | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | cited-artifact-abstract-type | Cited Artifact Abstract Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | cited-artifact-classification-type | Cited Artifact Classification Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | cited-artifact-contribution-type | Cited Artifact Contribution Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | cited-artifact-part-type | Cited Artifact Part Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | cited-artifact-status-type | Cited Artifact Status Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | cited-medium | Cited Medium | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | contributor-role | Contributor Role | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | contributor-summary-source | Contributor Summary Source | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | contributor-summary-style | Contributor Summary Style | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | contributor-summary-type | Contributor Summary Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | fhir-clinical-doc-information-recipient | FHIR Clinical Document Information Recipients Participant Types | active | 2025-04 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | fhir-clinical-doc-participant | FHIR Clinical Document Participant Types Value set | active | 2025-04 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | insurance-coverage-type | Insurance Coverage Type | active | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | insurance-product-type | Insurance Product Type | active | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | insuranceplan-plan-type | Insuranceplan Plan Type | active | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | ndh-healthcare-service-category | NDH Healthcare Service Category | draft | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | organization-affiliation-role | Organization Affiliation Role | active | 2020-02 | uv | hl7 | fhir tho |
| hl7.terminology.r3 | R3 | organization-alias-type | Organization Alias Type | draft | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | professional-credential-status | rofessional Credential Status | draft | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | published-in-type | Published In Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | service-delivery-method | Service Delivery Method | active | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | statistic-model-code | Statistic Model Code | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | title-type | Title Type | active | 2025-01 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | v3-DischargeDisposition | Discharge Disposition | active | 2024-09 | uv | hl7 | |
| hl7.terminology.r3 | R3 | variable-role-subtype | EvidenceVariableRoleSubtype | active | 2024-04 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | virtual-healthcare-delivery-method | Virtual Healthcare Delivery Method | draft | 2020-02 | uv | hl7 | tho |
| hl7.terminology.r3 | R3 | yes-no-unknown-not-applicable | Yes No Unknown NotApplicable | active | 2025-02 | uv | hl7 | tho |
| ig.fhir-il-community.org.t17 | R4 | http://ig.fhir-il-community.org/T17/ValueSet/t17-eligibilityrequest-purpose | T17 EligibilityRequest Purpose codes | draft | | | | fhir |
| ig.fhir-il-community.org.t17 | R4 | http://ig.fhir-il-community.org/T17/ValueSet/t17-eligibilityresponse-purpose | T17 EligibilityResponse Purpose codes | draft | | | | fhir |
| demis.fhir.profiles | R4 | https://demis.rki.de/fhir/ValueSet/laboratoryTestSARSCoV2 | SARS-CoV-2-Labortest | retired | 2021-09 | | | loinc |
| demis.fhir.profiles | R4 | https://demis.rki.de/fhir/ValueSet/laboratoryTestWBGP | Labortest für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit | active | 2021-11 | | | loinc |
| demis.fhir.profiles | R4 | https://demis.rki.de/fhir/ValueSet/materialSARSCoV2 | SARS-CoV-2-Material | retired | 2021-09 | | | |
| demis.fhir.profiles | R4 | https://demis.rki.de/fhir/ValueSet/materialWBGP | Material für Meldepflicht für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit | active | 2021-11 | | | sct |
| demis.fhir.profiles | R4 | https://demis.rki.de/fhir/ValueSet/methodSARSCoV2 | SARS-CoV-2-Nachweismethode | retired | 2021-09 | | | |
| ch.mediplan.chmed16af | R4 | chmed16af-valueset-cdtyp26 | Route of administration (ROA) | active | 2019-06 | | | internal |
| ch.mediplan.chmed16af | R4 | chmed16af-valueset-cdtyp9 | UnitCodes | active | 2019-06 | | | internal |
| ch.mediplan.chmed16af | R4 | chmed16af-valueset-risks-category | Risk categories | active | 2019-06 | | | internal |
| ch.mediplan.chmed16af | R4 | chmed16af-valueset-risks-cdscode | Risks | active | 2019-06 | | | internal |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Care_Plan_Activity_Status | Pflege Plan Aktivitäts Status | draft | | | | fhir |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_CompositionStatus | Kennzeichen Entlassbrief | draft | | | | fhir |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Contact_Level | Kontaktebene | draft | | | | |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Contact_Person_Relationship_Type | Kontaktperson Art der Beziehung | draft | | | | tho |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Contact_Type | KontaktArtDE | draft | | | | |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Encounter_Setting | Termin Setting | draft | | | | tho |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Encounter_Status | Termin Status | draft | | | | fhir |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Initiated_Services_SNOMED_CT | Veranlasste Leistungen | draft | | | | sct |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Results_Type | Befundtyp | draft | | | | sct |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Role_Care | Rolle in Bezug auf die Einrichtung | draft | | | | |
| kbv.mio.kh-entlassbrief | R4 | https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Role_Care_Team | Rolle in Bezug auf den bzw die Patientin | draft | | | | |
| de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/mii-vs-labor-identifier-type-codes | MII VS Labor Identifier Type Codes | active | | de | | fhir tho |
| de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/Laborbereich | MII VS Labor Laborbereich | active | 2023-12 | de | | tho loinc |
| de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/Laborergebnis-semiquantitativ | MII VS Labor Laborergbenis Semiquantitativ | active | 2023-12 | de | | sct |
| de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/Laborergebnis-qualitativ | MII VS Labor Laborergebnis Qualitativ | active | 2023-12 | de | | sct |
| de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/ValueSetOrderCodes | MII VS Labor Order Codes | active | 2023-12 | de | | loinc |
| de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/QuelleKlinischesBezugsdatum | MII VS Labor Quelle klinisches Bezugsdatum | active | | de | | sct |
| de.abda.erezeptabgabedatenpkv | R4 | http://fhir.abda.de/eRezeptAbgabedaten/ValueSet/DAV-PKV-VS-ERP-AbrechnungsTyp | DAV_PKV_VS_ERP_AbrechnungsTyp | active | | | | |
| de.abda.erezeptabgabedatenpkv | R4 | http://fhir.abda.de/eRezeptAbgabedaten/ValueSet/DAV-PKV-VS-ERP-ZusatzattributSchluesselAutidemAustausch | DAV_PKV_VS_ERP_ZusatzattributSchluesselAutidemAustausch | active | | | | |
| de.abda.erezeptabgabedatenpkv | R4 | http://fhir.abda.de/eRezeptAbgabedaten/ValueSet/DAV-PKV-VS-ERP-ZusatzdatenEinheitFaktorkennzeichen | DAV_PKV_VS_ERP_ZusatzdatenEinheitFaktorkennzeichen | active | | | | |
| ch.fhir.ig.ch-atc | R4 | AccessAuditTrailEventType | AccessAuditTrailEventType | draft | 2018-05 | ch | hl7 | oid |
| ch.fhir.ig.ch-atc | R4 | DocumentAuditEventType | DocumentAuditEventType | draft | 2018-05 | ch | hl7 | oid |
| ch.fhir.ig.ch-atc | R4 | EprParticipant | EprParticipant | draft | 2018-05 | ch | hl7 | oid |
| ch.fhir.ig.ch-atc | R4 | HpdAuditEventType | HpdAuditEventType | draft | 2022-06 | ch | hl7 | oid |
| ch.fhir.ig.ch-atc | R4 | PolicyAuditEventType | PolicyAuditEventType | draft | 2018-05 | ch | hl7 | oid |
| hl7.fhir.us.immds | R4 | ForecastReason | Forecast Reason | active | 2021-06 | us | hl7 | fhir |
| hl7.fhir.us.immds | R4 | ForecastStatus | Forecast Status | active | 2021-06 | us | hl7 | fhir |
| hl7.fhir.us.immds | R4 | StatusReason | Evaluation Status Reason | active | 2021-06 | us | hl7 | fhir |
| hl7.fhir.us.immds | R4 | targetDisease | Vaccine Target Disease | active | 2021-06 | us | hl7 | sct |
| de.thieme-compliance.anamnese | R4 | https://thieme-compliance.de/fhir/ValueSet/ConsentTags | Tags für FHIR-Ressourcen | draft | | | | |
| de.thieme-compliance.anamnese | R4 | https://thieme-compliance.de/fhir/ValueSet/SortOrder | Sortierreihenfolgen | draft | | | | |
| de.thieme-compliance.anamnese | R4 | https://thieme-compliance.de/fhir/ValueSet/UiWidgets | UiWidgets | draft | 2023-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/BiobankCapabilities | Biobank Capabilities | active | 2020-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/CollectionType | Collection Type | active | 2020-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/DataCategory | Data Category | active | 2020-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/OtherSampleDiagnosis | other sample diagnosis | active | 2020-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/QualityStandard | Quality Standard | active | 2020-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/ResourceType | Resource Type | active | 2020-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/SampleMaterialType | Sample Material Type | active | 2020-05 | | | |
| de.bbmri.fhir | R4 | https://fhir.bbmri.de/ValueSet/StorageTemperature | Storage Temperature | active | 2020-05 | | | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.1280649 | Sneezing and Itching Grouping | active | 2017-06 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.15972546 | Conditions Indicating Appropriate Sinonasal Imaging | active | 2017-06 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16432390 | Cerumen Impaction | active | 2017-06 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16929355 | Allergic Rhinitis Grouping | active | 2017-06 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.18316962 | Severe Asthma | active | 2017-06 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.19613338 | Immunoglobulin G Testing Grouping | active | 2022-03 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.23618223 | Hearing Aids Grouping | active | 2017-06 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.24927846 | Specific IgE testing | active | 2017-06 | us | | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.26050446 | Ear Surgery Affecting the Tympanic Membrane | active | 2017-06 | us | | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.26878039 | Specific IgE Testing | active | 2022-03 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.29996863 | Immunoglobulin G testing | active | 2017-06 | us | | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.4352590 | Benign Prostatic Hyperplasia | active | 2017-08 | us | | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.8867.26816.649902 | Office or Outpatient Encounter | active | 2017-07 | us | | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45 | Comfort Measures | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 | Selected non pharmaceutical therapies for moderate to severe chronic pain | active | 2015-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3 | selected first line medications for pain control | active | 2015-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3 | selected muscle relaxants for pain control | active | 2015-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3 | Selected topical agents for pain control | active | 2015-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2 | selected non opioids for moderate to severe pain | active | 2015-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2 | Selected opioids for moderate to severe pain | active | 2015-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1 | pain medication action plan | active | 2015-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1 | Selected urine drug screens for opioids indicating testing is complete | active | 2015-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 | selected follow up visit intervals for opioid monitoring | active | 2015-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2 | Selected urine screening for patients receiving opioid therapy | active | 2015-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1 | Opioids used for pain control | active | 2015-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.2 | All prescribable opioids used for pain control including Inactive Medications | active | 2015-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.1 | malignant neoplasms and cancer pain | active | 2015-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.2 | malignant neoplasms and cancer pain | active | 2015-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7 | malignant neoplasms and cancer pain | active | 2015-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9 | malignancy or cancer related pain | active | 2015-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150 | Cerumen on Otoscopy | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151 | Cerumen on Otoscopy | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152 | Cerumen on Otoscopy | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172 | Hearing Loss | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173 | Hearing Loss | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174 | Hearing Loss | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175 | Tinnitus | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176 | Tinnitus | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177 | Tinnitus | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178 | Ear Congestion | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179 | Ear Pruritus | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180 | Otalgia | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181 | Otalgia | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182 | Otalgia | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96 | Initial Encounter with Otolaryngologist or undefined clinician | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204 | Hearing Aids | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205 | Hearing Aids | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206 | Hearing Aids | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81 | Cerumen Impaction | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82 | Cerumen Impaction | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188 | Radiotherapy | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.189 | Radiotherapy | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190 | Radiotherapy | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191 | Head and Neck Anatomic Locations | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192 | Conditions Associated with Head and Neck Radiotherapy | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193 | Conditions Associated with Head and Neck Radiotherapy | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194 | Ear Canal Stenosis | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195 | Ear Canal Stenosis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196 | Ear Canal Stenosis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197 | Exostoses | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198 | Exostoses | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199 | Exostoses | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200 | Non intact Tympanic Membrane | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201 | Non Intact Tympanic Membrane | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202 | Non Intact Tympanic Membrane | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246 | Hearing Aids | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250 | DO NOT USE | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251 | Cerumenolytics | active | 2017-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252 | Irrigation | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253 | Irrigation | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288 | Otoscopy performed on exam | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291 | Otolaryngologist as a Clinician or Service | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123 | Cerumen Impaction | active | 2017-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275 | Dermatologic Diseases of the Ear | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20 | Keratoses Obturans | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221 | Tympanoplasty | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222 | Tympanoplasty | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223 | Myringoplasty | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224 | Myringoplasty | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225 | Mastoidectomy | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229 | Mastoidectomy | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227 | Ear Surgery, Other | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228 | Ear Surgery, Other | active | 2018-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334 | Sleep Apnea | active | 2018-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.335 | Sleep Apnea | active | 2018-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336 | Sleep Apnea | active | 2018-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237 | Allergic Rhinitis | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238 | Allergic Rhinitis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239 | Allergic Rhinitis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263 | Uncontrolled or severe asthma | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264 | Uncontrolled or severe asthma | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265 | Uncontrolled or severe asthma | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300 | Rhinosinusitis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301 | Rhinosinusitis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302 | Rhinosinusitis | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303 | Nasal Polyposis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304 | Nasal Polyposis | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305 | Nasal Polyposis | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306 | Suspected Nasal Neoplasm | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307 | Suspected Nasal Neoplasm | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308 | Suspected Nasal Neoplasm | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309 | Other sinus conditions potentially requiring imaging | active | 2017-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310 | Other sinus conditions potentially requiring imaging | active | 2017-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319 | Intranasal Antihistamines | active | 2017-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320 | Mast Cell Stabilizers | active | 2017-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321 | Ophthalmic Antihistamines | active | 2017-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215 | Sneezing as a finding | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216 | Sneezing as a Clinical Condition | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217 | Pruritus Unspecified or Other Location | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218 | Pruritus Unspecified or Other Location | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272 | Specific IgE Testing for Allergies | active | 2017-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273 | Immunoglobulin G Testing | active | 2017-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274 | Total IgE Testing | active | 2017-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290 | Clinicians who perform allergy testing | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279 | Radiography of face, head or neck | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315 | Intranasal Corticosteroids | active | 2017-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316 | Eustachian Tube Dysfunction | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317 | Eustachian Tube Dysfunction | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318 | Eustachian Tube Dysfunction | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287 | Oral Second Generation and Less Sedating Antihistamines | active | 2017-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266 | Leukotriene antagonist | active | 2017-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267 | Immunotherapy that is not Identified as Subcutaneous | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268 | Immunotherapy | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653 | Fidaxomicin | active | 2019-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654 | Proton Pump Inhibitors not including for H. pylori treatment | active | 2019-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655 | Clostridium difficile infection | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656 | Clostridium difficile infection | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657 | Clostridium difficile infection | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594 | Complete Blood Count (with Diff) | active | 2019-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662 | Metronidazole Systemic | active | 2019-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663 | Vancomycin non injectable | active | 2019-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665 | Creatinine | active | 2019-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722 | Ileus due to infection | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723 | Ileus due to infection | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724 | Ileus due to infection | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725 | Vomiting potentially due to CDI | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726 | Vomiting potentially due to CDI | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727 | Vomiting potentially due to CDI | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728 | Toxic Megacolon in adults | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729 | Toxic Megacolon in adults | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730 | Toxic Megacolon in adults | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731 | Abdominal Distension | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732 | Abdominal Distension | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688 | Septic Shock due to C. Diff | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689 | Septic Shock due to C. Diff | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690 | Septic Shock due to C. Diff | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658 | Antiperistaltic agents to avoid in C. diff | active | 2019-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734 | Systemic Antimicrobial Medications not used for CDI | active | 2019-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659 | Recurrent Clostridium difficile infection | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660 | History of CDI | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661 | Consult Infectious Disease | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691 | Abdominal Xrays for CDI | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692 | CT of abdomen with contrast for fulminant CDI | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693 | Surgical consult for CDI | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694 | Fecal microbiota transplantation | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645 | Hospitalist | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697 | Positive result indicator | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698 | Clostridium Difficile Test | active | 2019-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646 | Body Temperature | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647 | Body Temperature | active | 2019-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648 | Diarrhea Potentially due to CDI | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649 | Diarrhea Potentially due to CDI | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650 | Diarrhea Potentially due to CDI | active | 2019-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651 | Leukocyte count | active | 2019-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652 | Inpatient Setting | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1 | ONC Administrative Sex | active | 2015-03 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1 | Substance Reactant for Intolerance | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2 | Clinical Substance | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.4 | Medication Clinical Drug | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.5 | Medication Clinical Brand specific Drug | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6 | CVX Vaccines Administered Vaccine Set | active | 2025-04 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.7 | Clinical Drug Ingredient | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.8 | Vaccine Clinical Drug | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.240 | SNOMED CT CORE Problem List | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98 | Route of Administration | active | 2019-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.101 | Gender Identity USCDI core | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.102 | Unknown or did not answer | active | 2021-10 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.103 | Other or unknown or refused to answer | active | 2021-11 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12 | Low Molecular Weight Heparin for VTE prophylaxis ingredient specific | active | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.120 | Patient Sex for Quality Measurement | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.121 | Federal Administrative Sex | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.14 | Published test VS | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.24 | Birth Sex | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.30 | AdministrationUnitDoseForm | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.33 | Sexual Orientation | active | 2021-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.40 | MDP Test Intensional | active | 2019-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.41 | MDP Test HL7 Intensional | active | 2019-01 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.46 | Device Magnetic resonance (MR) Safety | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.47 | Device Latex Safety | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.48 | Implantable Device Status | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.56 | Medical Reason Not Done SCT | active | 2019-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.119 | Phototherapy | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.120 | Phototherapy | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.121 | Phototherapy | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.122 | Neonatal Jaundice | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.123 | Neonatal Jaundice | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124 | Neonatal Jaundice | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125 | Maternal Drug Use | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126 | Maternal Drug Use | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127 | Maternal Drug Use | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.128 | Fetal Conditions | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129 | Fetal Conditions | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130 | Fetal Conditions | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.131 | Congenital Malformations | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132 | Congenital Malformations | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133 | Congenital Malformations | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.134 | Social Indications | active | 2024-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135 | Social Indications | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136 | Social Indications | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.137 | Neonatal Severe Birth Trauma | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138 | Neonatal Severe Birth Trauma | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139 | Neonatal Severe Birth Trauma | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.140 | Neonatal Severe Hypoxia or Asphyxia | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141 | Neonatal Severe Hypoxia or Asphyxia | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142 | Neonatal Severe Hypoxia or Asphyxia | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.143 | Neonatal Severe Shock and Resuscitation | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144 | Neonatal Severe Shock and Resuscitation | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145 | Neonatal Severe Shock and Resuscitation | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.146 | Neonatal Severe Respiratory Complications | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147 | Neonatal Severe Respiratory Complications | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148 | Neonatal Severe Respiratory Complications | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.149 | Neonatal Severe Infection | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150 | Neonatal Severe Infection | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151 | Neonatal Severe Infection | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.152 | Neonatal Severe Neurological Complications | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153 | Neonatal Severe Neurological Complications | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154 | Neonatal Severe Neurological Complications | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.155 | Neonatal Severe Shock and Resuscitation Procedures | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156 | Neonatal Severe Shock and Resuscitation Procedures | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157 | Neonatal Severe Shock and Resuscitation Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.158 | Neonatal Severe Respiratory Procedures | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159 | Neonatal Severe Respiratory Procedures | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160 | Neonatal Severe Respiratory Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.161 | Neonatal Severe Neurological Procedures | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162 | Neonatal Severe Neurological Procedures | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163 | Neonatal Severe Neurological Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.164 | Neonatal Severe Septicemia | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165 | Neonatal Severe Septicemia | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166 | Neonatal Severe Septicemia | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.167 | Neonatal Moderate Birth Trauma | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168 | Neonatal Moderate Birth Trauma | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169 | Neonatal Moderate Birth Trauma | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.170 | Neonatal Moderate Respiratory Complications | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171 | Neonatal Moderate Respiratory Complications | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172 | Neonatal Moderate Respiratory Complications | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.173 | Neonatal Moderate Respiratory Complications Procedures | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174 | Neonatal Moderate Respiratory Complications Procedures | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175 | Neonatal Moderate Respiratory Complications Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.176 | Neonatal Moderate Birth Trauma with LOS | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177 | Neonatal Moderate Birth Trauma with LOS | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178 | Neonatal Moderate Birth Trauma with LOS | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.179 | Neonatal Moderate Respiratory Complications with LOS | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180 | Neonatal Moderate Respiratory Complications with LOS | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181 | Neonatal Moderate Respiratory Complications with LOS | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.182 | Moderate Neurological Complications with LOS Procedures | active | 2019-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.183 | Neonatal Moderate Neurological Complications with LOS Procedures | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.184 | Neonatal Moderate Neurological Complications with LOS Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.185 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2024-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.188 | Single Liveborn Newborn Vaginal | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189 | Single Liveborn Newborn Vaginal | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190 | Single Liveborn Newborn Vaginal | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.191 | Single Liveborn Newborn Cesarean | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192 | Single Liveborn Newborn Cesarean | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193 | Single Liveborn Newborn Cesarean | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.194 | Birth Weight | active | 2021-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.195 | Neonatal Moderate Infection with LOS | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196 | Neonatal Moderate Infection with LOS | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197 | Neonatal Moderate Infection with LOS | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.203 | Neonatal Intensive Care Unit | active | 2022-02 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.204 | Intensive Care Unit | active | 2021-02 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205 | Neonatal Intensive Care Unit | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206 | Intensive Care Unit | active | 2021-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.208 | Blood Transfusion Administration | active | 2024-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209 | Blood Transfusion Administration | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213 | Blood Transfusion | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.214 | Acute Respiratory Distress Syndrome | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.217 | Amniotic Fluid Embolism | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.219 | Aortic Aneurysm | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220 | Aortic Aneurysm | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.221 | Cardiac Arrest Ventricular Fibrillation | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.223 | Disseminated Intravascular Coagulation | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.225 | Eclampsia | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.227 | Heart Failure Cardiac Arrest Related to Procedure or Surgery | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228 | Heart Failure Cardiac Arrest Related to Procedure or Surgery | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.229 | Puerperal Cerebrovascular Disorder | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.231 | Pulmonary Edema | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.233 | Acute Heart Failure | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.235 | Severe Anesthesia Complications | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.237 | Sepsis | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.239 | Shock | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24 | Blood Transfusion Administration | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.241 | Sickle Cell Disease with Crisis | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.243 | Air and Thrombotic Embolism | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.245 | Blood Transfusion | active | 2024-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246 | Blood Transfusion | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.247 | Conversion of Cardiac Rhythm | active | 2022-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248 | Conversion of Cardiac Rhythm | active | 2021-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.249 | Hysterectomy | active | 2024-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250 | Hysterectomy | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.251 | Tracheostomy | active | 2022-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252 | Tracheostomy | active | 2021-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.253 | Ventilation | active | 2022-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254 | Ventilation | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.255 | Severe Maternal Morbidity Diagnoses | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256 | Severe Maternal Morbidity Procedures | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.267 | Gestational Diabetes | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.269 | Gestational Diabetes | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.271 | HIV in Pregnancy Childbirth and Puerperium | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.272 | HIV in Pregnancy Childbirth and Puerperium | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.274 | Preexisting Diabetes | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.275 | Preexisting Diabetes | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.277 | Previous Cesarean | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.278 | Previous Cesarean | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.279 | Pulmonary Hypertension | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.281 | Pulmonary Hypertension | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.282 | Multiple Pregnancy | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.284 | Multiple Pregnancy | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.286 | Bleeding Disorder | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287 | Bleeding Disorder | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.289 | Morbid or Severe Obesity | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.290 | Morbid or Severe Obesity | active | 2022-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.291 | Economic Housing Instability | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.292 | Economic Housing Instability | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.295 | Thyrotoxicosis | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.296 | Thyrotoxicosis | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.297 | Preterm Birth | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.299 | Preterm Birth | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.300 | Placenta Accreta | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.302 | Placenta Accreta | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.303 | Placental Abruption | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.305 | Placental Abruption | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.306 | Neuromuscular Disease | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.308 | Neuromuscular Disease | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.309 | Autoimmune Disease | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.311 | Autoimmune Disease | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.312 | Mental Health Disorder | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.314 | Mental Health Disorder | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.315 | Bariatric Surgery | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.317 | Bariatric Surgery | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.318 | Substance Abuse | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.320 | Substance Abuse | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.321 | Anemia | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.323 | Anemia | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.324 | Severe Preeclampsia | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.326 | Mild or Moderate Preeclampsia | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.327 | Severe Preeclampsia | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.329 | Mild or Moderate Preeclampsia | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.330 | Hypertension | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.332 | Hypertension | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.333 | Renal Disease | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.335 | Renal Disease | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.336 | Gastrointestinal Disease | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.338 | Gastrointestinal Disease | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.339 | Cardiac Disease | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.341 | Cardiac Disease | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344 | Aortic Aneurysm | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357 | Conversion of Cardiac Rhythm | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358 | Hysterectomy | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359 | Tracheostomy | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360 | Ventilation | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.361 | Venous Thromboembolism in Pregnancy | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.363 | Venous Thromboembolism in Pregnancy | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.364 | Long Term Anticoagulant Use | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.366 | Long Term Anticoagulant Use | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368 | Preadmission Observation Undelivered Mother | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369 | ED Visit and OB Triage | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.370 | Present on Admission is No or Unable To Determine | active | 2022-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.371 | COVID 19 Confirmed | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372 | COVID 19 Confirmed | active | 2022-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373 | COVID 19 Confirmed | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.374 | Respiratory Conditions Related to COVID 19 | active | 2022-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375 | Respiratory Conditions Related to COVID 19 | active | 2022-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376 | Respiratory Conditions Related to COVID 19 | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.377 | Respiratory Support Procedures | active | 2023-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378 | Respiratory Support Procedures | active | 2022-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379 | Respiratory Support Procedures Related to COVID 19 | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.387 | Placenta Increta or Percreta | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.388 | Placenta Increta or Percreta | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67 | Other Health Care Facility | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10 | Non essential Hypertension SNOMEDCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102 | Suicide Attempt | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.11 | Cirrhosis ICD9CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.12 | Cirrhosis ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14 | Cirrhosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151 | Polycystic Ovary Syndrome | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16 | Low Intensity Statin Therapy/Branded | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17 | Moderate Intensity Statin Therapy/Branded | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18 | High Intensity Statin Therapy/Branded | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.21 | ALT | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230 | Gestational Diabetes SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.231 | Gestational Diabetes ICD10CM | active | 2023-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233 | All Results of High Risk HPV Test | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234 | High Risk HPV Positive Results | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248 | Suicide Attempt SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26 | Nonopioid pain medications | active | 2023-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263 | High Risk Positive HPV Results Without HPV16 or HPV18 | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.265 | CDS Pregnancy Intensional | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267 | CDS Rhabdomyolysis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268 | HPV Negative Results | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.27 | Non pharmacologic treatments for chronic pain ICD10PCS | active | 2024-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.28 | Urine drug screen for pain management | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29 | Non pharmacologic treatments for chronic pain SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.292 | Non pharmacologic treatments for chronic pain NCI | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296 | SCT Findings 202209 | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.298 | Cervical Cytology Test | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.299 | HPV 16 Tests | active | 2023-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.300 | HPV 18 Tests | active | 2023-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303 | Statin Combinations | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.305 | Counseling for Physical Activity CPT | active | 2024-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.306 | Counseling for Physical Activity ICD10CM | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307 | Counseling for Physical Activity CDS | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk | active | 2024-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309 | SCT Findings 202309 | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311 | SCT Procedures 202209 | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312 | SCT Procedures 202309 | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319 | Steward Transfer Test | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320 | Opioids ATCPROD N02A | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.322 | Test 123 | active | 2025-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34 | Opioid pain medications | active | 2023-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36 | Non pharmacologic treatments for chronic pain | active | 2023-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.40 | Suicide attempt | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42 | Naloxone and Nalmefene medications | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43 | Benzodiazepine medications | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44 | Stool softeners and laxatives | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.47 | Anxiety | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48 | Anxiety | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.50 | Sleep disordered breathing | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51 | Sleep disordered breathing | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52 | Anxiety | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53 | Sleep disordered breathing | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54 | Adjuvant pain medications | active | 2023-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55 | Risk assessments relevant to pain management | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.6 | Non essential Hypertension ICD9CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.7 | Non essential Hypertension ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79 | Behavioral Counseling for Nutrition and Activity Referral | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85 | Impaired Glucose Tolerance | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.87 | Fasting Plasma Glucose | active | 2023-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.88 | Waist Circumference | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9 | Hypertension | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90 | Gestational Diabetes | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.92 | First Degree Family Member | active | 2024-06 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.94 | Glucose Tolerance Test Results | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.99 | Gestational Diabetes | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.460 | Cluster Headache (ICD10CM) | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.461 | Cluster Headache (ICD9CM) | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464 | Cluster Headache | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.467 | Medication Therapy for Cluster Headache (RXNORM) | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555 | Patient Declines Treatment for Cluster Headache (SNOMEDCT) | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558 | Acute Cluster Headache Medication (RXNORM) | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559 | Long Term Preventive Medication for Cluster Headache | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561 | Oral Steroid for Cluster Headache | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569 | Migraine Preventive Medication | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601 | Acute Migraine Attack Medication | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605 | NSAID OTC Migraine Attack Medication | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.606 | NSAID Prescribable Migraine Attack Medication | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.640 | Neurologic Disorders | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641 | Neuromodulation for migraine | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642 | No pain with headache | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643 | Antiplatelets | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644 | Anticoagulants | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645 | Statin Medications | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646 | Anxiety Disorders (ICD10 and SNOMED) | active | 2023-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648 | Depression Diagnosis (ICD10 and SNOMED) | active | 2023-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) | active | 2023-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651 | Galcanezumab (RxNorm) | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652 | Lithium (RxNorm) | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653 | Verapamil | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654 | Long term preventive medications for cluster headache | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655 | Short term preventive medication for cluster headache | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656 | Zolmitriptan | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657 | Sumatriptan | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658 | Dihydroergotamine | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659 | Acute cluster headache medication | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.661 | Short term preventive treatment for cluster headache | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.663 | Migraine diagnosis (ICD) | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.664 | Prescribable NSAIDs and Acute Migraine Attack Medication | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.103 | Abnormal Presentation | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.114 | Hematocrit Lab Test | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.117 | Potassium Lab Test | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.119 | Sodium Lab Test | active | 2022-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.127 | Platelet Count Lab Test | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.129 | White Blood Cells Count Lab Test | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.130 | Respiratory Rate | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.134 | Glucose Lab Test | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.139 | Bicarbonate Lab Test | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.151 | Oxygen Saturation by Pulse Oximetry | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.152 | Body Temperature | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.159 | Body Weight | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.163 | Systolic Blood Pressure | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.26 | Estimated Gestational Age at Delivery | active | 2021-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.38 | General Or Neuraxial Anesthesia | active | 2021-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39 | Low Dose Unfractionated Heparin for VTE Prophylaxis | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41 | Glycoprotein IIb IIIa Inhibitors | active | 2023-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55 | Oxytocin | active | 2021-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56 | Dinoprostone | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.58 | Delivery Procedures | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59 | Delivery Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.66 | PCI | active | 2017-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67 | PCI | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.68 | Endotracheal Intubation | active | 2018-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.98 | Delivery of Singleton | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241 | Schedule II, III and IV Opioid Medications | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.242 | Opioid Use Disorder | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.265 | Inpatient, Emergency, and Observation Locations | active | 2022-07 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269 | Medications for Opioid Use Disorder (MOUD) | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.274 | NHSN Inpatient Encounter Class Codes | active | 2024-04 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.277 | Emergency Department Location | active | 2024-04 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.278 | Emergency Department Treatment Location | active | 2025-02 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279 | Triage | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283 | Emergency Department Location | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284 | Emergency Department Location | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286 | Decision to Transfer | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.35 | Healthcare Agent or Proxy Choices | active | 2022-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10 | Breastfeeding | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia | active | 2021-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis | active | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107 | Low Intensity Statin Therapy | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12 | Liver Disease | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.19 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.22 | Liver Disease ICD9 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37 | Stable and Unstable Angina | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.39 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.41 | Ischemic Heart Disease or Related Diagnoses | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42 | Liver Disease | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.43 | Liver Disease | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.501 | Overweight or Obese | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502 | Overweight or Obese | active | 2018-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.512 | Elevated Blood Pressure Reading | active | 2019-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension | active | 2019-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.515 | Bariatric Procedures | active | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.517 | Age related macular degeneration intermediate dry | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.518 | Ophthalmologist visit | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.519 | Posterior vitreous detachment (PVD) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.521 | Ophthalmoscopic exam | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.523 | Opthalmoscopic exams with Scleral Depression | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.526 | Retina Ultrasound | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.529 | Vitreous hemorrhage | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.536 | Macula examination | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.539 | Fluorescein angiography | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.541 | Optical coherence tomography (OCT) | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.542 | Intravitreal injection | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543 | Bevacizumab injection | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.544 | Ranibizumab injection | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.545 | Aflibercept injection | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.552 | Uveitis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553 | Uveitis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.554 | Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.555 | Macular edema | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.556 | Corticosteroids for Injection | active | 2024-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557 | Corticosteroids for Injection | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560 | Tonometry | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.561 | Intraocular pressure | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.571 | Retinal Vein Occlusion Related Macular Edema | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage | active | 2020-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582 | Corticosteroids for Injection | active | 2020-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.583 | Endophthalmitis in the Right Eye | active | 2020-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.584 | Endophthalmitis in the Left Eye | active | 2020-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.585 | Panophthalmitis in the Right Eye | active | 2020-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.586 | Panophthalmitis in the Left Eye | active | 2020-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587 | Lost to follow up | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588 | Uveitis | active | 2020-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.610 | Scleral depressed exam | active | 2020-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615 | Physical Disability | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616 | Financial difficulty | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings | active | 2020-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.629 | Post operative follow up | active | 2020-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.67 | Breastfeeding | active | 2017-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73 | Breastfeeding | active | 2021-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.89 | Rhabdomyolysis | active | 2017-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care | active | 2019-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.91 | Familial Hypercholesterolemia | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.93 | Hypercholesterolemia ICD 9 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.97 | High Intensity Statin Therapy | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.98 | Moderate Intensity Statin Therapy | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.51 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.52 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.10 | ARBs (Angiotensin Receptor Blockers) | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1000 | OIA_V2_GLP1s_RxNorms | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1001 | OIA_V2_PCSK9s_RxNorms | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1002 | OIA_RFs_Secondary_Prevention_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1004 | OIA_RFs_Secondary_Prevention_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1006 | OIA_Asthma_COPD_Combo_Meds | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1007 | OIA_Asthma_COPD_Combo_Meds_SABA_SAMA | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1008 | OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1012 | PAE Conditions Short | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1016 | OIA_TEST_VS | active | 2025-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1017 | Triptan Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1018 | NSAID Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1019 | Statin Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1021 | Penicillin Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1022 | Macrolide Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1023 | Quinolone Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1025 | Beta blocker Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026 | ACE inhibitor Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1027 | ARB Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1028 | Sulfonylurea Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1030 | DPP4i Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1031 | GLP1RA Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1032 | Beta blocker allergy intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033 | SGLT2i Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1034 | MRA Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1036 | Meglitinide Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1037 | Alpha glucosidase inhibitor Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1038 | TZD Allergy NDFRT | active | 2025-04 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1041 | Hemoglobin | active | 2025-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1042 | Hematocrit | active | 2025-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043 | Anemia for Erythropoesis Simulating Agents I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1044 | Anemia for Erythropoesis Simulating Agents SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1045 | Anemia for Erythropoesis Simulating Agents | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1046 | AZT Meds | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1047 | Ferritin | active | 2025-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1048 | Knee pain I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1049 | Knee pain SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1050 | Knee pain | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1051 | Knee decreased ROM SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1052 | Knee effusion I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1054 | Knee effusion | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1055 | Knee crepitus SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1056 | OIA_Antiemetics | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1057 | OIA_PDE5is | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1058 | OIA_Vitamins | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1059 | OIA_Plavix | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1061 | OIA_Oral_Contraceptives | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1063 | OIA_Topical_Steroids | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1064 | OIA_Cough_Cold_Meds | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1065 | Antiperspirant aluminum salts | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1066 | Antiperspirant anticholinergics | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1067 | Antieplieptic medications | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1068 | Antidepressant medications | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1069 | Urinary incontinence SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1070 | Urinary incontinence I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1071 | Urinary incontinence | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1073 | Hemifacial spasm SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1074 | Hemifacial spasm I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1075 | Hemifacial spasm | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1076 | Spasmodic dysphonia SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1077 | Physical therapy procedure SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1078 | Occupational therapy SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1079 | Hyperhidrosis SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1080 | Hyperhidrosis I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1081 | Hyperhidrosis | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1082 | Tic disorder I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1083 | Tic disorder SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1084 | Tic disorder | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1085 | Esophageal achalasia SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1086 | Esophageal achalasia I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1087 | Esophageal achalasia | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1088 | ET propanolol or primidone | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1089 | ET topiramate alprazolam or gabapentin | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.109 | CKD stage4above I10 | active | 2024-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1090 | Blephraospasm SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1091 | Blepharospasm I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1092 | Blepharospasm | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1093 | Strabismus SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1094 | Strabismus I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1095 | Strabismus | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1096 | Overactive bladder SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1097 | Overactive bladder I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1098 | Overactive bladder | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1099 | Movement disorders SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110 | CKD stage4above SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1100 | Movement disorders I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1101 | Movement disorders | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1102 | Lateral epicondylitis SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1103 | Lateral epicondyltisis I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1104 | Lateral epicondylitis | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1105 | Plantar fasciitis SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1106 | Plantar fasciitis I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1107 | Plantar fasciitits | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1108 | Cardiac CT SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1109 | Cardiac CT CPT | active | 2025-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111 | CKD stage4above | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1111 | Cardiac CT | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1112 | Cardiac MRI SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1113 | Cardiac MRI CPT | active | 2025-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1114 | Cardiac MRI | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1115 | CT Angiography of Coronary Artery SCT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1116 | CT Angiography of Coronary Artery CPT | active | 2025-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1117 | CT Angiography of Coronary Artery | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.112 | Chronic kidney disease I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113 | Chronic kidney disease SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.116 | DigTx Cognitive Impairment I10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117 | DigTx Cognitive Impairment SCT | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120 | Diabetic ketoacidosis SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121 | Diabetic ketoacidosis | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124 | DKD | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.146 | Long Acting Muscarinic Antagonists (LAMA) | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147 | HFrEF SCT | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.148 | HFrEF I10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.15 | Kidney tansplant | active | 2023-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.150 | History of Hypoglycemia I10 | active | 2024-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151 | History of Hypoglycemia SCD | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.153 | Hyperlipidemia | active | 2024-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.159 | conditions_COPD I10 | active | 2024-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168 | medications_COPD | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.173 | Asthma I10 | active | 2025-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.175 | Asthma | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184 | DigTx Virtual Reality Contraindications Visual Impairment | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.186 | Beta blockers GDMT for heart failure | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.188 | medications_heart failure | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189 | SGLT2i | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.193 | relatedconditions_COPD I10 | active | 2023-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.197 | Blood (Serum and Plasma) Potassium | active | 2023-11 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.202 | Serum Creatinine | active | 2024-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21 | Thoracic aorta disease | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214 | Type 1 Diabetes Mellitus SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.224 | Systolic Heart Failure I10 | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.226 | Systolic Heart Failure | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.238 | MRA mineralocorticoid receptor antagonists | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244 | MRA Mineralocorticoid Receptor Antagonist Allergy | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.252 | relatedconditions_Heart failure I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260 | UACR SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.263 | Pregnancy I10 | active | 2023-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281 | Statins Allergy SCT | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.282 | Statin Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.292 | Metabolic syndrome I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.3 | Delivery I10 | active | 2024-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.314 | relatedconditions_hyperlipidemia I10 | active | 2023-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.322 | Angina I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.325 | Tachyarrhythmia I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.337 | Migraine I10 | active | 2023-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.34 | Blood pressure panel | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.35 | Systolic Blood Pressure | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.350 | Coronary artery disease I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.367 | Trandolapril | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.369 | Candesartan | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37 | relatedconditions_hypertension SCT | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.377 | Valsartan | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.38 | relatedconditions_hypertension I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.397 | eGFR | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.409 | Hypertension I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.412 | Statin Moderate Intensity | active | 2024-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.415 | LDL Cholesterol | active | 2024-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.43 | Urinalysis | active | 2024-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.434 | Insulin | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.437 | TZD Thiazolidinediones | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.438 | medications_T2DM | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.439 | relatedconditions_T2DM I10 | active | 2024-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440 | relatedconditions_T2DM SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.442 | Blood Glucose | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.45 | ACE inhibitor allergy RXNORM | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.455 | Metabolic acidosis I10 | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459 | Liver cancer | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47 | ACE inhibitor allergy SCT | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.473 | Tetanus toxoid, diphtheria (Td) Vaccine | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474 | Allergy to Tdap Vaccine | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475 | Allergy to Td Vaccine | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478 | Allergy to HPV Vaccine | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.481 | medications_hypertension | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492 | Inhaled Corticosteroids Allergy | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498 | Metformin AllergyIntolerance SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5 | Delivery - Procedure | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.508 | Abdominal aortic imaging CPT | active | 2023-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516 | Allergy to Herpes Zoster Vaccine SCT | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.517 | Hemoglobin A1c | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.518 | Drug hypersensitivity I10 | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519 | Drug hypersensitivity SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520 | Drug hypersensitivity | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.521 | Diabetic Kidney Disease I10 | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.523 | Diabetic kidney disease | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524 | Chronic Hepatitis SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525 | Chronic Hepatitis | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.527 | OCS_Prednisone | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.528 | High Dose Non Combo ICS Adult | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.529 | Medium Dose Non Combo Asthma ICS Adult | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.530 | Low Dose Non Combo ICS | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.531 | Anti IgE Medications | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532 | IL5 Antagonists | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.533 | Mast cell stabilizers for asthma | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.534 | Vasospastic disease I10 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535 | Vasospastic disease SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536 | Vasospastic disease | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.537 | Hemiplegic and basilar migraine I10 | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538 | Hemiplegic and basilar migraine SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539 | Hemiplegic and basilar migraine | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.540 | Peptic ulcer disease I10 | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541 | Peptic ulcer disease SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542 | Peptic ulcer disease | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.544 | Bleeding disorder I10 | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545 | Bleeding disorder SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548 | Electronic cigarettes or Vaping | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549 | Bleeding disorder | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.551 | Heart Rate | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.552 | Triptans | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.553 | CGRP receptor antagonists | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554 | Ditans | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.555 | Ergots | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.556 | Migraine specific NSAIDs | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.557 | OTC migraine analgesics | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.558 | Butalbital analgesics | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.559 | medications_migraine_acute | active | 2023-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.560 | relatedconditions_migraine I10 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561 | conditions_migraine | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562 | relatedconditions_migraine SCT | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563 | relatedconditions_migraine | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564 | Triptan Allergy Intolerance SCT | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565 | Triptan Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566 | Ischemic bowel disease SCT | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.567 | Ischemic bowel disease I10 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568 | Ischemic bowel disease | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.569 | Allergen Immunotherapy | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570 | Allergy to house dust mites SCT | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.571 | Allergy to house dust mites I10 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572 | Allergy to house dust mites | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.573 | conditions_hyperlipidemia I10 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574 | conditions_hyperlipidemia SCT | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575 | conditions_hyperlipidemia | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.578 | PIM_Schedule V | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.580 | PIM_Acarbose | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581 | PIM_Avandamet | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.582 | PIM_Dulaglutide | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.583 | PIM_Glimepiride | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.585 | PIM_Glucophage | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.587 | PIM_Glucovance | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.588 | Glyburide PIM | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.590 | Alpha glucosidase inhibitors | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.592 | Azotemia | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594 | Intolerance to ARB SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.595 | ICS Low | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.596 | ICS Medium | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.597 | ICS High | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.598 | Low Dose ICS Formoterol | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.599 | PIM_Vitamin B12 Level_LOINC_CPT | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.600 | PIM_Vitamin B12 Level_LOINC | active | 2023-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.601 | PIM_Vitamin B12 Level_CPT | active | 2023-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.604 | PIM_Glyburide | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.605 | PIM_Pioglitazone | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.606 | PIM_Semaglutide | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.607 | PIM_Linagliptin | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.609 | Macrolide_Azithromycin | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.61 | Secondary antihypertensives | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.610 | Long Acting Beta Agonists (LABA) Non_Formoterol | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.611 | relatedconditions_Asthma I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612 | Wolff Parkinson White SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.613 | Wolff Parkinson White I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614 | Wolff Parkinson White | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.615 | medications_Asthma | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.617 | HighICS_LABA_NonFormoterol | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618 | relatedconditions_Asthma SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.619 | ICS_LABA_LAMA | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.620 | Low Dose ICS_LABA_Non Formoterol | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.621 | Medium ICS_LABA Non Formoterol | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622 | relatedconditions_Asthma | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623 | LAMA Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624 | LABA Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625 | BetaBlock NonCS Secondary Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626 | Eplerenone Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627 | Spironolactone Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628 | SGLT2 Inhibitors Allergy SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.629 | PIM_Refill_Request_Antilipemics_LFTs | active | 2023-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631 | Pneumococcal Vaccine Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632 | Meglitinides Allergy SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633 | DPP4i Allergy SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635 | Alpha_glucosidase inhibitors allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636 | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637 | Insulins Allergy SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638 | TZD Allergy SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639 | T2DM_Medications Allergy SCT | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.642 | T2DM_Medications Allergy RXNORM | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656 | MRA Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.667 | Herpes Zoster Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.672 | LABA(Formoterol only) | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.674 | PIM_Tirzepatide | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.676 | PIM_Diabetes_Testing_Supplies | active | 2025-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.677 | PIM_H2_Antagonists | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.678 | SGLT2i DM CKD | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679 | SGLT2i DM ASCVD | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680 | GLP1RA DM ASCVD | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.683 | OIA_Gout_Medications | active | 2025-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.684 | GlumetzaSubstitution | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.685 | MetforminER500mg | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.686 | PIM_Metformin | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.687 | PIM_Glipizide | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.689 | PIM_Glipizide_Glyburide_Glimepiride | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.690 | PIM_Insulin_Meglitinides | active | 2023-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691 | PIM_Glyxambi | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.692 | PIM_Farxiga | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.693 | PIM_Invokana | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.694 | PIM_Jardiance | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695 | PIM_Invokana_Jardiance | active | 2023-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696 | Reclast | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.697 | LAMA_LABA Combination 1 Inhaler | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.698 | PIM_Contraceptives | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.699 | Selected Oral Antiemetics for Migraine | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.700 | PIM_DEXA_Scan | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.701 | PIM_DEXA_Scan_CPT_LOINC | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.702 | PIM_SSRIs | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.703 | PIM_SNRIs | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.704 | PIM_NRIs | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.705 | PIM_TCAs | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.706 | PIM_Citalopram | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.707 | PIM_Hydroxyzine | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.708 | PIM_Buspirone | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.709 | PIM_Bupropion | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.710 | PIM_Mirtazapine | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.711 | PIM_Trazodone | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.712 | PIM_IHD_CHD_CAD_ICD10 | active | 2023-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED | active | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.714 | PIM_Gabapentin | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.715 | PIM_Allergy_Nasal_Sprays | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.716 | PIM_Allergy_Oral_Meds | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.717 | PIM_Allergy_Nasal_Oral | active | 2023-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.719 | OCS_Prednisolone | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.72 | Inhaled corticosteroids (IC) | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.720 | COPD_Ofloxacin | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.721 | COPD_Ciprofloxacin | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.722 | COPD_Doxycycline | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT | active | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724 | Macrolide Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT | active | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT | active | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance | active | 2023-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT | active | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance | active | 2023-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.731 | Penicillin Allergy RXNORM | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT | active | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.734 | PIM_Metformin_Single_Ingredient_Only | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.735 | PIM_Metformin_Combo_Ingredient_Only | active | 2023-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.736 | Pneumonia I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738 | Pneumonia | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.739 | Pulmonary Embolism I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.744 | Influenza I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745 | Influenza SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.746 | Influenza (Tests for influenza A or B virus Antigen) | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747 | Influenza | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.748 | COVID 19 I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749 | COVID19 SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750 | COVID19 | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.752 | RSV I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753 | RSV SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754 | RSV | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.756 | Respiratory Rate LOINC | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757 | Respiratory Rate | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.758 | Acute Respiratory Failure I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.762 | Dyspnea I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763 | Dyspnea | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.764 | Confusion I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765 | Confusion SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766 | Confusion | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.768 | Drowsiness I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.769 | Drowsiness | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.770 | Cyanosis I10 | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.772 | Cyanosis | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.775 | Arterial oxygen saturation LOINC | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.779 | PIM_Potassium_Supplements | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.780 | PIM_PPIs | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.781 | PIM_Migraine_Medications_Abortive | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.782 | PIM_Migraine_Medications_Preventive | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.783 | PIM_Bisphosphonates | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.784 | PIM_BPH_Medications | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.785 | PIM_Thyroid_Replacement_Medications | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.786 | PIM_Overactive_Bladder_Medications | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.787 | PIM_Topical_Acne_Medications | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.788 | PIM_Antidepressant_Anxiolytic_Medications | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.789 | Simple Knee Pain I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.794 | Simple Right Knee Pain I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.795 | Simple Left Knee Pain I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.798 | Knee joint surgery CPT | active | 2024-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.800 | Knee joint surgery | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.801 | Knee Osteoarthritis I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.806 | Osteoarthritis of right knee I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.807 | Osteoarthritis of left knee I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.811 | Hip Osteoarthritis I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.813 | Hip joint surgery CPT | active | 2024-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.815 | Hip joint surgery | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.816 | Osteoarthritis of right hip I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.817 | Osteoarthritis of left hip I10 | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.822 | DigTx RelieVR inclusions I10 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.823 | Aminoglycosides | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.824 | Carbapenems | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.826 | Monobactams | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.827 | Penicillins | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.828 | Antimycobacterials | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.829 | Beta_lactamase | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.830 | Cyclic lipopeptides | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.831 | Lincosamides | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.832 | Macrolides | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.833 | Amphenicol | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.834 | Oxazolidinones | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.835 | Fluoroquinolones | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.836 | Sulfonamides | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.837 | Tetracyclines | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.838 | Phosphonics | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.839 | Pleuromutilin | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.840 | Streptogramins | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.841 | Lipoglycopeptides | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.842 | Nitroimidazoles | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.843 | PIM_Hyd_Bus_Mir_Tra | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.844 | Nitrofurans | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.845 | Rifamycins | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.846 | Glycylcycline | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.847 | Pyrimidines | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.849 | Antibiotics oral and parenteral | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.85 | PCSK9i | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.850 | Medications_hyperkalemia | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.852 | Hyperkalemia_ICD10 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.855 | Medications_Chronic Hyperkalemia | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.858 | PIM_Alpha_Blockers_2 | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.860 | PIM_Ambulatory_Visits_CPTs | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.863 | PIM_Thyroid_Stimulating_Hormone_(TSH) | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.864 | PIM_Triiodothyronine_(T3) | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.865 | PIM_Thyroxine_(T4) | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.866 | PIM_Magnesium_LOINC | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.867 | PIM_BMP_CMP_LOINC | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.868 | PIM_URIC_ACID_LOINC | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.869 | PIM_Migraine_Medications | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.870 | PIM_Triptans | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.871 | ICS_SABA Reliever | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.873 | PIM_Asthma_COPD_Meds | active | 2025-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.874 | PIM_Lipid_Panel_CPTs | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.875 | PIM_Hepatic_Function_Panel_CPTs | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876 | Alpha Glucosidase Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.877 | Inflammatory bowel disease I10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.878 | Inflammatory bowel disease SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.879 | Inflammatory bowel disease | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.88 | DEPRECATED Diabetes | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.880 | Gastrointestinal obstruction SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.881 | Gastrointestinal obstruction I10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.882 | Gastrointestinal obstruction | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883 | DPP4i Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.884 | Multiple endocrine neoplasia type 2 (MEN II) SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.885 | Multiple endocrine neoplasia type 2 (MEN II) I10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.886 | Multiple endocrine neoplasia type 2 (MEN II) | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.887 | Gastroparesis SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.888 | Gastroparesis I10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.889 | Gastroparesis | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890 | Meglitinide Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891 | Sulfonylurea Allergy Intolerance | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.892 | Peripheral edema I10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.893 | Peripheral edema SCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.894 | Peripheral edema | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895 | TZD Allergy Intolerance | active | 2025-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.896 | PIM_Beta_Blockers | active | 2024-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.897 | PIM_CCB_DHPs | active | 2024-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.898 | PIM_Loop_Diuretics | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.899 | PIM_Inhaled_Corticosteroids_(ICS) | active | 2025-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.9 | ACE inhibitors | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.90 | ASCVD I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.900 | PIM_Leukotrienes | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.901 | OIA_Asthma_COPD_Meds_Inhalers | active | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.902 | OIA_Asthma_COPD_Meds_Nebulizers | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.903 | OIA_Asthma_COPD_Meds_Oral | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.904 | OIA_GLP1_Injectables | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.905 | OIA_Insulin_Injectables | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.906 | OIA_Oral_Hypoglycemics | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.907 | OIA_DM1_DM2_Meds | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.908 | Medium Dose ICS Formoterol | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.909 | High Dose ICS Formoterol | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.910 | CKD stage5OrESRD I10 | active | 2024-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.914 | Anxiety_I10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.916 | Anxiety | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.918 | Stress_SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.919 | Stress_I10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.92 | ASCVD | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.920 | Stress | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.925 | PIM_CMP_CPTs | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.926 | Canagliflozin meds | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.927 | Empagliflozin meds | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.928 | Dapagliflozin meds | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.929 | Ertugliflozin meds | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.93 | Albuminuria I10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.930 | Dulaglutide meds | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931 | Liraglutide meds | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.932 | Semaglutide SC meds | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933 | T2DM meds benefitting ASCVD | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934 | T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.935 | T2DM meds benefitting CKD stage 5 | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.936 | T2DM meds benefitting HF with eGFR >= 20 mL/min | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.939 | Crohn disease I10 | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.940 | Crohn disease | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.942 | Celiac disease I10 | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.943 | Celiac disease | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.944 | OIA_Bisoprolol | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.945 | OIA_PVD_ICD10 | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.946 | Vibration Controlled Transient Elastography (VCTE) | active | 2024-12 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.947 | OIA_Antihypertensive_Medications | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.95 | Albuminuria | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.950 | OIA_CAD_ICD10 | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.951 | OIA_DM_ICD10 | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.952 | OIA_Creatinine_Levels_LOINC | active | 2024-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.959 | ACEi for HFrEF | active | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.96 | AlcoholicLiverDisease I10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.960 | ARB for HFrEF | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.961 | OIA_AntiHTN_Meds_Inclusion_List | active | 2024-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.962 | OIA_Thiazide_Diuretics | active | 2024-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.963 | OIA_RFs_ACS_ICD10 | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.964 | OIA_RFs_ACS_SNOMED | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.965 | OIA_RFs_ACS__ICD10_SNOMED | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.966 | OIA_Aortic_Calcifications_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.967 | OIA_Aortic_Calcifications_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.968 | OIA_Aortic_Calcifications_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.969 | OIA_Microalbumin | active | 2025-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.970 | OIA_LDL_Cholesterol | active | 2025-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.971 | Pioglitazone | active | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.972 | MASLD I10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.973 | MASLD SCT | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.974 | MASLD | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.975 | OIA_Sulfonylureas | active | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.976 | Ensifentrine | active | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.977 | Dupilumab | active | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.978 | OIA_RFs_ASCVD_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.979 | OIA_RFs_ASCVD_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.98 | BMI LOINC | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.980 | OIA_RFs_ASCVD_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.981 | OIA_TIA_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.982 | OIA_TIA_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.983 | OIA_TIA_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.984 | OIA_Angina_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.985 | OIA_Angina_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.987 | OIA_Angina_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.988 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.989 | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.99 | BMI SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.990 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.991 | OIA_Myocardial_Infarction_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.992 | OIA_Myocardial_Infarction_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.993 | OIA_Myocardial_Infarction_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.995 | OIA_PAD_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.996 | OIA_PAD_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.997 | OIA_PAD_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.998 | OIA_Coronary_Arterial_Revascularization | active | 2025-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.5 | Contact or Office Visit | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.6 | Contact or Office Visit | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.7 | Contact or Office Visit | active | 2022-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.10 | Nutrition Diagnosis SNOMED CT | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.101 | Hospice Status | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.14 | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.17 | Pediatric Enteral Formulas SNOMED CT | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.18 | Modified Amino Acid Formulas SNOMED CT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.19 | Nutrition Counseling Approach and Strategies SNOMED CT | active | 2020-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.20 | Enteral Nutrition Management SNOMED CT | active | 2020-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.21 | Nutrition Assessment | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.24 | Malnutrition Assessment | active | 2015-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.25 | Nutritional Status Severely Malnourished | active | 2016-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.30 | Malnutrition Risk Screening | active | 2015-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.31 | Malnutrition At Risk | active | 2015-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.32 | Malnutrition Risk Screening | active | 2016-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.33 | Nutrition Assessment Procedure | active | 2015-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.34 | Malnutrition Screening Finding of Not At Risk Result | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.35 | Malnutrition Screening Not at Risk | active | 2015-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.38 | Malnutrition Screening Finding of At Risk Result | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.39 | Malnutrition Risk Screening | active | 2016-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.40 | Malnutrition Risk Screening | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.41 | Nutritional Status Severely Malnourished | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.42 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.44 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.45 | Nutritional Status Moderately Malnourished | active | 2015-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.46 | Nutritional Status Moderately Malnourished | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.48 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.49 | Nutrition Focused Physical Findings Grouping | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.5 | Adult Enteral Formulas SNOMED CT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.50 | Enteral Nutrition Composition SNOMED CT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.51 | Enteral Nutrition Composition Grouping | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.52 | Parenteral Nutrition Management SNOMED CT | active | 2020-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.53 | Malnutrition Diagnosis | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.54 | Malnutrition Diagnosis | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.55 | Malnutrition Diagnosis | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.56 | Malnutrition Diagnosis | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.58 | Nutrition Order Item Grouping | active | 2018-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.59 | Diet Item Grouping | active | 2018-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.60 | Edible Substances | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.61 | Feeding Device SNOMED CT | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.65 | Nutrition Recommendation Grouping | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.7 | Modular Nutrition Formulas SNOMED CT | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT | active | 2020-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.71 | Coordination of Care by a Nutrition Professional SNOMED CT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.73 | Nutrition Anthropometric Measurement SNOMED CT | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.74 | Nutrition Anthropometric Measure Panel LOINC | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping | active | 2018-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.76 | Manage Feeding Environment | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.77 | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.78 | Food and Nutrition Related History LOINC | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.79 | Nutrition Encounter Individual and Group CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.80 | Nutrition Encounters HCPCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.81 | Nutrition Encounter Codes Grouping | active | 2018-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.84 | Food and Nutrition Related History SNOMED CT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.87 | Feeding Device Grouping | active | 2018-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.88 | Nutrition Intervention Care Planning | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.90 | Medical Nutrition Therapy Procedures | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.91 | Dietitian Referral | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.92 | Malnutrition Risk Screening | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.93 | Nutrition Care Plan | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.94 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.95 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.97 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.98 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.99 | Nutrition Diagnosis SNOMED CT (2) | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.1 | Findings Related to Medication Management, Referral Source | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.100 | Recommendations Related to Medication Regimen | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.101 | Interventions Related to Medication Regimen, Initiate Medication | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.102 | Interventions Related to Medication Regimen, Change Medication | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.103 | Interventions Related to Medication Regimen, Change Medication Dose | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.104 | Interventions Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.105 | Interventions Related to Medication Regimen, Change Medication Course | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.106 | Interventions Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.107 | Interventions Related to Medication Regimen, Discontinue Medication | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.109 | Interventions Related to Medication Regimen | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.11 | Interventions Related to Medication Management, Medication Reconciliation | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.110 | Interventions Related to Education, Medications | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.111 | Interventions Related to Education, Medical Equiptment and Devices | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.112 | Interventions Related to Medication Management, Notifications | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.113 | Interventions Related to Medication Management, Refill Synchronization | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.114 | Status of Patient Condition | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.115 | Interventions Related to Education, Diseases and Disorders | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.116 | Interventions Related to Education | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.118 | Interventions Related to Medication Management | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.119 | Interventions Related to Medication Management, Targeted Medication Review | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.120 | Interventions Related to Medication Management, Discussion | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.121 | Reasons for Interventions Related to Medication Management, Cost | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.122 | Interventions Related to Education, Immunizations | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.123 | Status of Recommendations | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.124 | Interventions Related to Medication Management, Provision of Documents | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.125 | Status of Compliance Ability | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.126 | Status of Interventions | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.127 | Status of Disease Control | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.128 | Status of Compliance | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.129 | Occupations of Providers | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.130 | Environments of Care | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.131 | Findings Related to Medication Management, Body Mass Index | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.139 | Status of Care Goal | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use | active | 2020-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.141 | Interventions Related to Administration, Immunizations | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.142 | Interventions Related to Care Coordination, Communication Needs | active | 2020-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.144 | Findings Related to Medication Management, Life Event | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.145 | Interventions Related to Medication Management, Device or Equipment Fitting | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.146 | Findings Related to Medication Management, Immunizations | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.148 | Findings Related to Medication Management, Cultural Beliefs | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.149 | Findings Related to Medication Management, Tobacco Use | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.150 | Interventions Related to Medication Regimen, Continue Medication | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.151 | Encounter Type | active | 2020-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.152 | Encounter Class | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.156 | Allergy/Intolerance Severity | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.160 | Allergy/Intolerance Manifestation | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.162 | Allergy/Intolerance Substance & Negation | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.163 | Allergy/Intolerance Negation | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.165 | Interventions Related to Care Coordination, Benefit Management | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.166 | Interventions Related to Administration | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.167 | Interventions Related to Administration, Medications | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.168 | Findings Related to Medication Management, Eating Habits | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.169 | Findings Related to Medication Management, Tobacco Exposure | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.170 | Interventions Related to Care Coordination | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.176 | Interventions Related to Medication Management, Information Gathering | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.177 | Interventions Related to Medication Management, Care Planning | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.178 | Interventions Related to Medication Management, Documentation | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.179 | Allergy/Intolerance Substance, Food | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.180 | Allergy/Intolerance Substance, Environmental | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.182 | Encounter Reason | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.211 | PharmacyAllergyIntoleranceType | active | 2018-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.214 | PharmacyEducation | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.218 | Reasons for Interventions Related to Medication Management, Discontinue Medication | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.224 | Social Determinants of Health Problem Observation | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.225 | Laboratory results that are used in medication management | active | 2020-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.230 | Maternity Health Interventions Value Set | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.231 | Social Determinants of Health Interventions | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.232 | Maternity Health Findings | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.233 | Reason Medication Discontinued Lack of Indication | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234 | Reason Medication Discontinued Lack of Effectiveness | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235 | Reason Medication Discontinued Safety Issue Occurred | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236 | Reason Medication Discontinued Compliance Issue other than cost | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237 | Recommendation to Resolve Medication Therapy Problem | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239 | Reason Medication Discontinued Patient Unable to Afford | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.240 | Medication Lists | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3 | Findings Related to Medication Management, Transitions Between Health Care Settings | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35 | Interventions Related to Medication Management, Comprehensive Medication Review | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5 | Reasons for Interventions Related to Medication Management, Unnecessary Therapy | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53 | Reasons for Interventions Related to Medication Management, Adverse Events | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55 | Reasons for Interventions Related to Medication Management, Adherence | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56 | Findings Related to Medication Management, Multiple Providers | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6 | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60 | Findings Related to Medication Management, Health Literacy | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61 | Findings Related to Medication Management | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7 | Reasons for Interventions Related to Medication Management, Ineffective Therapy | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8 | Reasons for Interventions Related to Medication Management, Dose Too Low | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83 | Assessments Related to Medication Management, General Assessments | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84 | Assessments Related to Medication Management | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85 | Assessments Related to Medication Management, Assessments Using Assessment Scales | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86 | Interventions Related to Medication Regimen, Monitoring | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87 | Interventions Related to Care Coordination, Consultations | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88 | Interventions Related to Care Coordination, Referrals to Other Providers | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89 | Interventions Related to Care Coordination, Referrals for Specific Services | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9 | Reasons for Interventions Related to Medication Management, Dose Too High | active | 2019-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90 | Recommendations Related to Medication Regimen, Continue Medication | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91 | Recommendations Related to Medication Regimen, Initiate Medication | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92 | Recommendations Related to Medication Regimen, Change Medication | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93 | Recommendations Related to Medication Regimen, Change Medication Dose | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94 | Recommendations Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95 | Recommendations Related to Medication Regimen, Change Medication Course | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97 | Recommendations Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98 | Recommendations Related to Medication Regimen, Discontinue Medication | active | 2017-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99 | Recommendations Related to Medication Regimen, Monitoring | active | 2021-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type | active | 2024-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.11 | Medication Status | active | 2024-06 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12 | Medication Route | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24 | Extended Pregnancy Status | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.28 | Problem Type (LOINC) | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29 | Allergy Clinical Status | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30 | Care Team Member Function | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.33 | External Cause of Injury/Morbidity | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35 | Arthritis Feedback Types (SNOMED) | active | 2019-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.36 | Arthritis Feedback Types (LOINC) | active | 2025-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.4 | DIRSectionTypeCodes LOINC | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.45 | Bidirectional Services eReferral Type | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.46 | Bidirectional Services eReferral Reason | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.49 | Disability Status Assessment | active | 2024-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50 | Transport vehicle type | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53 | Sex | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54 | Specimen type | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.55 | At Home In Vitro Patient Questions | active | 2024-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.57 | Advance Directives Content Type | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58 | Acute COVID 19 Diagnosis | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59 | Medication Adherence SCT | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.1 | Case Management for Behavioral Health | active | 2021-12 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.63 | Case Management for Behavioral Health | active | 2021-12 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.64 | Case Management for Behavioral Health | active | 2021-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.10 | Medicare FFS Payer | active | 2023-02 | us | hl7 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.12 | Medicare Advantage Payer | active | 2023-02 | us | hl7 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.101 | Myocardial Infarction | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.124 | Follow Up Within 6 Months | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.125 | Follow Up Within 6 Months | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.126 | Bone Scan | active | 2024-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.127 | Bone Scan | active | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15 | Hospice Care Ambulatory | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.175 | Office and Wellness Visits for General Screening | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.176 | Office and Wellness Visits for General Screening | active | 2024-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.177 | Office and Wellness Visits for General Screening | active | 2024-08 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.178 | Office and Wellness Visits for General Screening | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.180 | Outpatient Prenatal Visit | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.182 | Eclampsia | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.184 | Preexisting Hypertension in Pregnancy | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.185 | Postpartum Encounter | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.186 | Postpartum Encounter | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.189 | Spontaneous or Elective Abortion | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.192 | Spontaneous or Elective Abortion Procedure | active | 2025-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.28 | Non Acute Encounter Codes CPT | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.29 | Non Acute Encounter Codes HCPCS | active | 2024-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.31 | Bleeding Event Diagnosis Codes ICD9 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.78 | Statin Associated Muscle Symptoms | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.84 | Statin Associated Muscle Symptoms | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.85 | Statin Associated Muscle Symptoms | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.99 | Underweight | active | 2022-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.11 | Cornual Ectopic Pregnancy | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.12 | Cornual Ectopic Pregnancy | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.13 | Perforation of Uterus | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.14 | Perforation of Uterus | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.15 | Uterine Rupture | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.16 | Uterine Rupture | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.17 | Transabdominal Cerclage | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.18 | Transabdominal Cerclage | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.2 | Transabdominal Cerclage | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.23 | Intensive Care Unit | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.24 | Uterine Horn | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.25 | Metroplasty | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.3 | Medical Induction of Labor | active | 2021-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.35 | Placenta Previa | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.36 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.37 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.38 | Outpatient Surgery Service | active | 2019-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.41 | Statin Allergen | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42 | Statin Allergen | active | 2021-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50 | Rivaroxaban for VTE Prophylaxis | active | 2022-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.51 | Prasugrel | active | 2021-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52 | Pharmacological Contraindications For Antithrombotic Therapy | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.53 | Acute Renal Failure | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.54 | Total Parenteral Nutrition | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.55 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.56 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.57 | Ischemic Stroke Thrombosis | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.58 | Ischemic Stroke Thrombosis | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.59 | Ischemic Stroke Other | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.60 | Ischemic Stroke Other | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.61 | Antithrombotic Therapy Antiplatelet | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62 | Antithrombotic Therapy for Ischemic Stroke | active | 2021-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.63 | Present On Admission is Yes or Exempt | active | 2022-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.64 | Application of Venous Foot Pumps | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.65 | Application of Intermittent Pneumatic Compression Devices | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.66 | Application of Graduated Compression Stockings | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.67 | 20 to 42 Plus Weeks Gestation | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.68 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.69 | 37 to 38 Weeks Gestation | active | 2023-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.70 | 20 to 42 Plus Weeks Gestation | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.71 | 20 to 42 Plus Weeks Gestation | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.72 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.73 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.74 | 37 to 38 Weeks Gestation | active | 2023-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.75 | 37 to 38 Weeks Gestation | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.76 | History of Atrial Ablation | active | 2022-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.77 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.78 | Placenta Previa | active | 2023-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.126 | Hospital Settings | active | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143 | Observation Services | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.146 | Buprenorphine | active | 2022-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.159 | All Primary and Secondary Cancer | active | 2023-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161 | All Primary and Secondary Cancer | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.163 | Emergency Department Evaluation | active | 2020-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.164 | Admit Inpatient | active | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.166 | Codeine Schedule II and III | active | 2023-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.167 | Alfentanil | active | 2021-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.168 | Remifentanil | active | 2021-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.169 | Sufentanil | active | 2021-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.171 | Opioid Use Disorder | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.173 | Sickle Cell Disease with and without Crisis SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.174 | Sickle Cell Disease with and without Crisis ICD | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.175 | Sickle Cell Disease with and without Crisis | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.176 | Opioid Medication Assisted Treatment (MAT) HCPCS | active | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.177 | Opioid Medication Assisted Treatment (MAT) | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.178 | Cancer Related Pain ICD 10 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.179 | Cancer Related Pain SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.180 | Cancer Related Pain | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1114.14 | Medication drug class for allergen intolerance SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.10 | Care Experience Preferences at End of Life LOINC | active | 2024-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.11 | Care Experience Preferences Grouping | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.12 | Healthcare Agent Ordinality | active | 2020-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.13 | Healthcare Agent Powers or Limitations Indicator | active | 2024-11 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.14 | ADIClauseTypeVS | active | 2022-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.15 | Upon Death Preferences | active | 2025-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.17 | Preconditions for Treatment Preferences | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.18 | Treatment Intervention Preferences at End of Life Ordinal LOINC | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.2 | InstructionActStatus | active | 2017-11 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.20 | Advance Healthcare Directive Witness roleCode | active | 2023-08 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.21 | Witness Categories | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.22 | Advance Directive Document Types | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.23 | AD Conditions and Prognosis Scenarios | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.26 | Healthcare Agent or Advisor Indicator | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.27 | Initial Treatment portable medical order options | active | 2024-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.28 | Cardiopulmonary Resuscitation Order Options | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.30 | Cardiopulmonary Resuscitation Order Procedures | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.32 | Additional Portable Medical Order Procedures | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.34 | Additional portable medical order Procedures Grouping | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.35 | Medically Assisted Nutrition Order Options | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.36 | Medically Assisted Nutrition Portable Medical Order Procedures Grouping | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.37 | Healthcare Agent Powers | active | 2024-11 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.38 | Personal Health Goal Options LOINC | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.39 | Personal Health Goal Options Grouping | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.40 | Portable Medical Order Document Types | active | 2025-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.41 | Advance Healthcare Directive Document Types Grouper | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.5 | Advance Directive Content Type SCT | active | 2022-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.6 | Personal Health Goals LOINC | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.7 | Health Goals Grouping | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.8 | Treatment Intervention Preferences at End of Life LOINC | active | 2025-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.9 | Treatment Intervention Preferences Grouping | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.1 | Rituximab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.100 | Pathological M Stage M1c | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.101 | Pathological N Stage N3 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.102 | N Stage pN1a | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.103 | N Stage pN1b | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.105 | Pathological N Stage pN1mi | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.106 | Pathological N Stage N2b | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.107 | Pathological N Stage N2a | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.108 | Pathological N Stage N2 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.109 | Pathological N Stage N1b | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.110 | Pathological N Stage N1a | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.112 | Pathological N Stage N0 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.114 | Pathological T Stage T4d | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.115 | Pathological T Stage T4c | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.116 | Pathological T Stage T4b | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.117 | Pathological T Stage T4a | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.118 | Pathological T Stage T4 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.120 | N Stage N2C | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.121 | T Stage T3c | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.122 | T Stage T3b | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.123 | T Stage T3a | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.124 | Pathological T Stage T3 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.125 | T Stage T2c | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.126 | T Stage T2b | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.127 | T Stage T2a | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.128 | Pathological T Stage T2 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.129 | Pathological T Stage T1c | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.132 | Pathological T Stage T1b | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.135 | Pathological T Stage T1a | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.136 | Pathological T Stage T1 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.137 | Pathological T Stage T1mic | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.139 | Pathological T Stage T0 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.142 | Cancer Stage III | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.143 | Cancer Stage IIIA | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.144 | Cancer Stage IIIB | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.145 | Cancer Stage IIIC | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.146 | Cancer Stage IV | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.147 | Cancer Stage IVA | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.148 | Cancer Stage IVB | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.149 | Cancer Stage IVC | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.151 | Cisplatin Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.153 | Vinorelbine Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.154 | Gemcitabine Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.155 | Docetaxel | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.156 | Pemetrexed Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.158 | Vinblastine Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.160 | ECOG Performance Status | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.161 | ECOG Performance Status | active | 2020-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.164 | Karnofsky Performance Status | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.165 | Carboplatin Injectable | active | 2020-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.166 | Paclitaxel | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168 | Doxorubicin Injectable | active | 2022-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169 | Irinotecan Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179 | Bevacizumab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.181 | Methotrexate | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.184 | Breast Cancer | active | 2022-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.185 | Breast Cancer | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.191 | Cancer Stage II | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.192 | Cancer Stage IIA | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.193 | Cancer Stage IIB | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.194 | Pertuzumab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.196 | Ixabepilone Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.197 | Goserelin | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200 | Epirubicin Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.202 | Ramucirumab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.204 | Letrozole | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.206 | Exemestane | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.209 | Fluorouracil | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210 | Capecitabine Oral | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222 | Aprepitant Oral | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223 | Fosaprepitant Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.255 | Colorectal Cancer | active | 2021-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.256 | Colorectal Cancer | active | 2021-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.257 | Colorectal Cancer Chemotherapy | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.280 | Cancer Stage IA | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.281 | Cancer Stage IB | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.286 | Cancer Stage IIC | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.291 | Positive Result | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.292 | Negative Result | active | 2015-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.300 | Pathological N Stage N1C | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332 | Daunorubicin Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.336 | Palonosetron Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.341 | External Beam Radiotherapy | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.349 | Metastatic Cancer | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission | active | 2025-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.439 | T Category | active | 2018-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.440 | N Category | active | 2018-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.441 | M Category | active | 2018-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.442 | TNM Stage Group | active | 2018-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.449 | Opioids | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.492 | Pharmacological interventions for depression | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.535 | Ovarian Cancer | active | 2023-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.536 | Ovarian Cancer | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.537 | Fallopian Tube Cancer | active | 2022-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.539 | Fallopian Tube Cancer | active | 2022-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.541 | Peritoneal Cancer | active | 2022-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.542 | Peritoneal Cancer | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.547 | Cancer Stage 1C | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.555 | Gender Female | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.556 | Gender Male | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.557 | Pathological N Stage N3a | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.558 | Pathological N Stage N3b | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560 | Rolapitant Oral | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.599 | Obinutuzumab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.600 | Ofatumumab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602 | Neurokinin 1 Receptor Antagonist | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604 | Serotonin Receptor Antagonist | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61 | Cetuximab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.63 | Panitumumab Injectable | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81 | Palonosetron Oral | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.88 | Lung Cancer | active | 2015-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.89 | Lung Cancer | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.95 | M Stage M0 | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.97 | Pathological M Stage M1 | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.98 | Pathological M Stage M1a | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.99 | Pathological M Stage M1b | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.5 | Most/Moderately Effective Contraceptive Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.6 | Most/Moderately Effective Contraceptive SNOMED Findings | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1 | Schedule IV Benzodiazepines | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.7 | PROMIS Depression Assessment | active | 2023-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.11 | Sleep Apnea | active | 2018-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.12 | Toxic Megacolon in adults | active | 2019-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.13 | Septic Shock due to C. Diff | active | 2019-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.15 | Body Temperature | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.16 | Diarrhea Potentially due to CDI | active | 2019-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.17 | Abdominal Distension | active | 2019-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.18 | Vomiting potentially due to CDI | active | 2019-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.19 | Ileus due to infection | active | 2019-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection | active | 2019-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.3 | Radiation Therapy Indicators from CPT | active | 2017-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.4 | Diagnostic Radiology Surrounding Face and Sinus | active | 2017-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.5 | Ear Surgery Affecting the Tympanic Membrane | active | 2017-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.6 | Allergic Rhinitis Immunotherapy | active | 2017-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.8 | Radiology to Head and Sinus | active | 2017-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.9 | Immunotherapy For Allergic Rhinitis | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1136.63 | Aortic Dissection or Ruptured Aortic Aneurysm | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.564 | CABG or PCI Procedure | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.565 | CABG or PCI Procedure | active | 2025-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.566 | CABG or PCI Procedure | active | 2018-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.1 | C2S Alcohol Use Disorders | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.11 | C2S Amphetamine Use Disorders | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.12 | C2S Cannabis Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.13 | C2S Cannabis Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.14 | C2S Cannabis Use Disorders | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.15 | C2S Cannabis Use DIsorders | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.16 | C2S Cocaine Use Disorder | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.17 | C2S Cocaine Use Disorder | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.18 | C2S Cocaine Use Disorder | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.19 | C2S Hallucinogens | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.2 | C2S Alcohol Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.20 | C2S Hallucinogens | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.21 | C2S Hallucinogens | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.22 | C2S Hallucinogens | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.24 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.25 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.26 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.27 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.28 | C2S Inhalants | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.29 | C2S Inhalants | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.3 | C2S Alcohol Use Disorders | active | 2016-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.30 | C2S Inhalants | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.32 | C2S Mental Health Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.33 | C2S Mental Health Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.34 | C2S Mental Health Disorders | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.35 | C2S Mental Health Disorders | active | 2016-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.36 | C2S Mental Health Disorders | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.38 | C2S Opioids | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.39 | C2S Opioids | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.4 | C2S Alcohol Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.40 | C2S Opioids | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.42 | C2S Opioids | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.43 | C2S Other Psychoactive Substance
Use Disorder | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.44 | C2S Other Psychoactive Substance Use Disorder | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.45 | C2S Other Psychoactive Substance Use Disorder | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.46 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.47 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.48 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.49 | C2S Sexuality and reproductive health information sensitivity | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.5 | C2S Alcohol Use Disorders | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.51 | C2S Tobacco Use Disorders | active | 2016-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.52 | C2S Tobacco Use Disorders | active | 2016-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.53 | C2S Tobacco Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.54 | C2S Tobacco Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.55 | C2S Substance Use Information Sensitivity | active | 2016-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.56 | C2S Substance Use Information Sensitivity | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories | active | 2016-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.59 | C2S Opioids | active | 2016-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.6 | C2S Amphetamine Use Disorders | active | 2016-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.60 | C2S HIV/AIDS information Sensitivity | active | 2016-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.65 | Test C2S Alcohol Use Disorders | active | 2019-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.67 | Test C2S HIV/AIDS Information Sensitivity | active | 2019-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.7 | C2S Amphetamine Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.8 | C2S Amphetamine Use Disorders | active | 2016-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.9 | C2S Amphetamine Use Disorders | active | 2016-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.10 | Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1002 | Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1012 | S. Typhi Infection (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1016 | S. Paratyphi Infection (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1017 | S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1021 | Dark Urine (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1022 | Acute Onset [Qualifier Value] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1024 | Acute Viral Hepatitis (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1027 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1029 | Listeriosis [Listeria species] (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1030 | Meningitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1032 | Encephalitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1033 | Encephalitis [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1035 | Indeterminate or Equivocal Lab Result Value | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1037 | Smoking Status [Current Nonsmoker] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1040 | Organisms (Tests by Unspecified Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1041 | Organisms (Tests by Culture and Identification) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1044 | Candida auris Infection (Tests for Candida auris by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1045 | Candida auris Infection (Tests for Candida auris Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1047 | Parkinson’s disease (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1048 | Parkinson’s disease (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1049 | Parkinsonism [Secondary] (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1050 | Parkinsonism [Secondary] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1053 | Carbidopa Levodopa Combination (RXNORM) | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1065 | Consciousness [Decreased Level] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1071 | Drug Use [IV Evidence] (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1072 | Miosis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1076 | Opioid Overdose and Poisoning (Tests for Opioids [Quantitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1077 | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1078 | Opioid Overdose and Poisoning (Naloxone) (RxNorm) | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1083 | Rash [Pustular Vesicular] (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1084 | Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1090 | Syphilis [Congenital] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1091 | Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1092 | Congenital heart disease (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1093 | Hearing impairment (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1095 | Microcephaly (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1096 | Developmental delay (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1099 | Congenital heart disease (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1100 | Hearing impairment (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1104 | Developmental delay (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1106 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.112 | Tetanus (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1123 | COVID_19 (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1130 | Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1131 | Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1138 | Staphylococcus Aureus (Tests by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1139 | VISA/VRSA (Tests for Vancomycin Resistance Gene) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1142 | COVID_19 (Tests for SARS_CoV_2 Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1145 | Resistant Lab Result Value | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1148 | Tests for Vancomycin Susceptibility [Ord] | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1149 | Proteinuria (Tests for Total Protein in 24H Urine) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.115 | Mumps (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1150 | Thrombocytopenia (Tests for Platelets [#/volume] in Blood) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1156 | Staphylococcus aureus (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1158 | COVID_19 (Tests for SARS_CoV_2 Antigen) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1169 | Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.117 | Mumps (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1180 | Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative]) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1186 | Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative]) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1188 | Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative]) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1189 | California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative]) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1196 | Anthrax (Tests for Bacillus cereus by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1197 | Cervical Lymphadenitis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1207 | CRE (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1210 | Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1212 | Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1213 | NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1214 | Carbapenemase resistance mechanism (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1215 | Tests for carbapenemase production | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1216 | Tests for carbapenemase resistance mechanism | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1217 | Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem] | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1218 | Tests for carbapenem susceptibility [Ertapenem] | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1219 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1220 | NU_Tests for Enterobacteriaceae species by Culture and Identification Method | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1224 | Therapeutic Response to Medication [Improved] | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1225 | Altered Mental Status (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1230 | Eschar (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1231 | Hypotension (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1233 | Localized Edema (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1234 | Localized Edema (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1237 | Tachycardia (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1238 | Tachycardia (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1239 | RCKMS Conditions (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.124 | Poliomyelitis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1240 | Maternal Condition Puerperium (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1242 | Non pestis Yersiniosis Infection (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1244 | Blastomycosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1246 | Blastomycosis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1249 | Blastomycosis (Tests for Blastomyces species by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1250 | Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1251 | Blastomycosis (Tests for Blastomyces species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1252 | Blastomycosis (Tests for Blastomyces species Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1253 | Blastomycosis (Tests for Blastomyces species Antigen) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1265 | Fatigue (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1269 | Tuberculosis [Latent Infection] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1274 | Histoplasmosis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1275 | Histoplasmosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1281 | Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1294 | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1295 | Seizure [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1298 | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1299 | Seizure [Unspecified Cause] (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.130 | Influenza (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1304 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1305 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1306 | Body Temperature (Vital Sign) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1307 | Respiratory Rate (Vital Sign) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1309 | RSV (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1310 | RSV (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1312 | RSV (Tests for RSV Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1314 | Wheezing (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1317 | Bronchiolitis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1325 | Tobacco Use and Exposure (Social History) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1330 | Tobacco Smoking Status [Current] (Social History) (LOINC) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1335 | Hospitalized [Inpatient] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1336 | Creutzfeldt Jakob Disease (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1337 | Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1340 | Prion Disease (Tests for 14_3_3 Protein) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1341 | Prion Disease (Tests for Abnormal Prion Protein) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1349 | Cerebrospinal Fluid (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.135 | Chronic Hepatitis B Virus Infection (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1350 | Endocervical (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1351 | Tissue (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1352 | Specimen from a Normally Sterile Site (Specimen Type)(SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1353 | Urethral Swab (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1355 | Wound (Specimen Type) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1359 | Hepatitis E (Tests for hepatitis E virus IgM Antibody) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.136 | Invasive Pneumococcal Disease (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1360 | Hepatitis E (Tests for hepatitis E virus Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1363 | Epiglottitis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1364 | Organisms (Tests by Microscopic Observation by Gram Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1369 | Serum (Specimen Type) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1378 | Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1379 | Fish Poisoning (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1388 | Occupational Asthma (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1389 | Asthma (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1390 | Asthma (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1391 | Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1393 | WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1400 | Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative]) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1402 | Cancer [Malignant Neoplasms] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1403 | Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1404 | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1405 | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1407 | Cancer [Malignant Neoplasms] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1409 | COVID_19 (Tests for SARS_CoV_2 Genomic Sequence) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1418 | Alpha gal syndrome (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1420 | Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative]) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1422 | Ptosis of Eyelid [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1423 | Ptosis of Eyelid [Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1424 | Constipation [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1426 | Intubation [Respiratory Tract] (Procedure) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1430 | Infant Botulism (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1446 | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1447 | MRSA (Disorders (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1449 | Staphylococcus aureus infection (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.145 | Varicella (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1450 | Staphylococcus aureus infection (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1452 | MRSA (Tests by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1453 | MRSA (Tests for Methicillin Resistance Gene) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1454 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1458 | Tests for Cefoxitin Susceptibility [OrdQn] | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1459 | Organisms (Tests in Blood by Culture and Identification) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1460 | Bacteria (Tests in Blood by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1461 | Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1462 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1463 | VRE (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1464 | VRE (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1465 | VRE (Tests by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1466 | Enterococcus species (Tests by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1468 | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1469 | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1470 | Enterococcus species (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1471 | Amebiasis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1473 | Amebiasis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1476 | Amebiasis (Tests for Entamoeba histolytica Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1482 | Norovirus (Tests for Norovirus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1485 | Norovirus (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1487 | Clostridioides difficile infection (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1491 | C. diff infection (Tests for C diff Toxin Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1492 | C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1505 | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1507 | Arsenic Exposure and Toxicity (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1509 | Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1513 | Urine (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1514 | Mercury Exposure and Toxicity (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1515 | Cryptococcosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1516 | Cryptococcosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1520 | Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1523 | Cryptococcosis (Tests for Cryptococcus species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1524 | Cryptococcosis (Tests for Cryptococcus species Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1525 | Mercury Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1528 | Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1532 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1533 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1534 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1538 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154 | Hepatitis C Virus Infection (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1540 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1541 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1542 | Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1543 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1544 | Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1545 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1546 | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1551 | Meningitis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1552 | Bacterial Meningitis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1553 | Fungal Meningitis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1554 | Parasitic Meningitis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1555 | Bacterial Meningitis (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1559 | Photophobia (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1562 | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1563 | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1564 | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1565 | Viruses [Causing Meningitis] (Tests for Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1566 | Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1567 | Bacteria [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1574 | Invasive Group B Streptococcus (Disorders) (ICD10CM)) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1577 | Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1578 | Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1580 | Animal Bite [Dog] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1581 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1582 | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1584 | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1585 | Animal Bite [Dog] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1586 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1587 | Animal Bite [Excluding Mammals] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1588 | Cadmium Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1594 | HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1595 | HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1597 | HIV Infection (ARV Combination Treatment for HIV) (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1598 | HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600 | HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1604 | Vaccine Adverse Event (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1605 | Vaccine Adverse Event (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1606 | Vaccinia disease or adverse event (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.161 | Vibriosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1612 | Blepharitis [Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1613 | Keratitis [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1614 | Keratitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1618 | Smallpox Vaccine (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1620 | Anaphylaxis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1626 | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1634 | Sofosbuvir Velpatasvir Combination (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1640 | Typhus Fever (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1641 | Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1642 | Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1643 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1651 | Chagas Disease (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1654 | Chagas Disease (Tests for Trypanosoma cruzi Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1661 | Cervical lymphadenopathy [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1662 | Conjunctival injection (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1663 | Drying of lips (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1667 | Edema of hands or feet (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1676 | Tests for Acinetobacter baumannii Nucleic Acid | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1677 | Tests for Pseudomonas aeruginosa by Culture and Identification Method | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1678 | Tests for Pseudomonas aeruginosa Nucleic Acid | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1679 | Pseudomonas aeruginosa (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1687 | NU_Gunshot Wound (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1688 | NU_Gunshot Wound (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.169 | Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.170 | Chlamydia trachomatis Infection (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1700 | Encephalitis [Viral] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1702 | Encephalitis [Parasitic] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1712 | Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1714 | Parasites [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1715 | Viruses [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1716 | Drowning and Submersion (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1717 | Drowning and Submersion (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1718 | Motor Vehicle Injury (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1719 | Motor Vehicle Injury (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1720 | Enterovirus Infection [Non polio] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1721 | Enterovirus Infection [Non polio] (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1722 | Enterovirus Infection [Non polio] (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1723 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1725 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1726 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1735 | Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1739 | Head Injury (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1740 | Head Injury (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1742 | Brain Injury [Traumatic] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1745 | Rotavirus Disease (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1746 | Rotavirus Disease (Tests for Rotavirus Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1748 | Chemical Pneumonitis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1749 | Chemical Pneumonitis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1753 | Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1755 | Vomitus (Specimen Type) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1758 | Asbestosis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.176 | West Nile Virus Infection (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1763 | Byssinosis (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1769 | Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1772 | Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1773 | CLABSI (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1775 | Ophthalmia neonatorum (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1778 | Genital herpes (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1779 | Genital herpes (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1781 | Herpes (Tests for Herpes simplex virus Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1785 | Elevated liver enzyme (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1786 | Elevated liver enzyme (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1788 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1789 | Granuloma Inguinale (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1791 | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1792 | Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1797 | Bronchial Wash (Specimen Type) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1800 | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1803 | Bacteria (Tests in Sputum Specimen by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.181 | Coccidioidomycosis (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1819 | Louseborne relapsing fever (Tests for Borrelia species) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1820 | Louseborne relapsing fever (Tests for Borrelia species in Blood) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1823 | Borrelia species (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1824 | Spirochetes (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1829 | Polyarthritis [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1835 | Rheumatoid nodules (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1842 | Ventilator associated event (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1844 | Leishmaniasis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1846 | Leishmaniasis (Tests for Leishmania species Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1847 | Leishmaniasis (Tests for Leishmania species Antibody) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1848 | Leishmania species (Tests by Microscopic Observation in Tissue) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.185 | Brucellosis (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1864 | Taeniasis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1866 | Taeniasis (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.187 | Dengue Virus Infection (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1875 | Cysticercosis (Tests for Taenia solium Antibody) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1878 | Surgical Site Infection (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1880 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1881 | NU_Tests for Enterobacteriaceae species Nucleic Acid | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1882 | Carbapenemase production (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1892 | Toxoplasmosis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1893 | Toxoplasmosis (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1895 | Toxoplasmosis (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1897 | Toxoplasmosis (Tests by Microscopic Observation) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1898 | Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1901 | Toxoplasmosis (Tests for Toxoplasma gondii Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1902 | Orthopox (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1908 | Organisms (Tests by Electron Microscopic Observation) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1912 | Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM) | active | 2023-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1913 | Penicillin G [Procaine] [Injectable] (RXNORM) | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1919 | Fungi [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1923 | Coronary artery aneurysm (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1924 | Coronary artery dilatation (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1925 | Ectatic coronary artery (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1926 | Left ventricular ejection fraction [Decreased Level] (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1927 | Coronary artery aneurysm (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1928 | Shock (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1929 | Shock (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1930 | Troponin [Elevated Level] (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1931 | Oral mucosa Inflammation (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1932 | Oral mucosa Inflammation (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1933 | C reactive protein (Tests by Any Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1934 | Lymphocytes [Concentration] (Tests by Any Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1935 | Strongyloidiasis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1936 | Strongyloidiasis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1937 | Strongyloidiasis (Tests for Strongyloides Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1938 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1939 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1940 | Organisms (Tests by Microscopic Observation in Stool) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1941 | Strongyloidiasis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1942 | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1943 | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1944 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1945 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1946 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1947 | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1948 | Keystone Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1949 | La Crosse Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1950 | Snowshoe hare Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1951 | Trivittatus Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1952 | La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1953 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1954 | La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1955 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1956 | La Crosse Virus Diseases (Tests for La Crosse Virus Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1957 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1958 | Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1959 | Keystone Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1960 | La Crosse Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1961 | Snowshoe hare Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1962 | Trivittatus Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1963 | Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1964 | Encephalomyelitis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1965 | Encephalomyelitis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1966 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1967 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1968 | Hepatitis D Virus Infection (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1969 | Hepatitis D Virus Infection (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1970 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1971 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1972 | Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1973 | Hepatitis D Virus Infection (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1974 | Baylisascariasis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1975 | Baylisascariasis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1976 | Baylisascariasis (Tests for Baylisascaris species Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1978 | Larva Migrans (Neural, Ocular, or Visceral) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1979 | Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1980 | California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1981 | California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1982 | California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1983 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1984 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1985 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1986 | Pregnant (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1987 | Flank Pain (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1988 | Bone Pain (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1989 | Abscess (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1990 | Abscess (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1991 | Focal Brain Lesions (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1992 | Pathologic Fractures [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1993 | Pathologic Fractures [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1994 | Granulomas (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1995 | Granulomas (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1996 | Skin Lesions (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1997 | Skin Lesions (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1998 | Angiostrongyliasis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1999 | Lymphocytic Choriomeningitis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2000 | Lymphocytic Choriomeningitis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2001 | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2002 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2003 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2004 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2005 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2006 | Angiostrongyliasis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2007 | Eosinophilic meningitis (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2009 | Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2010 | Eosinophils [Concentration] (Tests in CSF by Any Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2011 | Eosinophils [Percentage] (Tests in CSF by Any Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2012 | Mpox (Tests for mpox virus by Genomic Sequencing) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2013 | Mpox (Test Panels for mpox virus by Genomic Sequencing) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2017 | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2018 | Interpretation of an Observation (High) | active | 2023-01 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2019 | Interpretation of an Observation (Low) | active | 2024-06 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.202 | Trichinellosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2020 | Lymphadenopathy [Acute] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2023 | Tick Paralysis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2024 | Bacillary angiomatosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2025 | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2026 | Animal Bite or Scratch [Cat] (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2027 | Bartonellosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2028 | Bartonellosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2029 | Bartonellosis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2030 | Bartonella henselae infection (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2031 | Bartonella quintana infection (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2032 | Bartonella bacilliformis infection (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2033 | Bartonella henselae infection (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2034 | Bartonella quintana infection (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2039 | Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2040 | Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2041 | Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2042 | Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2043 | Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2044 | Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2045 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2046 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2047 | Bartonellosis (Tests for Bartonella spp. Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2048 | Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2049 | Bartonella spp. (Tests by Microscopic Observation) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2050 | Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2051 | Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2053 | Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2055 | Cystic Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2057 | Alveolar Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2058 | Echinococcosis (Tests for Echinococcus species Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2059 | Echinococcus species (Tests by Microscopic Observation) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2063 | Genital Warts (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2065 | Diphyllobothriasis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2067 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2072 | Pelvic Inflammatory Disease (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2073 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2074 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2076 | Lower Abdominal Tenderness (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2081 | Leukocytosis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2084 | Pelvic Abscess (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2085 | Leukocytes [Concentration] (Tests in Blood by Any Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2088 | Nongonococcal Urethritis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2089 | Urethritis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2090 | Urethritis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2091 | Urethral discharge (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2092 | Urethral discharge (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2093 | Dysuria (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2094 | Dysuria (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2095 | Gonorrhea (Tests for Neisseria gonorrhoeae Antigen) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2096 | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2098 | Rhinitis (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2100 | Rhinitis (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2101 | Pleuritis (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2102 | Pleuritis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2103 | Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2105 | Methemoglobinemia (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2106 | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2107 | Methemoglobinemia (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2108 | Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2109 | Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative]) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2110 | Anencephaly (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2111 | Anencephaly (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2112 | Fetal Anencephaly (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2113 | Fetal Anencephaly (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2114 | Cleft Lip Alone (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2115 | Cleft Lip Alone (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2116 | Fetal Cleft Lip (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2117 | Cleft Palate Alone (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2118 | Cleft Palate Alone (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2119 | Cleft Lip with Cleft Palate (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2120 | Cleft Lip with Cleft Palate (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2121 | Fetal Spina Bifida (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2122 | Spina Bifida (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2123 | Spina Bifida (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2124 | Down Syndrome (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2125 | Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2126 | Fetal Down Syndrome (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2127 | Fetal Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2128 | Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2129 | Bacteremia (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2130 | Bacteremia (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2131 | Gastroschisis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2132 | Gastroschisis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2133 | Fatal Familial Insomnia (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2134 | Fatal Familial Insomnia (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2135 | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2136 | Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2137 | Prion Disease (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2138 | Prion Disease (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2139 | Prion Disease (Tests for Abnormal PRNP Gene Variant) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2140 | Phenylketonuria (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2141 | Phenylketonuria (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2142 | Linezolid (RXNORM) | active | 2023-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2143 | Tuberculosis (Pretomanid) (RXNORM) | active | 2023-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2144 | Tuberculosis (Bedaquiline) (RXNORM) | active | 2023-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2145 | Tuberculosis [Suspected] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2146 | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2147 | Limb Reduction (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2148 | Limb Reduction (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2149 | NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2150 | Congenital Hearing Loss (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2151 | Congenital Hearing Loss (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2152 | Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2153 | Primary Congenital Hypothyroidism (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2154 | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2155 | Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2156 | Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2157 | Mpox (Combination Tests that include mpox virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2158 | Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2159 | Mpox (Test Panels for mpox virus Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.216 | Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody]) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2160 | Orthopox (Test Panels for orthopoxvirus Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2161 | COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2163 | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2164 | Mumps [Suspected] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2165 | Pertussis [Suspected] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2166 | Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2167 | Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2168 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2169 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2170 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2171 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2172 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2173 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2174 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2175 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2176 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2177 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2178 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2179 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.218 | Listeriosis (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2180 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2181 | Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2183 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2187 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2188 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2189 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2190 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2192 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2193 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2194 | Organisms (Combination Tests by Culture and Identification) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2195 | Organisms (Combination Tests for Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2196 | Lung Tissue (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2197 | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2198 | Anaplasmosis (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2199 | NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2200 | Organisms (Tests by Animal Inoculation Method) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2201 | Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2202 | Abnormal Lung Sounds (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2203 | Abnormal Lung Sounds (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2204 | Anemia [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2205 | Anemia [Unspecified Cause] (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2206 | Creatinine (Tests in Serum by Any Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2207 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2208 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2209 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2210 | Histopathology or Cytopathology Tests by Microscopic Observation | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2211 | Ehrlichiosis (Tests for Ehrlichia species IgG Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2212 | Invasive Cronobacter Infection (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2213 | Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2214 | Necrotizing Enterocolitis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2215 | Necrotizing Enterocolitis (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2216 | Abscess [Brain] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2217 | Abscess [Brain] (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2218 | Urinary Tract Infection (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2219 | Urinary Tract Infection (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2220 | Amniotic Fluid (Specimen Type) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2221 | Congenital Cytomegalovirus (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2222 | Organisms (Tests in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2223 | Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2224 | Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2225 | Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2226 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2227 | Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2228 | Congenital Cytomegalovirus (Tests for CMV Antigen) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2229 | Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2230 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2231 | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2232 | Congenital Cytomegalovirus Infection (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2233 | Cytomegalovirus Disease (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2234 | Cytomegalovirus Disease (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2235 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2236 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2237 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2238 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2239 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2240 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2241 | Stillbirth (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2242 | Stillbirth (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2243 | Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2244 | Candida species (Tests by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2245 | Organisms (Tests in Extrapulmonary Specimen by Culture and Identification) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2246 | Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2247 | Extrapulmonary [NTM] (Specimen Type) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2248 | Plasmodium species (Tests by Microscopic Observation) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2249 | Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2250 | Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2251 | Organisms (Tests in Sputum Specimen by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2252 | Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2253 | Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] ) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2254 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2255 | Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2256 | CP_CRE (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2257 | Organisms (Tests in Stool by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2258 | Loss of Consciousness (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2259 | Neonatal Abstinence Syndrome (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.226 | Lyme Disease (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2260 | Neonatal Abstinence Syndrome (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2261 | High Pitched Cry (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2262 | Inability to Console (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2263 | Inability to Console (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2264 | Hypertonia (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2265 | Hypertonia (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2266 | Tremors (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2267 | Tremors (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2268 | Myoclonus (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2269 | Myoclonus (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.227 | Lyme Disease (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2270 | Poor Sleep (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2271 | Poor Sleep (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2272 | Alterations in Feeding (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2273 | Alterations in Feeding (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2274 | Excoriation (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2275 | Excoriation (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2276 | Sneezing (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2277 | Sneezing (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2278 | Nasal Congestion (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2279 | Nasal Congestion (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2280 | Yawning (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2281 | Cutaneous Mottling (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2282 | Sweating (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2283 | Sweating (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2284 | Feeding Intolerance (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2285 | Feeding Intolerance (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2286 | Respiratory Distress or Nasal Flaring (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2287 | Respiratory Distress or Nasal Flaring (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2288 | In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2289 | In Utero Substance Exposure (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2290 | In Utero Substance Exposure (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2291 | Childbirth (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2292 | Childbirth (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2293 | Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2294 | NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2295 | Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2296 | NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2297 | Exposure or suspected exposure to harmful algae or algae toxins (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2298 | Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2299 | Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2300 | Babesia species (Tests by Microscopic Observation) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2301 | Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2302 | Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2303 | Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2304 | Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2305 | Gram_negative Diplococcus (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2306 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2307 | D_Transposition of the Great Arteries (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2308 | L_Transposition of the Great Arteries (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2309 | Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2310 | Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2311 | Interrupted Aortic Arch (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2312 | Interrupted Aortic Arch (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2313 | Coarctation of the Aorta (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2314 | Coarctation of the Aorta (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2315 | Ebstein Anomaly (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2316 | Ebstein Anomaly (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2317 | Pulmonary valve atresia (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2318 | Pulmonary valve atresia (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2319 | Pulmonary valve stenosis (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2320 | Pulmonary valve stenosis (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2321 | Fetal Pulmonary valve stenosis (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2322 | Double Outlet Right Ventricle (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2323 | Double Outlet Right Ventricle (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2324 | Hypoplastic left heart syndrome (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2325 | Hypoplastic left heart syndrome (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2326 | Single Ventricle (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2327 | Single Ventricle (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2328 | Tetralogy of Fallot (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2329 | Tetralogy of Fallot (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2330 | Truncus Arteriosus (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2331 | Truncus Arteriosus (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2332 | Atrioventricular septal defect (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2333 | Atrioventricular septal defect (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2334 | Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2335 | Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2336 | Tricuspid valve atresia (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2337 | Tricuspid valve atresia (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2338 | Tricuspid valve stenosis (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2339 | Tricuspid valve stenosis (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2340 | Fetal Tricuspid valve stenosis (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2341 | Exposure to Measles (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2342 | Increased Risk for Exposure to Measles (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2343 | Giardiasis (Tests by Microscopic Observation) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2344 | Diphtheria (Tests for Diphtheria Toxin Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2345 | Lead in Blood (Tests for Lead in Venous Blood) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2346 | Lead in Blood (Tests for Lead in Capillary Blood) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2347 | Opioid Overdose and Poisoning (Test Panels for Opioids) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2348 | Rubella (Test Panels for rubella virus IgM Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2349 | Consistent with Tuberculosis (Finding in Chest Xray Imaging Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2350 | Acute Viral Hepatitis (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2351 | Shigellosis (Combination Tests that include Shigella species by Culture and Identification) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2352 | Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2353 | Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2354 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2355 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2356 | Skin (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2357 | Organisms (Tests by Microscopic Observation in Skin) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2358 | Unspecified Tissue (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2359 | Organisms (Tests by Microscopic Observation in Unspecified Tissue) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2360 | S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2361 | S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2362 | Tuberculosis (Ethambutol) (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2363 | Tuberculosis (Isoniazid [INH]) (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2364 | Tuberculosis (Pyrazinamide [PZA]) (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2365 | Tuberculosis (Rifabutin) (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2366 | Tuberculosis (Rifampin) (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2367 | Tuberculosis (Rifapentine) (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2368 | Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2369 | Necrotizing Fasciitis (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2370 | Necrotizing Fasciitis (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2371 | Renal Impairment [Acute or Unspecified] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2372 | Renal Impairment [Acute or Unspecified] (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2373 | Coagulopathy [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2374 | Coagulopathy [Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2375 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2376 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2377 | Soft Tissue Necrosis (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2378 | Soft Tissue Necrosis (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2379 | Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2380 | Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2381 | Specimen from a Nonsterile Site (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2382 | Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2383 | Absence of Skin Lesions (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2384 | Neuralgia (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2385 | Neuralgia (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2386 | Peripheral Nerve Thickening (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2387 | Nerve (Specimen Type) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2388 | Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.239 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.240 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2403 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2404 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2405 | Hepatitis D Virus Infection (Test for hepatitis D virus Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2406 | Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2407 | Firearm Injury (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2408 | Firearm Injury (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2409 | Babesiosis (Tests for B. microti IgG or Total Antibody [Titer]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2410 | Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2411 | Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2412 | Babesiosis (Tests for Babesia species IgG or Total Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2413 | Brucellosis (Tests for Brucella species IgG Antibody by ELISA) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2414 | Cranial Nerve Involvement (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2415 | Cranial Nerve Involvement (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2416 | Unusual Change in Behavior (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2417 | Radiculitis (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2418 | Subarachnoid Hemorrhage (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2419 | Subarachnoid Hemorrhage (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2420 | Discitis (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2421 | Discitis (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2423 | Respiratory Insufficiency [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2424 | Respiratory Insufficiency [Unspecified Cause] (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2425 | Conjunctival Suffusion (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2426 | Leptospira species (Tests by Microscopic Observation) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2427 | Leptospirosis (Tests for Leptospira Antibody by Agglutination) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2428 | Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2429 | Conjunctival Suffusion (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2430 | Pleural effusion (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2431 | Pleural effusion (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2432 | Abdominal swelling (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2433 | Abdominal swelling (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2434 | Neck swelling (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2435 | Neck swelling (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2436 | Diaphoresis (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2437 | Diaphoresis (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2438 | Edema (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2439 | Edema (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.244 | Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2440 | Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2441 | Anthrax (Tests for Bacillus species by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2442 | Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2443 | Influenza A (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2444 | Influenza B (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2445 | Influenza [Unspecified] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2446 | Influenza A (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2447 | Influenza [Unspecified] (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2448 | Influenza (Tests for unspecified influenza virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2449 | Influenza (Tests for influenza B virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2450 | Influenza (Tests for unspecified influenza virus Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2451 | Influenza (Tests for influenza B virus Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2452 | Influenza (unspecified influenza virus in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2453 | Influenza (influenza B virus in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2454 | Influenza (Tests for unspecified influenza virus by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2455 | Influenza (Tests for influenza B virus by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2456 | Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2457 | Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2458 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2459 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2460 | Borrelia species (Tests by Microscopic Observation) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2461 | Borrelia species (Tests by Microscopic Observation in Blood) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2462 | Spirochetes (Tests by Microscopic Observation) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2463 | Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2464 | CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2465 | CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2466 | CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2467 | CRE (Tests for Enterobacterales species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2468 | CRE (Combination Tests that include Enterobacterales by Culture and Identification) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2469 | Tests for Carbapenem Susceptibility [Meropenem and Doripenem] | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2470 | Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2471 | Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2473 | Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2474 | Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2475 | Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2476 | Aortic valve stenosis (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2477 | Anotia (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2478 | Microtia (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2479 | Microtia (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2480 | Anotia (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2482 | Anophthalmia (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2483 | Anophthalmia (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2484 | Microphthalmia (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2485 | Microphthalmia (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2486 | Atrial septal defect (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2487 | Atrial septal defect (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2488 | Fetal Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2489 | Congenital Posterior Urethral Valves (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2490 | Congenital Posterior Urethral Valves (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2491 | Bladder Exstrophy (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2492 | Bladder Exstrophy (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2493 | Encephalocele (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2494 | Fetal Encephalocele (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2495 | Encephalocele (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2496 | Choanal Atresia (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2497 | Choanal Atresia (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2498 | Cloacal Exstrophy (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2499 | Cloacal Exstrophy (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2500 | Renal Agenesis or Hypoplasia (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2501 | Renal Agenesis or Hypoplasia (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2502 | Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2503 | Trisomy 13 (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2504 | Fetal Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2505 | Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2506 | Galactosemia (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2507 | Galactosemia (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2508 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2509 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2510 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2511 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2512 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2513 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2514 | Galactosemia (Tests for GALT gene allele 1) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2515 | Galactosemia (Tests for GALT gene allele 2) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2516 | Hypospadias (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2517 | Hypospadias (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2518 | Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2519 | Fetal Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2520 | Fetal Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2521 | Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2522 | Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2523 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2524 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2525 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2526 | Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2527 | Chlamydia species [Unspecified] (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2528 | Ventricular septal defect (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2529 | Ventricular septal defect (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2530 | Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2531 | Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2532 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2533 | Congenital Cytomegalovirus (Tests for CMV Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.264 | Viral Hemorrhagic Fever (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.265 | Viral Hemorrhagic Fever (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.268 | Mumps (Tests for mumps virus IgM Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.272 | Present or Positive Lab Result Value | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.282 | Varicella (Tests for Varicella zoster virus by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.283 | Varicella (Tests for Varicella zoster virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.285 | Encephalitis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.287 | Varicella (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.289 | Carbon Monoxide Poisoning (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.293 | Toxic Effects of Lead (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.297 | Measles (Tests for measles virus Nucleic Acid) | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.299 | Measles (Tests for measles virus IgM Antibody) | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.300 | Meningococcal Disease (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.301 | Shigellosis (Tests for Shigella species by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.304 | Pesticide Related Illness (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.305 | Organisms (Tests by Microscopic Observation in Specimen from Normally Sterile Site by Gram Stain) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.307 | Leptospirosis (Tests for Leptospira IgM Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.308 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.310 | Bacteria (Tests by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.311 | Viruses (Tests by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.316 | Rubella (Tests for rubella virus IgM Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.317 | Shigellosis (Tests for Shigella species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.319 | Fungi (Tests by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.322 | Pesticide Related Illness (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.326 | Arboviral Disease [Other] (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.329 | Apnea (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.330 | Apnea (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.333 | Shigellosis (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.335 | Influenza (Tests for influenza A virus by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.336 | Influenza (Tests for influenza A or B virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.340 | Influenza (influenza A or B virus in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.341 | Campylobacteriosis (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.342 | Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.343 | Campylobacteriosis (Tests for Campylobacter species Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.344 | Campylobacteriosis (Tests for Campylobacter species Antigen) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.349 | Hepatitis A (Tests for hepatitis A virus IgM Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.353 | Diarrhea (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.356 | HIV Infection (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.359 | Botulism (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.362 | Hansen’s Disease (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.365 | Silicosis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.366 | Silicosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.371 | Cryptosporidiosis (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.372 | Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.375 | Cyclosporiasis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.376 | Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.379 | Giardiasis (Tests for Giardia species Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.384 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.386 | Vibriosis (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.388 | Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.390 | Trichinellosis (Tests for Trichinella species Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.395 | Syphilis (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.396 | Syphilis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.398 | Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.399 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.40 | STEC Infection (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.400 | Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.401 | Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.403 | Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.405 | Hantavirus Infection and Diseases (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.407 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.408 | Hepatitis B Virus Infection (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.422 | Tuberculosis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.427 | STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.43 | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.436 | Coccidioidomycosis (Tests for Coccidioides species IgM Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.437 | Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.438 | Coccidioidomycosis (Tests for Coccidioides species Antigen) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.44 | Gonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.445 | Legionellosis (Tests for Legionella species Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.446 | Legionellosis (Tests for Legionella species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.451 | Tuberculosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.460 | HIV Infection or AIDS (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.464 | Malaria (Tests for Plasmodium species Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.468 | Leptospirosis (Tests for Leptospira Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.471 | Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.472 | Leptospirosis (Tests for Leptospira Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.476 | Babesia species (Tests by Microscopic Observation in Blood) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.478 | Anthrax (Tests for Bacillus anthracis by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.479 | Anthrax (Tests for Bacillus anthracis Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.48 | Salmonellosis (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.480 | Anthrax (Tests for Bacillus anthracis Antigen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.481 | Anthrax (Tests for Bacillus anthracis Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.494 | Ehrlichiosis (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.496 | Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen]) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.500 | Q Fever (Tests for Coxiella burnetii Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.505 | Toxic Shock Syndrome (TSS) (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.507 | Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.512 | Brucellosis (Tests for Brucella species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.515 | Brucellosis (Tests for Brucella species Antibody [Quantitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.516 | Brucellosis (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.519 | Dengue Virus Infection (Tests for dengue virus Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.523 | Dengue Virus Infection (Tests for dengue virus Antigen) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.524 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative]) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.525 | Dengue Virus Infection (Tests for dengue virus IgM Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.527 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative]) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.530 | Borrelia species (Tests for Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.531 | Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.532 | Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.534 | Smallpox (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.542 | Spotted Fever Rickettsiosis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.548 | St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative]) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.550 | Syphilis (Tests for Treponema pallidum Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.553 | Anaplasma species (Tests by Microscopic Observation) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.555 | Yellow Fever (Tests for yellow fever virus Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.557 | Yellow Fever (Tests for yellow fever virus Antibody [Quantitative]) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.56 | Diarrhea (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.560 | West Nile Virus Infection (Tests for West Nile virus Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.569 | Plague (Tests for Yersinia pestis Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.575 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.576 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.577 | Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.578 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.579 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.58 | Pertussis (Tests for Bordetella pertussis Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.580 | Arboviral Disease [Other] (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.581 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.584 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.586 | Viral Hemorrhagic Fever (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.595 | Tularemia (Tests for Francisella tularensis Nucleic Acid) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.598 | Tularemia (Tests for Francisella tularensis Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.6 | Diphtheria (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.605 | Organisms (Tests by Microscopic Observation by Acid Fast Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.606 | Tuberculosis (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.614 | Pertussis (Tests for Bordetella pertussis Toxin Antibody) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.621 | Inspiratory Whoop (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.632 | Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.645 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.648 | Vomiting (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.650 | Jaundice (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.652 | Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.660 | Hypertonia [Excluding Congenital Hypertonia] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.662 | Chest Pain (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.663 | Erythema Nodosum (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.664 | Congenital Zika Syndromes (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.665 | Congenital Zika Syndromes (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.666 | Guillain Barré syndrome (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.668 | Rash (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.671 | Fever (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.672 | Arthralgia (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.673 | Arthralgia (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.674 | Conjunctivitis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.675 | Conjunctivitis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.676 | Pregnant (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.677 | Postpartum (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.678 | Postpartum (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.679 | Hearing Loss (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.680 | Abdominal Pain (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.681 | Abdominal Pain (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.686 | Erythema Multiforme (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.687 | Myalgia (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.689 | Periorbital Edema (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.691 | Eosinophilia (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.692 | Eosinophilia (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.70 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.702 | Weight Loss (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.705 | Syphilis (Tests for Treponemal or Non Treponemal Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.709 | Cough [Non Productive] (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.71 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.711 | Wound Infection (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.712 | Pneumonia (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.713 | Sepsis [Septicemia] [Unspecified Organism] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.714 | Sepsis [Septicemia] [Unspecified Organism] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.715 | Meningitis (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.717 | Cellulitis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.718 | Cellulitis (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.719 | Myositis [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.720 | Myositis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.721 | Otitis Media (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.722 | Otitis Media (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.723 | Otitis Externa (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.724 | Otitis Externa (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.727 | Acute Upper Respiratory Illness (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.728 | HIV Infection (Tests for HIV Nucleic Acid [Qualitative]) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.730 | HIV Infection (Tests for HIV Antibody) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.733 | Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.741 | Hepatitis B Immune Globulin (RXNORM) | active | 2023-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.744 | Coccidioidomycosis (Tests for Coccidioides species IgG Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.746 | Treponema pallidum (Tests by Microscopic Observation) | active | 2022-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.747 | Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM) | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.750 | Chest Pain (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.755 | Acute Upper Respiratory Illness (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.756 | Purpura (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.757 | Muscle Spasms (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.758 | Muscle Spasms (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.762 | Mumps (Test Panels for mumps virus IgM IgG Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.763 | Parotitis [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.764 | Mumps (Tests for mumps virus IgG Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.765 | Aseptic Meningitis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.766 | Encephalitis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.767 | Hearing Loss (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.770 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.773 | Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.777 | Mastitis (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.779 | Pancreatitis (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.780 | Pancreatitis (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.782 | Rubella (Test Panels for rubella virus IgM IgG Antibody) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.785 | Opioid Overdose and Poisoning (Tests for Opioids [Qualitative]) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.789 | Purpura (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.79 | Campylobacteriosis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.792 | Novel Influenza A Virus Infection (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.793 | Novel Influenza A Virus Infection (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.794 | Sore Throat (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.795 | Influenza (influenza A virus in Lab Results) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.796 | Influenza (Novel influenza A virus in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.797 | Influenza (Tests for influenza A or B virus by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.798 | Influenza (Tests for influenza A virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.799 | Influenza (Tests for influenza A virus Antigen) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.802 | Influenza (Tests for Novel influenza A virus Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.803 | Tests by Microscopic Observation in Tissue by H&E or PAS Stain | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.808 | Headache (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.809 | Headache (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.810 | Backache (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.811 | Backache (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.815 | NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative]) | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.816 | Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.818 | Measles (Tests for measles virus IgG Antibody [Ratio] in Serum) | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.820 | Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.822 | Pneumoconiosis (Unspecified) (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.823 | Pneumoconiosis (Unspecified) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.824 | Computerized Tomography of Chest (Imaging) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.830 | Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.835 | Lead in Blood (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.836 | Lead in Blood (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.839 | Acid Fast Bacilli (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.841 | Tuberculosis (Interferon Gamma Release Assays) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.842 | Tests by Microscopic Observation in Tissue | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.844 | Tuberculosis (Second Line Drugs for Treatment) (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.846 | SARS (Tests for SARS_CoV by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.847 | SARS (Tests for SARS_CoV Nucleic Acid) | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.86 | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.864 | Nausea (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.865 | Confusion (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.867 | Dyspnea (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.869 | Loss of Consciousness (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.87 | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.875 | SARS (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.878 | MERS (Tests for MERS_CoV Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.88 | Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.881 | Difficulty Breathing (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.884 | Tests by Microscopic Observation in Blood | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.889 | Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.892 | Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.895 | Rhinorrhea (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.896 | Tests by Microscopic Observation in Blood Smear | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.897 | Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.9 | Xray of Chest (Imaging) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.90 | Cough (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.900 | Organisms (Tests by Microscopic Observation) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.902 | Acute Renal Failure [Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.907 | Arthritis [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.91 | Cough (SNOMED) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.910 | Epididymitis [Unspecified Cause] (SNOMED) | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.911 | Epididymitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.914 | Osteomyelitis [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.915 | Osteomyelitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.918 | Spondylitis [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.919 | Arthritis [Unspecified Cause] (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.92 | Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.927 | Thrombocytopenia [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.928 | Bleeding [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.930 | ECG Abnormalities [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.931 | Hematemesis [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.932 | Hematemesis [Unspecified Cause] (ICD10CM) | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.934 | Hematuria [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.935 | Hemoptysis (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.937 | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.942 | Petechiae [Non Traumatic] (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.952 | Thrombocytopenia [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.956 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.957 | Regional Lymphadenitis [Including Bubo] (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.958 | Regional Lymphadenitis (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.96 | Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.963 | Arboviral Disease [Other] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.965 | Proteinuria [Unspecified Cause] (ICD10CM) | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.969 | Proteinuria [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.970 | Bulbar Weakness (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.971 | Bulbar Weakness (ICD10CM) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.976 | Dysphagia (SNOMED) | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.978 | Impaired Respiration [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.979 | Botulism (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.98 | Shigellosis (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.989 | Tests for Mycobacterium species by Culture and Identification Method | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.991 | Rifampin (RXNORM) | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.994 | Organisms (Tests for Nucleic Acid) | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.998 | Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid) | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.999 | Chlamydia species (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.109 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.110 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.112 | Pressure Injury Deep Tissue | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2022-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.119 | Inpatient Falls | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.120 | Major Injuries | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.122 | Inpatient Falls | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.125 | Bleeding at Non Critical Site | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.130 | Anticoagulants for VTE Prophylaxis | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.131 | Anticoagulants for Indications Other than VTE Prophylaxis | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.135 | Bleeding at Critical Site | active | 2021-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.143 | Bleeding at Critical Site | active | 2021-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.144 | Bleeding at Critical Site | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.145 | Bleeding at Non Critical Site | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.146 | Bleeding at Non Critical Site | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.163 | Ultrasound of Lower Extremities | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.164 | Ultrasound of Lower Extremities | active | 2024-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.171 | Inpatient Falls | active | 2021-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.183 | Anti Factor Xa Assay | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.187 | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.188 | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.190 | Intra Aortic Balloon Pump | active | 2022-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.191 | Intra Aortic Balloon Pump | active | 2022-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.193 | Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) | active | 2022-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.194 | Pressure Injury Deep Tissue Diagnoses | active | 2022-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.196 | Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses | active | 2022-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.197 | Present on Admission or Clinically Undetermined | active | 2022-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.198 | Not Present On Admission or Documentation Insufficient to Determine | active | 2022-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.1 | DEXA Dual Energy Xray Absorptiometry, Bone Density | active | 2016-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.11 | Bladder Cancer Staging Ta for Urology Care | active | 2016-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.12 | Bladder Cancer staging T1 for Urology Care | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.13 | Bladder Cancer staging Tis for Urology Care | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.15 | Carcinoma of urinary bladder, superficial | active | 2016-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.16 | Injection Leuprolide Acetate | active | 2017-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17 | High grade bladder cancer Ta for Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.18 | Immunocompromised state for Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.19 | Systemic chemotherapy for urology care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.2 | Bladder Cancer in Situ | active | 2016-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.20 | Corticosteroids for patients receiving Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21 | Calcineurin inhibitors for patients receiving Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.23 | Immunomodulators for patients undergoing Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.24 | Monoclonal antibody for patient undergoing Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.28 | Radiotherapy for patients undergoing Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.29 | Plasmacytoid cell, morphologic abnormality for urology care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.3 | Bladder Cancer in Situ | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.30 | Sarcomatoid, morphologic abnormality for Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.31 | Micropapillary, morphologic abnormality, for Urology Care | active | 2017-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.32 | Immunosuppressive Drugs for Urology Care | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.38 | DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care | active | 2017-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.39 | Mixed histology urothelial cell carcinoma for Urology Care | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4 | BCG Bacillus Calmette Guerin, Tice | active | 2016-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.40 | Cystectomy for Urology Care | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.44 | Unavailability of Bacillus Calmette Guerin for urology care | active | 2017-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.45 | Bladder Cancer for Urology Care | active | 2017-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.48 | Androgen deprivation therapy for Urology Care | active | 2021-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5 | BCG Bacillus Calmette Guerin, Connaught | active | 2016-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.52 | BCG Bacillus Calmette Guerin for Urology Care | active | 2020-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.53 | Cystectomy for Urology Care | active | 2018-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.54 | Acute Tuberculosis for Urology Care | active | 2018-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.55 | Cystectomy for Urology Care | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.56 | Active Tuberculosis for Urology Care | active | 2018-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.57 | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.58 | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.59 | Hospital Services for Urology | active | 2023-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.6 | Peripheral DXA Scan | active | 2016-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.60 | Chemotherapy Agents for Advanced Cancer | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.8 | Tuberculosis Diagnosis Prior to Urology Care | active | 2016-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.9 | Leukemia Diagnosis Prior to Urology Care | active | 2016-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.13 | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.14 | Intensive Lifestyle Interventions | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.15 | Intensive Lifestyle Interventions | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.16 | Intensive Lifestyle Interventions | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.17 | Intensive lifestyle interventions | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.21 | Outpatient Clinical Encounters | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.22 | Outpatient Clinical Encounters | active | 2025-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.23 | Outpatient Clinical Encounters | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.24 | Outpatient Clinical Encounters | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.25 | Reason for No Intensive Lifestyle Intervention | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.27 | Type 2 Diabetes Diagnoses | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.28 | Type 2 Diabetes Diagnoses | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.29 | Type 2 Diabetes Diagnoses | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.30 | Prediabetes HbA1c Tests | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.31 | Prediabetes HbA1c Tests | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.32 | Prediabetes HbA1c Tests | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.33 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.34 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.35 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.36 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.37 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.38 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.4 | Glycemic Screening Tests | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.40 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.41 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.42 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.43 | Analgesics for Acute Pain | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.49 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.5 | Glycemic Screening Tests | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.52 | Remote Physiologic Blood Pressure Monitoring | active | 2024-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.57 | Aldosterone Receptor Blocker for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.58 | Alpha Blocker for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.59 | Angiotensin Converting Enzyme Inhibitor for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.6 | Glycemic Screening Tests | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.60 | Angiotensin II Receptor Blocker for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.61 | Beta Blocker for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.62 | Calcium Channel Blocker Dihydropyridine for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.63 | Calcium Channel Blocker Non Dihydropyridine for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.64 | Central Acting for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.65 | Direct Renin Inhibitor for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.66 | Loop Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.67 | Neuronal Blocking Agent for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.68 | Potassium Sparing Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.69 | Thiazide Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.7 | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.70 | Vasodilator for Hypertension | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.73 | Analgesics for Acute Pain (Non Parenteral Route) | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.74 | Analgesics for Acute Pain (Parenteral Route) | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.75 | Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes | active | 2024-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.77 | Antihypertensive Medication Classes | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.78 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.79 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.8 | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.84 | Renal Colic | active | 2025-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.85 | Renal Colic | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.86 | Renal Colic | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.88 | Direct LDL Cholesterol | active | 2025-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.89 | Calculated LDL Cholesterol | active | 2025-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.9 | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.50 | Urinary retention | active | 2017-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.51 | Urinary retention | active | 2017-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.52 | Urinary retention | active | 2017-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.65 | Morbid Obesity | active | 2018-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.66 | Morbid Obesity | active | 2018-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.67 | Morbid Obesity | active | 2018-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.68 | BMI greater than 40 | active | 2019-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.69 | Morbid Obesity | active | 2019-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.1 | Pregnancy Status | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.10 | Pap Smear Tests | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.103 | Female Sterilization HCPCS Devices | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.105 | Female Sterilization ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.109 | Sterilization SNOMED Findings | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.11 | HIV Tests | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.110 | Pregnancy Bundle Visits | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.111 | Prenatal Care Specific Visits CPT | active | 2021-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.112 | Prenatal Care Specific Visits HCPCS | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.113 | Prenatal Care Specific Visits SNOMED | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.114 | Prenatal Care Specific Visits | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.115 | Self Identified Need for Contraception (SINC) | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.117 | Syphilis Tests | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.118 | Infecund Not for Contraceptive Reasons CPT Procedures | active | 2024-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.119 | Infecund Not for Contraceptive Reasons HCPCS Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.12 | Human Papilloma Virus Tests | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.120 | Prenatal Care Visits CPT | active | 2021-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.121 | Prenatal Care Visits HCPCS | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.122 | Prenatal Care Visits SNOMED | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.123 | Pregnancy Related Diagnoses ICD10CM | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.124 | Pregnancy Related Diagnoses SNOMED | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.125 | Non Live Birth Diagnoses ICD10CM | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.126 | Non Live Birth Diagnoses SNOMED | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.127 | Non Live Birth CPT Procedures | active | 2022-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.128 | Non Live Birth ICD10PCS Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.129 | Contraceptive Ring RXNORM Medications | active | 2021-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.13 | Chlamydia Trachomatis Tests | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.130 | Contraceptive Implants RXNORM Medications | active | 2021-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.131 | Injectable Contraceptive RXNORM Medications | active | 2021-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.132 | Oral Contraceptive Pills RXNORM Medications | active | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.133 | Pregnancy Related Diagnoses | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.134 | Female Sterilization SNOMED Provision Procedures | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.135 | General Prenatal Care Visits | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.136 | Non Live Birth Procedures | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.137 | Non Live Birth Diagnoses | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.138 | IUD Surveillance | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.139 | IUD Provision Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.14 | Neisseria Gonorrhoeae Tests | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.140 | IUD Devices | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.141 | Contraceptive Patch SNOMED Devices | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.142 | Female Sterilization Provision Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.143 | Live Birth Delivery CPT Procedures | active | 2024-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.144 | Contraceptive Patch SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.145 | Contraceptive Patch SNOMED Findings | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.146 | Contraceptive Patch ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.147 | Contraceptive Patch ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.148 | Live Birth Delivery ICD10PCS Procedures | active | 2024-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.149 | Contraceptive Patch HCPCS Devices | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.15 | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.150 | Contraceptive Patch LOINC | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.151 | Infecund Not for Contraceptive Reasons Procedures | active | 2022-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.152 | Live Birth Delivery Procedures SNOMED CT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.153 | Contraceptive Ring SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.154 | Contraceptive Ring SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.155 | Contraceptive Ring SNOMED Findings | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.156 | Contraceptive Ring ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.157 | Contraceptive Ring ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.159 | Contraceptive Ring HCPCS Devices | active | 2022-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.160 | Contraceptive Ring LOINC | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.161 | Contraceptive Implant SNOMED Devices | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.162 | Contraceptive Implant ICD10PCS Provision Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.163 | Contraceptive Implant SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.164 | Contraceptive Implant SNOMED Findings | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.165 | Infecund Not for Contraceptive Reasons SNOMED Procedures | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.167 | Contraceptive Implant LOINC | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.168 | Pregnancy Bundle CPT | active | 2021-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.169 | Pregnancy Bundle HCPCS | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.17 | Contraceptive Type | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.170 | Contraceptive Implant ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.171 | Contraceptive Implant ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.173 | Contraceptive Implant HCPCS Devices | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.174 | Contraceptive Patch Devices | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.177 | Live Birth Delivery Procedures | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.178 | Contraceptive Ring Surveillance | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.180 | Contraceptive Implant CPT Provision Procedures | active | 2021-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.181 | Injectable Contraceptive SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.182 | Injectable Contraceptive SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.183 | Injectable Contraceptive SNOMED Findings | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.185 | Injectable Contraceptive ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.186 | Injectable Contraceptive ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.187 | Injectable Contraceptive HCPCS Provision Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.188 | Injectable Contraceptive LOINC | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.189 | Oral Contraceptive Pill SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.190 | Oral Contraceptive Pill SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.191 | Oral Contraceptive Pill SNOMED Findings | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.192 | Contraceptive Implant SNOMED Surveillance Procedures | active | 2021-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.193 | Oral Contraceptive Pill ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.194 | Oral Contraceptive Pill ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.195 | Oral Contraceptive Pill HCPCS Provision Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.196 | Oral Contraceptive Pill LOINC | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.197 | Injectable Contraceptive Provision Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.198 | Injectable Contraceptive Surveillance | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.199 | Oral Contraceptive Pill Provision Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.200 | Oral Contraceptive Pill Surveillance | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.201 | Contraceptive Implant Devices | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.202 | Contraceptive Implant Provision Procedures | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.203 | Contraceptive Implant Surveillance | active | 2021-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.204 | Prenatal Care Bundle CPT | active | 2021-11 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.205 | Prenatal Care Bundle Visits | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.206 | Infecund Not for Contraceptive Reasons ICD10PCS Procedures | active | 2022-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.209 | Yes and No Answers | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.210 | Pap Smear Results | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.211 | Contraceptive discussion | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.22 | Pregnancy Intention | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.29 | Insurance Coverage Type | active | 2023-07 | us | hl7 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.3 | Organism Detection | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.31 | English Proficiency | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.76 | Contraceptive Patch RXNORM Medications | active | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.78 | Intrauterine Devices CPT Provision Procedures | active | 2021-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.79 | Intrauterine Devices HCPCS Devices | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.80 | Intrauterine Devices LOINC | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.81 | Intrauterine Devices HCPCS Provision Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.83 | Intrauterine Devices ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.84 | Intrauterine Devices ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.85 | Intrauterine Devices RXNORM Medications | active | 2021-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.86 | Intrauterine Devices SNOMED Devices | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.87 | Intrauterine Devices SNOMED Findings | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.88 | Intrauterine Device SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.89 | Intrauterine Devices SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.91 | Intrauterine Devices ICD10PCS Provision Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.93 | Female Sterilization CPT Provision Procedures | active | 2021-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.96 | Infecund Not for Contraceptive Reasons SNOMED Findings | active | 2021-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.97 | Infecund Not for Contraceptive Reasons ICD10CM | active | 2021-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.98 | Female Sterilization LOINC | active | 2021-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.99 | Female Sterilization ICD10PCS Provision Procedures | active | 2021-10 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.10 | ASN Screening Declined | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.11 | Transportation Insecurity Diagnosis | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.12 | Food Insecurity Diagnosis | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.13 | Homelessness Diagnosis | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.14 | Housing Instability Diagnosis | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.15 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.16 | Intervention for Positive Food Insecurity Screen | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.17 | Intervention for Positive Food Insecurity Screen | active | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.18 | Intervention for Positive Food Insecurity Screen | active | 2024-11 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.19 | Intervention for Positive Food Insecurity Screen | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2 | Intracranial or Intraspinal surgery | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.20 | Intervention for Positive Homelessness Screen | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.21 | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.22 | Emergency Department Observation | active | 2024-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.27 | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.28 | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.29 | Bed Assigned | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.3 | Malignant Intracranial Neoplasm Group | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.31 | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.32 | Healthcare Agent and Power of Attorney Documentation | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.33 | Advance Directive Documentation | active | 2024-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.34 | Advance Directive Documentation | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.35 | Advance Directive Documentation | active | 2024-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.36 | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.37 | Portable Medical Order(s) Documentation | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.38 | Advance Care Planning Discussion Documentation | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.4 | Thrombolytic medications | active | 2021-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.40 | Advance Care Planning Documentation | active | 2024-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.41 | Advance Care Planning Documentation | active | 2024-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.45 | Advance Care Planning Documentation | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.46 | Advance Care Planning Documentation | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.47 | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.49 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.5 | Allergy to thrombolytics | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.50 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.51 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.52 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.53 | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.54 | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.55 | Intervention for Positive Homelessness Screen | active | 2024-11 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.56 | Intervention for Positive Homelessness Screen | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.57 | Non Invasive Oxygen Therapy Device Codes | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.58 | Goals, preferences, and priorities for medical treatment | active | 2025-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6 | Thrombolytics Adverse Event | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.7 | Intraspinal surgery | active | 2024-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.8 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.9 | Utility Insecurity Diagnosis | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1176.58 | Food Insecurity Screening Positive | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.1 | Ezetimibe Therapy | active | 2023-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.10 | Antihypertensive Medications | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.100 | Allergy or Intolerance to ACE Medication | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.101 | Allergy or Intolerance to ARB Medication | active | 2024-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.102 | Chronic Kidney Disease Stage 1 | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.103 | Chronic Kidney Disease Stage 2 | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.104 | Chronic Kidney Disease Stage 3 | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.105 | Chronic Kidney Disease Stage 4 | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.106 | Chronic Kidney Disease Stage 5 | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.107 | ICD10 CM Chronic Kidney Disease Stage 1 | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.108 | ICD10 CM Chronic Kidney Disease Stage 2 | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.111 | AHA GWTG Chronic Kidney Disease Stage 2 | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.112 | ICD10 CM Chronic Kidney Disease Stage 3 | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.113 | ICD10 CM Chronic Kidney Disease Stage 4 | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.114 | ICD10 CM Chronic Kidney Disease Stage 5 | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.115 | AHA GWTG Chronic Kidney Disease Stage 1 | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.116 | AHA GWTG Chronic Kidney Disease Stage 3 | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.117 | AHA GWTG Chronic Kidney Disease Stage 4 | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.118 | SNOMED CT Atrial Fibrillation | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.119 | ICD10 CM Atrial Fibrillation | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.121 | AHA GWTG Atrial Fibrillation | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.123 | SNOMED CT Hyperlipidemia | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.124 | ICD10 CM Hyperlipidemia | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.125 | AHA GWTG Hyperlipidemia | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.126 | SNOMED CT Hypertriglyceridemia | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.127 | ICD10 CM Hypertriglyceridemia | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.129 | AHA GWTG Hypertriglyceridemia | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.130 | SNOMED CT Gestational Diabetes | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.131 | ICD10 CM Gestational Diabetes | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.132 | AHA GWTG Gestational Diabetes | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.133 | SNOMED CT Hyperglycemia | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.134 | ICD10 CM Hyperglycemia | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.135 | AHA GWTG Hyperglycemia | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.136 | SNOMED CT Nonobstructive CAD | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.137 | ICD10 CM Nonobstructive Coronary Artery Disease | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.138 | AHA GWTG Nonobstructive coronary artery disease | active | 2024-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.139 | AHA GWTG Anti Obesity Pharmacotherapy | active | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.15 | Non Tobacco Smoking Product User | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.16 | Antihypertensive Fixed Dose Combination Medications | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2 | PCSK9 Inhibitors | active | 2023-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.20 | CCB and Thiazide and Thiazide Like Diuretics | active | 2021-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.21 | Referral to cardiac rehab | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.22 | Cardiac Rehabilitation | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.25 | 2 Hour Blood Glucose Test | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.26 | NYHA Functional Classification | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27 | ARNI Therapy | active | 2022-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29 | MRA Therapy | active | 2022-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.3 | Cholesterol non HDL Laboratory Test | active | 2021-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.30 | SGLT2 Inhibitors | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.31 | Heart Transplant | active | 2022-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.32 | Heart Transplant | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.33 | Heart Transplant | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.34 | Allergy to MRA Therapy | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.35 | Aspirin or Clopidogrel | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.39 | Cardiac Rehabilitation | active | 2024-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.4 | Hypothyroidism | active | 2021-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.40 | Cardiac Rehabilitation | active | 2022-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.43 | SGLT2 Ingredients | active | 2022-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.44 | MRA Ingredients | active | 2022-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.49 | Minnesota Living with Heart Failure Questionnaire | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.5 | Hypothyroidism | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.50 | Kansas City Cardiomyopathy Questionnaire | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.51 | Cardiac Pacer | active | 2021-11 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.52 | Cardiac Pacer | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53 | Cardiac Pacer | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.54 | Heart Transplant Complications | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.55 | Heart Transplant Complications | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.56 | Heart Transplant Complications | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.57 | Left Ventricular Assist Device Complications | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.58 | Left Ventricular Assist Device Complications | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.59 | Left Ventricular Assist Device Placement | active | 2023-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.6 | Hypothyroidism | active | 2021-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.60 | Left Ventricular Assist Device Placement | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.61 | Left Ventricular Assist Device Placement | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.62 | Left Ventricular Assist Device Placement | active | 2022-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.63 | Heart Transplant | active | 2022-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.65 | Cardiac Pacer | active | 2022-11 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.66 | Diastolic Heart Failure | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.67 | Diastolic Heart Failure | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.68 | Diastolic Heart Failure | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.69 | Allergy to SGLT2 Inhibitors | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.7 | Anorexia Nervosa | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70 | Intolerance to SGLT2 Inhibitors | active | 2022-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71 | Intolerance to MRA Therapy | active | 2022-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.72 | ARNI Ingredient | active | 2022-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.73 | Mitral Stenosis | active | 2022-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.74 | Mitral Stenosis | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.75 | Mitral Stenosis | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.76 | Mechanical Prosthetic Heart Valve | active | 2022-11 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.77 | Mechanical Prosthetic Heart Valve | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.78 | Mechanical Prosthetic Heart Valve | active | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.79 | Mechanical Prosthetic Heart Valve in Situ | active | 2022-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.8 | Anorexia Nervosa | active | 2021-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.82 | Systolic Heart Failure | active | 2023-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.83 | Systolic Heart Failure | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.84 | Systolic Heart Failure | active | 2023-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.85 | Carotid Intervention | active | 2023-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.86 | Serum Creatinine | active | 2023-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.87 | Urine Creatinine | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.88 | Urine Albumin | active | 2023-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.9 | Anorexia Nervosa | active | 2021-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.90 | Non Steroidal Mineralcorticoid Receptor Antagonist | active | 2024-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.91 | Glucagon like peptide 1 medications | active | 2024-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.96 | AHA GWTG Long COVID19 | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.97 | AHA GWTG Long COVID19 SNOMEDCT | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.98 | AHA GWTG Long COVID19 ICD10CM | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.1 | Wound internal item and/or body structure visible value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.11 | Wound exudate appearance value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.12 | Wound exudate color value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.13 | Exudate odor value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.14 | Wound anatomic location value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.16 | Skin temperature value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.17 | Skin color enumerated value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.18 | Skin turgor value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.19 | Skin and mucous membrane integrity value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.2 | Periwound condition value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.20 | Skin moisture value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.3 | Wound Type Etiology value set | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.4 | Wound episode value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.6 | Wound bed appearance value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.60 | Wound type reference set | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.7 | Wound bed color value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.74 | Nonverbal pain indicators reference set | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.76 | Pain associated signs and symptoms reference set | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.77 | Pain body location reference set | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.8 | Wound edge description value set (foundation metadata concept) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.80 | Pain quality reference set | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.81 | Pain speed of onset reference set | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.9 | Presence absence value set (foundation metadata concept) | active | 2018-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.1 | Common drug substances for allergy and intolerance documentation | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.2 | Common drug classes for allergy and intolerance documentation | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.3 | Common dietary substances for allergy and intolerance documentation | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.4 | Common environmental substances for allergy and intolerance documentation | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.5 | Common refutations for substance causes for allergy and intolerance documentation | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.7 | Common substances for allergy and intolerance documentation | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.8 | Common substances for allergy and intolerance documentation including refutations | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.10 | NHSNCriterionOfDiagnosisCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.11 | NHSNCriterionOfDiagnosisCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.12 | NHSNInfectionConditionCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.13 | NHSNInfectionConditionCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.14 | NHSNInfectionTypeCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.15 | NHSNInfectionTypeCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.16 | NHSNInfectionFirstReportedSource(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.17 | NHSNInfectionFirstReportedSource(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.18 | NHSNLOS/MENDischargeDisposition(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.19 | NHSNLOS/MENDischargeDisposition(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.20 | NHSNPopulationSummaryReportTypeCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.21 | NHSNPopulationSummaryReportTypeCode(LOINC) | active | 2020-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.22 | NHSNSameDayOutcomeMeasure(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.23 | NHSNSameDayOutcomeMeasure(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.24 | NHSNSignificantPathogenCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.25 | NHSNSignificantPathogenCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.26 | NHSNSpinalFusionApproachCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.27 | NHSNSpinalFusionApproachCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.28 | NHSNVascularAccessTypeCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.29 | NHSNVascularAccessTypeCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.30 | NHSNVascularSpecimenCollectionSite(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.31 | NHSNVascularSpecimenCollectionSite(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.38 | Blood Glucose Laboratory and Point of Care Tests | active | 2023-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.58 | Diabetes Medications | active | 2022-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.6 | NHSNPathogenCodeARO | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.62 | Lab Tests for Clostridioides difficile | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.63 | Bacterial and Fungal Blood Culture Tests | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.7 | NHSNRoleOfPerformerCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.74 | Enteral Medication Route | active | 2022-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.75 | Intravenous Medication Route | active | 2022-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.76 | Fidaxomicin | active | 2022-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.77 | Vancomycin | active | 2022-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.78 | Metronidazole | active | 2022-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.79 | Fidaxomicin, Vancomycin, and Metronidazole | active | 2022-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.8 | NHSNRoleOfPerformerCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.85 | Baloxavir | active | 2023-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.86 | Peramivir | active | 2023-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.87 | Zanamivir | active | 2023-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.88 | Digestive, Intramuscular, Intravenous Route of Administration | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.89 | Maternal Diagnoses | active | 2023-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.9 | NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy) | active | 2020-08 | us | hl7 | nucc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.90 | NHSN LTC AU Antimicrobial Agents | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.91 | Long Term Care Discharge Disposition | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.94 | NHSNNeurogenicBladder | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.95 | NHSNSpinalCordInjury | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1139 | S4G Hyperlipidemia | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1291 | S4G Cardiomyopathy | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1292 | S4G Tricuspid valve disorder | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1293 | S4G Pompe disease | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1294 | S4G Malignant hyperthermia | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1295 | S4G Malignancy | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1297 | S4G Intestinal polyp | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1298 | S4G Hamartoma | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1299 | S4G Diabetes mellitus | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1300 | S4G Muscular dystrophy and weakness | active | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1325 | S4G Hamartoma and S4G Intestinal Polyp | active | 2022-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1326 | S4G Malignancy and S4G Intestinal Polyp | active | 2022-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1344 | Tests for Neisseria gonorrhoeae of unspecified site reported by presence | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1352 | Body weight | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1354 | Cefixime preparations for oral administration | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1358 | Beta lactam medicinal product SNOMED | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1370 | Beta lactam ingredients for allergy determination RXNORM | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.147 | SCIP Major Surgical Procedure | active | 2019-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158 | Multiple Myeloma Regimen Drugs | active | 2019-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.226 | Opioids, All | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3483 | Financial Insecurity Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3484 | Food Insecurity Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3485 | Health Literacy Screening Assessments Questions | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3486 | Homelessness Screening Assessments Questions | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3487 | Housing Instability Screening Assessments Questions | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3488 | Less Than High School Education Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3519 | Health Insurance Coverage Status Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3520 | Inadequate Housing Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.393 | Hypoglycemics Severe Hypoglycemia | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.394 | Hypoglycemics Treatment Medications | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4436 | Gentamicin medications | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4437 | Azithromycin medications | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4448 | Lidocaine | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4466 | Pharyngeal specimens | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4467 | Urogenital & Anorectal Specimens | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4469 | Cabotegravir Injectable Products | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4470 | Emtricitabine oral for HIV PrEP | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4474 | HIV Laboratory Based Tests | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4502 | Ceftriaxone all code types | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491 | Medium Dose ICS Formoterol Preparations | active | 2021-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.495 | ICS LABA LAMA Preparations | active | 2021-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.788 | Social Determinants of Health Conditions | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.789 | Social Determinants of Health Procedures | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.790 | Social Determinants of Health Service Requests | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93 | CPIC RxNORM abacavir SCDG | active | 2019-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.94 | CPIC RxNORM allopurinol SCDG | active | 2019-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.95 | CPIC RxNORM amitriptyline SCDG | active | 2019-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96 | CPIC RxNORM atazanavir SCDG | active | 2019-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.97 | CPIC RxNORM atomoxetine SCDG | active | 2019-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.99 | CPIC RxNORM capecitabine SCDG | active | 2019-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.1 | Mechanical Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.10 | Surgical Site Bleeding and Other Surgical Site Complications | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.11 | Procedures Resulted From Surgical Site Bleeding and Other Surgical Site Complications | active | 2019-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.12 | Opioid (Oral Tablets and Patches only) | active | 2019-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.13 | Comorbidity Risk Factors | active | 2020-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.14 | Treatment of Hemorrhage or Hematoma | active | 2020-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.15 | General Surgery | active | 2020-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.17 | Coagulation Disorder Conditions | active | 2020-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.18 | Acute Respiratory Failure | active | 2020-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.19 | Anticoagulant Medications | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.2 | Fracture Exclusions For Hip And Knee Procedures | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.20 | Anticoagulant Medications, Oral | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.21 | Anticoagulant Medications, Injection | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.28 | Active Bleeding | active | 2020-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.29 | Fall Risk Increasing Drugs (FRIDs) | active | 2021-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.3 | Pulmonary Embolism Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.30 | Fall Risk Factors | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.32 | Total Hip Arthroplasty Surgery | active | 2021-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.33 | Total Knee Arthroplasty Surgery | active | 2021-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.34 | AbnormalityOfGaitAndMobility | active | 2021-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.35 | Assymetry Symptoms | active | 2021-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.36 | Hemiplegia Symptoms | active | 2021-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.37 | Leg Weakness Symptoms | active | 2021-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.38 | Osteopenia Symptoms | active | 2021-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.39 | Stroke Symptoms | active | 2021-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.4 | Sepsis Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.40 | Vestibular Symptoms | active | 2021-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.41 | TricyclicAntidepressants | active | 2021-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.42 | Benzodiazepines | active | 2021-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.43 | LoopDiuretics | active | 2021-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.44 | Antiepileptics | active | 2021-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.45 | Antipsychotics | active | 2021-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.46 | Opioid Medications | active | 2021-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.47 | Imaging Related to VTE | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.48 | Anticoagulant Medication | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.49 | VTE Diagnoses | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.5 | Nonprimary Total Hip, Total Knee Replacement | active | 2019-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.50 | Bisphosphonate Therapy | active | 2022-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.51 | VTE Symptoms | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.52 | Oncology Critical Care Units | active | 2022-03 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.53 | Provider Types | active | 2022-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.56 | FOBT_Lab | active | 2024-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.57 | Colorectal Screening | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.58 | Screening Mammogram (CPT) | active | 2024-08 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.59 | Screening Mammogram (LOINC) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.6 | Pneumonia Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.60 | Screening Mammogram (SNOMEDCT) | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.61 | Screening Mammogram (Grouping) | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.62 | Diagnostic Mammography (CPT) | active | 2024-08 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.63 | Diagnostic Mammography (LOINC) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.64 | Diagnostic Mammography (SNOMEDCT) | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.65 | Diagnostic Mammography | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.66 | Breast Cancer Biopsy and Surgical Excision | active | 2024-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.67 | BI_RADS Categories 0, 4, and 5 | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.68 | BI_RADS Categories 1, 2, and 3 | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.7 | Malignant Neoplasm Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.8 | Periprosthetic Joint Infection/Wound Infection and Other Wound Complications | active | 2019-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.9 | Procedures Resulted From Periprosthetic Joint Infection/Wound Infections | active | 2019-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.101 | Local Anesthetics | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.102 | Ophthalmic Epinephrines | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.103 | Inhaled Epinephrines | active | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.104 | Clopidogrels | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.105 | Cytochrome P450 2C19 inhibitors | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.106 | Cytochrome P450 2C9 inhibitors | active | 2023-10 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.107 | Aspirin Ingredient and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109 | Oral Anticoagulant Ingredients and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.110 | Corticosteroid Ingredients and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.111 | Antidepressant Ingredients and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.112 | PPI and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.113 | Antiplatelet Ingredients and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.114 | NSAIDs Ingredients and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.115 | Kratom containing compounds | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117 | Clopidogrel Ingredients and Risk of GI Bleeding | active | 2024-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.121 | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 | active | 2024-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.122 | Gastrointestinal bleeding episode and Risk of GI Bleeding 2 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.123 | Gastrointestinal bleeding episode and Risk of GI Bleeding | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.24 | Oxycodones | active | 2024-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1217.2 | TESTSemanticBitsValueSet | active | 2020-10 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.1 | Bronchiectasis Disorder SNOMED | active | 2020-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.10 | Interstitial Lung Disease ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.100 | Occupational Therapy Procedure HCPCS | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.101 | Occupational Therapy Procedure | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.102 | Speech Language Therapy Procedure HCPCS | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.103 | Speech Language Therapy Procedure | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.104 | Home Health Procedure | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.105 | Intermittent Skilled Nursing Home Health Procedure | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.106 | pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.107 | Breathing Test Procedure During Sleep | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.108 | Ambulance Transport Procedure | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.109 | Prefabricated Spinal Orthotic Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.11 | Interstitial Lung Disease SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.110 | Custom Fitted Spinal Orthotic Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.111 | Custom Fabricated Spinal Orthotic Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.112 | Orthotic Device Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.113 | Spinal Orthotic Device or Supply | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.115 | Spine or Neck Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.116 | Spine or Neck Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.117 | Spine or Neck Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.118 | Total Electric Hospital Bed Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.119 | Hypoventilation Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.12 | Interstitial Lung Disease | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.120 | Hypoventilation Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.121 | Hypoventilation Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.122 | Respiratory Assist Device Qualifying Condition | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.123 | Apnea Hypopnea Index Rate Measurement | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.124 | Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.125 | Maximal Inspiratory Pressure Measurement | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.126 | Forced Vital Capacity (FVC) Measurement by Spirometry | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.127 | Oxygen Saturation Measurement At Rest | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.128 | Respiratory Assist Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.129 | Respiratory Assist Device Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.13 | Cystic Fibrosis Lung Disease ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.130 | Home Oxygen Therapy Accessory | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.131 | Forced Vital Capacity (FVC) Measurement Prediction | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.132 | Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.133 | Respiratory Disturbance Index | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.134 | Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.135 | Past Medical History Condition Related to Need for Positive Airway Pressure Device | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.136 | Home or Facility Care Location | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.137 | Fracture of Bone Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.138 | Fracture of Bone Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.139 | Fracture of Bone Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.14 | Cystic Fibrosis Lung Disease SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.140 | Severe Obesity Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.141 | Severe Obesity Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.142 | Severe Obesity Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.143 | Transfer from Bed Impairment SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.144 | Bed Confinement Impairment | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.145 | Transfer from Bed Impairment | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.146 | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.147 | Mobility Impairment or Fall From Chair ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.148 | Ability to Safely Sit in Chair or Wheelchair Impairment | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.149 | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.15 | Cystic Fibrosis Lung Disease | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.150 | Fall or Fall Risk from Wheelchair or Scooter ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.152 | Muscle, Tendon or Joint Contracture Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.153 | Muscle, Tendon or Joint Contracture Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.154 | Muscle, Tendon or Joint Contracture Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.155 | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.156 | Muscle Weakness or Myasthenia Gravis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.158 | Myocardial Infarction Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.159 | Myocardial Infarction Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.16 | Neoplasm of Lung or Trachea Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.160 | Myocardial Infarction Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.161 | Amputation Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.162 | Amputation Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.164 | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.165 | Lower Extremity Deep Vein Thrombosis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.167 | Spinal Cord Injury or Paralysis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.168 | Spinal Cord Injury or Paralysis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.169 | Spinal Cord Injury or Paralysis Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.17 | Neoplasm of Lung or Trachea Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.170 | Demyelinating Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.171 | Demyelinating Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.172 | Demyelinating Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.173 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.174 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.176 | Wound Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.177 | Wound Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.178 | Wound Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.179 | Danger to Self or Others Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.18 | Neoplasm of Lung or Trachea Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.180 | Danger to Self or Others Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.181 | Danger to Self or Others Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.182 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.183 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.184 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.185 | Pain on Movement or Joint Pain Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.186 | Pain in Joint Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.187 | Pain on Movement or Joint Pain Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.188 | Non Emergency Ambulance Transport Reason | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.189 | Osteoarthritis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.19 | Secondary Erythrocytosis Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.190 | Osteoarthritis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.191 | Osteoarthritis Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.192 | Immunosuppressive Medication RxNorm | active | 2022-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.193 | Medication Supporting Immunosupressive Medication RxNorm | active | 2022-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.194 | Non Emergency Ambulance Transport Qualifying Procedure | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.197 | Turalio | active | 2022-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.198 | Hepatic Medical History | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.2 | Bronchiectasis Disorder ICD10CM | active | 2020-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.20 | Secondary Erythrocytosis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.21 | Secondary Erythrocytosis Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.22 | Acute or Chronic Heart Failure Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.23 | Acute or Chronic Heart Failure Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.24 | Acute or Chronic Heart Failure Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.25 | Home Oxygen Therapy Qualifying Condition | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.26 | Device Use Patient Activity Level | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.27 | Portable Liquid Oxygen Therapy Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.28 | Stationary Liquid Oxygen Therapy Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.29 | Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.3 | Bronchiectasis Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.30 | Sleep Apnea or Breathing Related Sleep Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.31 | Sleep Apnea or Breathing Related Sleep Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.32 | Positive Airway Pressure Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.33 | Diabetes Mellitus Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.34 | Diabetes Mellitus Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.35 | Diabetes Mellitus Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.36 | Restrictive Lung Disease SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.37 | Restrictive Lung Disease ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.38 | Restrictive Lung Disease | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.39 | Chest Wall Deformity Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.4 | Chronic Obstructive Lung Disease (COPD) ICD10CM | active | 2020-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.40 | Chest Wall Deformity Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.41 | Chest Wall Deformity Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.42 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.43 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.44 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.45 | Chronic Respiratory Failure Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.46 | Chronic Respiratory Failure Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.47 | Chronic Respiratory Failure Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.48 | Ventilator Therapy Qualifying Condition | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.49 | Ventilator Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.5 | Chronic Obstructive Lung Disease SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.50 | Fixed Height Hospital Bed Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.51 | Variable Height Hospital Bed Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.52 | Semi electric Hospital Bed Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.53 | Heavy Duty Extra Wide Hospital Bed Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.54 | Extra Heavy Duty Hospital Bed Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.55 | Hospital Bed Trapeze Accessory Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.56 | Hospital Bed Cradle Accessory Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.57 | Hospital Bed Side Rail or Safety Enclosure Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.58 | Hospital Bed Supply | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.59 | Intermittent Urinary Catheter or Urological Supply for Intermittent Urinary Catheter Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.6 | Chronic Obstructive Lung Disease (COPD) | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.60 | Indwelling Urinary Catheter Supply or Urological Supply for Indwelling Urinary Catheter Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.61 | Urinary Collection and Irrigation System Device or Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.62 | External Catheter or Urinary Collection Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.63 | Miscellaneous Urinary Catheter Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.64 | Urinary Incontinence Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.65 | Urinary Incontinence ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.66 | Urinary Incontinence Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.67 | Chronic Urinary Retention Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.68 | Urinary Retention Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.69 | Chronic Urinary Retention Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.7 | Hypoxemia Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.70 | Urinary Incontinence or Chronic Urinary Retention Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.72 | Portable Compressed Gas Oxygen Therapy Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.73 | Stationary Oxygen Concentrator Therapy Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.74 | Compressed Gas Oxygen Therapy Device | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.75 | Stationary Compressed Gas Oxygen Therapy Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.76 | Portable Oxygen Concentrator Therapy Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.77 | Liquid Oxygen Therapy Device | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.78 | Oxygen Concentrator Therapy Device | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.79 | Portable Oxygen Therapy Device | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.8 | Hypoxemia Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.80 | Stationary Oxygen Therapy Device | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.81 | Organ Transplant History Significant to Immunosuppressive Therapy | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.82 | Immunosuppressive Medication HCPCS | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.83 | Medication Supporting Immunosuppressive Medication HCPCS | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.84 | Home Blood Glucose Monitor Device | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.85 | Insulin Medication | active | 2022-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.86 | Hyperglycemia or Hypoglycemia Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.87 | Hyperglycemia or Hypoglycemia Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.88 | Hyperglycemia or Hypoglycemia Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.89 | Diabetic Test Strip or Lancet Supply | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.9 | Hypoxemia Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.90 | Organ Transplant Procedure Significant to Immunosuppressive Therapy | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.91 | Pulmonary Hypertension Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.92 | Pulmonary Hypertension Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.93 | Pulmonary Hypertension Disorder | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.94 | Laboratory Test for Home Glucose Monitor Evaluation | active | 2022-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.95 | Physical Therapy Procedure SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.96 | Occupational Therapy Procedure SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.97 | Speech Language Therapy Procedure SNOMED CT | active | 2022-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.98 | Physical Therapy Procedure HCPCS | active | 2022-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.99 | Physical Therapy Procedure | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.135 | Last Menstrual Period (LMP) | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.146 | Abortion, All (ICD 10 CM) | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.149 | Abortion, All (SNOMED CT) | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.150 | Abortion, All | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.151 | Abortion, All (CPT) | active | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.152 | Abortion, 1st Trimester | active | 2024-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.153 | Abortion, 2nd Trimester | active | 2024-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.154 | Abortion, 2nd Trimester | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.155 | Abortion, 3rd Trimester | active | 2024-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.156 | Abortion, Elective | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.157 | Abortion, Elective | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.158 | Abortion, Failed Attempt | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.159 | Abortion, Induced | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.160 | Abortion, Induced | active | 2024-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.161 | Abortion, Induced | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.162 | Abortion, Medical Management | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.163 | Abortion, Medical Management | active | 2024-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.164 | Abortion, Medical Management | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.165 | Abortion, Elective | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.166 | Abortion, Surgical Management | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.167 | Abortion, Surgical Management | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.168 | Abortion, Surgical Management | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.169 | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.170 | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.171 | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.172 | Contraception, Counseling | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.173 | Contraception, Counseling | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.174 | Contraception, Counseling | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.175 | Contraception, Counseling | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.176 | Methotrexate Injection | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.177 | Mifepristone | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.178 | Misoprostol | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.179 | Abortion Medications | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.180 | Contraception, Surveillance | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.181 | Contraception, Surveillance | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.182 | Contraception, Surveillance | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.183 | Clomiphene (Selective Estrogen Receptor Modulator / SERM) | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.184 | Letrozole (Aromatase inhibitor) | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.185 | Infertility, Female Medications | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.186 | Infertility, Female | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.187 | Infertility, Female | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.188 | Infertility, Female | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.189 | Infertility, Male | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.190 | Infertility, Male | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.191 | Infertility, Male | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.192 | Infertility, All | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.193 | Gender Dysphoria | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.194 | Gender Identity | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.195 | Intersex Surgery, History | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.196 | Intersex Surgery, Non specific | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.197 | Intersex Surgery, Female to Male | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.198 | Intersex Surgery, Female to Male | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.199 | Intersex Surgery, Female to Male | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.200 | Intersex Surgery, Male to Female Sex | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.201 | Intersex Surgery, Male to Female Sex | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.202 | Intersex Surgery, Male to Female Sex | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.203 | Intersex Surgery, All | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.204 | Pregnancy Labs, Blood/Serum/Plasma/Urine | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.205 | Stillbirth | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.206 | Stillbirth | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.208 | Sexual Orientation | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.209 | Transfeminine Regimens, Antiandrogens | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.210 | Transfeminine Regimens, Estrogens | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.211 | Transfeminine Regimens, GnRH Agonists | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.212 | Transfeminine Regimens, All | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.213 | Transmasculine Regimens, Testosterone, Transdermal | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.214 | Transmasculine Regimens, Testosterone, Parenteral | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.215 | Transmasculine Regimens, All | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.216 | Abortion, 1st Trimester | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.100 | Sleep Apnea Disorders SCT | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1005 | Sexual Satisfaction | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.101 | Sleep Apnea Disorders ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1015 | Substance Use | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1016 | Tobacco Use | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.102 | Sleep Apnea Disorders | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1020 | Screen Time | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1022 | Fluid Management | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1023 | Fat Intake | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1024 | Unsaturated Fat Intake | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1025 | Saturated Fat Intake | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1026 | Carbohydrate Intake | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1027 | Salt Intake | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1028 | Vegetable Intake | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1029 | Fruit Intake | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.103 | PostTraumatic Stress Disorder PTSD | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1030 | English Proficiency | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.104 | PostTraumatic Stress Disorder PTSD ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1042 | Neglect | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1048 | Current or Former Occupation | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.105 | PostTraumatic Stress Disorder PTSD SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1050 | Work Productivity | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1053 | Income Level | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1057 | Caregiver Characteristics | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1058 | Caregiver Availability | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1060 | Living Situation | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1064 | Marital or Spousal Status | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1065 | Dependents in Home | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1068 | Physical Activity Level | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1069 | Leisure Activity Engagement | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1075 | Exposure to Environmental Hazards | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1076 | Neighborhood Safety | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1080 | Experiences of Discrimination | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1082 | Criminal Justice Involvement or Incarceration | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1083 | Immigration Status | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.111 | Creatinine in blood, serum or plasma | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.113 | Blood Urea Nitrogen | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.114 | Hemoglobin | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.118 | Iron Saturation (Transferrin Saturation/TSAT) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.119 | Hemoglobin A1C | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1197 | Sleep Behavior | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.120 | Potassium in blood, serum or plasma | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1203 | Medication Literacy | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1213 | Elder and Child Abuse SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.122 | Corrected Calcium | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1229 | Education Level SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.123 | Phosphorus in blood, serum or plasma | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.126 | Vitamin D Levels | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.128 | KT/V Hemodialysis Ratio | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1281 | Elder and Child Abuse | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.129 | Intact Parathyroid Hormone | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.130 | Bicarbonate in blood, serum or plasma | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.131 | Sodium in blood, serum or plasma | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.132 | Chloride in blood, serum or plasma | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1336 | Elder and Child Abuse ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.135 | High Density Lipoprotein | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.137 | Triglyceride in blood, serum or plasma | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1375 | Tinnitus | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1377 | Brain Fog | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1378 | Depression Symptoms | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1379 | Mood Swings | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.138 | Cystatin C | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1380 | Anxiety | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1381 | Lightheadedness | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1382 | Stress | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1383 | Grief and Suffering | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1384 | Insomnia and Other Sleep Difficulties | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1385 | Impaired Sense of Taste | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1386 | Pink Eye Diagnosis SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1387 | Pink Eye Diagnosis ICD10 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1388 | Pink Eye Diagnosis | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.139 | Total Cholesterol | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1392 | Lymphadenopathy Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1393 | Lymphadenopathy Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1394 | Lymphadenopathy Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1395 | Visual Changes | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1396 | Impaired Sense of Smell | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1398 | Fatigue | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1399 | Chills | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.140 | Ferritin | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1400 | Fever | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1401 | Functional and Mobility Impairment | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1403 | Orthostatic Intolerance | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1405 | Cough | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1406 | Dyspnea | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1409 | Wheezing | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.141 | Red Blood Cell Count (Erythrocytes) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1413 | Sinonasal Congestion | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1414 | Respiratory Distress | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1415 | Edema | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1419 | Weight Changes | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.142 | White Blood Cell (Leukocytes) Count | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1422 | Immunologic Changes | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1424 | Pain | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1425 | Arthralgia | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1426 | Chest Pain | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1427 | Headache | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1428 | Myalgia | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1429 | Back Pain | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.143 | Hematocrit | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1430 | Pain in Extremities | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1431 | Pain in Throat | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1432 | Palpitations | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1433 | Tachycardia | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1434 | Bleeding | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1435 | Abdominal Pain | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1436 | Diarrhea | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1437 | Gastroesophageal Reflux | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1438 | Nausea | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1439 | Vomiting | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.144 | Mean Corpuscular Volume | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1440 | Constipation | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1441 | Difficulty Swallowing | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1442 | Bronchiectasis Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1443 | Loss of Appetite | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1444 | Paresthesia | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1445 | Rash | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1447 | Itching | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1448 | Menstrual Cycle Irregularities | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1449 | Lower Urinary Tract Symptoms | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.145 | Mean Corpuscular Hemoglobin Concentration | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1450 | Urinary Incontinence | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1451 | Dizziness | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1453 | Hair Loss | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1455 | Disability Severity | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1456 | Hypercoagulability | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1457 | Post Exertional Malaise | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1458 | Chronic Pain | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1459 | Neurogenic Pain | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.146 | Platelet Count | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1460 | Impaired Hearing | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1461 | Parkinsonia Like Symptoms | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1462 | Bronchiectasis Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1463 | Bronchiectasis Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1464 | Chronic obstructive pulmonary disease (COPD) Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1465 | Chronic obstructive pulmonary disease (COPD) Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1466 | Chronic obstructive pulmonary disease (COPD) Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1467 | Interstitial lung disease Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1468 | Interstitial lung disease Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1469 | Interstitial lung disease Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.147 | Erythrocyte Distribution Width | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1470 | Asthma Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1471 | Asthma Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1472 | Asthma Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1473 | Fibromyalgia Diagnosis SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1474 | Fibromyalgia Diagnosis ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1475 | Fibromyalgia Diagnosis | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1476 | Herpes zoster Diagnosis ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1477 | Herpes zoster Diagnosis SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1478 | Herpes zoster | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1479 | Pulmonary embolism Diagnosis SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.148 | Platelet Distribution Width | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1480 | Pulmonary embolism Diagnosis ICD10 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1481 | Pulmonary embolism Diagnosis | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1482 | Hypertension, Pulmonary Hypertension SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1483 | Hypertension, Pulmonary Hypertension Diagnosis ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1484 | Hypertension, Pulmonary Hypertension | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1485 | Language and Speech Problems | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1486 | Postural tachycardia syndrome (POTS) Diagnosis SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1487 | Postural tachycardia syndrome (POTS) Diagnosis ICD10 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1488 | Postural tachycardia syndrome (POTS) Diagnosis | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1489 | Functional disorder of gastrointestinal tract Diagnosis SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.149 | Platelet Mean Volume | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1490 | Functional disorder of gastrointestinal tract Diagnosis ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1491 | Functional disorder of gastrointestinal tract Diagnosis | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1492 | Autonomic dysfunction | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1496 | Mast Cell Activation Syndrome (MCAS) Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1497 | Mast Cell Activation Syndrome (MCAS) Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1498 | Mast Cell Activation Syndrome (MCAS) Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.150 | Estimated Average Glucose | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1500 | Debility or Frailty SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1501 | Debility or Frailty ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1502 | Debility or Frailty | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1503 | Ehlers Danlos syndrome (EDS) Diagnosis SCT | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1504 | Ehlers Danlos syndrome (EDS) Diagnosis ICD10 | active | 2024-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1505 | Ehlers Danlos syndrome (EDS) Diagnosis | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1506 | Malnutrition Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1507 | Malnutrition Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1508 | Narcolepsy Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1509 | Narcolepsy Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.151 | Albumin in Blood, Plasma, or Serum | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1510 | Narcolepsy | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1514 | Small Fiber Neuropathy Diagnosis SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1515 | Small Fiber Neuropathy Diagnosis ICD10 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1516 | Small Fiber Neuropathy Diagnosis | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1517 | Malnutrition Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1518 | Neuropathy Diagnosis | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1519 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1520 | Multisystem Inflammatory Syndrome in Adults (MIS A) ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1521 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1522 | Congestive heart failure Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1523 | Congestive heart failure Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1524 | Congestive heart failure Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1525 | Cognitive disorder Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1526 | Cognitive disorder SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1527 | Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1529 | Post Acute Sequelae of Sars Cov 2 infection (PASC) ICD10 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.153 | Anion Gap | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1530 | Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1531 | Hypertension, Persistent SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1532 | Acute Renal Failure Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1533 | Acute Renal Failure Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1534 | Acute Renal Failure Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1535 | Complication due to Diabetes Mellitus Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1536 | Complication due to Diabetes Mellitus Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1537 | Complication due to Diabetes Mellitus Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1538 | Coronary Revascularization History SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1539 | Coronary Revascularization History ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.154 | Urine Urea Nitrogen | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1540 | Coronary Revascularization History | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1541 | Heart Failure Diagnosis SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1542 | Heart Failure Diagnosis ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1543 | Heart Failure Diagnosis | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1547 | Hypertension, Primary and Secondary Diagnosis | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1548 | Cerebrovascular Disease Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1549 | Cerebrovascular Disease Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.155 | Bone Density | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1550 | Migraine Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1551 | Migraine Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1552 | Migraine Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1553 | Chronic Tension type Headache Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1554 | Chronic Tension type Headache Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1555 | Chronic Tension type Headache Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1556 | Low Back Pain SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1557 | Low Back Pain ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1558 | Low Back Pain | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1559 | Metabolic Syndrome Diagnosis SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.156 | Bone Survey X Rays | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1560 | Metabolic Syndrome Diagnosis ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1561 | Metabolic Syndrome Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1562 | Hypertension, Persistent ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1563 | Hypertension, Persistent | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1564 | Pregnancy SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1565 | Pregnancy ICD10 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1566 | Pregnancy | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1568 | Low Density Lipoprotein | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1569 | Physical findings of the abdomen | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.157 | Chronic Kidney Disease All Stages (1 through 5) SNOMED | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1571 | Chest US | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1572 | Sleep Disorder Assessment | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1573 | Cerebral Spinal Fluid (CSF) Analysis | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1574 | Comprehensive Metabolic Panel (CMP) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1575 | Arterial Blood Gas (ABG) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1576 | Coagulation Assay (PT, aPTT, Fibrinogen) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1577 | D Dimer Test | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1578 | Procalcitonin in Blood, Serum, or Plasma | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1579 | Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.158 | Chronic Kidney Disease All Stages (1 through 5) ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1580 | COVID 19 (SARS CoV 2), SARS CoV, Influenza virus A and B Tests | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1581 | Microorganisms Detection by Blood Culture | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1582 | Microorganisms Detection by Sputum Culture | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1583 | Cystography | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1584 | Cognitive Health Related Questionnaire Panel Codes | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1585 | Alcohol Use Related Questionnaire Panel Codes | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1586 | Functional Status Related Questionnaire Panel Codes | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1587 | Kidney Disease Related Questionnaire Panel Codes | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1588 | Long Covid Related Questionnaire Panel Codes | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1589 | Nutrition Status Related Questionnaire Panel Codes | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.159 | Chronic Kidney Disease All Stages (1 through 5) | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1590 | Pain Perception Related Questionnaire Panel Codes | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1591 | Patient Goal Related Questionnaire Panel Codes | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1592 | Social Determinant of Health Related Questionnaire Panel Codes | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1593 | Covid 19 Related Health Questionnaire Panel Codes | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1594 | Caregiver Considerations Related Questionnaire Panel Codes | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1595 | Acute COVID 19 Diagnosis SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1597 | Drugs of Abuse Screen | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1598 | Criminal Justice Involvement or Incarceration History | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1599 | Cardiomyopathy Diagnosis SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1600 | Cardiomyopathy Diagnosis ICD10 | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1601 | Atherosclerotic Cardiovascular Disease SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1602 | Neuropathy Diagnosis ICD10 | active | 2024-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1603 | Neuropathy Diagnosis SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1605 | Left Ventricular Hypertrophy ICD10 | active | 2024-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1606 | Left Ventricular Hypertrophy | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1607 | Alanine Aminotransferase (ALT) in Blood, Plasma, or Serum | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1608 | Aspartate Aminotransferase (AST) in Blood, Plasma, or Serum | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1609 | Erythrocyte Sedimentation Rate (ESR) in Blood | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1610 | Oxygen Saturation in Blood | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.176 | Urine Sediment | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.179 | Estimated Glomerular Filtration Rate (eGFR) | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.22 | Alcohol Use Disorder SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.23 | Alcohol Use Disorder ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24 | Alcohol Use Disorder | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.25 | Peripheral Vascular Disease SCT | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.26 | Peripheral Vascular Disease ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.27 | Peripheral Vascular Disease | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.28 | Hepatitis C Condition SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.30 | Hepatitis C Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.31 | Diabetic Neuropathy SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.32 | Diabetic Neuropathy ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.33 | Diabetic Neuropathy Conditions | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.35 | Obesity ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.36 | Obesity Conditions | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.37 | Obesity SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.4 | Chronic Kidney Disease Type or Cause SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.41 | Tuberculosis (Disorders) SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.417 | Prediabetes (Borderline Diabetes) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.418 | Prediabetes (Borderline Diabetes) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.419 | Prediabetes (Borderline Diabetes) | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.420 | Maturity Onset Diabetes of the Young (MODY) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.43 | Tuberculosis Disorders | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.44 | Tuberculosis (Disorders) Ext | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.45 | Hypoalbuminemia Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.450 | CKD Progression Risk | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.46 | Hypoalbuminemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.47 | Hypoalbuminemia Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.48 | Hyperkalemia Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.480 | Diabetic Coma | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.481 | Diabetic Coma | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.482 | Diabetic Coma | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.49 | Hyperkalemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.490 | Diabetic Peripheral Angiopathy | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.491 | Diabetic Peripheral Angiopathy | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.492 | Diabetic Peripheral Angiopathy | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.496 | Cataract of the Eye | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.497 | Cataract of the Eye | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.498 | Cataract of the Eye | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.499 | Rubeosis Iridis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.5 | Chronic Kidney Disease Type or Cause ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.50 | Hyperkalemia Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.500 | Rubeosis Iridis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.501 | Rubeosis Iridis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.502 | Rubeosis Iridis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.506 | Emotional Distress caused by Chronic Condition | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.507 | Emotional Distress caused by Chronic Condition | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.508 | Emotional Distress caused by Chronic Condition | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.51 | Anemia Conditions SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.510 | Hypoglycemic Event | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.512 | Hypoglycemic Event | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.513 | Hypoglycemic Event | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.514 | Hypoglycemia Unawareness | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.515 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.516 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.517 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.518 | Ketoacidosis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.519 | Ketoacidosis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.52 | Anemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.520 | Ketoacidosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.521 | Diabetic Foot | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.522 | Diabetic Foot | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.523 | Diabetic Foot | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.524 | Diabetic Foot Ulcer | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.525 | Diabetic Foot Ulcer | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.526 | Diabetic Foot Ulcer | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.529 | Charcot Foot | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.53 | Anemia Conditions | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.530 | Charcot Foot | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.531 | Charcot Foot | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.533 | Cellulitis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.535 | Diabetic Hand or Diabetic Cheiroarthropathy | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.538 | Necrobiosis Lipoidica (Skin Lesions) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.539 | Necrobiosis Lipoidica (Skin Lesions) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.540 | Necrobiosis Lipoidica (Skin Lesions) | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.541 | Gangrene | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.542 | Gangrene | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.543 | Gangrene | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.544 | Dupuytren's Contracture | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.545 | Dupuytren's Contracture | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.546 | Dupuytren's Contracture | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.547 | Scleroderma or Thick Skin Syndrome | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.548 | Scleroderma or Thick Skin Syndrome | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.549 | Scleroderma or Thick Skin Syndrome | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.554 | Acanthosis Nigricans | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.555 | Acanthosis Nigricans | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.556 | Acanthosis Nigricans | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.557 | Eruptive Xanthomatosis | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.558 | Periodontitis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.559 | Periodontitis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.560 | Periodontitis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.561 | Amputated Limb (Not Traumatic) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.562 | Amputated Limb (Not Traumatic) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.563 | Amputated Limb (Not Traumatic) | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.564 | Hypertension, Essential or Primary ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.565 | Hypertension, Essential or Primary SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.567 | Hypertension, Secondary ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.568 | Hypertension, Secondary SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.571 | Hypertension Stage | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.579 | Cardiomyopathy | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.58 | Hypercalcemia Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.580 | NYHA Heart Failure Functional Classifications | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.581 | American Heart Association Heart Failure Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.582 | Framingham Risk Assessments | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.583 | American College of Cardiology or American Heart Association Ascvd Risk Score (acc/aha Ascvd Risk) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.584 | Atherosclerotic Cardiovascular Disease | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.586 | Gout | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.587 | Psoriatic Arthritis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.588 | Reactive Arthritis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.59 | Hypercalcemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.590 | Experience of Traumatic Events | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.591 | Cannabis Use | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.592 | Hearing Impairment | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.6 | Chronic Kidney Disease Type or Cause | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.60 | Hypercalcemia Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.606 | Angina | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.607 | Angina | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.608 | Angina | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.609 | Unstable Angina | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.61 | Hypocalcemia Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.610 | Unstable Angina | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.611 | Unstable Angina | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.613 | Ischemic Heart Disease | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.614 | Ischemic Heart Disease | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.615 | Left Ventricular Hypertrophy SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.616 | Stroke History | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.618 | Stroke | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.619 | Transient Ischemic Attack | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.62 | Hypocalcemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.620 | Transient Ischemic Attack | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.621 | Transient Ischemic Attack | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.625 | Aneurysm | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.626 | Aneurysm | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.627 | Aneurysm | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.63 | Hypocalcemia Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.634 | Aortic Disease | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.635 | Aortic Disease | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.636 | Aortic Disease | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.637 | Carotid Stenosis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.638 | Carotid Stenosis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.639 | Carotid Stenosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.64 | Hyperphosphatemia Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.640 | Intracranial Stenosis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.641 | Intracranial Stenosis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.642 | Intracranial Stenosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.643 | Pulmonary Edema | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.644 | Pulmonary Edema | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.645 | Pulmonary Edema | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.646 | Osteoarthritis (Oa) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.647 | Osteoarthritis (Oa) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.648 | Osteoarthritis (Oa) | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.649 | Rheumatoid Arthritis (Ra) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.65 | Hyperphosphatemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.650 | Rheumatoid Arthritis (Ra) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.651 | Rheumatoid Arthritis (Ra) | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.652 | Infectious Arthritis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.653 | Infectious Arthritis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.654 | Infectious Arthritis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.656 | Temporomandibular Disorder Diagnosis | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.658 | Irritable Bowel Syndrome | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.659 | Irritable Bowel Syndrome | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.66 | Hyperphosphatemia Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.660 | Irritable Bowel Syndrome | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.661 | Neuropathic Pain (Neuralgia) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.662 | Neuropathic Pain (Neuralgia) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.663 | Neuropathic Pain (Neuralgia) | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.664 | Neuromas | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.665 | Neuromas | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.666 | Neuromas | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.667 | Phantom Pain | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.668 | Phantom Pain | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.669 | Phantom Pain | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.67 | Hematuria Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.670 | Entrapment Neuropathy | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.671 | Entrapment Neuropathy | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.672 | Entrapment Neuropathy | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.673 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome | active | 2023-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.674 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.675 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.676 | Psychotic Depression | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.677 | Psychotic Depression | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.678 | Psychotic Depression | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.679 | Post Partum Depression | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.68 | Hematuria Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.680 | Post Partum Depression | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.681 | Post Partum Depression | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.682 | Seasonal Affective Disorder | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.683 | Seasonal Affective Disorder | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.684 | Seasonal Affective Disorder | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.685 | Psychological Trauma | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.686 | Psychological Trauma | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.687 | Psychological Trauma | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.688 | Grief or Loss | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.689 | Grief or Loss | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.69 | Hematuria Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.690 | Grief or Loss | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.691 | Suicide Risk | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.692 | Suicide Risk | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.693 | Suicide Risk | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.694 | Vaping | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.695 | Vaping | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.696 | Vaping | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.697 | Tobacco Use or Exposure | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.699 | Tobacco Use or Exposure | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.70 | Metabolic Acidosis Conditions | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.701 | Binge Drinking | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.702 | Binge Drinking | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.703 | Binge Drinking | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.704 | Drug Misuse | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.705 | Drug Misuse | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.706 | Drug Misuse | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.707 | Drug Misuse | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.708 | Sensory Status | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.709 | Sensory Status | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.71 | Metabolic Acidosis Conditions ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.711 | Fall Risk | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.713 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.714 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.715 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.716 | Urinary Incontinence | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.717 | Urinary Incontinence | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.718 | Urinary Incontinence | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.719 | Urinary Urgency | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.72 | Metabolic Acidosis Conditions SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.720 | Urinary Urgency | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.721 | Urinary Urgency | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.722 | Urinary Frequency | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.723 | Urinary Frequency | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.724 | Urinary Frequency | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.725 | Nocturia | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.726 | Nocturia | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.727 | Nocturia | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.728 | Pelvic Organ Prolapse | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.729 | Pelvic Organ Prolapse | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.73 | Hyperlipidemia Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.730 | Pelvic Organ Prolapse | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.731 | Erectile Dysfunction | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.732 | Erectile Dysfunction | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.733 | Erectile Dysfunction | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.734 | Interstitial Cystitis or Bladder Pain Syndrome | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.735 | Interstitial Cystitis or Bladder Pain Syndrome | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.736 | Interstitial Cystitis or Bladder Pain Syndrome | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.737 | Recurrent Urinary Tract Infections | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.738 | Recurrent Urinary Tract Infections | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.739 | Recurrent Urinary Tract Infections | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.74 | Hyperlipidemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.740 | Hypertriglyceridemia | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.741 | Hypertriglyceridemia | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.742 | Hypertriglyceridemia | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.743 | Hypothyroidism | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.744 | Hypothyroidism | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.745 | Hypothyroidism | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.746 | Menopause | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.747 | Menopause | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.748 | Menopause | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.749 | Testicular Hypofunction | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.75 | Hyperlipidemia Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.750 | Testicular Hypofunction | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.751 | Testicular Hypofunction | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.752 | Primary Aldosteronism | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.753 | Primary Aldosteronism | active | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.754 | Primary Aldosteronism | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.755 | Restless Leg Syndrome | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.756 | Restless Leg Syndrome | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.757 | Restless Leg Syndrome | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.759 | Claudication | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.76 | Chronic Pain Conditions | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.760 | Claudication | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.761 | Claudication | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.762 | Angioedema | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.763 | Angioedema | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.764 | Angioedema | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.768 | Nonalcoholic Fatty Liver Disease | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.769 | Nonalcoholic Fatty Liver Disease | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.77 | Chronic Pain ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.770 | Nonalcoholic Fatty Liver Disease | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.771 | Thalassemia | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.772 | Thalassemia | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.773 | Thalassemia | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.78 | Chronic Pain SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.79 | Arthritis Disorders SCT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.790 | Urine Protein to Creatinine Ratio (UPCR) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.791 | 24 Hour Urine Volume | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.792 | 24 Hour Urine Protein Excretion | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.793 | Total Carbon Dioxide or Bicarbonate in blood, serum or plasma | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.794 | Calcium (Not Corrected for Serum Albumin) in Blood, Plasms, or Serum | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.795 | B Type Natriuretic Peptide [Bnp] in Blood, Serum or Plasma | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.797 | N Terminal Pro_B_Type Natriuretic Peptide [Nt_Probnp] in blood, serum or plasma | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.799 | Temporomandibular Disorder Diagnosis | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.80 | Arthritis Disorders ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.800 | Temporomandibular Disorder Diagnosis | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.801 | High Sensitivity Troponin | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.804 | Aspartate Transaminase or Alanine Aminotransferase Ratio | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.805 | Alkaline Phosphatase (Alp) in Blood, Serum or Plasma | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.806 | Gamma Glutamyl Transpeptidase (Ggt) in blood, serum or plasma | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.807 | Triiodothyronine in serum or plasma | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.808 | Fasting Blood Glucose | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.809 | Random Blood Glucose Test | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.81 | Arthritis Disorders | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.810 | Uric Acid (Urate) in blood, serum or plasma | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.811 | Aldosterone/Renin Ratio | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.812 | Serum Rheumatoid Factor | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.813 | Blood Ethanol Level | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.814 | Drugs of Abuse Screen in Hair | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.815 | Drugs of Abuse Screen in Urine | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.816 | Drugs of Abuse Screen in Blood | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.817 | Drugs of Abuse Screen in Tissue | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.818 | Drugs of Abuse Screen in Body Fluid | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.819 | Urea Reduction Ratio | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.82 | Preeclampsia Disorders SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.822 | Bowel Sounds | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.823 | Uroflowmetry | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.826 | Gait Quality | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.828 | Balance Assessments | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.83 | Preeclampsia Disorders ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.836 | Sit to Stand Ability | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.84 | Preeclampsia Disorders | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.840 | Spinal Cord Compression | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.841 | Spinal Cord Compression | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.842 | Alcohol Use (Revised 2021) | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.843 | Alcohol Use (Revised 2021) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.844 | Alcohol Use (Revised 2021) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.845 | Alcohol Use | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.85 | Hyperuricemia Conditions | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.86 | Hyperuricemia Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.864 | Kidney Biopsy Report | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.867 | Skin Biopsy Report | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.868 | Muscle Biopsy Report | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.869 | Gastric Tissue Biopsy Report | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.87 | Hyperuricemia Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.870 | Bone Biopsy Report | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.873 | Echocardiogram | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.88 | Vitamin D Deficiency Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.880 | Spinal or Back CT | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.881 | Chest CT | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.882 | Abdominal or Pelvic CT | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.883 | Limb CT | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.884 | Heart Calcium Score | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.885 | Coronary CT Angiogram | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.886 | Limb CT Angiogram | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.888 | Chest CT Angiogram | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.889 | Head and Neck CT Angiogram | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.89 | Vitamin D Deficiency Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.891 | Gastrointestinal Tract X Ray | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.892 | Gallbladder X Ray | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.893 | Kidney X Ray | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.894 | Abdomen X Ray | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.895 | Pelvis X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.896 | Hand X Ray | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.897 | Wrist X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.898 | Forearm X Ray | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.899 | Elbow X Ray | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.90 | Vitamin D Deficiency Conditions | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.900 | Upper Arm X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.901 | Shoulder X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.902 | Upper Extremity X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.903 | Foot X Ray | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.904 | Ankle X Ray | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.905 | Shin X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.906 | Knee X Ray | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.907 | Thigh X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.908 | Hip X Ray | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.909 | Lower Extremity X Ray | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.91 | Alkaline Phosphatase Deficiency Conditions SCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.910 | Abdominal MRI | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.911 | Adrenal Gland MRI | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.912 | Kidney MRI | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.913 | Pancreas MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.915 | Kidney MRA | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.916 | Chest Region MRI | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.917 | Pulmonary MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.918 | Cardiac MRI | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.92 | Alkaline Phosphatase Deficiency Conditions ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.920 | Spine MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.921 | Head and Neck MRI | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.922 | Brain MRI | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.923 | Pelvic Region MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.924 | Knee MRI | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.925 | Foot MRI | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.927 | Shoulder MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.928 | Lower Extremity MRA | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.93 | Alkaline Phosphatase Deficiency Conditions | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.930 | Spine X Ray | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.933 | Hip MRI | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.934 | Thigh or Femur MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.935 | Ankle MRI | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.936 | Lower Extremity MRI | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.937 | Forearm MRI | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.938 | Elbow MRI | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.939 | Wrist MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.94 | Uremic Pruritus Conditions ICD10 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.940 | Hand MRI | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.942 | Upper Extremity MRI | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.943 | Abdominal MRA | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.944 | Chest MRA | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.945 | Upper Extremity MRA | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.947 | Head and Neck MRA | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.948 | Pelvic Region MRA | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.949 | Functional MRI | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.95 | Uremic Pruritus Conditions SCT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.951 | Optical Coherence Tomography | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.954 | Bathing or grooming/hygiene (ADL/IADL) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.955 | Dressing (ADL or IADL) | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.956 | Toileting (ADL or IADL) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.957 | Transferring (ADL or IADL) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.958 | Walking or ambulation/locomotion (ADL/IADL) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.96 | Uremic Pruritus Conditions | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.960 | Domestic Duties or Household Tasks (ADL/IADL) | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.961 | Telephone Use (ADL or IADL) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.962 | Bed Mobility (ADL or IADL) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.963 | Stair Use (ADL or IADL) | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.964 | Medication Management (ADL or IADL) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.967 | Electromyography | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.968 | Electroencephalogram | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.969 | Exercise Stress Test | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.97 | Insomnia Disorders | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.976 | Sleep Duration, Device | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.977 | Steps Per Time, Device | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.978 | Physical Activity Level, Device | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.979 | Cognitive Function Clinician Interpretation | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.98 | Insomnia Disorders ICD10 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.987 | Psychosis | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.99 | Insomnia Disorders SCT | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.991 | Suicidal Ideation and Behaviors | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.994 | Sleep Duration | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.996 | Pain Intensity or Severity | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.997 | Pain Quality | active | 2024-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.4 | Glaucoma ICD10 | active | 2022-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.5 | Glaucoma SNOMED | active | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.1 | Scleritis | active | 2021-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.2 | Scleritis | active | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.3 | Scleritis | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.1 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography | active | 2021-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.2 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Non Diagnostic or Non CT | active | 2021-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.3 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Nuclear Medicine With CT | active | 2021-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.4 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography CT Without Specified Body Region | active | 2021-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.6 | Outpatient Encounter Locations | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.7 | Outpatient Activity Codes | active | 2023-02 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.6 | Anaphylaxis, ICD10CM codes for AE reporting | active | 2021-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.60 | Guillain Barre Syndrome, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.61 | Febrile seizure, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.62 | Encephalomyelitis and encephalitis, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.63 | Disseminated Intravascular Coagulation, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.64 | Deep Vein Thrombosis, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.65 | Bells Palsy, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.66 | Appendicitis, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.67 | Anaphylaxis, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.68 | Acute Myocardial Infarction, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.69 | Multisystem Inflammatory Syndrome, SNOMED codes for AE reporting | active | 2021-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.7 | Anaphylaxis, SNOMED codes for AE reporting | active | 2021-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.70 | Multisystem Inflammatory Syndrome, diagnosis codes for AE reporting | active | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.71 | Transfusion CPT codes for exposure identification | active | 2021-12 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.72 | Transfusion ICD9 codes for exposure identification | active | 2021-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.73 | Transfusion ICD10PCS codes for exposure identification | active | 2021-12 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.74 | Transfusion CPT, ICD9, ICD10PCS codes for exposure identification | active | 2021-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75 | COVID19 vaccine ICD10PCS codes for exposure identification | active | 2022-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.8 | Appendicitis, SNOMED codes for AE reporting | active | 2021-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.9 | Appendicitis, ICD10CM codes for AE reporting | active | 2021-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.1 | Test Diabetes codes | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.12 | Metabolic Syndrome LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.15 | MetabolicSyndromeCondition | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.16 | Annual Physical ICD9 CN5 | active | 2023-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.164 | Diabetic Retinal Screening HD CPT for Tax Pair | active | 2023-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.165 | Optometrist and Ophthalmologist Taxonomy HD Taxonomy | active | 2023-03 | us | hl7 | nucc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.167 | End Stage Renal Disease (ESRD)_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.168 | End Stage Renal Disease (ESRD)_HD_ICD9 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.169 | End Stage Renal Disease (ESRD)_HD_ICD10 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.17 | Annual Physical ICD10 CN5 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.170 | End Stage Renal Disease (ESRD)_HD_HCPCS | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.171 | End Stage Renal Disease (ESRD)_HD_LOINC | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.172 | End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.173 | Systolic Blood Pressure_HD_SNOMED | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.174 | Systolic Blood Pressure_HD_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.175 | Systolic Blood Pressure_HD_LOINC | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.177 | Diastolic Blood Pressure_HD_SNOMED | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.178 | Diastolic Blood Pressure_HD_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.179 | Diastolic Blood Pressure_HD_LOINC | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.18 | Annual Physical SNOMED CN5 | active | 2023-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.181 | Remote Blood Pressure_HD_SNOMED | active | 2023-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.182 | Remote Blood Pressure_HD | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.183 | Remote Blood Pressure_HD_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.184 | Acute Inpatient_CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.185 | Acute Inpatient_CN_HD_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.186 | Acute Inpatient_HD_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.187 | ED Visit_CN_HD_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.188 | ED Visit_CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.19 | Annual Physical Taxonomy CN5 | active | 2024-06 | us | hl7 | nucc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.191 | Pregnancy_CN_HD_SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.192 | Pregnancy_CN_HD_ICD10 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.193 | ED Visit_HD_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.194 | Lipid Panel_Event_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.195 | Lipid Panel_Event_HCPCS | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.196 | Lipid Panel_Event_LOINC | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.197 | Lipid Panel_Event_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.199 | Unknown Glucose_Event_ICD9 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.20 | Annual Physical CN5 | active | 2023-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.200 | Unknown Glucose_Event_ICD10 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.201 | Unknown Glucose_Event_LOINC | active | 2023-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.202 | Unknown Glucose_Event_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.203 | Unknown Glucose_Event_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.205 | Bone Marrow Transplant CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.206 | Bone Marrow Transplant CN_HD_ICD10 | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.207 | Bone Marrow Transplant_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.208 | Immunocompromising Conditions CN_HD_ICD9 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.209 | Immunocompromising Conditions CN_HD_ICD10PCS | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.21 | Annual Physical CPT CN5 | active | 2023-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.210 | Immunocompromising Conditions CN_HD_ICD10CM | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.211 | Immunocompromising Conditions_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.212 | Immunocompromising Conditions CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.213 | Cerebrospinal Fluid Leak CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.214 | Cerebrospinal Fluid Leak CN_HD_ICD10 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.215 | Cerebrospinal Fluid Leak_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.216 | Anatomic or Functional Asplenia CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.217 | Anatomic or Functional Asplenia CN_HD_ICD9 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.218 | Anatomic or Functional Asplenia CN_HD_ICD10 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.219 | Anatomic or Functional Asplenia_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.22 | Annual Physical HCPCS CN5 | active | 2023-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.220 | Sickle cell Anemia and HB S Disease CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.221 | Sickle cell Anemia and HB S Disease CN_HD_ICD10 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.222 | Sickle cell Anemia and HB S Disease_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.223 | Pneumococcal Vaccine CN_HD_SNOMED | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.224 | Pneumococcal Vaccine CN_HD_HCPCS | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.225 | Pneumococcal Vaccine CN_HD_CVX | active | 2025-04 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.226 | Pneumococcal Vaccine CN_HD_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.227 | Pneumococcal Vaccine_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228 | Influenza Vaccine CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.229 | Influenza Vaccine CN_HD_HCPCS | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.23 | Annual Physical CPT for Tax Pair CN5 | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.230 | Influenza Vaccine CN_HD_CVX | active | 2023-01 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231 | Influenza Vaccine CN_HD_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.232 | Influenza Vaccine_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.233 | Cochlear Implant CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.234 | Cochlear Implant CN_HD_ICD10 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.235 | Cochlear Implant CN_HD_HCPCS | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.236 | Cochlear Implant CN_HD_CPT | active | 2023-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.237 | Cochlear Implant_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.238 | Chemotherapy CN_HD_SNOMED | active | 2023-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.239 | Chemotherapy CN_HD_ICD10 | active | 2023-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.24 | Annual Physical ICD9 for Tax Pair CN5 | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.240 | Chemotherapy CN_HD_CPT | active | 2023-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.241 | Chemotherapy_HD_CN_Grouping | active | 2023-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.244 | Fasting Blood Glucose_Lab_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.245 | Chronic Heart Failure (CHF)_ICD9 | active | 2023-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.246 | Chronic Heart Failure (CHF)_ICD10 | active | 2023-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.251 | Asthma_LOINC | active | 2023-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.253 | Asthma_Clinical Condition Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.254 | Pregnancy Loss_HD_SNOMED | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.255 | Pregnancy Loss_HD_ICD10 | active | 2024-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.257 | Pregnancy Loss_HD_Clinical Condition Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.258 | Heart Failure (CHF)_ICD9 | active | 2023-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.259 | Heart Failure (CHF)_ICD10 | active | 2023-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.260 | Heart Failure (CHF)_SNOMED | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.261 | Heart Failure (CHF)_HCPCS | active | 2023-11 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.262 | Heart Failure (CHF)_LOINC | active | 2023-11 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.263 | Heart Failure (CHF)_CPT | active | 2023-11 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.264 | Heart Failure (CHF)_RxNorm | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.270 | Triglyceride_Lab_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.274 | Total Cholesterol_CPT | active | 2023-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.275 | Total Cholesterol_Lab_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.276 | LDL_SNOMED | active | 2023-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.280 | LDL_Lab_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.284 | HDL_LOINC | active | 2023-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.285 | HDL_Lab_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.286 | Colectomy_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.288 | Colectomy_ICD9 | active | 2023-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.29 | Hospice Exclusions Grouping | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.290 | Colectomy_Event_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.291 | CT Colonography_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.292 | CT Colonography_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.294 | CT Colonography_Event_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.295 | FIT DNA_LOINC | active | 2023-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.296 | FIT DNA_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.297 | FIT DNA_HCPCS | active | 2023-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.298 | FIT DNA_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.299 | FIT DNA Test_Lab_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.30 | Annual Physical Codes for Tax Pair CN5 | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.300 | Sigmoidoscopy_CPT | active | 2023-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.302 | Sigmoidoscopy_ICD9 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.303 | Sigmoidoscopy_SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.304 | Sigmoidoscopy_Event_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.305 | Colonoscopy_CPT | active | 2023-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.306 | Colonoscopy_HCPCS | active | 2023-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.307 | Colonoscopy_ICD9 | active | 2023-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.308 | Colonoscopy_SNOMED | active | 2023-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.309 | Colonoscopy_Event_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.310 | FOBT Lab_CPT | active | 2023-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.311 | FOBT Lab_HCPCS | active | 2023-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.312 | FOBT Lab_LOINC | active | 2023-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.313 | FOBT Lab_SNOMED | active | 2023-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.315 | Colorectal Cancer_HD_ICD10 | active | 2023-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.316 | Colorectal Cancer_HD_ICD9 | active | 2023-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.317 | Colorectal Cancer_HD_SNOMED | active | 2023-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.318 | Colorectal Cancer_HD_Grouping | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.319 | Absence of Cervix Diagnosis_HD_ICD10 | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.320 | Absence of Cervix Diagnosis_HD_ICD9 | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.321 | Absence of Cervix Diagnosis_HD_SNOMED | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.322 | Absence of Cervix Diagnosis_HD_Grouping | active | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.323 | Hysterectomy With No Residual Cervix_HD_CPT | active | 2023-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.324 | Hysterectomy With No Residual Cervix_HD_ICD10 | active | 2023-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.325 | Hysterectomy With No Residual Cervix_HD_ICD9 | active | 2023-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.326 | Hysterectomy With No Residual Cervix_HD_SNOMED | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.327 | Hysterectomy With No Residual Cervix_HD_Grouping | active | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328 | High Risk HPV Test_HD_CPT | active | 2023-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329 | High Risk HPV Test_HD_HCPCS | active | 2023-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330 | High Risk HPV Test_HD_LOINC | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331 | High Risk HPV Test_HD_SNOMED | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping | active | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.333 | Cervical Cytology_HD_CPT | active | 2023-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.334 | Cervical Cytology_HD_HCPCS | active | 2023-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.335 | Cervical Cytology_HD_LOINC | active | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.336 | Cervical Cytology_HD_SNOMED | active | 2023-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping | active | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.338 | AFib (Atrial Fibrillation)_ICD9 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.339 | AFib (Atrial Fibrillation)_ICD10 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.340 | AFib (Atrial Fibrillation)_SNOMED | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.341 | AFib (Atrial Fibrillation)_LOINC | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.342 | AFib (Atrial Fibrillation)_RxNORM | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.343 | AFib (Atrial Fibrillation)_CPT | active | 2023-08 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.345 | COVID19 Vaccine_CPT | active | 2023-08 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.346 | COVID19 Vaccine_HCPCS | active | 2023-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.348 | COVID19 Vaccine_RxNorm | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.349 | COVID19 Vaccine_CVX | active | 2025-04 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350 | COVID19 Vaccine_Event Clinical Grouping | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.351 | Coronary Artery Disease (CAD)_ICD9 | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.352 | Coronary Artery Disease (CAD)_ICD10PCS | active | 2023-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.353 | Coronary Artery Disease (CAD)_ICD10CM | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.354 | Coronary Artery Disease (CAD)_CPT | active | 2023-08 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.355 | Coronary Artery Disease (CAD)_HCPCS | active | 2023-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.356 | Coronary Artery Disease (CAD)_LOINC | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.357 | Coronary Artery Disease (CAD)_SNOMED | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.358 | Coronary Artery Disease (CAD)_CUI_UMLS | active | 2023-08 | us | hl7 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.360 | Allergy List_SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.361 | Allergy List_ICD10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.362 | Allergy List_Clinical Grouping Event | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.363 | Statin Use_RxNorm | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.364 | Other Revascularization_SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.365 | Other Revascularization_CPT | active | 2023-09 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.366 | Other Revascularization_Grouping | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.367 | Ischemic Vascular Disease (IVD)_SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.368 | Ischemic Vascular Disease (IVD)_ICD10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.369 | Ischemic Vascular Disease (IVD)_Grouping | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.370 | Muscular Pain and Disease_SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.371 | Muscular Pain and Disease_ICD10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.372 | Muscular Pain and Disease_Grouping | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.373 | Cirrhosis_SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.374 | Cirrhosis_ICD10 | active | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.375 | Cirrhosis_Grouping | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.376 | IVF_SNOMED | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.377 | IVF_HCPCS | active | 2023-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.378 | IVF_Grouping | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.379 | Estrogen Agonists Medications_RXNORM | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.382 | Pre_Hypertension (Pre_HTN)_Clinical Condition Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.384 | Family History Hypertension (HTN)_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.385 | Family History Hypertension (HTN)_Clinical Condition Grouping | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.386 | Obesity_Condition_UMLS | active | 2024-04 | us | hl7 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.387 | Podiatry_Taxonomy | active | 2023-11 | us | hl7 | nucc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.388 | Cardiology _Taxonomy | active | 2023-11 | us | hl7 | nucc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.393 | BMI >=40_Event_Clinical Condition Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.400 | Smoker Status_Event_Clinical Condition Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.401 | First Trimester_ICD10 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.402 | First Trimester_SNOMED | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.403 | First Trimester_LOINC | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.404 | First Trimester_CPT | active | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.405 | First Trimester_UMLS CUI | active | 2024-02 | us | hl7 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.408 | Birth Event_ICD10 | active | 2024-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.409 | Birth Event_SNOMED | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.413 | Birth Event_Clinical Grouping Event | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.414 | Obesity_Condition_SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.415 | Obesity_Condition_ICD10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.416 | Obesity_Condition_ICD9 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.418 | Pre_Hypertension (Pre_HTN)_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.419 | Pre_Hypertension (Pre_HTN)_ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.420 | Pre_Hypertension (Pre_HTN)_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.424 | BMI >=30_Event_Clinical Condition Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.427 | Obesity_Condition_LOINC | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.428 | Vitals Body Height LOINC | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.429 | Vitals Body Height SnoMed | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.430 | Vitals Body Height | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.431 | bwell_Vital_Blood Glucose_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.432 | Anxiety_Clinical Grouping Condition_ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.433 | Anxiety_Clinical Grouping Condition_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.434 | Anxiety_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.435 | Anxiety_Clinical Grouping Condition_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.437 | bwell_Vital_Blood Oxygen_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.438 | bwell_Vital_Systolic Blood Pressure_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.439 | bwell_Vital_Diastolic Blood Pressure_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.440 | bwell_Vital_Heart Rate_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.441 | bwell_Vital_BMI_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.442 | bwell_Vital_Body Fat_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.443 | bwell_Vital_Body Temperature_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.444 | bwell_Vital_Body Height_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.445 | bwell_Vital_Body Weight_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.446 | bwell_Vital_Respiratory Rate_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.447 | bwell_Vital_Waist Circumference_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.448 | bwell_Vital_Blood Glucose_Clinical Grouping Lab | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.453 | bwell_Vital_BMI_Clinical Grouping Event | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.454 | bwell_Vital_Body Fat_Clinical Grouping Event | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.456 | bwell_Vital_Body Height_Clinical Grouping Event | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.457 | bwell_Vital_Body Weight_Clinical Grouping Event | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.458 | bwell_Vital_Respiratory Rate_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.459 | bwell_Vital_Waist Circumference_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.460 | Pregnancy_CN_HD_LOINC | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.461 | Pregnancy_CN_HD_CPT | active | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.462 | Pregnancy_CN_HD_UMLS | active | 2024-02 | us | hl7 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.463 | Second Trimester_ICD10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.464 | Second Trimester_SNOMED | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.466 | Third Trimester_SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.467 | Third Trimester_ICD10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.469 | Pregnancy Due Date_LOINC | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.470 | Second Trimester_LOINC | active | 2024-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.472 | OGTT_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.473 | OGTT_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475 | OGTT_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.476 | OGTT_Grouping | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.477 | Second Trimester_CPT | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.479 | Prostate Cancer Screening_HD_ICD9 | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.482 | Prostate Cancer Screening_HD_Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.484 | Prostate Dysplasia_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.486 | Prostate Dysplasia_Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.487 | Prostectomy_ICD10 | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.488 | Prostectomy_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.490 | Prostectomy_Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.494 | PSA Testing _LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.495 | PSA Testing_Grouping | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.496 | Active Pregnancy_CPT | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.497 | Active Pregnancy_ICD10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.498 | Active Pregnancy_LOINC | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.499 | Active Pregnancy_SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.5 | ADD/ADHD Condition | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.501 | Abnormal PSA Testing _SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.502 | Prediabetes_Clinical Grouping Condition_ICD10 | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.503 | Prediabetes_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.504 | Prediabetes_Clinical Grouping Condition | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.505 | Third Trimester_CPT | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.506 | Third Trimester_LOINC | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.508 | bwell_Vital_Waist Circumference_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.509 | bwell_Vital_Blood Oxygen_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.510 | bwell_Vital_Body Temperature_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.511 | bwell_Vital_Diastolic Blood Pressure_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.512 | bwell_Vital_Systolic Blood Pressure_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.513 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.514 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.515 | bwell_Vital_Heart Rate_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.516 | bwell_Vital_Respiratory Rate_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.517 | Lupus_Clinical_Condition_ICD10 | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.519 | Lupus_Clinical_Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.520 | Lupus_Clinical Condition Grouping | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.523 | UTI_Clinical_Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.524 | UTI_Clinical Condition Grouping | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.525 | Postpartum_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.526 | Postpartum_HCPCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.527 | Postpartum_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.528 | Postpartum_ICD9CM | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.529 | Postpartum_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.530 | Postpartum_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.531 | Postpartum_Clinical Grouping Event | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.532 | bwell_Vital_Head Circumference_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.533 | bwell_Vital_Head Circumference_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.535 | bwell_Vital_Body Surface Area_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.536 | bwell_Vital_Body Surface Area_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.538 | bwell_Vital_Vital Signs Panel_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.539 | bwell_Vital_Vital Signs Panel_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.540 | bwell_Vital_Vital Signs Panel_Clinical Grouping Event | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.541 | bwell_Vital_Blood Pressure Panel_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.542 | bwell_Vital_Blood Pressure Panel_Clinical Grouping Event | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.543 | Depression_Clinical Grouping Condition_CPT | active | 2025-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.544 | Depression_Clinical Grouping Condition_HCPCS | active | 2025-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.545 | Depression_Clinical Grouping Condition_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.546 | Depression_Clinical Grouping Condition_ICD9 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.547 | Depression_Clinical Grouping Condition_LOINC | active | 2025-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.548 | Depression_Clinical Grouping Condition_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition | active | 2024-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.550 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.551 | MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.552 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.553 | MI (Myocardial Infarction)_Clinical Grouping Condition | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.554 | CABG_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.555 | CABG_Clinical Grouping Condition_HCPCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.556 | CABG_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.557 | CABG_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.558 | CABG_Clinical Grouping Condition | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.559 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.56 | Diabetic Retinal Screening HD CPT | active | 2024-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.560 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_HCPCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.561 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.562 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD9PCS | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.563 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.564 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.565 | Essential HTN_HD_Clinical Grouping Condition_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.566 | Essential HTN_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.567 | Essential HTN_HD_Clinical Grouping Condition | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.568 | Total and Partial Neph_HD_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.569 | Total and Partial Neph_HD_Clinical Grouping Condition_ICD10 | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.570 | Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.571 | Total and Partial Neph_HD_Clinical Grouping Condition | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.572 | Kid Trans and Hx_HD_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.573 | Kid Trans and Hx_HD_Clinical Grouping Condition_HCPCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.574 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10CM | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.575 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.576 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.577 | Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.578 | Kid Trans and Hx_HD_Clinical Grouping Condition | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.579 | HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.580 | HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.581 | Systolic Less than 140_HD_Clinical Grouping Event_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.582 | Diastolic Less than 90_HD_Clinical Grouping Event_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.583 | Systolic Less than 140_HD_Clinical Grouping Event | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.584 | Diastolic Less than 90_HD_Clinical Grouping Event | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.585 | COPD_Clinical_Grouping_Condition_ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.586 | COPD_Clinical_Grouping_Condition_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.587 | COPD_Clinical_Grouping_Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.588 | COPD_Clinical Condition Grouping | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.589 | Polypharmacy_Clinical_Grouping_Condition_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.590 | Polypharmacy_Clinical_Grouping_Condition_ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.591 | Polypharmacy_Clinical_Grouping_Condition_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.592 | Polypharmacy_Clinical_Grouping_Condition_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.595 | Thyroid Cancer_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.596 | Thyroid Cancer_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.597 | Thyroid Cancer_Grouping | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.598 | Allergy Iodine_SNOMED | active | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.599 | Allergy to contrast_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.600 | Allergy to contrast_ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.601 | Allergy to contrast_Grouping | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.602 | Contrast induced nephropathy_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.603 | Contrast induced nephropathy_ICD10 | active | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.604 | Contrast induced nephropathy_Grouping | active | 2025-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.607 | Diastolic Blood Pressure_Compliant_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.608 | Systolic Blood Pressure_Compliant_CPT | active | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.609 | bwell Systolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.610 | bwell Systolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.611 | bwell Diastolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.612 | bwell Diastolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.613 | bwell Combo Blood Pressure Vitals_UI_LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.614 | bwell Combo Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.615 | bwell Systolic Blood Pressure_UI | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.616 | bwell Diastolic Blood Pressure_UI | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.617 | bwell Combo Blood Pressure_UI | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.618 | b.well Herpes Zoster Vaccine CN_HD | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.619 | b.well Herpes Zoster Vaccine CN_HD_SNOMED | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.620 | b.well Herpes Zoster Vaccine CN_HD_CVX | active | 2025-03 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.621 | b.well Herpes Zoster Vaccine CN_HD_CPT | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.622 | b.well Herpes Zoster Vaccine CN_HD_2dose | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.623 | b.well Herpes Zoster Vaccine CN_HD_2dose_CPT | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.624 | b.well Herpes Zoster Vaccine CN_HD_2dose_CVX | active | 2025-03 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.625 | b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.626 | b.well Herpes Zoster Vaccine CN_HD_Exclusions | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.627 | b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.628 | b.well Adult RSV Vaccine CN_CVX | active | 2025-03 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.629 | b.well Adult RSV Vaccine CN_CPT | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.630 | b.well Adult RSV Vaccine CN_HCPCS | active | 2025-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.631 | b.well Adult RSV Vaccine CN_SNOMED | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.635 | LP(a) Test_ICD | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.638 | b.well Adult Tetanus Vaccine CN | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.639 | BWellAdultTetanusVaccineCN_SNOMED | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.640 | b.well Adult Tetanus Vaccine CN_CPT | active | 2025-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.641 | b.well Adult Tetanus Vaccine CN_CVX | active | 2025-04 | us | hl7 | cvx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.642 | b.well Adult Tetanus Vaccine CN_Exclusions_SNOMED | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.643 | b.well Adult Tetanus Vaccine CN_Exclusions | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.644 | BWellAdultTetanusVaccineCN_RxNorm | active | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.645 | Pneumococcal Vaccine HD_CN_ Allergy | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.646 | bwell COVID Vaccine CN_Allergy | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.647 | bwell Covid Vaccine CN_Allergy_SNOMED | active | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.648 | bwell COVID Vaccine CN_Met | active | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.9 | Metabolic Syndrome ICD10 | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.91 | Cardiomyopathy Dilated ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.92 | Cardiomyopathy Dilated ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.93 | Cardiomyopathy Dilated SNOMED | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition | active | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.95 | Cardiomyopathy Dilated LOINC | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.96 | Cardiomyopathy Hypertrophic ICD9 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.97 | Cardiomyopathy Hypertrophic ICD10 | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.98 | Cardiomyopathy Hypertrophic SNOMED | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.99 | Cardiomyopathy Hypertrophic LOINC | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.12 | SNOMEDFindingValuesQualifierValue | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.13 | SNOMED Organism from LOINC Answer List | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.18 | Medication Prescribable Brand Name | active | 2021-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.2 | SNOMED Organisms | active | 2021-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.22 | Medicinal Ingredients RXNORM | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.1 | Mental Status Observation | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.10 | Other Unknown Nulls | active | 2023-11 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.11 | Sexual Orientation Including nulls and Data Absent Reason | active | 2023-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.12 | Pregnancy Status Observation | active | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.2 | No Healthcare Agent Included Reason | active | 2024-08 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.3 | Sex | active | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.4 | Asked Declined Data Absent Reason | active | 2023-06 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.5 | Act Encounter Codes | active | 2023-10 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.6 | Completed or Nullified Act Status | active | 2023-10 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.7 | Data Absent Reason Types of Unknown | active | 2023-10 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.8 | Medication Adherence | active | 2023-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.2 | Sickle Cell Disease | active | 2022-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.4 | Depression | active | 2022-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.1 | Food Insecurity Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.100 | Intimate Partner Violence Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.101 | Less Than High School Education Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.102 | Less Than High School Education Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.103 | Less Than High School Education Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.106 | Transportation Insecurity Interventions SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.107 | Financial Insecurity Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.108 | Financial Insecurity Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.109 | Financial Insecurity Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.11 | Food Insecurity Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.110 | Medical Cost Burden Goals SNOMED CT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.111 | Health Insurance Coverage Status Goals SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.112 | Health Literacy Diagnoses SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.113 | Health Literacy Diagnoses ICD10CM | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.114 | Health Literacy Goals SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.115 | Health Literacy Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.116 | Health Literacy Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.117 | Health Literacy Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.118 | Health Literacy Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.119 | Health Literacy Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.120 | Medical Cost Burden Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.121 | Health Insurance Coverage Status Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.122 | Medical Cost Burden Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.123 | Medical Cost Burden Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.124 | Health Insurance Coverage Status Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.125 | Health Insurance Coverage Status Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.126 | Social Determinants of Health Screening Assessments | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.127 | Food Insecurity Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.128 | Transportation Insecurity Screening Assessments | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.129 | Homelessness Screening Assessments | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.13 | Homelessness Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.130 | Housing Instability Screening Assessments | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.131 | Inadequate Housing Screening Assessments | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.132 | Less Than High School Education Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.133 | Unemployment Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.134 | Veteran Status Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.135 | Social Connection Screening Assessments | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.136 | Stress Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.137 | Cognitive disorder Diagnosis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.138 | Financial Insecurity Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.139 | Material Hardship Screening Assessments | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.14 | Homelessness Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.140 | Intimate Partner Violence Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.141 | Health Literacy Screening Assessments | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.142 | Medical Cost Burden Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.143 | Health Insurance Coverage Status Screening Assessments | active | 2022-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.144 | Elder Abuse Screening Assessments | active | 2022-10 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.145 | Less Than High School Education Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.146 | Financial Insecurity Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.147 | Health Insurance Coverage Status Diagnoses ICD10CM | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.148 | Health Insurance Coverage Status Diagnoses | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.149 | Health Insurance Coverage Status Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.15 | Food Insecurity Interventions CPT | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.150 | Material Hardship Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.151 | Medical Cost Burden Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.152 | Medical Cost Burden Diagnoses SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.153 | Medical Cost Burden Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.154 | Medical Cost Burden Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.157 | Transportation Insecurity Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.158 | Homelessness Goals SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.159 | Homelessness Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.16 | Food Insecurity Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.160 | Housing Instability Goals SNOMED CT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.161 | Housing Instability Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.162 | Transportation Insecurity Goals SNOMED CT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.163 | Transportation Insecurity Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.164 | Veteran Status Interventions SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.167 | Inadequate Housing Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.168 | Material Hardship Screening Assessments Questions | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.169 | Stress Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.17 | Food Insecurity Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.170 | Transportation Insecurity Screening Assessments Questions | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.171 | Unemployment Screening Assessments Questions | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.172 | Veteran Status Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.173 | Financial Insecurity Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.174 | Food Insecurity Screening Assessments Answers | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.175 | Health Literacy Screening Assessments Answers | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.176 | Homelessness Screening Assessments Answers | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.177 | Housing Instability Screening Assessments Answers | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.178 | Inadequate Housing Screening Assessments Answers | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.179 | Less Than High School Education Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.18 | Homelessness Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.180 | Material Hardship Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.181 | Stress Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.182 | Transportation Insecurity Screening Assessments Answers | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.183 | Unemployment Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.184 | Veteran Status Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.185 | Health Insurance Coverage Status Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.186 | Health Insurance Coverage Status Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.187 | Medical Cost Burden Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.188 | Medical Cost Burden Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.189 | Elder Abuse Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.19 | Homelessness Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.190 | Elder Abuse Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.191 | Elder Abuse Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.192 | Veteran Status Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.193 | Financial Insecurity Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.194 | Food Insecurity Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.195 | Health Literacy Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.196 | Homelessness Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.197 | Housing Instability Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.198 | Intimate Partner Violence Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.199 | Less Than High School Education Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.20 | Homelessness Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.200 | Material Hardship Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.201 | Medical Cost Burden Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.202 | Social Connection Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.203 | Stress Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.204 | Transportation Insecurity Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.205 | Unemployment Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.206 | Social Determinants of Health Screening Assessments And Questions | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.207 | Social Determinants of Health Screening Assessments Questions | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.208 | Social Determinants of Health Screening Assessments Answers | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.209 | Intimate Partner Violence Screening Assessments Answers | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.21 | Homelessness Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.210 | Social Connection Screening Assessments Answers | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.211 | Intimate Partner Violence Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.212 | Social Connection Screening Assessments Questions | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.213 | Health Insurance Coverage Status Diagnoses SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.214 | Veteran Status Goals | active | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.215 | Veteran Status Goals SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.217 | Digital Literacy Diagnoses SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.218 | Digital Literacy Diagnoses ICD10CM | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.219 | Digital Literacy Goals SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.22 | Housing Instability Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.220 | Digital Literacy Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.224 | Digital Literacy Diagnoses | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.225 | Digital Literacy Goals | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.226 | Digital Literacy Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.227 | Digital Literacy Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.229 | Digital Access Diagnoses SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.23 | Housing Instability Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.230 | Digital Access Diagnoses ICD10CM | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.231 | Digital Access Diagnoses | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.232 | Digital Access Goals SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.233 | Digital Access Goals | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.234 | Digital Access Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.235 | Digital Access Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.236 | Digital Access Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.237 | Digital Access Screening Assessments | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.238 | Digital Access Screening Assessments Questions | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.239 | Digital Access Screening Assessments Answers | active | 2023-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.24 | Housing Instability Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.240 | Digital Access Screening Assessments And Questions | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.241 | Utility Insecurity Diagnoses SNOMED CT | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.242 | Utility Insecurity Diagnoses ICD10CM | active | 2024-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.243 | Utility Insecurity Diagnoses | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.244 | Utility Insecurity Goals SNOMED CT | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.245 | Utility Insecurity Goals | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.246 | Utility Insecurity Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.247 | Utility Insecurity Procedures | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.248 | Utility Insecurity Screening Assessments | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.249 | Utility Insecurity Screening Assessments Questions | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.25 | Transportation Insecurity Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.250 | Utility Insecurity Screening Assessments Answers | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.251 | Utility Insecurity Screening Assessments And Questions | active | 2023-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.252 | Utility Insecurity Service Requests | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.253 | Social Determinants of Health General Interventions HCPCS | active | 2024-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.254 | Incarceration Status Diagnoses ICD10CM | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.255 | Incarceration Status Diagnoses SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.256 | Incarceration Status Goals SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.257 | Incarceration Status Goals | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.258 | Incarceration Status Diagnoses | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.259 | Incarceration Status Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.26 | Transportation Insecurity Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.260 | Incarceration Status Procedures | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.261 | Incarceration Status Service Requests | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.262 | Language Access Diagnoses | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.263 | Language Access Diagnoses ICD10CM | active | 2024-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.264 | Language Access Diagnoses SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.265 | Language Access Goals SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.266 | Language Access Goals | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.267 | Language Access Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.268 | Language Access Procedures | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.269 | Language Access Service Requests | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.27 | Transportation Insecurity Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.270 | Language Access Screening Assessments | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.271 | Language Access Screening Assessments Answers | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.272 | Language Access Screening Assessments Questions | active | 2024-12 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.273 | Language Access Screening Assessments And Questions | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.28 | Transportation Insecurity Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.29 | Financial Insecurity Goals SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.3 | Food Insecurity Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.30 | Financial Insecurity Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.31 | Financial Insecurity Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.32 | Financial Insecurity Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.33 | Material Hardship Diagnoses ICD10CM | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.34 | Material Hardship Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.35 | Material Hardship Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.36 | Material Hardship Goals SNOMED CT | active | 2023-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.37 | Material Hardship Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.38 | Material Hardship Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.39 | Material Hardship Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.4 | Food Insecurity Goals SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.40 | Unemployment Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.41 | Unemployment Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.42 | Unemployment Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.43 | Housing Instability Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.44 | Housing Instability Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.45 | Housing Instability Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.46 | Inadequate Housing Diagnoses SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.47 | Inadequate Housing Diagnoses ICD10CM | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.48 | Inadequate Housing Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.49 | Inadequate Housing Goals SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.5 | Social Determinants of Health General Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.50 | Inadequate Housing Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.51 | Inadequate Housing Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.52 | Inadequate Housing Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.53 | Inadequate Housing Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.54 | Less Than High School Education Goals SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.55 | Less Than High School Education Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.56 | Less Than High School Education Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.57 | Less Than High School Education Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.58 | Unemployment Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.59 | Unemployment Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.6 | Food Insecurity Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.60 | Unemployment Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.61 | Elder Abuse Diagnoses ICD10CM | active | 2023-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.62 | Elder Abuse Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.63 | Elder Abuse Diagnoses | active | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.64 | Elder Abuse Goals SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.65 | Elder Abuse Goals | active | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.66 | Elder Abuse Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.67 | Elder Abuse Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.68 | Elder Abuse Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.69 | Unemployment Goals SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.7 | Food Insecurity Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.70 | Unemployment Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.71 | Social Determinants of Health Goals | active | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.72 | Stress Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.73 | Stress Interventions SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.74 | Stress Diagnoses ICD10CM | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.75 | Stress Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.76 | Veteran Status Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.77 | Veteran Status Diagnoses ICD10CM | active | 2023-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.78 | Veteran Status Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.79 | Social Connection Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.8 | Social Determinants of Health General Interventions CPT | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.80 | Social Connection Diagnoses ICD10CM | active | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.81 | Social Connection Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.82 | Intimate Partner Violence Diagnoses SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.83 | Intimate Partner Violence Diagnoses ICD10CM | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.84 | Intimate Partner Violence Diagnoses | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.85 | Stress Goals SNOMED CT | active | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.86 | Stress Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.87 | Stress Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.88 | Social Connection Goals SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.89 | Social Connection Goals | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.9 | Food Insecurity Interventions HCPCS | active | 2024-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.90 | Veteran Status Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.91 | Veteran Status Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.92 | Stress Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.93 | Social Connection Interventions SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.94 | Social Connection Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.95 | Social Connection Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.96 | Intimate Partner Violence Interventions SNOMED CT | active | 2024-12 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.97 | Intimate Partner Violence Procedures | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.98 | Intimate Partner Violence Service Requests | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.99 | Intimate Partner Violence Goals SNOMED CT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.105 | Mechanical Ventilation Procedures | active | 2022-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.106 | Mechanical Ventilation | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.107 | Mechanical Ventilation | active | 2022-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.109 | aPTT Tests | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119 | Opioid Antagonist | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.12 | High Risk Diagnosis for AKI | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.120 | Opioids | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.124 | Immune Modulators | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.130 | Suicide Attempt | active | 2023-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.134 | Central Nervous System Depressants | active | 2025-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.136 | Leukemia or Lymphoma | active | 2022-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.137 | Liver Disease Moderate to Severe | active | 2022-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.138 | COVID19 | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.139 | COVID 19 | active | 2022-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.14 | Hemolytic Uremic Syndrome (HUS) | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.140 | COVID 19 | active | 2022-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.162 | Obesity | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.163 | Antidepressants | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.164 | Antihypertensives | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.165 | Delirium | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.166 | Dementia | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.167 | Psychosis | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.168 | Delirium or Dementia and Other Psychoses | active | 2022-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.169 | Depression | active | 2022-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.170 | Diuretics | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.171 | Epilepsy | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.172 | Neurologic Movement Disorders | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.173 | Neurologic Disorders, Other | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.174 | Neurologic Movement and Related Disorders | active | 2022-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.175 | Peripheral Neuropathy | active | 2022-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.176 | Stroke | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.177 | Abnormal Weight Loss and Malnutrition | active | 2022-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.178 | Intubation | active | 2023-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.179 | Intubation | active | 2022-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.180 | Tracheostomy Procedures | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.181 | Tracheostomy Procedures | active | 2022-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.182 | Head and Neck Surgeries with High Risk Airway Compromise | active | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.185 | Spinal Surgery | active | 2024-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.187 | Routes of Administration for Opioid Antagonists | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.19 | High Risk Procedures for AKI | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.197 | Hospital Based Dialysis Services | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.198 | Hospital Based Dialysis Services | active | 2023-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.199 | Hospital Based Dialysis Services | active | 2023-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.200 | Nephrectomy | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.201 | Thrombotic Thrombocytopenic Purpura | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.204 | VTE Prophylaxis | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.205 | Moderate Injuries | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.206 | General and Neuraxial Anesthesia | active | 2023-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.207 | General and Neuraxial Anesthesia | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.208 | General and Neuraxial Anesthesia | active | 2023-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.209 | Non Invasive Oxygen Therapy by Nasal Cannula or Mask | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.21 | Creatinine Mass Per Volume | active | 2022-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.210 | Continuous and Bilevel Positive Airway Pressure | active | 2023-05 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.211 | Continuous and Bilevel Positive Airway Pressure | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.213 | Non Invasive Oxygen Therapy | active | 2023-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.214 | Non Invasive Oxygen Therapy Devices | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.216 | Procedural Hospital Locations | active | 2023-05 | us | hl7 | cdc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.217 | ASA physical status class | active | 2023-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.218 | Blood urea nitrogen lab test | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.219 | Hemoglobin lab test | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.22 | Anticoagulants for All Indications | active | 2022-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.220 | Smoking status | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.221 | Albumin lab test | active | 2023-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.222 | Leukocyte count lab test | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.223 | Bilirubin lab test | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.224 | Aspartate transaminase lab test | active | 2023-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.226 | Cardiac Arrest | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.23 | Coagulation Disorders | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.230 | PO Antibacterials | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.231 | Injectable Antifungals | active | 2023-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.238 | Neuromuscular Disorder | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.239 | Neuromuscular Disorder | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.24 | Malignant Bone Disease | active | 2022-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.240 | Degenerative Neurological Disorder | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.241 | Degenerative Neurological Disorder | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.242 | Heart and Lung Transplants | active | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.243 | Heart and Lung Transplants | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.245 | Lung Resections and Excisions | active | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.246 | Lung Resections and Excisions | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.247 | Chest Wall Procedures | active | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.248 | Chest Wall Procedures | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.249 | Maxillary Procedures | active | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.250 | Maxillary Procedures | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.251 | Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.252 | Anesthesia Requiring Monitored Care | active | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.253 | Anesthesia Requiring Monitored Care | active | 2024-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.255 | Anesthesia Requiring Monitored Care | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.256 | Osteoporosis | active | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.260 | Rivaroxaban Anticoagulant | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.262 | Fondaparinux Anticoagulant | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.263 | Dalteparin Anticoagulant | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.264 | Heparin | active | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.268 | Enoxaparin Anticoagulant | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.271 | Undetectable Lab Result Value | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.272 | Undetectable Lab Result Value | active | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.274 | Dietary Recommendations | active | 2025-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.275 | Bariatric Procedures | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.276 | Telemedicine Services | active | 2025-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.277 | Prostate Cancer Treatment | active | 2025-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.28 | Traumatic Avulsion of Kidney | active | 2022-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.29 | Rapidly Progressive Nephritic Syndrome | active | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.301 | LDL Cholesterol | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.33 | Obstetrics and VTE Obstetrics | active | 2022-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.34 | Glucose Lab Test Mass Per Volume | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.349 | Tuberculosis for Urology Care | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.350 | Tuberculosis for Urology Care | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351 | Tuberculosis for Urology Care | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.352 | Androgen Deprivation Therapy for Urology Care | active | 2025-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353 | Bacillus Calmette Guerin for Urology Care | active | 2025-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354 | Bladder Cancer for Urology Care | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355 | Chemotherapy Agents for Advanced Cancer | active | 2025-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.356 | Cystectomy for Urology Care | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.357 | Cystectomy for Urology Care | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358 | Cystectomy for Urology Care | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.359 | DEXA Bone Density for Urology Care | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.360 | Hospital Services for Urology Care | active | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.361 | Immunocompromised Conditions | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.362 | Immunocompromised Conditions | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363 | Immunocompromised Conditions | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364 | Immunosuppressive Drugs for Urology Care | active | 2025-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365 | Mixed Histology Urothelial Cell Carcinoma for Urology Care | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.366 | Morbid Obesity | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.367 | Morbid Obesity | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368 | Morbid Obesity | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.369 | Unavailability of Bacillus Calmette Guerin for Urology Care | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.370 | Urinary Retention | active | 2025-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.371 | Urinary Retention | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372 | Urinary Retention | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.374 | Face to Face Interaction | active | 2025-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.375 | Face to Face Interaction | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.376 | HIV Viral Load Tests | active | 2025-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.377 | HIV Viral Load Tests | active | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.389 | Syphilis Tests | active | 2025-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.4 | Nephrectomy | active | 2023-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.79 | Acute Brain or Spinal Injury or Hemorrhage | active | 2024-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.8 | Large Body Surface Area (BSA) Burns | active | 2022-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.80 | Pulmonary Arterial Thrombectomy | active | 2024-06 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.81 | Extracorporeal Membrane Oxygenation | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.85 | Elective Inpatient Encounter | active | 2023-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.86 | Intubation | active | 2022-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.88 | Acute Respiratory Failure | active | 2023-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.89 | Tracheostomy Diagnoses | active | 2022-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.90 | Tracheostomy Procedures | active | 2023-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.91 | Neuromuscular Disorder | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.92 | Degenerative Neurological Disorder | active | 2024-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.93 | Head and Neck Surgeries with High Risk Airway Compromise | active | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.94 | Oxygen Partial Pressure in Arterial Blood | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.95 | Carbon Dioxide Partial Pressure in Arterial Blood | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.96 | Arterial Blood pH | active | 2024-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.2 | Psychological Neuropsychological or Neurobehavioral Testing | active | 2023-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.3 | Psychological or Neuropsychological Testing | active | 2023-11 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.10 | Tricuspid Valve Regurgitation | active | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.12 | Hypertension | active | 2022-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.2 | Valvular Heart Disease | active | 2022-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.22 | Acute Kidney Injury | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.23 | Anemia | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.24 | Cardiac Arrhythmias | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.25 | Attention Deficit and Hyperactivity Disorder | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.26 | Cerebrovascular Disease | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.27 | Seizure Disorder | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.28 | Proteinuria | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.29 | Thyroid Hormone Disorder | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.30 | Thromboembolic Disease | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.31 | Parkinson's Disease and Parkinsonism | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.32 | Upper GI Diseases | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.33 | Failure to Thrive | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.34 | Osteoporosis | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.35 | Mood Disorders | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.36 | Dyslipidemia | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.37 | Heart Failure | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.38 | Coronary Artery Disease | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.39 | Chronic Kidney Disease | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.40 | Chronic Obstructive Pulmonary Disease | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.41 | Diabetes Mellitus | active | 2023-10 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.1 | EventTiming-TimingEvent | active | 2024-05 | us | hl7 | tho |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.2 | EventTiming-EventTiming | active | 2024-05 | us | hl7 | fhir |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.1 | Gonorrhea Screening | active | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.2 | Abnormal Weight Loss | active | 2024-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.2 | Prescribable brand and generic non insulin drugs for hyperglycemia in Type 2 Diabetes | active | 2023-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.3 | Prescribable brand and generic insulins and analogues | active | 2023-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.4 | eGFR Using 2021 Race Free Formulas | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.5 | Fructosamine in Serum or Plasma | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.6 | Glucose tests in venous blood, capillary blood, serum/plasma for Diabetes | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.7 | Creatinine in serum/plasma | active | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.9 | IgE Agonists, prescribable | active | 2023-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.10 | Estrogen Receptor Testing for Orserdu | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.100 | MMR Proficient | active | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.101 | Systemic Cancer Directed Therapy | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.102 | Face To Face Interaction | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.104 | Erdafitinib | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.107 | Chemotherapy Encounter | active | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.108 | Urothelial Cancers ICD9 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.109 | Urothelial Cancer ICD10 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.11 | Estrogen Receptor Test for Orserdu | active | 2023-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.110 | Urothelial Cancers | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.111 | Prior Therapies for Erdafitinib | active | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.112 | Urothelial Cancer Histologies | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.113 | Malignant Tumor Behavior | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.114 | Localized Bladder Cancer Stage SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.116 | Localized Bladder Cancer Staging | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.117 | Advanced Bladder Cancer Stage | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.118 | Localized Bladder Cancer T Stage | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.119 | Localized Bladder Cancer T Stage | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.12 | Negative | active | 2023-08 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.120 | Localized Bladder Cancer N Stage | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.121 | Localized Bladder Cancer M Stage | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.122 | Advanced Bladder Cancer M Stage | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.124 | Locoregional Urothelial Cancer ICD9 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.125 | Locoregional Urothelial Cancer ICD10 | active | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.126 | Locoregional Urothelial Cancer SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.127 | Locoregional Urothelial Cancer | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.128 | FGFR3 Gene | active | 2024-02 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.129 | FGFR3 Gene Interpretation Positive SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.13 | HER2 Negative | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.130 | FGFR3 Gene Interpretation Positive LOINC | active | 2024-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.131 | FGFR3 Gene Interpretation Positive NCI | active | 2024-02 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.133 | FGFR3 Gene Interpretation Positive | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.134 | FGFR3 Gene Interpretation Negative SNOMED | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.135 | FGFR3 Gene Interpretation Negative NCI | active | 2024-02 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.137 | FGFR3 Gene Interpretation Negative | active | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.138 | FGFR3 Molecular Variants | active | 2024-02 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.139 | Tumor Behavior | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.14 | Endocrine Therapy | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.140 | Physcological Support for Cancer | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.141 | Referral For Pain From Cancer | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.142 | Cancer Pain Education | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.143 | Telehealth Encounters | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.144 | Pain Assessment Score | active | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.146 | Telehealth Encounters SNOMEDCT | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.147 | Telehealth Encounters CPT | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.148 | Telehealth Encounters HCPCS | active | 2024-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.149 | Telehealth Encounters All | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.15 | All Metastatic Sites | active | 2023-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.150 | Chemo Admin SNOMEDCT | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.151 | Chemo Admin CPT | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.152 | Chemo Admin HCPCS | active | 2024-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.153 | Chemotherapy Administration All | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.154 | Radiation Treatment CPT | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.155 | Radiation Treatment HCPCS | active | 2024-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.156 | Radiation Treatment SNOMEDCT | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.157 | Radiation Treatment All | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.158 | Bipolar Diagnosis Codes | active | 2024-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.159 | Telephone Visits SNOMED | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.16 | All Metastatic Sites | active | 2023-10 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.160 | Telephone Visit CPT | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.161 | Telephone Visits All | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.162 | Adolescent depression screening assessment | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.163 | Adult depression screening assessment LOINC | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.165 | Referral for Depression Adult | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.166 | Referrals for Adolescent Depression | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.167 | Follow Ups for Adolescent Depression | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.168 | FollowUps for Adult Depression | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.169 | Depression Screen Declined for Medical Reason | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.17 | Metastatic Breast Cancer | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.170 | Physical Therapy Evaluations SNOMEDCT | active | 2024-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.171 | Physical Therapy Evaluation CPT | active | 2024-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.172 | Physical Therapies Evaluations | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.173 | Non Opioid Analgesics | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.174 | Adjuvant Analgesics | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.176 | Lung Cancer ICD9 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.177 | Lung Cancer ICD10 | active | 2024-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.178 | Lung Cancer | active | 2024-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.179 | Prior Therapies for Osimertinib | active | 2024-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.18 | Stage IA | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.181 | Plan of Care for Pain | active | 2024-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.182 | All Antineoplastic Agents | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.183 | Locally Advanced NSCLC Stage Group | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.185 | Localized NSCLC Stage Group SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.186 | Radiation Treatment Management | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.187 | Plan of Care | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.188 | Documentation of Plan of Care | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.189 | Pain Present | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.19 | Stage IB | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.190 | Localized NSCLC Stage Group NCIM | active | 2024-04 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.192 | Localized NSCLC Stage Group | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.193 | Advanced NSCLC Stage Group | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.194 | NSCLC M Stage (metastatic) | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.195 | NSCLC T Stage | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.196 | NSCLC N Stage | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.197 | SCLC and rarer lung cancer histology | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.198 | EGFR Gene | active | 2024-04 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.199 | EGFR Gene Interpretation Positive SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.20 | Stage IIA | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.200 | EGFR Gene Interpretation Positive LOINC | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.201 | EGFR Gene Interpretation Positive | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.202 | EGFR Osimertinib Molecular Variants | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.203 | EGFR Generic Molecular Variant NCIM | active | 2024-04 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.204 | EGFR Generic Molecular Variant SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.205 | EGFR Generic Molecular Variant LOINC | active | 2024-04 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.206 | EGFR Molecular Variants Osimertinib PM | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.207 | Osimertinib | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.208 | Pemetrexed | active | 2024-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.209 | Radiation Treatment Management SNOMEDCT | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.21 | Stage IIB | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.210 | Radiation Treatment Management Codes | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.211 | Radiation Treatment Delivery CPT | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.212 | 77427 Management Code | active | 2024-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.213 | Radiation Treatment Delivery HCPCS | active | 2024-04 | us | hl7 | cms |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.214 | Radiation Treatment Delivery NCIM | active | 2024-04 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.215 | Radiation Treatment Delivery SNOMED | active | 2024-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.216 | Radiation Treatment Delivery | active | 2024-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.217 | MET Gene Test | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.219 | Tepotinib | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.22 | Stage IIIA | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.220 | MET Positive gene interpretation | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.227 | MET Exon 14 skipping molecular variant | active | 2024-05 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.23 | Stage IIIB | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.230 | All Cancer Directed therapies | active | 2024-05 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.231 | EGFR Amivantamab Molecular Variants | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.232 | EGFR Molecular Variants Amivantamab PM | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.233 | test43 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.234 | ROS1 Molecular Variants Repotrectinib PM | active | 2024-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.235 | ROS1 Repotrectinib Molecular Variants | active | 2024-05 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.236 | ROS1 Negative (geneinterpretation) SNOMEDCT | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.237 | ROS1 Negative (geneinterpretation) NCI | active | 2024-05 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.238 | ROS1 Negative (geneinterpretation) SNOMEDCT,NCI | active | 2024-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.239 | ROS1 Positive (geneinterpretation) | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.24 | Stage IIIC | active | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.240 | ROS1 results (HGNC) | active | 2024-05 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.241 | ROS1 Gene Rearrangement | active | 2024-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.242 | RET Test (HGNC) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.243 | RET Positive (Genei interpretation ) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.244 | RET Gene Rearrangement | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.245 | RET Negative (geneinterpretaion) SNOMED | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.246 | RET Negative (geneinterpretaion) NCI | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.247 | RET Negative (geneinterpretaion) SNOMEDCT,NCI | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.248 | RET Fusion Molecular Variants | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.249 | pralsetinib | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.25 | ESR1 Gene Test | active | 2023-08 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.250 | Repotrectinib Value set | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.251 | Amivantamab | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.252 | Alectinib Drug | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.253 | Gemcitabine Drug Value set | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.254 | vinorelbine Drug | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.255 | NSCLC_Tumor_resection SNOMEDCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.256 | NSCLC_Tumor_resection CPT | active | 2024-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.257 | NSCLC_Tumor_resection SNOMEDCT CPT | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.258 | ALK results (HGNC) | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.259 | ALK Positive (geneinterpretation) SNOMED | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.26 | ESR1 Genetic Mutation | active | 2023-08 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.260 | ALK Positive (geneinterpretation) NCI | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.261 | ALK Positive (geneinterpretation) SNOMEDCT NCI | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.262 | ALK Negative (geneinterpretation) SNOMEDCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.263 | ALK Negative (geneinterpretation) NCI | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.264 | ALK Negative (geneinterpretation) SNOMEDCT NCI | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.265 | Locoregional Sites | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.266 | NSCLC N2 Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.267 | NSCLC N1 Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.268 | NSCLC N0 Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.269 | NSCLC T3_T4 Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.27 | Genetic Test Finding | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.270 | NSCLC T2 Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.271 | NSCLC T1 Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.272 | Locally_Advanced_Metastatic_NSCLC Stage Group | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.273 | Localized_Inclusion_NSCLC Stage Group | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.274 | Localized_Exclusion_NSCLC Stage Group | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.275 | tarlatamab dlle | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.276 | Extensive SCLC Stage Group SNOMEDCT | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.277 | Extensive SCLC Stage Group NCIM | active | 2024-06 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.278 | Extensive SCLC Stage Group | active | 2024-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.279 | Localized SCLC Stage Group | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.28 | Her2 Negative | active | 2023-09 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.280 | SCLC M Stage (metastatic) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.281 | SCLC T Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.282 | SCLC N Stage | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.283 | SCLC histology (to include those patients) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.284 | Binimetinib | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.285 | Encorafenib | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.286 | Encorafenib PM Molecular variant | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.288 | BRAF Positive (geneinterpretation) | active | 2024-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.289 | BRAF test (HGNC) | active | 2024-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.29 | HER2 Positive | active | 2023-09 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.292 | Prior therapy for Amivantamab | active | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.293 | ENHERTU Drug | active | 2024-08 | us | hl7 | rx |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.294 | Metastatic_Solid_Cancer_Stage Group SNOMED CT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.295 | Locally_Advanced_Solid_Cancer_Stage Group SNOMED CT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.296 | Localized_Solid_Cancer_Stage Group SNOMED CT | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.297 | Solid cancer M Stage (metastatic) | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.298 | Solid Cancer T Stage | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.299 | Solid Cancer N Stage | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.30 | HER2 Positive | active | 2023-12 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.302 | HER2_IHC_Positive | active | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.303 | HER2 Negative (geneinterpretation/Labtestvalue) SNOMED | active | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.304 | HER2 Negative (geneinterpretation/Labtestvalue) LOINC | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.305 | HER2 Negative (geneinterpretation/Labtestvalue) NCI | active | 2024-07 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.307 | HER2 Negative (geneinterpretation/Labtestvalue) | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.308 | Solid Cancer Diagnosis ICD 9 | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.309 | Solid Cancer Diagnosis SNOMED CT | active | 2024-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.31 | HER2 Positive | active | 2023-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.310 | Solid Cancer Diagnosis | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.311 | Localized_Solid_Cancer_Stage Group NCIM | active | 2024-07 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.313 | Localized_Solid_Cancer_Stage Group | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.314 | Locally_Advanced_Solid_Cancer_Stage Group NCIM | active | 2024-07 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.315 | Locally_Advanced_Solid_Cancer_Stage Group | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.316 | Metastatic_Solid_Cancer_Stage Group NCIM | active | 2024-07 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.317 | Metastatic_Solid_Cancer_Stage Group | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.318 | Solid Cancer T Stage LOINC | active | 2024-07 | us | hl7 | loinc |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.319 | Solid Cancer T Stage NCI | active | 2024-07 | us | hl7 | ncit |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.32 | HER2 Positive | active | 2023-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.320 | Solid Cancer T Stage codes | active | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.321 | Prior_Systemic_therapy_Enhertu | active | 2024-08 | us | hl7 | rx |
XIG built as of 30 May 2025. Found 73338 resources in 1215 packages.
FHIR